Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMPRSS15,Enteropeptidase,28091,-0.181861296458984,0.00600203093449233,-0.193625277090589,-0.170097315827379,1.80677088498108e-198
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MFGE8,Lactadherin,28187,-0.0877599165921347,0.00291221295887432,-0.0934678539915284,-0.0820519791927411,2.20665048290647e-196
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGFBP1,Fibroblast growth factor-binding protein 1,28307,0.0651370124048832,0.00218991895929258,0.0608447712446697,0.0694292535650966,1.84259872868676e-191
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G7,Platelet-activating factor acetylhydrolase,28187,0.0602189988238604,0.00212663530033669,0.0560507936352005,0.0643872040125203,5.92221584324713e-174
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GCG,Pro-glucagon,27562,-0.232889480827669,0.00827475862124591,-0.249108007725311,-0.216670953930027,7.56413886688098e-172
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PYY,Peptide YY,23071,-0.174633329923142,0.00648332716753617,-0.187340651171513,-0.161926008674771,2.27920387342762e-157
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP1,Insulin-like growth factor-binding protein 1,28500,0.212308787361496,0.00816632877978569,0.196302782953116,0.228314791769876,2.7282018702437e-147
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIP,Gastric inhibitory polypeptide,23198,-0.0876433592575366,0.00341164683929835,-0.0943301870625613,-0.0809565314525118,1.56108244488759e-143
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOF,Apolipoprotein F,23872,0.0388915338248082,0.0016604477058341,0.0356370563213734,0.042146011328243,5.72016239721963e-120
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRAP1,Proline-rich acidic protein 1,23862,-0.063089123759747,0.00271849403609824,-0.0684173720704995,-0.0577608754489944,7.75748714753172e-118
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C9,Complement component C9,23872,0.0760488345144392,0.00358135731161427,0.0690293741836752,0.0830682948452032,3.78376625391016e-99
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPTL7,Angiopoietin-related protein 7,28452,-0.0515629233580115,0.00248026338257997,-0.0564242395878682,-0.0467016071281548,2.77007996660608e-95
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGSF9,Protein turtle homolog A,23846,-0.115199779791078,0.0055731110144623,-0.126123077379424,-0.104276482202732,4.26252230359732e-94
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCG2,Secretogranin-2,28292,-0.0449475693443703,0.00219615142165395,-0.049252026130812,-0.0406431125579285,2.00393963081428e-92
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACY1,Aminoacylase-1,28224,-0.0831187601609044,0.00416232082563878,-0.0912769089791564,-0.0749606113426524,4.14148587025784e-88
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEP1A,Meprin A subunit alpha,23738,-0.09501247186771,0.00483662681658846,-0.104492260428223,-0.0855326833071966,3.07571859120692e-85
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFASC,Neurofascin,28521,-0.0374073866091314,0.00190854442365509,-0.0411481336794954,-0.0336666395387675,5.61862614298642e-85
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPY,Pancreatic prohormone,28148,-0.133876318587969,0.00683848555358515,-0.147279750272996,-0.120472886902942,8.93359701788368e-85
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRSS8,Prostasin,28091,-0.0533108396428542,0.00276164553411483,-0.0587236648897193,-0.0478980143959891,1.70398576215485e-82
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17RB,Interleukin-17 receptor B,27791,0.0695213510588074,0.00361190411656044,0.0624420189903489,0.0766006831272658,5.04052941400663e-82
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LPA,Apolipoprotein(a),23428,0.229098487923048,0.0120045678708424,0.205569534896197,0.252627440949899,1.39675894269079e-80
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PON3,Serum paraoxonase/lactonase 3,28320,0.0355416295930061,0.00187966093817615,0.0318574941541808,0.0392257650318313,2.99094520711706e-79
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G10,Group 10 secretory phospholipase A2,27965,-0.0747655246870394,0.00396727638466196,-0.0825413864009769,-0.066989662973102,9.84444089289329e-79
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGFBP3,Fibroblast growth factor-binding protein 3,23775,0.0459326575034766,0.00246579793976364,0.0410996935415399,0.0507656214654134,6.74070752670154e-77
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CES1,Liver carboxylesterase 1,28239,-0.0978268155519579,0.00546194371273477,-0.108532225228918,-0.0871214058749978,2.4213604754254e-71
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALPI,Intestinal-type alkaline phosphatase,23188,-0.145320891342057,0.00826488052579817,-0.161520057172621,-0.129121725511492,9.31115765072133e-69
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGSF3,Immunoglobulin superfamily member 3,28091,-0.0426187239814925,0.00242744079558172,-0.0473765079408327,-0.0378609400221523,1.22323677491286e-68
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACE2,Angiotensin-converting enzyme 2,27682,-0.0612137861700191,0.00350343338881284,-0.0680805156120922,-0.0543470567279459,5.3829191646102e-68
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MUC13,Mucin-13,27544,-0.0568668322978335,0.00346925947069388,-0.0636665808603935,-0.0500670837352735,4.2300231073616e-60
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGR2,Anterior gradient protein 2 homolog,27338,-0.110437096498196,0.00679578783903599,-0.123756840662706,-0.097117352333685,4.17517785421907e-59
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSE,Cathepsin E,23337,-0.056096862785519,0.00350974279841632,-0.062975958670415,-0.049217766900623,3.37020350189933e-57
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFPI,Tissue factor pathway inhibitor,28184,0.0339598835739522,0.00213244662190022,0.0297802881950277,0.0381394789528766,7.49186155152991e-57
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM3B,Protein FAM3B,28091,-0.0378365488647184,0.00239307710202072,-0.042526979984679,-0.0331461177447577,4.5750823516828e-56
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBPL1,Insulin-like growth factor-binding protein-like 1,28224,-0.0359252150918744,0.00229419075712559,-0.0404218289758405,-0.0314286012079082,4.90363324180979e-55
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MET,Hepatocyte growth factor receptor,28253,0.0208365238951115,0.00133124070759833,0.0182272921082188,0.0234457556820042,5.48733475874491e-55
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPM,Carboxypeptidase M,28321,-0.0359844634424441,0.00230785376015278,-0.0405078568123435,-0.0314610700725446,1.38857431823906e-54
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTSL2,ADAMTS-like protein 2,23862,-0.0340358797894344,0.00221447694434675,-0.0383762546003541,-0.0296955049785148,4.69564837476297e-53
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTS,6-pyruvoyl tetrahydrobiopterin synthase,27418,-0.0567545846582156,0.00372245824550783,-0.0640506028194109,-0.0494585664970202,2.84634221039027e-52
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,27682,-0.085674208078671,0.00564301205578626,-0.0967345117080121,-0.07461390444933,7.4920495620078e-52
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FTCD,Formimidoyltransferase-cyclodeaminase,23737,-0.0871164332072518,0.00573650093618731,-0.0983599750421789,-0.0758728913723246,7.63902276456912e-52
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSD,Cathepsin D,26272,-0.0413770148467847,0.00274895420602144,-0.0467649650905867,-0.0359890646029826,5.4759011713932e-51
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAMDC4,Apical endosomal glycoprotein,23725,-0.0549786998893645,0.00372417982930047,-0.0622780923547934,-0.0476793074239356,4.21593428304363e-49
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THBS2,Thrombospondin-2,28187,-0.0370088120208972,0.0025330730224358,-0.0419736351448714,-0.032043988896923,3.62700207940392e-48
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HEPH,Hephaestin,23846,-0.0257770162686493,0.00177001498223749,-0.0292462456338348,-0.0223077869034639,7.73510911772578e-48
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGR3,Anterior gradient protein 3,27529,-0.0581011680970538,0.0040190543407078,-0.0659785146048411,-0.0502238215892665,3.4018044574079e-47
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL15,Interleukin-15,28176,-0.0318608094421093,0.00222116756927185,-0.0362142978778821,-0.0275073210063365,1.69041214556896e-46
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UPB1,Beta-ureidopropionase,23846,-0.08834879945236,0.00615859494462521,-0.100419645543825,-0.0762779533608946,1.77295038364274e-46
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPA2,Carboxypeptidase A2,28313,-0.0626811060259271,0.0044001274421639,-0.0713053558125684,-0.0540568562392859,6.91203752524448e-46
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSTA1,Glutathione S-transferase A1,28174,-0.080502145764276,0.00569073786476046,-0.0916559919792065,-0.0693482995493455,2.81924565460525e-45
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHBG,Sex hormone-binding globulin,23872,0.0490366018273735,0.00346961920464458,0.0422361481862701,0.0558370554684768,3.61183960016605e-45
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF21,Fibroblast growth factor 21,28404,-0.112911493099971,0.00801053452916078,-0.128612140777126,-0.0972108454228158,5.75103068637478e-45
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALDH1A1,Retinal dehydrogenase 1,28187,-0.0505781469012308,0.003594097622546,-0.057622578241421,-0.0435337155610406,7.94679160334432e-45
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,28336,0.0360112130172117,0.00256796344191978,0.0309780046710489,0.0410444213633745,1.58339980485378e-44
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRG1,Adhesion G-protein coupled receptor G1,28091,-0.0657773323223992,0.00470119376838963,-0.0749916721084429,-0.0565629925363555,2.4714796195404e-44
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS4,Galectin-4,28195,-0.0512434310136667,0.00368920321086112,-0.0584742693069545,-0.0440125927203789,1.01374217452454e-43
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP2,Insulin-like growth factor-binding protein 2,28494,0.0582866400042052,0.00420141980263281,0.0500518571910449,0.0665214228173655,1.27908825164373e-43
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MME,Neprilysin,28091,-0.0748665253695453,0.00542400000606901,-0.0854975653814406,-0.0642354853576501,3.39202803511908e-43
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOA2,Apolipoprotein A-II,23872,0.0447283626394305,0.00325462787190717,0.0383492920104925,0.0511074332683686,8.1686435670675e-43
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHI3L1,Chitinase-3-like protein 1,27705,-0.0719770891306323,0.00531254231992382,-0.082389672077683,-0.0615645061835816,1.0980140683828e-41
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPTL1,Angiopoietin-related protein 1,27795,-0.026651101991235,0.00197010426545736,-0.0305125063515314,-0.0227896976309386,1.45239104060857e-41
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VWA1,von Willebrand factor A domain-containing protein 1,28404,-0.0378500823356791,0.00284410552867346,-0.0434245291718791,-0.0322756354994791,2.7374051801726e-40
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SKAP1,Src kinase-associated phosphoprotein 1,27910,-0.0640445764128304,0.00489508989972339,-0.0736389526162882,-0.0544502002093725,5.3355847642502e-39
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA14,Carbonic anhydrase 14,28452,0.0314065181658791,0.00240467801364348,0.0266933492591379,0.0361196870726203,7.15547203540334e-39
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF10,Tumor necrosis factor ligand superfamily member 10,28521,0.0228221884477847,0.00174819677308484,0.0193957227725385,0.026248654123031,7.72256104260334e-39
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRP2,Neuropilin-2,28187,0.0251413095781654,0.00193495984017463,0.0213487882914231,0.0289338308649076,1.72549191347955e-38
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF12,Tumor necrosis factor ligand superfamily member 12,28521,0.0250125105089257,0.00192888348622166,0.0212318988759312,0.0287931221419201,2.40601030713279e-38
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MVK,Mevalonate kinase,27702,-0.0690691819903482,0.00537394048381955,-0.0796021053386345,-0.0585362586420619,1.06596295592947e-37
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,23188,-0.0386573042914258,0.00301133307569297,-0.044559517119784,-0.0327550914630675,1.36187771591558e-37
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRL5,Fc receptor-like protein 5,28187,0.0499638327781728,0.00389502824716803,0.0423295774137235,0.0575980881426222,1.46367338684125e-37
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIT1,Signaling threshold-regulating transmembrane adapter 1,27702,-0.047548405391591,0.00370790916417674,-0.0548159073533774,-0.0402809034298046,1.54890549171509e-37
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,23322,-0.040887914624624,0.00319644192217625,-0.0471529407920894,-0.0346228884571585,2.43663493157803e-37
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,23337,0.0352778106973424,0.00276132800501541,0.0298656078075122,0.0406900135871726,2.98958670873056e-37
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH15,Cadherin-15,28373,-0.0499096286482015,0.00393167899650733,-0.0576157194813559,-0.0422035378150472,8.01860551107469e-37
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOM,Apolipoprotein M,28291,0.0237350871063066,0.00187256382335547,0.0200648620125298,0.0274053122000833,1.02177905456763e-36
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT18,"Keratin, type I cytoskeletal 18",28091,-0.0694311021889542,0.00551089413825705,-0.080232454699938,-0.0586297496779704,2.68549901855728e-36
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FURIN,Furin,28307,-0.0284172488884417,0.00225576062785138,-0.0328385397190304,-0.023995958057853,2.72334064528752e-36
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRF,Receptor-type tyrosine-protein phosphatase F,28553,0.0244572883758203,0.00194576528173141,0.0206435884236267,0.0282709883280139,3.87391479093724e-36
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRS,Receptor-type tyrosine-protein phosphatase S,28553,0.0208113422146495,0.00166516463372315,0.0175476195325521,0.0240750648967469,9.48973545719321e-36
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,23071,-0.0473456481514481,0.00378723540326096,-0.0547686295418396,-0.0399226667610566,9.5826965701555e-36
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDC,Aromatic-L-amino-acid decarboxylase,28182,-0.0408451755949226,0.0032686570425146,-0.0472517433982512,-0.034438607791594,9.76469214803779e-36
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CKB,Creatine kinase B-type,23862,0.0497086786021789,0.00398238171146549,0.0419032104477066,0.0575141467566513,1.20764921920952e-35
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH17,Cadherin-17,28224,-0.0569778261393182,0.0045869259040398,-0.0659682009112362,-0.0479874513674002,2.46300479317569e-35
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OXT,Oxytocin-neurophysin 1,28428,-0.116503262472338,0.00938356782270922,-0.134895055404848,-0.098111469539828,2.65368390647987e-35
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENO3,Beta-enolase,23198,-0.0502033092944037,0.00404509262537752,-0.0581316908401437,-0.0422749277486638,2.95146274495135e-35
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SDC4,Syndecan-4,28224,0.0386026471221119,0.00312922954236381,0.0324693572190788,0.0447359370251449,7.1175465287228e-35
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,28176,0.0323851560997923,0.00264631287874464,0.0271983828574528,0.0375719293421318,2.38613735465196e-34
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSZ,Cathepsin Z,28236,-0.0261092201893195,0.00213521797019195,-0.0302942474108957,-0.0219241929677433,2.69414086046477e-34
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGRP,Agouti-related protein,28521,-0.0425722751625896,0.00350459301986815,-0.0494412774815311,-0.035703272843648,7.16712891577479e-34
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADIPOQ,Adiponectin,23893,0.0545870491777795,0.00454152466987616,0.0456856608248222,0.0634884375307368,3.49773513468696e-33
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACHE,Acetylcholinesterase,23337,-0.026831136667246,0.00223789493668596,-0.0312174107431505,-0.0224448625913415,5.04703544249302e-33
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1R2,Interleukin-1 receptor type 2,28145,-0.0160524335897232,0.00134348782738814,-0.0186856697314039,-0.0134191974480424,7.95502920047608e-33
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBKS,Ribokinase,27554,-0.0399238038828532,0.00334418776310788,-0.0464784118985447,-0.0333691958671618,9.00788328918071e-33
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL2,C-C motif chemokine 2,27918,-0.0421524307006258,0.00353766156618357,-0.0490862473703456,-0.035218614030906,1.18182698456205e-32
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,28384,-0.0244991137516285,0.00206490789369239,-0.0285463332232656,-0.0204518942799914,2.15899444773921e-32
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADH1B,All-trans-retinol dehydrogenase,23337,-0.0604624605347672,0.00510513789876462,-0.0704685308163459,-0.0504563902531885,2.87917401686312e-32
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,23337,-0.0395056131991488,0.0033376129305837,-0.0460473345430929,-0.0329638918552048,3.12695620462648e-32
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,27562,-0.0507750886313575,0.0042919018004621,-0.0591872161602632,-0.0423629611024518,3.25198977547569e-32
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCAN,Neurocan core protein,28428,0.0298490711017958,0.00252341290703754,0.0249031818040022,0.0347949603995894,3.295869797833e-32
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,27965,-0.0567016501757648,0.00480991566203404,-0.0661290848733515,-0.0472742154781781,5.32868493551179e-32
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK14,Kallikrein-14,28452,0.0364952257253366,0.00311298957633156,0.0303937661557268,0.0425966852949465,1.14220348294327e-31
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",23198,-0.0451440321818948,0.00385699293841739,-0.0527037383411929,-0.0375843260225967,1.4836309447598e-31
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LSP1,Lymphocyte-specific protein 1,28176,-0.0316875200063658,0.00270902588396234,-0.036997210738932,-0.0263778292737996,1.56173162071856e-31
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GH1,Somatotropin,28182,0.139914381010814,0.0119679557498772,0.116457187741055,0.163371574280574,1.68069380997548e-31
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICAM3,Intercellular adhesion molecule 3,28553,0.020575975003809,0.00176521467144619,0.0171161542477745,0.0240357957598435,2.50801104465233e-31
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRTG,Protogenin,28452,-0.0196078192950653,0.00168234345421703,-0.0229052124653306,-0.0163104261247999,2.54773234527177e-31
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAST,Gastrin,23775,-0.102331615564939,0.0088026074466267,-0.119584726160327,-0.0850785049695506,3.72898813075514e-31
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSTA3,Glutathione S-transferase A3,27562,-0.0601226585180111,0.00518106189053479,-0.0702775398234592,-0.0499677772125629,4.62790866929917e-31
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPY,Pro-neuropeptide Y,28452,-0.0509394215491106,0.00438996125482196,-0.0595437456085617,-0.0423350974896596,4.64140432811428e-31
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGT1,Glutathione hydrolase 1 proenzyme,28135,-0.0391600276943157,0.00340389060821858,-0.0458316532864242,-0.0324884021022073,1.46600101795996e-30
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ISM1,Isthmin-1,28176,-0.0302459438142675,0.00265220094374347,-0.0354442576640047,-0.0250476299645303,4.6439574444521e-30
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADM,Pro-adrenomedullin,28452,-0.019925501953013,0.00179209846592398,-0.023438014946224,-0.016412988959802,1.16801211212442e-28
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KHK,Ketohexokinase,23198,-0.0476972003178433,0.00430698394934162,-0.0561388888585529,-0.0392555117771337,1.96837149137596e-28
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCS1,Neuronal calcium sensor 1,28452,-0.0212349444385736,0.00192640159113227,-0.0250106915571928,-0.0174591973199543,3.37217641057261e-28
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SELE,E-selectin,28553,-0.0373689769500832,0.00339271395062393,-0.0440186962933061,-0.0307192576068603,3.70841859226009e-28
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXADR,Coxsackievirus and adenovirus receptor,28176,-0.0378039870291469,0.0034608026202184,-0.0445871601647749,-0.0310208138935188,1.01195206158635e-27
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPT2,Angiopoietin-2,28452,-0.0279066206833578,0.00256407796459603,-0.032932213493966,-0.0228810278727495,1.56241837488778e-27
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERBB2,Receptor tyrosine-protein kinase erbB-2,28307,-0.0181411076008487,0.00167558657015097,-0.0214252572783446,-0.0148569579233529,2.90904940643146e-27
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIT,Mast/stem cell growth factor receptor Kit,28291,0.0215549333190659,0.00199443804445646,0.0176458347519312,0.0254640318862006,3.58389534468668e-27
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAG3,Lymphocyte activation gene 3 protein,28091,0.0298125798078666,0.00276857325309378,0.0243861762318028,0.0352389833839304,5.4916320646367e-27
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AREG,Amphiregulin,28091,-0.0329583878336446,0.00307243318979368,-0.0389803568856402,-0.0269364187816489,8.55647770502447e-27
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FEN1,Flap endonuclease 1,27562,-0.0455190188128364,0.00426045323291753,-0.0538695071493548,-0.0371685304763181,1.36247222187859e-26
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,B4GAT1,"Beta-1,4-glucuronyltransferase 1",28187,0.0174919978980595,0.00163983039255191,0.0142779303286578,0.0207060654674613,1.63277624843815e-26
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KITLG,Kit ligand,28224,0.0269654844652402,0.00252995176001184,0.022006779015617,0.0319241899148634,1.78734261712628e-26
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSF,Cathepsin F,28307,-0.0286460078741006,0.00270646539665501,-0.0339506800515444,-0.0233413356966568,3.94446631551433e-26
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCLY,Selenocysteine lyase,28363,-0.0346932491813387,0.00327993513696652,-0.0411219220497931,-0.0282645763128844,4.24233167673738e-26
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRD1,Adhesion G-protein coupled receptor D1,23337,-0.0274537968407801,0.00262153931637667,-0.0325920139008784,-0.0223155797806818,1.31850401350638e-25
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EZR,Ezrin,28428,-0.0169613105449003,0.00162358131724013,-0.020143529926691,-0.0137790911631097,1.68484547108505e-25
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSPAN8,Tetraspanin-8,23738,-0.0703587768551355,0.00674024672425154,-0.0835696604346686,-0.0571478932756025,1.87596772073824e-25
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SELPLG,P-selectin glycoprotein ligand 1,28176,-0.0194573301894651,0.00186542601845405,-0.0231135651856351,-0.0158010951932952,2.0020034824922e-25
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMPD3,AMP deaminase 3,23775,-0.0496628154706387,0.00476325172039481,-0.0589987888426126,-0.0403268420986649,2.13502697835518e-25
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPO,Erythropoietin,28176,-0.0531560272518725,0.0051063993104651,-0.0631645699003841,-0.0431474846033609,2.48966601884459e-25
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSO,Cathepsin O,28521,-0.0212696219162461,0.00204512858931117,-0.025278073951296,-0.0172611698811962,2.74767430981517e-25
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM3D,Protein FAM3D,23738,-0.0588599545828033,0.00569960154271096,-0.0700311736065168,-0.0476887355590898,6.00662199937657e-25
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBP5,Retinol-binding protein 5,28091,-0.0390323947613163,0.00380728517226078,-0.0464946736989474,-0.0315701158236851,1.28070936030684e-24
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AFM,Afamin,23893,-0.0134644849449475,0.00131490355987964,-0.0160416959223116,-0.0108872739675834,1.4766644155051e-24
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,28091,0.0136264211851698,0.00133720657451238,0.0110054962991256,0.0162473460712141,2.41765074339387e-24
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IDUA,Alpha-L-iduronidase,28452,-0.0315739938678119,0.00310962912661895,-0.037668866955985,-0.0254791207796387,3.51119246832092e-24
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFHR4,Complement factor H-related protein 4,23820,0.0501079930005658,0.00493790310110483,0.0404297029224003,0.0597862830787312,3.80210163526938e-24
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPCAM,Epithelial cell adhesion molecule,28199,-0.0662221135605387,0.00654756462290071,-0.0790553402214241,-0.0533888868996533,5.26250927616041e-24
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,23198,-0.0250779073315029,0.00248432618449185,-0.0299471866531069,-0.0202086280098988,6.55047805957914e-24
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RSPO1,R-spondin-1,27965,0.0238153339600301,0.00236544190079143,0.0191790678344789,0.0284516000855813,8.39927887992025e-24
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCXR,L-xylulose reductase,28307,-0.0364808115546481,0.00363011209160161,-0.0435958312541872,-0.0293657918551089,1.01200435865378e-23
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTGR1,Prostaglandin reductase 1,23846,-0.0553659396841234,0.0055096563402585,-0.0661648661110301,-0.0445670132572168,1.0358200015622e-23
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FMNL1,Formin-like protein 1,27544,-0.0414767444113981,0.00414061099742471,-0.0495923419663506,-0.0333611468564457,1.40766548257148e-23
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GUSB,Beta-glucuronidase,28344,-0.0404387499150264,0.00404122742737948,-0.0483595556726902,-0.0325179441573626,1.56075015091424e-23
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,23893,0.0173472215542455,0.00174210786120681,0.0139326901462801,0.0207617529622108,2.59412282248188e-23
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLB1,Beta-galactosidase,27965,-0.0280063109253254,0.00282989849034291,-0.0335529119663975,-0.0224597098842533,4.70077620782655e-23
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CGREF1,Cell growth regulator with EF hand domain protein 1,28224,-0.0284734091336747,0.00287727953209174,-0.0341128770165745,-0.0228339412507749,4.72657284656069e-23
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL12,Stromal cell-derived factor 1,27702,0.0267484100444715,0.0027096105418353,0.0214375733824744,0.0320592467064687,6.02693478943224e-23
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPR37,Prosaposin receptor GPR37,27682,-0.0440107267439592,0.00447101527874981,-0.0527739166903089,-0.0352475367976096,7.96675903236522e-23
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC11A,C-type lectin domain family 11 member A,28132,0.0317955797087976,0.00324865550362352,0.0254282149216955,0.0381629444958997,1.38714094066154e-22
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM20A,Pseudokinase FAM20A,23846,-0.0186887830802927,0.00190921200240419,-0.0224308386050049,-0.0149467275555805,1.38817740937042e-22
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C4BPB,C4b-binding protein beta chain,28307,0.0264282373359409,0.00270217669643689,0.0211319710109246,0.0317245036609572,1.48471518381465e-22
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MXRA8,Matrix remodeling-associated protein 8,23337,0.0201271167387957,0.00206179181590347,0.0160860047796249,0.0241682286979665,1.81047857456165e-22
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MZB1,Marginal zone B- and B1-cell-specific protein,28281,0.0338810317371924,0.00347455534027734,0.0270709032702488,0.040691160204136,1.97800637292929e-22
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THOP1,Thimet oligopeptidase,28097,-0.0203174139412728,0.0020868318335618,-0.0244076043350539,-0.0162272235474917,2.29678690328507e-22
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MNDA,Myeloid cell nuclear differentiation antigen,28174,-0.0641675894520838,0.0065939843358616,-0.0770917987503726,-0.0512433801537951,2.40635841423702e-22
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,27965,-0.0215321009598887,0.00222283980320078,-0.0258888669741622,-0.0171753349456151,3.71947063704108e-22
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NME3,Nucleoside diphosphate kinase 3,28237,0.0156558568449013,0.00161658543757585,0.0124873493872527,0.01882436430255,3.79839148246083e-22
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GDF15,Growth/differentiation factor 15,28553,-0.0290674388811473,0.00300980093888308,-0.0349666487213581,-0.0231682290409364,4.93314843033681e-22
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPTL4,Angiopoietin-related protein 4,28276,0.0293263075108602,0.00304193862079722,0.0233641078140977,0.0352885072076228,5.81991860565655e-22
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKR7L,Aflatoxin B1 aldehyde reductase member 4,23188,-0.0454653640083852,0.00471541695377402,-0.0547075812377823,-0.0362231467789881,5.85201199037605e-22
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LPL,Lipoprotein lipase,28224,0.0304633890176377,0.00316894266940746,0.024252261385599,0.0366745166496763,7.60365398792228e-22
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PVR,Poliovirus receptor,28428,-0.0240879383374764,0.00250782572261869,-0.029003276753809,-0.0191725999211437,8.21129013708319e-22
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPEP2,Dipeptidase 2,28091,0.0189279687446226,0.00198584543463981,0.0150357116927286,0.0228202257965167,1.67185467390608e-21
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,28336,0.0281486478943641,0.00295570744241908,0.0223554613072227,0.0339418344815055,1.80330381662395e-21
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HAO1,Hydroxyacid oxidase 1,28452,-0.0823193641378984,0.00865469133150395,-0.0992825591476462,-0.0653561691281507,2.02181754376771e-21
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GP5,Platelet glycoprotein V,23337,0.0230918034777701,0.0024314418293155,0.0183261774923117,0.0278574294632284,2.3573483563561e-21
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFHR5,Complement factor H-related protein 5,23561,0.0265942270308,0.00282226568543112,0.0210625862873551,0.032125867774245,4.77420097124691e-21
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A14,Protein S100-A14,23795,-0.0333987881014447,0.0035694370524108,-0.0403948847241699,-0.0264026914787196,8.91644305922076e-21
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC39A5,Zinc transporter ZIP5,28176,-0.0335387346096347,0.00359677004983213,-0.0405884039073057,-0.0264890653119637,1.19211171618574e-20
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,27682,-0.022269452299408,0.00238882471110692,-0.0269515487331776,-0.0175873558656385,1.22004721281266e-20
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHL1,Neural cell adhesion molecule L1-like protein,28288,0.0195183745924421,0.00209674394995557,0.0154087564505292,0.023627992734355,1.38224892820371e-20
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CILP,Cartilage intermediate layer protein 1,23862,-0.0340875546945753,0.00366307152948623,-0.0412671748923683,-0.0269079344967823,1.44190864763333e-20
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGXT,Serine--pyruvate aminotransferase,28224,-0.0485316400210565,0.0052202531303339,-0.058763336156511,-0.0382999438856021,1.54859382657639e-20
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REN,Renin,28224,-0.047742076862163,0.00516059522394996,-0.0578568435011049,-0.0376273102232211,2.3703783348646e-20
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BMPER,BMP-binding endothelial regulator protein,23337,-0.0142634251144235,0.00154418701316507,-0.0172900316602271,-0.01123681856862,2.74906676321617e-20
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF19,Fibroblast growth factor 19,28320,-0.0477999983140405,0.00520987842478801,-0.058011360026625,-0.037588636601456,4.81935608707665e-20
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SELL,L-selectin,23893,0.0142983369208431,0.00156192437769246,0.0112369651405659,0.0173597087011203,5.89736432025769e-20
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNGR2,Interferon gamma receptor 2,27965,-0.0322206651108184,0.00352243097836081,-0.0391246298284056,-0.0253167003932312,6.22422477369598e-20
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOA4,Apolipoprotein A-IV,23893,-0.0218805936095832,0.0023986860486466,-0.0265820182649305,-0.0171791689542359,7.94864467766592e-20
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,27850,-0.0292441176897276,0.0032073535264485,-0.0355305306015667,-0.0229577047778885,8.16595240709843e-20
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMBS,Porphobilinogen deaminase,28452,-0.0265059305527397,0.00290809482818529,-0.0322057964159828,-0.0208060646894965,8.40628126898416e-20
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL3A1,Collagen alpha-1(III) chain,23862,-0.0142819522955815,0.00156894835934976,-0.017357091079907,-0.011206813511256,9.46782374337664e-20
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPA33,Cell surface A33 antigen,28091,-0.0827988888858213,0.00912338706227005,-0.100680727527871,-0.064917050243772,1.20413225015137e-19
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SORD,Sorbitol dehydrogenase,28326,-0.0417700655423086,0.00460853247580012,-0.0508027891948768,-0.0327373418897404,1.3409662413929e-19
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIPC2,PDZ domain-containing protein GIPC2,23775,-0.0182223479264336,0.00201079798132098,-0.0221635119698228,-0.0142811838830445,1.37401213274958e-19
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HAVCR1,Hepatitis A virus cellular receptor 1,28411,-0.0385222153555866,0.00425892293792513,-0.0468697043139199,-0.0301747263972533,1.58870885051335e-19
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SBSN,Suprabasin,23832,0.021036479660724,0.00232634422383614,0.0164768449820052,0.0255961143394428,1.64184819055301e-19
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GP1BA,Platelet glycoprotein Ib alpha chain,28126,0.0200872738778045,0.00222289326980978,0.0157304030689773,0.0244441446866316,1.71809592989499e-19
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TREH,Trehalase,23862,-0.0455565432995097,0.00505163483453885,-0.0554577475752058,-0.0356553390238135,2.05288646104067e-19
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,28091,-0.0240259919290468,0.00267148574968854,-0.0292621039984364,-0.0187898798596573,2.54192216631952e-19
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA4D,Semaphorin-4D,28428,0.0181327021513261,0.00202534958070955,0.0141630169731354,0.0221023873295168,3.66957453275928e-19
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA5A,"Carbonic anhydrase 5A, mitochondrial",27682,-0.0555618597950504,0.00621580987618472,-0.0677448471523725,-0.0433788724377284,4.17346494514563e-19
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGBL1,Integrin beta-like protein 1,23862,-0.0224562039161262,0.00252136167867804,-0.0273980728063352,-0.0175143350259173,5.64062383540457e-19
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PODXL2,Podocalyxin-like protein 2,28307,0.016821259033466,0.0018926246042628,0.0131117148091109,0.0205308032578211,6.59516474575011e-19
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VMO1,Vitelline membrane outer layer protein 1 homolog,28091,-0.0407642206110933,0.00459878758177389,-0.0497778442713702,-0.0317505969508165,8.15705981260529e-19
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FRZB,Secreted frizzled-related protein 3,27872,0.0153281361149633,0.00172981414758199,0.0119377003857026,0.018718571844224,8.38096874401864e-19
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GHR,Growth hormone receptor,23337,-0.0170946068479389,0.00193007451113956,-0.0208775528897725,-0.0133116608061054,8.79607097436399e-19
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBAC1,Ubiquitin-associated domain-containing protein 1,28091,-0.0205732767194636,0.00232343835161506,-0.0251272158886291,-0.0160193375502981,8.87689927762407e-19
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTH,Parathyroid hormone,23163,-0.048010974201173,0.00546517422512629,-0.0587227156824205,-0.0372992327199255,1.67162982910541e-18
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RTN4R,Reticulon-4 receptor,28452,-0.0200755708163035,0.00228560413460037,-0.0245553549201203,-0.0155957867124868,1.67208069393315e-18
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PALM2,Paralemmin-2,23775,-0.0224003385493336,0.00255295993550685,-0.027404140022927,-0.0173965370757402,1.83368336269743e-18
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DSG2,Desmoglein-2,28187,0.015947068456354,0.0018202343698328,0.0123794090914818,0.0195147278212263,2.04173548188936e-18
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SRP14,Signal recognition particle 14 kDa protein,28091,-0.0352733854643482,0.00402796840924586,-0.04316820354647,-0.0273785673822263,2.11344771184755e-18
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INHBC,Inhibin beta C chain,28187,-0.0242812494065543,0.00277296303845846,-0.0297162569619329,-0.0188462418511757,2.12596566615217e-18
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL15,C-C motif chemokine 15,28553,-0.025900413058048,0.00297513716995431,-0.0317316819111584,-0.0200691442049375,3.32550843106727e-18
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LECT2,Leukocyte cell-derived chemotaxin-2,23846,-0.0387074085559896,0.00444798936609781,-0.0474254677135413,-0.0299893493984379,3.46117007297843e-18
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHSP,Alpha-hemoglobin-stabilizing protein,28144,-0.0495241250951141,0.00569754640322573,-0.0606913160454366,-0.0383569341447917,3.74503371015205e-18
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK4,Serine protease inhibitor Kazal-type 4,28176,-0.0383815674981895,0.00444207390960705,-0.0470880323610193,-0.0296751026353597,5.8898692343592e-18
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTSS1,Protein MTSS 1,23738,-0.064640455039302,0.00748883146463641,-0.0793185647099893,-0.0499623453686146,6.42469507692203e-18
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGFR2,Fibroblast growth factor receptor 2,28307,-0.0129046711678943,0.0014952766325302,-0.0158354133676535,-0.00997392896813508,6.43495643270999e-18
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD84,SLAM family member 5,28176,0.0181930832793641,0.0021116053054312,0.0140543368807189,0.0223318296780092,7.30519191937748e-18
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRCP,Lysosomal Pro-X carboxypeptidase,28396,-0.018239649309996,0.0021188399695221,-0.0223925756502594,-0.0140867229697327,7.79086284039144e-18
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRG1,Leucine-rich alpha-2-glycoprotein,23893,0.0151301136055369,0.00175754198486867,0.0116853313151943,0.0185748958958795,7.83933177514825e-18
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGT5,Glutathione hydrolase 5 proenzyme,27965,-0.0135786655683449,0.00157976194618168,-0.016674998982861,-0.0104823321538288,8.72433049196733e-18
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOD,Apolipoprotein D,22764,0.0250035711660719,0.00291896519266192,0.0192823993884545,0.0307247429436893,1.13935994117249e-17
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSRC1,Proline/serine-rich coiled-coil protein 1,27562,-0.0342806496735903,0.00400911739973021,-0.0421385197770615,-0.0264227795701191,1.28614696945302e-17
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,23725,-0.0218909019520761,0.00256042597890737,-0.0269093368707346,-0.0168724670334177,1.30733323903533e-17
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCAN,Brevican core protein,27965,0.0196735201074445,0.0023041403671967,0.0151574049877389,0.02418963522715,1.42973492520462e-17
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPOCK1,Testican-1,27965,0.0147920835176892,0.0017399626621414,0.0113817566998921,0.0182024103354864,1.96547122650155e-17
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCTN3,Tectonic-3,23846,-0.0170924257198366,0.00201269158171803,-0.021037301220004,-0.0131475502196693,2.14204489789021e-17
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINF1,Pigment epithelium-derived factor,23521,-0.0149880067338123,0.00176539954515218,-0.0184481898423106,-0.0115278236253141,2.18934321546369e-17
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH2,Cadherin-2,28224,-0.0201273054760617,0.00239013752561993,-0.0248119750262767,-0.0154426359258466,3.90813191141484e-17
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPD1,Glycerol-3-phosphate dehydrogenase,23725,-0.029744093733988,0.00353287888093919,-0.0366685363406288,-0.0228196511273472,4.0016028918313e-17
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRELD1,Protein disulfide isomerase CRELD1,23337,-0.0212376039288271,0.00252724279494619,-0.0261909998069216,-0.0162842080507325,4.5792349805704e-17
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,27682,-0.0311642353021481,0.00371163354666094,-0.0384390370536036,-0.0238894335506927,4.82231704125359e-17
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OCLN,Occludin,23795,-0.0249053468662399,0.00296649630378328,-0.0307196796216551,-0.0190910141108246,4.89279459451848e-17
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TREML2,Trem-like transcript 2 protein,28187,0.0192477067614462,0.00229905755128807,0.0147415539609216,0.0237538595619708,5.92420595593907e-17
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,23393,-0.024955754699238,0.00298226766527445,-0.0308009993231759,-0.0191105100753001,6.1820162230949e-17
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSC,Dipeptidyl peptidase 1,28192,-0.024479054196012,0.00293344120156249,-0.0302285989510745,-0.0187295094409495,7.45406585338397e-17
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,28307,-0.0201744743453578,0.00242619849777491,-0.0249298234009966,-0.0154191252897189,9.56099722333777e-17
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APCS,Serum amyloid P-component,23662,0.0192809212897273,0.00232905344958477,0.0147159765285412,0.0238458660509135,1.31332187745634e-16
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYL4,Myosin light chain 4,23198,-0.0290260849703929,0.00350697738345229,-0.0358997606419594,-0.0221524092988264,1.33427482974073e-16
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",23795,0.0510037280276853,0.00617167035190679,0.0389072541379479,0.0631002019174226,1.47937442886001e-16
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CREG1,Protein CREG1,27840,-0.0211471337949595,0.00257124380087341,-0.0261867716446713,-0.0161074959452476,2.04505280816759e-16
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUOM,Fucose mutarotase,23337,-0.0353451604775804,0.00431445145053942,-0.0438014853206376,-0.0268888356345231,2.69379395258388e-16
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPRC5C,G-protein coupled receptor family C group 5 member C,23725,-0.03151679807149,0.00384855631714103,-0.0390599684530864,-0.0239736276898936,2.75981604177008e-16
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH1,Cadherin-1,27268,-0.0221879454398836,0.00271962322863082,-0.027518406968,-0.0168574839117672,3.53793114337054e-16
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC4M,C-type lectin domain family 4 member M,23815,0.0269348237844816,0.00330148965453162,0.0204639040615996,0.0334057435073635,3.56169434994162e-16
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VPS37A,Vacuolar protein sorting-associated protein 37A,28091,-0.0438746899767496,0.00537973028167507,-0.0544189613288327,-0.0333304186246665,3.61945511930772e-16
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,28091,-0.0239614890762487,0.00294260805484786,-0.0297290008637505,-0.0181939772887469,4.01632486865464e-16
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL5A1,Collagen alpha-1(V) chain,23337,-0.0222512478284913,0.00273300913941782,-0.0276079457417502,-0.0168945499152324,4.09217140440263e-16
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD5L,CD5 antigen-like,23766,0.0257714513884912,0.00319557801445758,0.0195081184801543,0.032034784296828,7.68422081298778e-16
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL3,C-X-C motif chemokine 3,28194,0.0512767358930601,0.00636064783611881,0.0388098661342672,0.063743605651853,7.82887295052671e-16
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NHLRC3,NHL repeat-containing protein 3,22802,-0.0174816408218107,0.00217046484317969,-0.0217357519144429,-0.0132275297291785,8.38021291307283e-16
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNM1,Dynamin-1,23738,0.0620434134087992,0.00771215620786401,0.0469275872413857,0.0771592395762126,9.03367915680941e-16
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HJV,Hemojuvelin,23795,-0.0239460105493584,0.00297688734885957,-0.0297807097531232,-0.0181113113455937,9.09983636261057e-16
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DLK1,Protein delta homolog 1,28553,-0.0303014756308332,0.00377083137925907,-0.037692305134181,-0.0229106461274854,9.65676634420655e-16
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA3,Alpha-1-antichymotrypsin,23812,0.00802769815858877,0.000999261761001791,0.00606914510702526,0.00998625121015228,9.89890597392413e-16
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",23738,0.0555962750703237,0.00693574668980978,0.0420022115582965,0.0691903385823508,1.14336626226652e-15
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFAP,Glial fibrillary acidic protein,27519,0.0251320789676665,0.00313750778019974,0.018982563718475,0.031281594216858,1.1901499395395e-15
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CENPF,Centromere protein F,23393,-0.0292945888245505,0.00365954259256923,-0.0364672923059862,-0.0221218853431149,1.25002776630383e-15
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KEL,Kell blood group glycoprotein,27544,-0.0194046394021916,0.002430318477266,-0.024168063617633,-0.0146412151867502,1.46674071693818e-15
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBP2,Retinol-binding protein 2,28091,0.0414600612719904,0.00519876713657131,0.0312704776843106,0.0516496448596702,1.5816440057803e-15
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",28237,0.0181025197282353,0.00228017434495774,0.0136333780121181,0.0225716614443525,2.11179700276938e-15
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PKLR,Pyruvate kinase PKLR,28233,-0.0346418520608019,0.00436655569986993,-0.043200301232547,-0.0260834028890569,2.209858866117e-15
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASGR1,Asialoglycoprotein receptor 1,27965,-0.0159679168110831,0.00201329641213053,-0.0199139777788589,-0.0120218558433072,2.25042186881039e-15
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSME1,Proteasome activator complex subunit 1,27940,-0.0198237792833931,0.0025028285831688,-0.024729323306404,-0.0149182352603823,2.45201941969836e-15
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ELN,Elastin,23846,-0.0187249152573902,0.00236927849075872,-0.0233687010992773,-0.0140811294155031,2.83504415113665e-15
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YOD1,Ubiquitin thioesterase OTU1,23071,-0.0332186175324307,0.00420484282046618,-0.0414601094605444,-0.024977125604317,2.9110390528201e-15
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPPC,C-type natriuretic peptide,28176,-0.0254804344611795,0.00324197831920163,-0.0318347119668147,-0.0191261569555443,3.99268026001099e-15
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MENT,Protein MENT,23337,0.0120535416171931,0.00153538170573001,0.00904419347396227,0.0150628897604239,4.32074420865899e-15
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,28336,-0.0307588498834462,0.00391862662353366,-0.0384393580655722,-0.0230783417013202,4.32738866817801e-15
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL11,C-X-C motif chemokine 11,28428,0.0415888347269286,0.00532588960133016,0.0311500911083215,0.0520275783455357,5.9713294547947e-15
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HEG1,Protein HEG homolog 1,23337,-0.0143572434591375,0.00183862525020051,-0.0179609489495305,-0.0107535379687445,6.0211602119803e-15
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRP1,Neuropilin-1,28367,0.0146669039485632,0.00187952093684804,0.0109830429123411,0.0183507649847854,6.22617460615883e-15
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF11,Tumor necrosis factor ligand superfamily member 11,28176,0.032150085697751,0.00412071717456983,0.0240734800355942,0.0402266913599079,6.30055148995597e-15
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPB1,Carboxypeptidase B,28553,-0.0311056659450059,0.00398772601168914,-0.0389216089279166,-0.0232897229620952,6.38342486689705e-15
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1RN,Interleukin-1 receptor antagonist protein,28122,-0.0283400818254919,0.00363949858535268,-0.0354734990527832,-0.0212066645982006,7.10795223206973e-15
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,28336,-0.0221619306785528,0.00284986925882494,-0.0277476744258497,-0.016576186931256,7.7099294920728e-15
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCGN,Secretagogin,27702,-0.0231029395647126,0.00298130298438739,-0.0289462934141119,-0.0172595857153133,9.55749178447869e-15
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA9,Carbonic anhydrase 9,28452,-0.0240158666754138,0.00310032524179795,-0.0300925041493378,-0.0179392292014898,9.7794549055944e-15
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSN,Gelsolin,23769,0.00998644045228429,0.00129214434138145,0.00745383754317665,0.0125190433613919,1.13047919788553e-14
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTIF3,"Translation initiation factor IF-3, mitochondrial",23738,0.0455181604108643,0.00592511113808716,0.0339049425802135,0.0571313782415151,1.62357861594587e-14
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGR,Tyrosine-protein kinase Fgr,27544,-0.0295603167992518,0.00385072849947559,-0.037107744658224,-0.0220128889402796,1.68835363714307e-14
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF23,Fibroblast growth factor 23,28422,-0.0293769528063243,0.00382968794698614,-0.0368831411824171,-0.0218707644302315,1.7632329290367e-14
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PXN,Paxillin,27544,-0.0265687659134144,0.00347834961905978,-0.0333863311667716,-0.0197512006600572,2.27202824553618e-14
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FXN,"Frataxin, mitochondrial",28452,0.0378906200116712,0.00496098919173501,0.0281670811958706,0.0476141588274719,2.28048190439365e-14
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSB,Cathepsin B,28223,0.0269481168960323,0.00352963361657014,0.0200300350075548,0.0338661987845098,2.33278643926698e-14
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA3F,Semaphorin-3F,28224,-0.013582546073051,0.00178092801129818,-0.0170731649751954,-0.0100919271709065,2.48475465647871e-14
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTHRC1,Collagen triple helix repeat-containing protein 1,23862,-0.0144292602638863,0.00189445225913073,-0.0181423866917825,-0.0107161338359901,2.70134793931864e-14
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS1,Galectin-1,28224,0.0177317358634441,0.0023304494748142,0.0131640548928083,0.02229941683408,2.85449463986971e-14
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BLVRB,Flavin reductase,28187,-0.0334558429927858,0.00439850718340431,-0.0420769170722583,-0.0248347689133134,2.91108402951812e-14
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMB1,Laminin subunit beta-1,23198,-0.0155774218501654,0.00204841252416009,-0.0195923103975191,-0.0115625333028116,2.96558000285919e-14
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C9orf40,Uncharacterized protein C9orf40,23738,-0.0411257166576797,0.00541305570561614,-0.0517353058406873,-0.030516127474672,3.13042450208503e-14
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,POSTN,Periostin,23862,0.0193957117621531,0.00255346023097313,0.0143909297094457,0.0244004938148604,3.16989512155319e-14
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC4A1,Band 3 anion transport protein,23862,-0.0239675925072248,0.00315995459596871,-0.0301611035153235,-0.0177740814991261,3.45175796882327e-14
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACAN,Aggrecan core protein,27951,0.0145104663560017,0.00191393702019372,0.010759149796422,0.0182617829155814,3.52243665839235e-14
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSME2,Proteasome activator complex subunit 2,27833,-0.0184837548971104,0.0024400617356311,-0.0232662758989473,-0.0137012338952734,3.69941020378153e-14
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,27376,-0.044346416743106,0.00586292132425719,-0.0558377425386501,-0.032855090947562,4.03507516668784e-14
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRIM1,Cysteine-rich motor neuron 1 protein,28320,0.0104754328704501,0.00138591443494614,0.00775904057795562,0.0131918251629445,4.20076235477749e-14
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PIGR,Polymeric immunoglobulin receptor,27877,-0.0184844206838772,0.00244648241560442,-0.0232795262184619,-0.0136893151492926,4.30022725405659e-14
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LIFR,Leukemia inhibitory factor receptor,28176,-0.0123999155421038,0.00164396223662955,-0.0156220815258977,-0.00917774955830985,4.74211008042856e-14
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSIP1,PC4 and SFRS1-interacting protein,28176,-0.0326298868100116,0.00432940550157578,-0.0411155215931002,-0.0241442520269231,4.96095687629859e-14
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",28553,0.0148168618435763,0.00197082286381607,0.0109540490304968,0.0186796746566558,5.72052647110382e-14
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYBPC1,"Myosin-binding protein C, slow-type",23846,-0.0354448360514156,0.00472338433233408,-0.0447026693427904,-0.0261870027600408,6.40066373492377e-14
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT8,"Keratin, type II cytoskeletal 8",23056,-0.037447325412406,0.00499260085921482,-0.047232823096467,-0.0276618277283449,6.58394115483897e-14
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAT,Catalase,23530,-0.0270494876954092,0.0036067847134321,-0.0341187857337361,-0.0199801896570823,6.6270899373869e-14
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRB,Receptor-type tyrosine-protein phosphatase beta,23846,-0.0149421758557934,0.00199568617594894,-0.0188537207606533,-0.0110306309509335,7.27769398225421e-14
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VASN,Vasorin,27829,0.0139446946321508,0.00186526511167676,0.0102887750132644,0.0176006142510373,7.88849316957932e-14
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,28251,0.0248981580611245,0.00333436754105043,0.0183627976806656,0.0314335184415833,8.43292168099402e-14
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PADI4,Protein-arginine deiminase type-4,27500,-0.0357226408889688,0.004819574081639,-0.0451690060889813,-0.0262762756889564,1.2800177971215e-13
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,28452,-0.0171371848671935,0.00231472164911605,-0.021674039299461,-0.0126003304349261,1.36253204002759e-13
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DMP1,Dentin matrix acidic phosphoprotein 1,23198,0.0302649911860988,0.00409223696092556,0.0222442067426847,0.0382857756295129,1.45430545832748e-13
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LY9,T-lymphocyte surface antigen Ly-9,27885,0.0147575847243284,0.00199687626811485,0.0108437072388232,0.0186714622098335,1.50571919599105e-13
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",23198,-0.0185384871407287,0.00250871993939094,-0.023455578221935,-0.0136213960595225,1.52230489998822e-13
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDN1,Endothelin-1,23198,-0.0145348197319718,0.00196725312014267,-0.0183906358474515,-0.0106790036164922,1.53649696624809e-13
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTA4H,Leukotriene A-4 hydrolase,28452,0.0292922681462221,0.00396642189635167,0.0215180812293728,0.0370664550630714,1.56564111852882e-13
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCOF1,Treacle protein,23846,-0.0156910117589683,0.00212571666807024,-0.0198574164283859,-0.0115246070895506,1.61622921080556e-13
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BMP4,Bone morphogenetic protein 4,27918,-0.0230631328029414,0.00312556271747806,-0.0291892357291984,-0.0169370298766844,1.64083730995282e-13
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD2AP,CD2-associated protein,28224,-0.0317449583690135,0.00430297840330339,-0.0401787960394882,-0.0233111206985388,1.65808957253519e-13
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL11,Eotaxin,28521,-0.0186870146588103,0.00253563515347876,-0.0236568595596286,-0.0137171697579919,1.75579341978748e-13
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KYNU,Kynureninase,28521,-0.0224938064281105,0.00306423593933087,-0.028499708869199,-0.016487903987022,2.18066981058649e-13
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UMOD,Uromodulin,28485,0.0267760641523937,0.00365682822478551,0.0196086808318141,0.0339434474729733,2.50380788252249e-13
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMG3,Proteasome assembly chaperone 3,28176,-0.0249146316858844,0.00340264002582505,-0.0315838061365015,-0.0182454572352673,2.50569250346543e-13
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZHX2,Zinc fingers and homeoboxes protein 2,23775,-0.0156969657195233,0.00215207932217169,-0.0199150411909798,-0.0114788902480667,3.10632685377356e-13
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAN2B2,Epididymis-specific alpha-mannosidase,23846,-0.0292671916905725,0.00401448662323107,-0.0371355854721054,-0.0213987979090396,3.18681563122437e-13
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOE,Apolipoprotein E,23893,-0.0354097215767417,0.00487008902638293,-0.0449550960684522,-0.0258643470850311,3.68207556804738e-13
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MIA,Melanoma-derived growth regulatory protein,28307,0.0181537781883673,0.00250179554202027,0.0132502589260075,0.023057297450727,4.08052872987816e-13
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT19,"Keratin, type I cytoskeletal 19",28121,-0.0331813727539675,0.00458796004477806,-0.0421737744417325,-0.0241889710662025,4.87115807737466e-13
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,23775,-0.0307581163456039,0.00425435637015815,-0.0390966548311139,-0.0224195778600939,4.98359319183918e-13
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJA4,DnaJ homolog subfamily A member 4,23775,-0.0341208795328999,0.00473102425116559,-0.0433936870651844,-0.0248480720006153,5.67226833732832e-13
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",23198,0.0443366250040906,0.00617115022706509,0.032241170559043,0.0564320794491382,6.94935816207989e-13
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLITRK1,SLIT and NTRK-like protein 1,23188,0.0156813701527583,0.00218722282310917,0.0113944134194643,0.0199683268860522,7.75107381927895e-13
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHRDL2,Chordin-like protein 2,28224,-0.0257222178806793,0.00360154296601577,-0.0327812420940702,-0.0186631936672884,9.42102494579033e-13
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTSL4,ADAMTS-like protein 4,23198,-0.011546473022847,0.00161676038793967,-0.0147153233832088,-0.00837762266248525,9.48819854904406e-13
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSIG2,V-set and immunoglobulin domain-containing protein 2,23725,-0.0287415638148721,0.00402544421366676,-0.0366314344736589,-0.0208516931560852,9.60408450121294e-13
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TREML1,Trem-like transcript 1 protein,23872,0.025486779382211,0.00357038763463947,0.0184888196183176,0.0324847391461043,9.71418227797508e-13
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",27702,-0.0288722968496061,0.00404742899254509,-0.0368052576749944,-0.0209393360242177,1.00258190972577e-12
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD40LG,CD40 ligand,28521,0.0374304030569487,0.00525158542758688,0.0271372956188784,0.047723510495019,1.04676725707144e-12
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEBPB,CCAAT/enhancer-binding protein beta,27682,-0.0181599431480734,0.0025530739937406,-0.023163968175805,-0.0131559181203418,1.16330030740574e-12
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GUCA2A,Guanylin,28080,-0.0164736945339199,0.0023161642922452,-0.0210133765467205,-0.0119340125211193,1.16696814061858e-12
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD209,CD209 antigen,28274,0.0186342443814924,0.00262350709646577,0.0134921704724195,0.0237763182905653,1.25146018213916e-12
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CES3,Carboxylesterase 3,28091,-0.0333765352033366,0.0047184478804034,-0.0426246930489273,-0.024128377357746,1.54471566073601e-12
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMNDC1,Survival of motor neuron-related-splicing factor 30,23738,-0.0284527541309718,0.0040272181565026,-0.0363461017177169,-0.0205594065442267,1.64919705228146e-12
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EGFR,Epidermal growth factor receptor,28553,0.00783315436717333,0.00110919661545434,0.00565912900088283,0.0100071797334638,1.67870512192143e-12
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLSTN2,Calsyntenin-2,28521,-0.018896323145516,0.00267713782428728,-0.0241435132811191,-0.0136491330099129,1.72275628134538e-12
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFF2,Trefoil factor 2,28276,-0.0274347553075271,0.0038892883547973,-0.0350577604829298,-0.0198117501321244,1.77939845732961e-12
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDHR2,Cadherin-related family member 2,28091,-0.0345415201652893,0.00490017118212134,-0.0441458556822471,-0.0249371846483315,1.8431277697041e-12
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLA,Alpha-galactosidase A,23287,-0.0179476235988533,0.00254611701029635,-0.0229380129390341,-0.0129572342586724,1.85216858807661e-12
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASGR2,Asialoglycoprotein receptor 2,23872,0.0124072669988757,0.00176140892926168,0.00895490549752275,0.0158596285002286,1.91946584150206e-12
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMP1,Lysosome-associated membrane glycoprotein 1,23216,-0.0132749137092619,0.0018845701683016,-0.016968671239133,-0.00958115617939076,1.92014601736937e-12
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PQBP1,Polyglutamine-binding protein 1,27562,-0.0265327734900887,0.00376803339386714,-0.0339181189420683,-0.0191474280381091,1.94578602218414e-12
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HIP1R,Huntingtin-interacting protein 1-related protein,23720,-0.0203925643904404,0.00290169851213816,-0.0260798934742312,-0.0147052353066496,2.15493395887086e-12
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOL1,Apolipoprotein L1,23872,0.0282324850048952,0.0040331334083129,0.0203275435246019,0.0361374264851884,2.62486415608947e-12
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",23846,-0.0354982627035182,0.00507136113709205,-0.0454381305322187,-0.0255583948748178,2.63216861862899e-12
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASS1,Argininosuccinate synthase,23071,-0.0375193810952618,0.00536092355363419,-0.0480267912603848,-0.0270119709301388,2.65466884485656e-12
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1B,Interleukin-1 beta,27528,0.0266065725085225,0.00380326495238401,0.0191521732018498,0.0340609718151951,2.69939100659037e-12
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",23795,-0.0198717493466425,0.00284555428455312,-0.0254490357443666,-0.0142944629489183,2.95627043154797e-12
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEPTIN8,Septin-8,23733,-0.0151169425665141,0.00216825340857648,-0.019366719247324,-0.0108671658857042,3.20786445899311e-12
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CBS,Cystathionine beta-synthase,23198,-0.0241346181995312,0.00346256751666983,-0.030921250532204,-0.0173479858668583,3.2508821584058e-12
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,28304,0.0147231803702269,0.00212043641009345,0.0105671250064438,0.0188792357340101,3.90852328720116e-12
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CBLIF,Cobalamin binding intrinsic factor,28182,-0.0348721664322815,0.00505277547312259,-0.0447756063596018,-0.0249687265049613,5.25137434344648e-12
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFC1,Cryptic protein,27562,-0.0219270665672008,0.00318032354426554,-0.0281605007139613,-0.0156936324204404,5.51805528841577e-12
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL16,C-C motif chemokine 16,28553,-0.0242936104091034,0.00352562812763635,-0.0312038415392707,-0.0173833792789362,5.67204241595655e-12
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNLIP,Pancreatic triacylglycerol lipase,23872,-0.0292822917567927,0.00425984601915979,-0.0376315899543459,-0.0209329935592395,6.39530799101496e-12
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EGLN1,Egl nine homolog 1,28176,-0.0253296127495609,0.00368572860404543,-0.03255364081349,-0.0181055846856319,6.44683484695008e-12
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MERTK,Tyrosine-protein kinase Mer,28521,0.0117862008946749,0.00171508163127515,0.0084246408973756,0.0151477608919742,6.45677219442516e-12
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AARSD1,Alanyl-tRNA editing protein Aarsd1,28091,-0.0254610199916837,0.00370724244506719,-0.0327272151840154,-0.018194824799352,6.65050279008608e-12
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INHBB,Inhibin beta B chain,23337,0.0239636675170149,0.00349846894503358,0.0171066683847491,0.0308206666492807,7.58141411076213e-12
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDA,Cytidine deaminase,23815,-0.0215858525017398,0.00315176008408518,-0.0277633022665467,-0.0154084027369328,7.62720166395393e-12
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SFRP4,Secreted frizzled-related protein 4,23337,-0.019076356399412,0.00278798896067308,-0.0245408147623312,-0.0136118980364928,7.98412342065374e-12
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC7,Sialic acid-binding Ig-like lectin 7,28224,-0.0129567462564714,0.00189780518767558,-0.0166764444243155,-0.00923704808862724,8.83251550307094e-12
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,23738,-0.0138788045228537,0.00203695894017629,-0.0178712440455992,-0.0098863650001082,9.75369571640016e-12
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRDX2,Peroxiredoxin-2,23493,-0.0283295825731893,0.00416012880288921,-0.0364834350268521,-0.0201757301195264,1.00103490526468e-11
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCF2,Neutrophil cytosol factor 2,28137,-0.0382116528619028,0.00561319363742188,-0.0492135123912497,-0.0272097933325559,1.0132430288734e-11
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLT3LG,Fms-related tyrosine kinase 3 ligand,28521,-0.0156046801591188,0.00229896048801493,-0.020110642715628,-0.0110987176026095,1.16157563980238e-11
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ELOA,Elongin-A,28091,-0.0240195213295908,0.00354341130091442,-0.0309646074793831,-0.0170744351797986,1.23709448078698e-11
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,28428,0.0208429371956644,0.00308730145359885,0.0147918263466107,0.0268940480447181,1.49465163479825e-11
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C19orf12,Protein C19orf12,27544,-0.0295802585828229,0.00438540662471622,-0.0381756555672666,-0.0209848615983791,1.55885892366075e-11
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXNDC15,Thioredoxin domain-containing protein 15,28307,0.0125015028840327,0.00185386790487258,0.00886792179048246,0.016135083977583,1.57621767244554e-11
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRTAC1,Cartilage acidic protein 1,28553,0.0136718371992867,0.00203928802599031,0.00967483266834571,0.0176688417302277,2.06255980225631e-11
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCAM2,Neural cell adhesion molecule 2,28187,0.0122183795943645,0.00182325312623403,0.00864480346694584,0.0157919557217832,2.10297127437714e-11
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RASSF2,Ras association domain-containing protein 2,27562,-0.0253656344401182,0.0037899059866482,-0.0327938501739487,-0.0179374187062877,2.22916953058536e-11
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARG1,Arginase-1,27969,-0.0234003152528963,0.0035024401803674,-0.0302650980064164,-0.0165355324993762,2.41529007037255e-11
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP2,"Fatty acid-binding protein, intestinal",28224,0.0354434616781688,0.00530954024389975,0.0250367628001253,0.0458501605562123,2.51077022404941e-11
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CARHSP1,Calcium-regulated heat-stable protein 1,27544,-0.0231410042431054,0.00346735066319704,-0.0299370115429716,-0.0163449969432392,2.53694005742899e-11
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRSS2,Trypsin-2,28336,-0.0241358248236605,0.00362104280549717,-0.031233068722435,-0.0170385809248861,2.68724516980126e-11
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MATN2,Matrilin-2,28237,-0.0133684181652494,0.00200738175597191,-0.0173028864069543,-0.00943394992354441,2.79556505397964e-11
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALCA,Calcitonin,27910,-0.0279655956172608,0.00420131791948166,-0.0362001787394449,-0.0197310124950768,2.8584219891788e-11
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRAF2,TNF receptor-associated factor 2,28176,-0.0315960193801166,0.00475094899975455,-0.0409078794196355,-0.0222841593405977,2.97512400267566e-11
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYL3,Myosin light chain 3,23198,-0.0328029466931006,0.00493413789372889,-0.0424738569648092,-0.023132036421392,3.0337186102994e-11
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INSL5,Insulin-like peptide INSL5,23738,-0.0437375719266454,0.00659458516240872,-0.0566629588449665,-0.0308121850083243,3.37499376610242e-11
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPKOW,G-patch domain and KOW motifs-containing protein,27544,-0.0125355752267897,0.00189751434687003,-0.0162547033466549,-0.00881644710692444,4.011889174172e-11
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NBN,Nibrin,27702,-0.0235207751050024,0.00356375867661924,-0.0305057421111761,-0.0165358080988287,4.18606310281942e-11
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNC,Tenascin,28336,0.0213409194360413,0.00323413604175161,0.0150020127942081,0.0276798260778744,4.2224549716748e-11
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FSTL1,Follistatin-related protein 1,23198,-0.0101296808008984,0.00153585168955301,-0.0131399501124223,-0.00711941148937448,4.33007830703172e-11
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SFRP1,Secreted frizzled-related protein 1,27871,0.0192695585964675,0.00292480984594038,0.0135369312984244,0.0250021858945107,4.52783044017944e-11
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,27682,-0.0254522489179353,0.00386753654185003,-0.0330326205399614,-0.0178718772959093,4.75649297571788e-11
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KCTD5,BTB/POZ domain-containing protein KCTD5,23377,-0.0194874523696244,0.00296353486797483,-0.0252959807108551,-0.0136789240283938,4.94321836264388e-11
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPA1,Carboxypeptidase A1,28553,-0.0269804180859949,0.00410472053848182,-0.0350256703414193,-0.0189351658305706,5.01537520757697e-11
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRP,Gastrin-releasing peptide,23198,-0.0238131508722351,0.00362314609484682,-0.0309145172181348,-0.0167117845263353,5.05261852618992e-11
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OLFM4,Olfactomedin-4,22492,-0.0547466933884989,0.00833463786328873,-0.0710825836005448,-0.0384108031764529,5.19096944616496e-11
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",23198,0.0309138031205688,0.00471103129427822,0.0216801817837834,0.0401474244573541,5.42102164312433e-11
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA1,Carbonic anhydrase 1,27641,-0.0263921393492058,0.00403834877962815,-0.0343073029572769,-0.0184769757411346,6.45530555074442e-11
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFB4A_DEFB4B,Beta-defensin 4A,27785,-0.0648257625456419,0.00992728631171666,-0.0842832437166065,-0.0453682813746772,6.68785774060809e-11
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD70,CD70 antigen,28176,0.0188938534730689,0.00290053546057591,0.0132088039703401,0.0245789029757977,7.44487526544929e-11
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSNL1,Visinin-like protein 1,23775,-0.0167954953729196,0.00257905832562385,-0.0218504496911423,-0.0117405410546968,7.55081693394447e-11
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PROC,Vitamin K-dependent protein C,28291,0.011388382726707,0.00174943879570737,0.0079594826871206,0.0148172827662935,7.6543864799953e-11
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CYTL1,Cytokine-like protein 1,23862,0.0106314673709759,0.00163328909014885,0.00743022075428418,0.0138327139876677,7.70338869578069e-11
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMSB10,Thymosin beta-10,28187,0.0333885959742988,0.00513190727585799,0.0233300577136172,0.0434471342349805,7.84307639857879e-11
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WDR46,WD repeat-containing protein 46,23725,-0.0158795544034434,0.00244114453455551,-0.0206641976911722,-0.0110949111157146,7.92617976690181e-11
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASAH2,Neutral ceramidase,27965,-0.0231677434470467,0.00356747312183359,-0.0301599907658405,-0.0161754961282529,8.48985760006165e-11
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBFOX3,RNA binding protein fox-1 homolog 3,23795,-0.0168859555052185,0.00260697423734831,-0.0219956250104212,-0.0117762860000158,9.52514322033814e-11
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PZP,Pregnancy zone protein,23893,0.0230616356945743,0.00356714909337108,0.016070023471567,0.0300532479175816,1.0325247507436e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA4,Carbonic anhydrase 4,28553,0.0103952603626007,0.00160871639717405,0.00724217622413951,0.0135483445010618,1.05107117238664e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMCN2,Hemicentin-2,23301,-0.0251644765603849,0.00389709865823557,-0.0328027899305266,-0.0175261631902432,1.08736973017068e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSPB6,Heat shock protein beta-6,28452,-0.0167122169836777,0.00260003141124401,-0.021808278549716,-0.0116161554176395,1.31602005544871e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PKD1,Polycystin-1,23846,-0.0115015447229033,0.00179128146573826,-0.0150124563957503,-0.00799063305005628,1.38071102255716e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA2,Carbonic anhydrase 2,28113,-0.0296642398443804,0.00463517745586047,-0.0387491876578669,-0.0205792920308939,1.58024703942095e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WIF1,Wnt inhibitory factor 1,28452,0.0147177922206567,0.00230276381200569,0.0102043751491256,0.0192312092921879,1.66962820593569e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IQGAP2,Ras GTPase-activating-like protein IQGAP2,28091,-0.0233239312965374,0.00365568104445896,-0.030489066143677,-0.0161587964493978,1.79626209413688e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRAF3,"TNF receptor-associated factor 3, Isoform 2",23188,-0.0155163306178104,0.00243512584866611,-0.020289177281196,-0.0107434839544248,1.90235535010811e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOTCH2,Neurogenic locus notch homolog protein 2,23862,0.00922618413072385,0.00145019533919112,0.00638380126590926,0.0120685669955384,2.02721527839872e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LCN2,Neutrophil gelatinase-associated lipocalin,27374,0.0165021839070121,0.00260217558626364,0.0114019197579353,0.0216024480560888,2.3081020891884e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DTNB,Dystrobrevin beta,23687,-0.0186025768815152,0.00293744094249305,-0.0243599611288016,-0.0128451926342288,2.44886755861441e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NID1,Nidogen-1,28266,0.016254096524029,0.00256768863001977,0.0112214268091903,0.0212867662388678,2.48446939159561e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1RL,Complement C1r subcomponent-like protein,23852,0.00834001329829582,0.00131910063703553,0.00575457604970618,0.0109254505468855,2.61927092633401e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G15,Phospholipase A2 group XV,28307,-0.0113514996345363,0.00179843934279409,-0.0148764407464127,-0.00782655852265991,2.79784180963255e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",23198,0.0328510247978335,0.00520640213485977,0.0226464766135084,0.0430555729821587,2.84565635694647e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FSTL3,Follistatin-related protein 3,28096,-0.0135928712513462,0.00215988111523785,-0.0178262382372124,-0.00935950426547999,3.15287079468968e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDCD6,Programmed cell death protein 6,28224,0.0299157921174052,0.0047568470552922,0.0205923718890325,0.0392392123457779,3.24206636020831e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,23337,-0.00928544736646056,0.00147672581404274,-0.0121798299619843,-0.0063910647709368,3.27575732146385e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ABCA2,ATP-binding cassette sub-family A member 2,23071,-0.0154633217674844,0.00246051084737762,-0.0202859230283445,-0.0106407205066243,3.34586666459383e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANKRD54,Ankyrin repeat domain-containing protein 54,27562,-0.0243209283504761,0.00387185010158279,-0.0319097545495784,-0.0167321021513738,3.40384801358304e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNAPIN,SNARE-associated protein Snapin,23795,-0.0245299667318409,0.00390656656220204,-0.0321868371937569,-0.0168730962699249,3.46287542893836e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OLR1,Oxidized low-density lipoprotein receptor 1,27968,0.0247469123423296,0.00395061406889312,0.0170037087672991,0.0324901159173601,3.80522783032475e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASPN,Asporin,23846,0.0116849100667994,0.00186540222252648,0.0080287217106475,0.0153410984229513,3.81598445190081e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THPO,Thrombopoietin,27682,0.0162786423873644,0.00260874321361954,0.0111655056886701,0.0213917790860587,4.43817564317326e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FBP1,"Fructose-1,6-bisphosphatase 1",28224,-0.0307438342342783,0.00495616490789261,-0.0404579174537478,-0.0210297510148087,5.6112187986258e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OPTC,Opticin,28091,0.018942204058229,0.00305875640657912,0.012947041501334,0.0249373666151241,5.99313363340238e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLAMF7,SLAM family member 7,28176,0.0246005211599325,0.00397715040804417,0.0168053063601659,0.0323957359596991,6.27712974833299e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD27,CD27 antigen,28307,0.0174231223693793,0.0028169638038536,0.0119018733138262,0.0229443714249323,6.29235675937827e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIAP1,TP53-regulated inhibitor of apoptosis 1,28452,0.0262275900038265,0.00424456314855545,0.0179082462326578,0.0345469337749952,6.53412113551373e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REG1B,Lithostathine-1-beta,28553,-0.0235858099085169,0.00381749585881042,-0.0310681017917854,-0.0161035180252485,6.56514258425982e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM3C,Protein FAM3C,28182,-0.0125222065911882,0.00203334846653098,-0.0165075695855889,-0.00853684359678745,7.44686472820449e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC4A,C-type lectin domain family 4 member A,28176,0.0145416544248218,0.00236280498156425,0.00991055666095583,0.0191727521886877,7.63765436150765e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",27562,-0.0344001324512219,0.00558965137816447,-0.0453558491524243,-0.0234444157500196,7.64713109551712e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL25,C-C motif chemokine 25,28521,-0.0204327212708171,0.00332016133387196,-0.0269402374852061,-0.013925205056428,7.64932811289218e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEMIP2,Cell surface hyaluronidase,23188,-0.0138003810849033,0.00224345957509612,-0.0181975618520917,-0.00940320031771489,7.80670561377224e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFA,Protransforming growth factor alpha,28176,0.0194742664561003,0.00316796135407599,0.0132650622021114,0.0256834707100892,7.98930872018926e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL6R,Interleukin-6 receptor subunit alpha,28111,0.0140974942791268,0.00229442918710165,0.00960041307240762,0.0185945754858461,8.1432321100681e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNRPB2,U2 small nuclear ribonucleoprotein B'',23775,-0.0173171833673085,0.00282014663563077,-0.0228446707731448,-0.0117896959614722,8.35525042997958e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,28237,0.0140073188058625,0.00228381791182206,0.00953103569869123,0.0184836019130337,8.72219590094883e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGM2,Protein-glutamine gamma-glutamyltransferase 2,28173,-0.0305932011098463,0.0049975247816245,-0.0403883496818303,-0.0207980525378623,9.38216517408703e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLXNB2,Plexin-B2,28437,-0.00987192045078238,0.00161463026784261,-0.0130365957757539,-0.00670724512581086,9.84016738251262e-10
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100G,Protein S100-G,23795,0.0191524366761605,0.00313851492000423,0.0130009474329522,0.0253039259193688,1.06110128024587e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCTN1,Dynactin subunit 1,28452,-0.0267822923226173,0.00439198366559298,-0.0353905803071795,-0.018174004338055,1.08790156883395e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFPI2,Tissue factor pathway inhibitor 2,28215,0.0160856381584827,0.00264233481808207,0.0109066619150418,0.0212646144019235,1.16049833435046e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QL2,Complement C1q-like protein 2,23188,0.0177102296353097,0.00290965451799146,0.0120073067800464,0.0234131524905729,1.17062716884964e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK1,Serine protease inhibitor Kazal-type 1,28187,-0.0175594181438247,0.00289407533847757,-0.0232318058072407,-0.0118870304804086,1.31680622159441e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LY96,Lymphocyte antigen 96,27965,0.0146289628562109,0.00241313393938687,0.00989922033501264,0.0193587053774092,1.35969009681997e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFRA1,GDNF family receptor alpha-1,28404,-0.0115767728958794,0.00191306133330006,-0.0153263731091475,-0.00782717268261129,1.45354585818974e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DKK4,Dickkopf-related protein 4,27918,-0.0186903068379588,0.00309036458549178,-0.0247474214255227,-0.0126331922503949,1.48583127492187e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFP,Properdin,23893,0.0094332533294461,0.00156027448700556,0.00637511533491521,0.012491391323977,1.50789143146746e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOA1,Apolipoprotein A-I,23893,0.0111933417834852,0.00185148113004313,0.00756443876860067,0.0148222447983698,1.5104959478747e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALPP,"Alkaline phosphatase, placental type",28091,-0.042359092629899,0.00700855013739143,-0.0560958508991862,-0.0286223343606118,1.52311386028166e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZBTB16,Zinc finger and BTB domain-containing protein 16,27562,-0.0292996386738537,0.00484980439321901,-0.0388052552845629,-0.0197940220631444,1.54734529983561e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLNS1A,Methylosome subunit pICln,23163,-0.013684934005559,0.00226678242344502,-0.0181278275555112,-0.00924204045560677,1.59235491826864e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STC1,Stanniocalcin-1,28428,-0.0177099214212187,0.00294215958283459,-0.0234765542035745,-0.0119432886388629,1.7725089455272e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GP6,Platelet glycoprotein VI,28144,0.0357804007960048,0.00594509060491578,0.0241280232103698,0.0474327783816397,1.78240525164338e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLIN1,Perilipin-1,27544,-0.0142170063041106,0.00236364599430049,-0.0188497524529395,-0.00958426015528161,1.82308289093567e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TANK,TRAF family member-associated NF-kappa-B activator,27702,-0.0286016234381535,0.0047560213655444,-0.0379234253146205,-0.0192798215616865,1.83526261616552e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAMPT,Nicotinamide phosphoribosyltransferase,27562,-0.0209695202091746,0.00349383162766418,-0.0278174301993964,-0.0141216102189528,1.9749498272003e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF14,Tumor necrosis factor ligand superfamily member 14,27965,0.0233325612608245,0.00389234117177557,0.0157035725641444,0.0309615499575046,2.06638025016901e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ESM1,Endothelial cell-specific molecule 1,28195,0.0138524163336063,0.00231149644543715,0.00932188330054948,0.0183829493666631,2.08716756533663e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDT,D-dopachrome decarboxylase,23862,-0.0164922078956377,0.00275186955482878,-0.0218858722231021,-0.0110985435681733,2.08843804902524e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100P,Protein S100-P,27682,-0.0216991814270752,0.00362313489284809,-0.0288005258170575,-0.014597837037093,2.13656500788771e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C2,Complement C2,28291,0.00948060006817765,0.00158338339324832,0.00637716861741093,0.0125840315189444,2.15582130058373e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA3,Carbonic anhydrase 3,28500,-0.0242783820831441,0.00405654363310848,-0.0322292076040368,-0.0163275565622515,2.18984702369268e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACOT13,Acyl-coenzyme A thioesterase 13,23738,0.0458180308948352,0.00767892058361219,0.0307673465509554,0.0608687152387151,2.45491718408919e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,28122,0.024010470782657,0.00403071479688761,0.0161102697807573,0.0319106717845567,2.60159431604304e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BPIFB1,BPI fold-containing family B member 1,28086,0.0254020226288408,0.00426845324231322,0.0170358542739069,0.0337681909837747,2.69491655381601e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GOT1,"Aspartate aminotransferase, cytoplasmic",23862,-0.0167790244016249,0.00282138004027841,-0.0223089292805706,-0.0112491195226792,2.76739234392819e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GALNT7,N-acetylgalactosaminyltransferase 7,28091,-0.00845257256677481,0.0014218346266257,-0.0112393684349612,-0.00566577669858843,2.80001292044756e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCN1,CCN family member 1,28044,-0.0298665107206324,0.00502744593356554,-0.0397203047504209,-0.020012716690844,2.87166753721716e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CIRBP,Cold-inducible RNA-binding protein,23738,0.0384301084993316,0.00646997208623537,0.0257489632103103,0.0511112537883529,2.89409698653275e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TAX1BP1,Tax1-binding protein 1,23775,-0.0253404105924469,0.00426659137131771,-0.0337029296802296,-0.0169778915046642,2.90287242141268e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CIT,Citron Rho-interacting kinase,23163,-0.0182103591409863,0.0030678611759928,-0.0242233670459321,-0.0121973512360404,2.96494140148986e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP85,Centrosomal protein of 85 kDa,27562,-0.0257229318348696,0.00433714347393631,-0.0342237330437847,-0.0172221306259544,3.04969412049017e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPRR3,Small proline-rich protein 3,23775,-0.0270930119351245,0.00457829930966509,-0.036066478582068,-0.0181195452881809,3.30946673092125e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC51B,Organic solute transporter subunit beta,23071,-0.0304719588142372,0.00516198440932998,-0.040589448256524,-0.0203544693719505,3.61621324235682e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA9,Serpin A9,27969,-0.0289000905867068,0.00490193342298788,-0.0385078800957631,-0.0192923010776506,3.77488707353894e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLRB1,Killer cell lectin-like receptor subfamily B member 1,28521,-0.0151332679505364,0.00256720891806662,-0.020164997429947,-0.0101015384711259,3.79278208146173e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUOX,"Sulfite oxidase, mitochondrial",23795,-0.024906790220131,0.00422587055052928,-0.0331894964991683,-0.0166240839410936,3.82309133884011e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUSD1,Sushi domain-containing protein 1,27682,0.0194244783806512,0.00330835769960428,0.0129400972894268,0.0259088594718756,4.37230034834091e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTBS,Di-N-acetylchitobiase,23589,-0.0107372395588361,0.00183154880566428,-0.0143270752179381,-0.00714740389973414,4.62350534512026e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL18R1,Interleukin-18 receptor 1,28521,-0.0129882583189477,0.0022161127635975,-0.0173318393355988,-0.00864467730229656,4.6562499492374e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKR1B10,Aldo-keto reductase family 1 member B10,23163,-0.0248830053079064,0.00424604225099412,-0.0332052481198549,-0.0165607624959579,4.68341985889466e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDI2,Protein DDI1 homolog 2,23337,-0.0303153844805302,0.00517696284833798,-0.0404622316632726,-0.0201685372977878,4.81013478780504e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL16,Pro-interleukin-16,28521,-0.0163407428870072,0.00279287049303026,-0.0218147690533465,-0.0108667167206679,4.94326805410889e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL5RA,Interleukin-5 receptor subunit alpha,28176,0.0222516062854724,0.00380453143189341,0.0147947246789613,0.0297084878919835,5.00864738309741e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOLR2,Folate receptor beta,28428,0.0115852674899425,0.00198152368747795,0.00770148106248573,0.0154690539173993,5.07063747215995e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPPK1,Epiplakin,23198,-0.0290338674968054,0.00497304092338396,-0.0387810277066379,-0.0192867072869728,5.34543984353142e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD4,T-cell surface glycoprotein CD4,28127,-0.0116457784264217,0.00199948765264759,-0.015564774225611,-0.00772678262723245,5.79482671602353e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTP4A3,Protein tyrosine phosphatase type IVA 3,23188,-0.0206411185483701,0.00354422583352566,-0.0275878011820804,-0.0136944359146598,5.82589437172628e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LEP,Leptin,28224,-0.0263813034845805,0.00453520430313041,-0.0352703039187161,-0.0174923030504449,6.05579335797182e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BECN1,Beclin-1,23198,-0.0236675726613928,0.00406915365617068,-0.0316431138274874,-0.0156920314952983,6.09408872538791e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,27084,-0.0148402823300282,0.00255275541945375,-0.0198436829521576,-0.00983688170789889,6.18896813741645e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRIP2,Cysteine-rich protein 2,27965,-0.0141951498373144,0.00245016645800956,-0.0189974760950131,-0.00939282357961563,6.96546556014591e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPL,N-acetylneuraminate lyase,23846,-0.0175827940860142,0.00303517387936911,-0.0235317348895777,-0.0116338532824508,7.00052763017056e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G1B,Phospholipase A2,28522,0.016794303617033,0.002904265185636,0.0111019438531865,0.0224866633808796,7.43068956974298e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNLIPRP1,Inactive pancreatic lipase-related protein 1,23775,-0.0309867095119139,0.00536699166520848,-0.0415060131757225,-0.0204674058481053,7.85748905883318e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,27965,-0.021923607834336,0.00379883934392664,-0.0293693329484322,-0.0144778827202398,7.95714974210414e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EGFLAM,Pikachurin,23738,-0.0120036148242606,0.00208238501052543,-0.0160850894448904,-0.00792214020363072,8.29844644824126e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP7,Insulin-like growth factor-binding protein 7,28553,-0.0118415162020165,0.00206052769360871,-0.0158801504814896,-0.00780288192254346,9.18531962160592e-09
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRDX6,Peroxiredoxin-6,28452,-0.0231892118473245,0.00404622813023706,-0.0311198189825891,-0.0152586047120599,1.0080747046314e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PBLD,Phenazine biosynthesis-like domain-containing protein,27544,-0.020091523686089,0.00350679330540958,-0.0269648385646918,-0.0132182088074862,1.01887609660384e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NTRK3,NT-3 growth factor receptor,28428,0.00838623015629025,0.001464243988374,0.00551631193907721,0.0112561483735033,1.03043036620152e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PON1,Serum paraoxonase/arylesterase 1,23872,0.0102154248996077,0.00178462470970989,0.00671756046857636,0.0137132893306391,1.05211147590885e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THBS4,Thrombospondin-4,28266,-0.0175341705402761,0.00306514956824218,-0.0235418636940308,-0.0115264773865214,1.07286420027725e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OBP2B,Odorant-binding protein 2b,27887,0.0242127808188602,0.00423452514461202,0.0159131115354206,0.0325124501022998,1.08921136492963e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDT16,U8 snoRNA-decapping enzyme,23703,0.0338131489304002,0.00592014206612068,0.0222096704808037,0.0454166273799968,1.13296310087705e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,27965,-0.0110252061462946,0.00193205561928224,-0.0148120351600877,-0.00723837713250137,1.16512506726731e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RILPL2,RILP-like protein 2,23846,0.0375114814478696,0.00660906689458341,0.0245577103344861,0.0504652525612531,1.39676847295659e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATXN3,Ataxin-3,23775,-0.0235871075558666,0.00416476367606467,-0.0317500443609534,-0.0154241707507799,1.50035419637268e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL7,Interleukin-7,28176,0.0246584335329811,0.00435976476002805,0.0161132946033262,0.0332035724626361,1.56524746314438e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,28224,-0.0242290621610061,0.00429299004641404,-0.0326433226519776,-0.0158148016700346,1.67867344617042e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMAD1,Mothers against decapentaplegic homolog 1,27562,-0.0313648032535949,0.00557241840550615,-0.042286743328387,-0.0204428631788029,1.83464498099503e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,22706,-0.0187763308615247,0.00334298734077089,-0.0253285860494357,-0.0122240756736138,1.96994787994572e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCN5,CCN family member 5,28187,0.0147534103045958,0.00262905247808182,0.00960046744755546,0.0199063531616362,2.02248901191879e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRH,Receptor-type tyrosine-protein phosphatase H,23738,-0.0185812792416264,0.00331202482809184,-0.0250728479046864,-0.0120897105785664,2.0428938326133e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IKBKG,NF-kappa-B essential modulator,28176,-0.0347142257530497,0.00619470958922003,-0.0468558565479209,-0.0225725949581784,2.11600016493874e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRG3,Proteoglycan 3,23862,0.0188254898892697,0.00336177690208242,0.0122364071611881,0.0254145726173512,2.16882878611606e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINF2,Alpha-2-antiplasmin,23460,0.0051400635244527,0.000919532675974061,0.00333777947954354,0.00694234756936186,2.29773233419592e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HPCAL1,Hippocalcin-like protein 1,28521,0.0276646381508017,0.00495013462434997,0.0179623742870758,0.0373669020145277,2.30912812796239e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HBEGF,Proheparin-binding EGF-like growth factor,28363,0.0274459966339122,0.0049139391295408,0.0178146759400122,0.0370773173278122,2.35386729382747e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MANF,Mesencephalic astrocyte-derived neurotrophic factor,28320,0.0450164458470793,0.00806321806875542,0.0292125384323187,0.0608203532618399,2.38655231524111e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,POF1B,Protein POF1B,23188,-0.0172804300191663,0.00310056883021264,-0.0233575449263831,-0.0112033151119495,2.52724656326359e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,27562,-0.0164993666849672,0.00297511264151102,-0.0223305874623288,-0.0106681459076055,2.95303920144272e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC6A,C-type lectin domain family 6 member A,27562,0.017631010407481,0.00318093056443763,0.0113963865011832,0.0238656343137787,3.00532427990774e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD99L2,CD99 antigen-like protein 2,28187,0.00906956261247304,0.00163653245921624,0.00586195899240921,0.0122771662325369,3.0181590027317e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",28176,0.0308893889993492,0.00557920056838178,0.019954155885321,0.0418246221133775,3.11279519336011e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGS10,Regulator of G-protein signaling 10,23795,0.0222803209711771,0.00403220488510772,0.014377199396366,0.0301834425459883,3.31816720422839e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,23725,-0.0179780648160814,0.0032621842607088,-0.0243719459670707,-0.0115841836650922,3.60407454021569e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,28237,-0.00990133638152914,0.00179967039296123,-0.0134286903517332,-0.00637398241132512,3.79302896032091e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMN,Protein amnionless,27702,-0.0176792887183682,0.00321438675177067,-0.0239794867518387,-0.0113790906848977,3.83037184002172e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFX1,Transcriptional repressor NF-X1,23071,-0.0251543632522284,0.00457987384550054,-0.0341309159894094,-0.0161778105150473,4.00762030850599e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARSA,Arylsulfatase A,28187,-0.0165945691899122,0.00302661955827478,-0.0225267435241308,-0.0106623948556937,4.22063625726366e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENTR1,Endosome-associated-trafficking regulator 1,23198,-0.0219384813931229,0.00401308095480702,-0.0298041200645447,-0.0140728427217011,4.6310680048988e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICAM4,Intercellular adhesion molecule 4,28176,0.0194407234432158,0.0035605007913593,0.0124621418921516,0.02641930499428,4.79858633404471e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTUS1,Microtubule-associated tumor suppressor 1,23393,-0.0207853001660659,0.00380687803899013,-0.0282467811224866,-0.0133238192096453,4.81160060947429e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,28276,0.0328793470341963,0.00602433385496889,0.0210716526784573,0.0446870413899353,4.86237780449265e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DHPS,Deoxyhypusine synthase,23725,-0.0149183712826719,0.00274920605633612,-0.0203068151530907,-0.00952992741225308,5.80558133575018e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPR,Nucleoprotein TPR,23071,-0.0176202177866973,0.00324876059273713,-0.0239877885484621,-0.0112526470249325,5.89733740496113e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBC1D17,TBC1 domain family member 17,27544,-0.0163308288680507,0.00301865685720832,-0.022247396308179,-0.0104142614279224,6.35621814242392e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPIB,Peptidyl-prolyl cis-trans isomerase B,28210,0.034617227653901,0.0064052529125332,0.022062931945336,0.0471715233624661,6.55138230858037e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,23337,0.0232258298749705,0.0043018853483537,0.0147941345921972,0.0316575251577438,6.76719670411478e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UNC5D,Netrin receptor UNC5D,23188,0.00958481087962335,0.00177584082829545,0.00610416285616427,0.0130654589030824,6.83012372266544e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFNA1,Ephrin-A1,28135,0.0103282291267892,0.0019168678983075,0.00657116804610651,0.0140852902074719,7.1787873107618e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MARCO,Macrophage receptor MARCO,28224,0.0095795802197198,0.00178102029136424,0.00608878044864589,0.0130703799907937,7.56205005293284e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MFAP4,Microfibril-associated glycoprotein 4,23337,-0.0116909946266131,0.00217578283912518,-0.0159555289912985,-0.00742646026192775,7.80771667633265e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGA6,Integrin alpha-6,28176,0.018965155814175,0.00353415045322603,0.0120382209258519,0.025892090702498,8.10222343349048e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IMMT,MICOS complex subunit MIC60,23725,-0.0160877812809257,0.00299801178270937,-0.0219638843750361,-0.0102116781868154,8.11893124933528e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA13,Carbonic anhydrase 13,27879,0.0378756451031913,0.00706275242185778,0.0240326503563501,0.0517186398500326,8.26249313344311e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCTN2,Dynactin subunit 2,28091,-0.0342000228577443,0.00639393469898813,-0.046732134867761,-0.0216679108477276,8.92201631417962e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LEPR,Leptin receptor,28224,0.0111343537037701,0.00208927886177557,0.00703936713468993,0.0152293402728502,9.93586486131696e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MBL2,Mannose-binding protein C,23549,0.0389395825783078,0.00730760664455606,0.0246166735549779,0.0532624916016377,9.9862355314363e-08
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RFC4,Replication factor C subunit 4,23725,-0.00766598320962232,0.0014408809717626,-0.010490109914277,-0.00484185650496761,1.04510351650778e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NADK,NAD kinase,28224,-0.0194318529281513,0.00365964333807991,-0.026604753870788,-0.0122589519855147,1.10595451105709e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLB,Beta-klotho,27544,0.0265680803572005,0.00500952972220226,0.016749402101684,0.0363867586127169,1.1447443319092e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GZMB,Granzyme B,28176,0.0234360502398743,0.00441918766108329,0.014774442424151,0.0320976580555975,1.14617375885042e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATG4A,Cysteine protease ATG4A,27562,-0.0210800634466064,0.00398719845155387,-0.028894972411652,-0.0132651544815608,1.25329157902033e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFD,Complement factor D,23893,0.00700333925503988,0.00132547820775024,0.00440540196784941,0.00960127654223035,1.2775779120793e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LBP,Lipopolysaccharide-binding protein,28336,0.0207597078938089,0.0039420902282935,0.0130332110463537,0.0284862047412642,1.40317085820557e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRP11,Low-density lipoprotein receptor-related protein 11,28224,-0.0128686486530575,0.00244514713175774,-0.0176611370313027,-0.00807616027481237,1.42809930838947e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMA4,Laminin subunit alpha-4,28320,0.0118816056850219,0.00226681038525599,0.00743865732992021,0.0163245540401237,1.60372198756171e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPD52L2,Tumor protein D54,23337,0.0382875187480004,0.00730712228439392,0.0239655590705883,0.0526094784254125,1.62188755784158e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTN3,Contactin-3,28187,-0.01138884452003,0.00217499020219887,-0.0156518253163398,-0.00712586372372024,1.65025824165022e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGLC2,Immunoglobulin lambda constant 2,23843,0.00882306573659137,0.00169151914502222,0.00550768821234783,0.0121384432608349,1.84296248039414e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MOG,Myelin-oligodendrocyte glycoprotein,28452,0.011629858878353,0.00223217567048815,0.00725479456419623,0.0160049231925098,1.90053832322767e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINI2,Serpin I2,23738,-0.0199863524638632,0.00383702004130324,-0.0275069117448175,-0.0124657931829088,1.91630592903135e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,27965,-0.0259421442352826,0.0049844325244194,-0.0357116319831446,-0.0161726564874205,1.9575242368009e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REG4,Regenerating islet-derived protein 4,28237,-0.0175202286966144,0.00336968947872697,-0.0241248200749192,-0.0109156373183095,2.01368782506648e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LPCAT2,Lysophosphatidylcholine acyltransferase 2,28091,-0.0136987099429369,0.00263506949302852,-0.0188634461492728,-0.00853397373660097,2.02184664190071e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,28176,-0.0214993287356964,0.00413953216040834,-0.0296128117700967,-0.013385845701296,2.07631180979277e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MPI,Mannose-6-phosphate isomerase,28091,0.0301031527536541,0.00579716273512538,0.0187407137928083,0.0414655917144998,2.08666401662898e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC27,Cell division cycle protein 27 homolog,27562,-0.0214330283022649,0.00412939701135747,-0.0295266464445255,-0.0133394101600042,2.11383625773822e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSTN,Growth/differentiation factor 8,27682,-0.0184908680951629,0.0035635075868802,-0.0254753429654481,-0.0115063932248777,2.12972491884753e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SULT2A1,Bile salt sulfotransferase,28176,-0.0196924320720098,0.00379621894282489,-0.0271330211999466,-0.012251842944073,2.1474819597714e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOTCH1,Neurogenic locus notch homolog protein 1,28553,0.00556168709070861,0.00107325018232745,0.00345811673334681,0.00766525744807041,2.20896361319103e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEZ6L,Seizure 6-like protein,28307,0.00966236679972182,0.0018654596591708,0.00600606586774705,0.0133186677316966,2.23864001504453e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LBR,Delta(14)-sterol reductase LBR,28428,-0.0233471051961318,0.00451258089528454,-0.0321917637508895,-0.0145024466413741,2.30960768282014e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TDP1,Tyrosyl-DNA phosphodiesterase 1,23725,-0.0238314517873499,0.00461255530816508,-0.0328720601913534,-0.0147908433833463,2.40258103497269e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PMM2,Phosphomannomutase 2,23071,0.0209522460612404,0.00407115213059442,0.0129727878852754,0.0289317042372055,2.67546083980499e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VIT,Vitrin,23846,-0.0130783659613768,0.00254534434080007,-0.018067240869345,-0.00808949105340871,2.79640564823864e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VASP,Vasodilator-stimulated phosphoprotein,23872,0.0252432842527812,0.0049186496078107,0.0156027310214722,0.0348838374840901,2.88684949160141e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GHRL,Appetite-regulating hormone,28224,0.0280126745643925,0.00548031600510747,0.0172712551943818,0.0387540939344031,3.21683511787342e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,23775,-0.0298249895509095,0.00583617135419324,-0.0412638854051282,-0.0183860936966907,3.24019310317124e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,27965,-0.0135861776773692,0.00265998719148194,-0.0187997525726738,-0.00837260278206462,3.28400554293472e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTN,Pleiotrophin,27682,0.0172409325334854,0.00338526289598131,0.0106058172573621,0.0238760478096088,3.54870025984983e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",28121,-0.0225801132787826,0.0044450571188696,-0.031292425231767,-0.0138678013257982,3.80196857331527e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCER2,Low affinity immunoglobulin epsilon Fc receptor,28187,0.0174652667867861,0.00343847102406336,0.0107258635796219,0.0242046699939503,3.81102284812656e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SGSH,N-sulphoglucosamine sulphohydrolase,23507,-0.0192616501280007,0.00379282036560867,-0.0266955780445937,-0.0118277222114077,3.8343395393892e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MANSC1,MANSC domain-containing protein 1,28307,0.00947812590845352,0.00186685188384976,0.00581909621610798,0.0131371556007991,3.85741093445419e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRH,Corticoliberin,27520,0.0298538062067336,0.00588019977288098,0.0183286146518869,0.0413789977615803,3.85928910680486e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G2A,"Phospholipase A2, membrane associated",28155,0.0191568441893855,0.00377475588993304,0.0117583226451168,0.0265553657336543,3.89983370650554e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA7,Thyroxine-binding globulin,23893,0.00633033205315445,0.00124872322102602,0.00388283453994344,0.00877782956636546,4.01959428350191e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,23188,-0.0116011375583497,0.00228850075523972,-0.0160865990386196,-0.00711567607807985,4.02316097473011e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLC,Galectin-10,28174,0.0226531052756658,0.0044810952653004,0.013870158555677,0.0314360519956546,4.32493941672716e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPQ,Carboxypeptidase Q,23844,-0.0125661067897922,0.00248853761752397,-0.0174436405201391,-0.00768857305944516,4.46010995562265e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLF4,Krueppel-like factor 4,23056,-0.0135504962764934,0.0026981925242678,-0.0188389536240583,-0.00826203892892855,5.15005740077219e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP6,Gastrotropin,27639,0.0191639388329073,0.00381795784550925,0.0116807414557092,0.0266471362101054,5.21491847386265e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAYN,Layilin,27910,-0.0118735992262336,0.00236574863403844,-0.016510466548949,-0.00723673190351829,5.2271120452213e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AZU1,Azurocidin,27324,-0.0259175464634547,0.00517524335504059,-0.0360610234393342,-0.0157740694875751,5.53449590559241e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CX3CL1,Fractalkine,27965,0.0114348162569571,0.00228537518854797,0.00695548088740304,0.0159141516265111,5.66474468903237e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OMD,Osteomodulin,28320,0.0145505233167751,0.0029145396576112,0.00883802558785718,0.0202630210456931,5.9990079468001e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHA1,Ephrin type-A receptor 1,28277,-0.01119071603672,0.00224369679955871,-0.0155883617638551,-0.00679307030958493,6.14883344509895e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NT5C1A,Cytosolic 5'-nucleotidase 1A,23775,-0.0105681540091909,0.00211885921596332,-0.014721118072479,-0.00641518994590281,6.15449593979042e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,28428,0.0154551207510542,0.00310266194615999,0.00937390333658064,0.0215363381655278,6.35466042460632e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC4G,C-type lectin domain family 4 member G,28176,0.01119525585535,0.00224804357478559,0.00678909044877025,0.0156014212619298,6.39600742500728e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RETN,Resistin,28117,0.01413597906713,0.00283980241448907,0.00856996633473142,0.0197019917995286,6.46898859212947e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD46,Membrane cofactor protein,28087,0.00967128233612869,0.00194319412875854,0.00586262184376196,0.0134799428284954,6.49582533717178e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SORBS1,Sorbin and SH3 domain-containing protein 1,23795,-0.0132721795838853,0.0026666353395244,-0.0184987848493531,-0.00804557431841749,6.49860532295761e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJB2,DnaJ homolog subfamily B member 2,23337,-0.0179820207048726,0.00362100388580703,-0.0250791883210544,-0.0108848530886909,6.88191694873173e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STXBP1,Syntaxin-binding protein 1,23795,0.0259482102205272,0.00522709737340811,0.0157030993686473,0.0361933210724071,6.94717814804205e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRK1,Protein BRICK1,27544,0.0150963187933344,0.00304472365967764,0.00912866042036623,0.0210639771663026,7.15757000154235e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RPL14,60S ribosomal protein L14,23198,-0.0134007727708847,0.00270559957743236,-0.0187037479426522,-0.00809779759911732,7.36003964175163e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNAP25,Synaptosomal-associated protein 25,23056,0.015891662970553,0.00320943008655166,0.00960118000091177,0.0221821459401943,7.41438021847534e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CST5,Cystatin-D,27657,-0.0186110815784858,0.00375978335523368,-0.0259802569547438,-0.0112419062022278,7.4634158923901e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GDNF,Glial cell line-derived neurotrophic factor,27544,-0.0128233401839732,0.00259126510471476,-0.0179022197892142,-0.0077444605787323,7.51594044065419e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",28091,-0.014781951853303,0.00299086250369828,-0.0206440423605516,-0.00891986134605436,7.76223211010191e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM21,E3 ubiquitin-protein ligase TRIM21,28176,-0.0256895332582026,0.0052049227377996,-0.0358911818242899,-0.0154878846921154,8.03515044923532e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HYOU1,Hypoxia up-regulated protein 1,28553,0.00742975031935543,0.0015067241828093,0.0044765709210492,0.0103829297176617,8.22426872361706e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MCAM,Cell surface glycoprotein MUC18,28336,0.0110932141617805,0.00225200700272653,0.00667928043643653,0.0155071478871245,8.44356986173245e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOTCH3,Neurogenic locus notch homolog protein 3,28553,0.0113546847661247,0.00230541455599539,0.00683607223637371,0.0158732972958756,8.4734120901393e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FDX2,"Ferredoxin-2, mitochondrial",23071,0.0187884880223762,0.00381934290031138,0.0113025759377659,0.0262744001069865,8.74529160911707e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BACH1,Transcription regulator protein BACH1,28176,-0.0245231683851129,0.00498583991182989,-0.0342954146122995,-0.0147509221579263,8.76727230431416e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMPD1,Sphingomyelin phosphodiesterase,28270,-0.0163612050449241,0.00333013032883898,-0.0228882604894485,-0.00983414960039971,9.01565375118426e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL32,Interleukin-32,28176,0.014509323830637,0.00295348148945221,0.00872050011131064,0.0202981475499633,9.03723473843206e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDGFB,Platelet-derived growth factor subunit B,28320,0.0284302713631494,0.00578779826589491,0.0170861867619954,0.0397743559643035,9.06061273777103e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDCD1,Programmed cell death protein 1,28389,0.0143123205778003,0.00291436128775446,0.00860017245380158,0.0200244687017991,9.11336580224484e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTBP2,Latent-transforming growth factor beta-binding protein 2,28553,0.0105569002972726,0.00215171982056871,0.00633952944895791,0.0147742711455872,9.3339543225822e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPT,Dermatopontin,28553,0.00868264108625347,0.00177426279951593,0.00520508599920226,0.0121601961733047,9.95164480800912e-07
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BGN,Biglycan,27516,-0.03960255423597,0.00809992413781809,-0.0554784055460934,-0.0237267029258465,1.0179124629718e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSHB,Thyrotropin subunit beta,28224,0.025493931319289,0.00521559452529067,0.0152713660497193,0.0357164965888587,1.02414058630817e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD300LG,CMRF35-like molecule 9,28187,0.0123530772206776,0.00253047940455426,0.00739333758775124,0.017312816853604,1.05742644223153e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRISP3,Cysteine-rich secretory protein 3,23663,0.00892792646188501,0.00183292087977311,0.00533540153752971,0.0125204513862403,1.11823572381215e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",28109,-0.0219343281844192,0.00450580503482492,-0.030765706052676,-0.0131029503161623,1.13335968743325e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP3R1,Calcineurin subunit B type 1,27965,0.0134690525125563,0.00276722659543445,0.00804528838550473,0.0188928166396078,1.1372255974146e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,23071,-0.0224044693441318,0.00460559428654976,-0.0314314341457693,-0.0133775045424942,1.15432722288162e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,28176,0.0394442391117283,0.0081088807247697,0.0235508328911797,0.0553376453322769,1.15467125763561e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MESD,LRP chaperone MESD,28187,0.0399400296064193,0.00821544410076288,0.0238377591689241,0.0560423000439146,1.1707982379663e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRYBB1,Beta-crystallin B1,23846,0.0214567671630946,0.00441690298542148,0.0127996373116685,0.0301138970145207,1.19404534732292e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDH17,Protocadherin-17,28224,-0.0118776148754023,0.00244597017560415,-0.0166717164195865,-0.0070835133312182,1.20425633033067e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD248,Endosialin,23862,0.0131540846707922,0.00271194976662203,0.007838663128213,0.0184695062133714,1.23979387537576e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYPD8,Ly6/PLAUR domain-containing protein 8,27562,-0.0170116591730939,0.00350891294144013,-0.0238891285383165,-0.0101341898078713,1.25310603371288e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RRM2,Ribonucleoside-diphosphate reductase subunit M2,27562,-0.0166753386949003,0.00345730808512903,-0.0234516625417531,-0.00989901484804736,1.42016940956593e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM5,Tripartite motif-containing protein 5,28176,-0.0280274732059849,0.00581531948767322,-0.0394254994018244,-0.0166294470101454,1.44600310843718e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB6,Integrin beta-6,27702,-0.00991279047377807,0.0020595860083908,-0.013949579050224,-0.0058760018973321,1.49463417412964e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMP2,Lysosome-associated membrane glycoprotein 2,27373,-0.00641181963594531,0.00133263644610355,-0.00902378707030828,-0.00379985220158235,1.50690198377776e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSNAX,Translin-associated protein X,23071,-0.0128515843774445,0.00267122300012139,-0.0180871814576824,-0.00761598729720662,1.51032438491732e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNLY,Granulysin,28187,0.0169392950742029,0.00352660410411036,0.0100271510301466,0.0238514391182592,1.56882910223283e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBM17,Splicing factor 45,23795,0.024833247209927,0.00517049268195345,0.0146990815532982,0.0349674128665557,1.57352752759369e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLU,Clusterin,23893,0.0101657975490391,0.00212042739371732,0.00600975985735311,0.014321835240725,1.64291067518092e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CBLN4,Cerebellin-4,28452,-0.010288891692605,0.00214822054789696,-0.0144994039664831,-0.006078379418727,1.6804300084573e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RALY,RNA-binding protein Raly,23725,-0.0155232556063819,0.00324831010932591,-0.0218899434206607,-0.0091565677921031,1.77337477143794e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,23846,0.0109051239360042,0.00228314965841475,0.00643015060551131,0.0153800972664971,1.79565901818228e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VNN1,Pantetheinase,23872,-0.0234852310268772,0.00491979018344983,-0.0331280197864388,-0.0138424422673155,1.82011641131096e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UROS,Uroporphyrinogen-III synthase,23163,-0.022047469460017,0.00462205358590748,-0.0311066944883956,-0.0129882444316383,1.85293205939291e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F2R,Proteinase-activated receptor 1,28276,0.0185037379954548,0.0038798360305121,0.0108992593756511,0.0261082166152585,1.85874724306661e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCAM1,Neural cell adhesion molecule 1,28336,0.0097842483813972,0.00205215048261285,0.00576203343547601,0.0138064633273184,1.8717100788732e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUS,RNA-binding protein FUS,27532,-0.0127318133129654,0.00267862810277498,-0.0179819243944043,-0.00748170223152642,2.01323289574083e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLRX,Glutaredoxin-1,28044,-0.0180329146940186,0.00379443831938348,-0.0254700138000102,-0.010595815588027,2.01952857699371e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPP1,Tripeptidyl-peptidase 1,28031,-0.0147073199747068,0.00309821766030854,-0.0207798265889115,-0.00863481336050205,2.07448353959468e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,23194,-0.0125173578917225,0.00263759147555201,-0.0176870371838044,-0.00734767859964055,2.08970607708541e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,28187,0.01150687541998,0.00243209545254433,0.00673996833299314,0.0162737825069669,2.24212130240176e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF2,Granulocyte-macrophage colony-stimulating factor,23071,-0.0114530307944293,0.00242391912499796,-0.0162039122794253,-0.00670214930943331,2.31465619995711e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMBP,Protein AMBP,28411,-0.00642871364451707,0.00136179915329148,-0.00909783998496837,-0.00375958730406577,2.36096523940762e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMP3,Metalloproteinase inhibitor 3,28320,0.0415270150357459,0.00879811259006709,0.0242827143592144,0.0587713157122774,2.36981989380646e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH2D1A,SH2 domain-containing protein 1A,28176,-0.0182393333716761,0.00387679505014935,-0.0258378516699689,-0.0106408150733834,2.5538905575022e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AIF1L,Allograft inflammatory factor 1-like,23198,0.0181698794583337,0.00386274899716106,0.010598891423898,0.0257408674927693,2.56743240656216e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCARF1,Scavenger receptor class F member 1,28553,0.0134816215778848,0.00287009740503459,0.00785623066401699,0.0191070124917526,2.64889096491749e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEGF10,Multiple epidermal growth factor-like domains protein 10,28195,-0.0125951454296911,0.00268207092379087,-0.0178520044403212,-0.00733828641906097,2.66486291586678e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA4,Annexin A4,28093,0.0228825153568813,0.00488163411513468,0.0133145124912174,0.0324505182225453,2.77900474771835e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFKBIE,NF-kappa-B inhibitor epsilon,27562,-0.0157068640140298,0.00335590347329897,-0.0222844348216958,-0.00912929320636383,2.87721638920708e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH3GLB2,Endophilin-B2,23775,-0.0209762867708278,0.00448602622752925,-0.0297688981767851,-0.0121836753648704,2.94250551973139e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",23337,0.0281374345503132,0.00602191122158378,0.016334488556009,0.0399403805446174,2.992031950951e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",28091,-0.0308190353811014,0.00659695379706622,-0.0437490648233512,-0.0178890059388516,3.00090362060213e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFF1,Trefoil factor 1,28070,-0.0249203092160139,0.00533764351313023,-0.0353820905017491,-0.0144585279302786,3.0438749548514e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLYR1,Putative oxidoreductase GLYR1,23725,-0.0186690071982058,0.00400310872767156,-0.0265151003044421,-0.0108229140919695,3.12377065099443e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,23846,-0.00865299711013571,0.00186076705286393,-0.012300100533749,-0.0050058936865224,3.33341099763547e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C8B,Complement component C8 beta chain,23893,0.0094889668434391,0.00205200957281148,0.0054670280807286,0.0135109056061496,3.77959606878526e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCN1,Ficolin-1,23841,-0.0173991108074624,0.00377827212839422,-0.024804524179115,-0.0099936974358097,4.14508371770503e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,27702,0.01321040067952,0.00286899491262099,0.00758717065078284,0.0188336307082571,4.15215896045388e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPB2,Carboxypeptidase B2,23845,0.00702895679668116,0.00152860659269285,0.00403288787500318,0.0100250257183591,4.2818707279146e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADD1,Alpha-adducin,23337,-0.0217736349763984,0.00473552848557331,-0.0310552708081221,-0.0124919991446747,4.28945376672304e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,28091,-0.00869347890088809,0.00189082032685415,-0.0123994867415222,-0.00498747106025396,4.28982298026961e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PHACTR2,Phosphatase and actin regulator 2,23795,0.0353036179329104,0.00769814290421085,0.0202152578406572,0.0503919780251637,4.54138869122116e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGSF8,Immunoglobulin superfamily member 8,28224,-0.00944137530415587,0.00206133247133662,-0.0134815869479756,-0.00540116366033609,4.66451022544549e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA5,Plasma serine protease inhibitor,23585,-0.00985305615968299,0.00215255155270958,-0.0140720572029938,-0.00563405511637222,4.73228187280794e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GZMH,Granzyme H,27682,0.0237933341294826,0.00519952686777574,0.0136022614686421,0.0339844067903231,4.75877271640167e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOS3,"Nitric oxide synthase, endothelial",27544,-0.016269052192191,0.0035601786880249,-0.0232470024207198,-0.00929110196366218,4.90474485673947e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL5,C-C motif chemokine 5,28336,0.0310159540421499,0.00679868836046584,0.0176905248556369,0.0443413832286629,5.08689743927625e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F9,Coagulation factor IX,28291,-0.00561521227717572,0.00123276885090254,-0.0080314392249447,-0.00319898532940673,5.26143015189789e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,28340,-0.0317553714966341,0.00697779961610348,-0.0454318587441969,-0.0180788842490713,5.36349270208621e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFBR2,TGF-beta receptor type-2,28307,-0.0100976940667659,0.00222403177813602,-0.0144567963519125,-0.00573859178161934,5.64149524022309e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1S,Complement C1s subcomponent,23893,0.00640674605454697,0.00141205298330213,0.0036391222072748,0.00917436990181914,5.72876156073599e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD276,CD276 antigen,28195,-0.011026959527102,0.00243089000423626,-0.0157915039354051,-0.00626241511879896,5.75178299821946e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,27682,0.00658658837503722,0.00145486487977006,0.00373505321068791,0.00943812353938654,5.99951859540191e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,23071,0.0124179511755906,0.0027446519646817,0.0070384333248145,0.0177974690263668,6.08642454848734e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL4A1,Collagen alpha-1(IV) chain,28224,-0.0121257093024821,0.00268087074223217,-0.0173802159572571,-0.00687120264770701,6.12033562427755e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMD9,26S proteasome non-ATPase regulatory subunit 9,28091,-0.0165592655590718,0.00366541689346591,-0.023743482670265,-0.00937504844787863,6.27686184430236e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF41,E3 ubiquitin-protein ligase NRDP1,27562,-0.020374025884614,0.0045152351610606,-0.0292238868002928,-0.0115241649689352,6.43980479186184e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGLYRP1,Peptidoglycan recognition protein 1,28411,0.0128985469835694,0.00285965342611191,0.00729362626839009,0.0185034676987488,6.49252488495888e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGAM,Integrin alpha-M,28187,0.00962609131379154,0.00213450725772167,0.00544245708865706,0.013809725538926,6.5166113506304e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYH9,Myosin-9,23862,-0.0342997761975493,0.00762335273686236,-0.0492415475617995,-0.0193580048332991,6.84984232219608e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAP18,Chromatin complexes subunit BAP18,23775,-0.020170483580873,0.0044840787783425,-0.0289592779864243,-0.0113816891753217,6.88412080731604e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,23738,0.0269031562858824,0.00601431019647178,0.0151151083007977,0.0386912042709671,7.74186855971785e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNCG,Gamma-synuclein,27965,-0.0202433879481341,0.0045258942114766,-0.0291141406026283,-0.01137263529364,7.7508477229823e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GMPR,GMP reductase 1,28521,-0.0149331391275445,0.00334058683988613,-0.0214806893337213,-0.00838558892136767,7.84422390852271e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTN5,Contactin-5,28253,0.0111897471621832,0.00250925800042658,0.00627160148134709,0.0161078928430193,8.25118638788231e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GYS1,"Glycogen [starch] synthase, muscle",27682,0.02803726429472,0.00628835560417841,0.0157120873105303,0.0403624412789097,8.28207501590336e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GET3,ATPase GET3,23846,-0.0165453537554942,0.0037151752842211,-0.0238270973125676,-0.00926361019842086,8.48845915490041e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,23198,0.0159204327356404,0.00357854548461679,0.00890648358579148,0.0229343818854893,8.67305301356721e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,27965,-0.0160857090298332,0.00361647218036414,-0.023173994503347,-0.0089974235563195,8.70478019668024e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",23795,0.0127158160670374,0.00286205242282845,0.00710619331829368,0.0183254388157812,8.91543486032976e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL27,C-C motif chemokine 27,28224,-0.0182732347765866,0.00413085000202423,-0.0263697007805541,-0.0101767687726192,9.74319115596681e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRTAM,Cytotoxic and regulatory T-cell molecule,27965,0.0151910411339053,0.00343628297665301,0.00845592649966538,0.0219261557681452,9.87168313607632e-06
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAXX,Protein PAXX,23337,-0.0136800693022528,0.00310270076355696,-0.0197613627988244,-0.00759877580568115,1.04272380004039e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARFIP1,Arfaptin-1,23795,0.020535217555316,0.00466185574467411,0.0113979802957548,0.0296724548148773,1.06272723707315e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAG6,Large proline-rich protein BAG6,27682,-0.0108908958219714,0.00247283203735484,-0.0157376466151869,-0.00604414502875594,1.06563292415097e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BSG,Basigin,28496,-0.00611832029306657,0.00139157410687422,-0.00884580554254004,-0.0033908350435931,1.1031170987188e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZBTB17,Zinc finger and BTB domain-containing protein 17,27682,-0.0123471109259667,0.00280927540293131,-0.0178532907157121,-0.00684093113622133,1.11121851354994e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACRBP,Acrosin-binding protein,23725,0.0115590162350857,0.00263011469786953,0.00640399142726138,0.0167140410429099,1.11319366886489e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,28428,0.0211099822167262,0.0048203311911115,0.0116621330821477,0.0305578313513048,1.19451693817417e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA10,Annexin A10,27544,-0.0243299303071722,0.00555793363423052,-0.035223480230264,-0.0134363803840804,1.20482764083891e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1GALT1C1,C1GALT1-specific chaperone 1,23071,0.0096573382545455,0.00220707592495494,0.00533146944163382,0.0139832070674572,1.216161086642e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTSL5,ADAMTS-like protein 5,23846,-0.011632714866979,0.00265955757116091,-0.0168454477064543,-0.00641998202750357,1.22547752412781e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F2,Prothrombin,23893,0.00437500474318694,0.00100140495194629,0.00241225103737221,0.00633775844900167,1.2541916360042e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VASH1,Tubulinyl-Tyr carboxypeptidase 1,28176,0.0241814644124167,0.00554130481484556,0.0133205069753194,0.035042421849514,1.28243259887791e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB44,Ras-related protein Rab-44,23725,-0.0123896237716348,0.00284570396323945,-0.0179672035395841,-0.00681204400368548,1.34358508726155e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEZ6L2,Seizure 6-like protein 2,28091,0.00705985474967788,0.001622463479578,0.003879826329705,0.0102398831696508,1.35798917310941e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SART1,U4/U6.U5 tri-snRNP-associated protein 1,23071,-0.0107846877229189,0.00247909312610294,-0.0156437102500807,-0.00592566519575715,1.36562951072465e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCS,Copper chaperone for superoxide dismutase,27965,-0.0139411805963958,0.00320573419454703,-0.020224419617708,-0.0076579415750836,1.37352123183463e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MGMT,Methylated-DNA--protein-cysteine methyltransferase,28176,0.0355858766649753,0.0081889072795087,0.0195356183971382,0.0516361349328123,1.39369038386659e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RSPO3,R-spondin-3,28452,0.00834787613767273,0.00192236088304061,0.00458004880691313,0.0121157034684323,1.41349299922772e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FXYD5,FXYD domain-containing ion transport regulator 5,27702,0.0193154783989727,0.00445143209730631,0.0105906714882523,0.028040285309693,1.43534246959051e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDAR,Tumor necrosis factor receptor superfamily member EDAR,28176,0.0268012287092184,0.00619866690858721,0.0146518415683874,0.0389506158500493,1.53954659142869e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL5,C-X-C motif chemokine 5,28134,0.0332626959387204,0.00769758209209978,0.0181754350382049,0.048349956839236,1.55724004418928e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIAA0319,Dyslexia-associated protein KIAA0319,23775,0.00897468879707618,0.0020768900392813,0.00490398432008484,0.0130453932740675,1.55802301036686e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYOM3,Myomesin-3,23337,-0.0272455410227232,0.00631657594549959,-0.0396260298759024,-0.014865052169544,1.61466969059796e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUSD5,Sushi domain-containing protein 5,23235,0.00999377018804339,0.00231847572345086,0.00544955777007969,0.0145379826060071,1.63562412161412e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BDNF,Brain-derived neurotrophic factor,23862,0.0241273253312007,0.00560617987483309,0.0131392127765279,0.0351154378858736,1.68636920522874e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VWC2L,von Willebrand factor C domain-containing protein 2-like,23795,0.0136056710752624,0.00316256352018295,0.00740704657570386,0.019804295574821,1.6986019025016e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",28176,-0.0283396530991273,0.00660005399490405,-0.0412757589291392,-0.0154035472691154,1.76186813258668e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL22,Interleukin-22,23725,-0.0195931046084394,0.00456490873065366,-0.0285403257205206,-0.0106458834963583,1.77682531492526e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FADD,FAS-associated death domain protein,28224,0.0221555480514003,0.00516911734725663,0.0120240780507773,0.0322870180520233,1.82409019582671e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IMPA1,Inositol monophosphatase 1,27965,0.0176883826993838,0.00413186882446911,0.00958991980342436,0.0257868455953432,1.86704891683426e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPP1,Osteopontin,28494,0.0133281217935239,0.0031176783636731,0.00721747220072459,0.0194387713863231,1.91745693946399e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP4,"Fatty acid-binding protein, adipocyte",28553,-0.0143750961761129,0.00337889349001154,-0.0209977274165355,-0.00775246493569028,2.1029682389792e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTRL,Chymotrypsin-like protease CTRL-1,23775,0.0194954272726071,0.00458277954757653,0.0105131793593571,0.0284776751858571,2.10730278293949e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,23393,0.0105061934770413,0.00247134756330045,0.00566235225297247,0.0153500347011102,2.13452354801012e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRCAM,Neuronal cell adhesion molecule,28224,-0.00817256451529972,0.00192313684687356,-0.0119419127351719,-0.00440321629542755,2.14838509831811e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOB,Apolipoprotein B-100,23872,0.00647326897736706,0.00152388333208006,0.00348645764649014,0.00946008030824399,2.16623305920014e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM24,Transcription intermediary factor 1-alpha,23348,-0.0186417180562048,0.00440214326185054,-0.0272699188494318,-0.0100135172629777,2.29741847821292e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FST,Follistatin,28276,0.0144498053458108,0.00341332497070508,0.00775968840322885,0.0211399222883928,2.30960486609115e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGA11,Integrin alpha-11,28176,0.00982436961351837,0.00232158185948196,0.00527406916893373,0.014374670058103,2.32606411729058e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYAR,Cell growth-regulating nucleolar protein,27562,-0.015206205364164,0.00359846484883903,-0.0222591964678885,-0.00815321426043954,2.3891422348154e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,28091,0.026842350604971,0.006357684615744,0.0143812887581127,0.0393034124518292,2.42870523835358e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PROK1,Prokineticin-1,28176,0.0174149749987953,0.00413382839592314,0.00931267134278596,0.0255172786548047,2.53013158691014e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJB1,DnaJ homolog subfamily B member 1,28091,-0.0246658809726331,0.00585890367580868,-0.0361493321772181,-0.0131824297680481,2.56184978106153e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDGFA,Platelet-derived growth factor subunit A,28553,0.0204107556116199,0.00485313993661511,0.0108986013358543,0.0299229098873856,2.61091204454148e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",28044,-0.0215169667131161,0.0051183919044712,-0.0315490148458796,-0.0114849185803525,2.63222492877644e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MDK,Midkine,28199,0.0144784587990724,0.00344472640784222,0.00772679503970167,0.0212301225584431,2.64118831210028e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP8,Neutrophil collagenase,28378,0.0205881012846191,0.00489934146507388,0.0109853920130743,0.0301908105561639,2.65120357465663e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB2,Integrin beta-2,28031,0.00815399473838743,0.00194151920990424,0.00434861708697512,0.0119593723897997,2.67974449913679e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,23188,-0.0138696339198411,0.00331067843151309,-0.0203585636456067,-0.00738070419407542,2.80773384101786e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PVALB,Parvalbumin alpha,28330,0.0318256815576873,0.00759872366354242,0.0169321831771442,0.0467191799382304,2.81910328610518e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENSA,Alpha-endosulfine,23725,0.0149037437476326,0.0035644896911321,0.00791734395301366,0.0218901435422515,2.91051376926859e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGAV,Integrin alpha-V,28452,0.00470136086721159,0.00112484645438381,0.00249666181661933,0.00690605991780385,2.92948822085759e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EGF,Pro-epidermal growth factor,28125,0.0291639413526428,0.00698482948359918,0.0154736755647884,0.0428542071404972,2.98455116514117e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK2,Serine protease inhibitor Kazal-type 2,23337,0.0104249938678294,0.00249741641016477,0.00553005770390641,0.0153199300317523,2.99972331757053e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,23071,0.00731137986068345,0.00175349325602932,0.00387453307886598,0.0107482266425009,3.062379927042e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,27562,-0.0191538069140584,0.00459382641397215,-0.0281577066854438,-0.010149907142673,3.06245894595069e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMG4,Proteasome assembly chaperone 4,23188,-0.0158237312395534,0.00379728408197184,-0.0232664080402182,-0.00838105443888861,3.09592959166311e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD207,C-type lectin domain family 4 member K,27597,-0.0109164233969464,0.0026199951935969,-0.0160516139763963,-0.00578123281749643,3.10142501389492e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VEGFB,Vascular endothelial growth factor B,23188,0.00816392996623964,0.00195954817599448,0.00432321554129046,0.0120046443911888,3.10798895848041e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB7,Integrin beta-7,28452,-0.0128672667518238,0.00309984948639712,-0.0189429717451622,-0.00679156175848546,3.32086619051521e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C7,Complement component C7,23319,-0.00913548866150011,0.00220114811625683,-0.0134497389693635,-0.00482123835363673,3.33176370910965e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINC1,Antithrombin-III,23845,0.00413804114104617,0.000998567460144784,0.0021808489191624,0.00609523336292995,3.42511164887295e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIL1,Nucleotide exchange factor SIL1,23198,-0.00895274074630233,0.00216158729941738,-0.0131894518531604,-0.00471602963944426,3.45895531816375e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",23775,-0.0112016146064504,0.00270510548060569,-0.0165036213484376,-0.00589960786446327,3.47115602604606e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFRA3,GDNF family receptor alpha-3,27905,-0.0078934057523434,0.0019063127320255,-0.0116297787071134,-0.00415703279757342,3.47315628459065e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOS1,"Nitric oxide synthase, brain",27544,-0.0152058349294631,0.0036730777295122,-0.022405067279307,-0.00800660257961917,3.48631589356236e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPM1F,Protein phosphatase 1F,23846,0.014758566678496,0.00356834465383699,0.00776461115697546,0.0217525222000165,3.54669117565687e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDH12,Protocadherin-12,23795,-0.00714051909797598,0.00172671801036195,-0.0105248863982854,-0.00375615179766656,3.55687660233594e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRF5,Adhesion G protein-coupled receptor F5,23846,0.00794156241138652,0.00192132575668741,0.00417576392827919,0.0117073608944938,3.58694364065949e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A12,Protein S100-A12,27777,-0.0208906599796167,0.00506242620186538,-0.0308130153352728,-0.0109683046239606,3.69222643475478e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SYT1,Synaptotagmin-1,23775,0.0110422178467397,0.00267819623375305,0.00579295322858372,0.0162914824648957,3.7523041238456e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EREG,Proepiregulin,27910,0.0223784579202638,0.00543277930831324,0.0117302104759699,0.0330267053645578,3.81360553209558e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDHB15,Protocadherin beta-15,23725,-0.0111323997196279,0.00270382016414462,-0.0164318872413514,-0.00583291219790446,3.84658424142154e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL10RB,Interleukin-10 receptor subunit beta,28320,-0.00807385043433993,0.00196860278593924,-0.0119323118947808,-0.00421538897389903,4.11965010883543e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL23,C-C motif chemokine 23,28320,0.011495093424675,0.0028063804989992,0.00599458764663655,0.0169955992027134,4.21415210199254e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC4C,C-type lectin domain family 4 member C,28176,0.0129987853726829,0.00317962349657729,0.00676672331939139,0.0192308474259743,4.36028346253738e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDGFRA,Platelet-derived growth factor receptor alpha,28224,-0.00787125997669311,0.00192880587997196,-0.0116517195014382,-0.00409080045194806,4.49854121823494e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL36A,Interleukin-36 alpha,23188,0.0160746099491837,0.00394104850253972,0.00835015488420584,0.0237990650141615,4.5426899420555e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VCAN,Versican core protein,28428,0.00827254777716869,0.0020304453917829,0.00429287480927421,0.0122522207450632,4.62875709420503e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AZI2,5-azacytidine-induced protein 2,23795,-0.015239358048146,0.00374169828280448,-0.0225730866824428,-0.00790562941384925,4.65926745458638e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,23795,0.0273467929479455,0.00671703324972618,0.0141814077784822,0.0405121781174088,4.69105913504317e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPME1,Protein phosphatase methylesterase 1,28091,-0.0164475828592832,0.00404227173193821,-0.0243704354538821,-0.00852473026468435,4.73655034272291e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENO1,Alpha-enolase,28138,0.0217111526285223,0.0053372604446355,0.0112501221570368,0.0321721831000079,4.75790543544071e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP9,Matrix metalloproteinase-9,28156,0.0166548225025331,0.00409682918806348,0.00862503729392867,0.0246846077111375,4.81019044604773e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLG,Plasminogen,23365,0.00608596046192028,0.00150079240028821,0.00314440735735539,0.00902751356648517,5.02614916811436e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNDP1,Beta-Ala-His dipeptidase,28336,-0.0126074663851832,0.00311344511694901,-0.0187098188144033,-0.00650511395596319,5.1494033651389e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRPEL1,"GrpE protein homolog 1, mitochondrial",28091,-0.0165971817264773,0.004099212502773,-0.0246316382319123,-0.0085627252210422,5.16033529928289e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLUL1,Clusterin-like protein 1,28182,0.012347410014761,0.003050254621613,0.00636891095639951,0.0183259090731225,5.17966042998992e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",23795,0.0194731516830265,0.00481127651347671,0.0100430497166121,0.0289032536494408,5.19538686823008e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",28091,0.0190123930888823,0.00470007086742932,0.00980025418872085,0.0282245319890438,5.24340506321236e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C5,Complement C5,23893,0.00414690364098132,0.00102623072585346,0.00213549141830854,0.00615831586365411,5.34113677967751e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDR1,Epithelial discoidin domain-containing receptor 1,28428,-0.0063825224108916,0.00158111980420753,-0.00948151722713836,-0.00328352759464484,5.43479616952424e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VEGFC,Vascular endothelial growth factor C,28307,0.0151688771612718,0.00375833511833679,0.00780254032933172,0.0225352139932119,5.44985480477589e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCARA5,Scavenger receptor class A member 5,28428,-0.00822713203151179,0.00203953398905304,-0.0122246186500557,-0.00422964541296784,5.50185428749991e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DIPK2B,Divergent protein kinase domain 2B,23337,0.00765013370418077,0.00189652377489307,0.00393294710539036,0.0113673203029712,5.5064636458135e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",28091,0.0115450011747847,0.00286743922626941,0.00592482029129661,0.0171651820582727,5.68243978490122e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAX,Protein max,27544,0.0287068295199195,0.00713683690358393,0.014718629188895,0.042695029850944,5.77749593188086e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHAD,Chondroadherin,23337,0.0140356651525428,0.00349151485816926,0.00719229603053107,0.0208790342745546,5.83969443114759e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPXM2,Inactive carboxypeptidase-like protein X2,23846,-0.00689087587161104,0.00171464725670597,-0.0102515844947547,-0.00353016724846734,5.86674996948441e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AP3S2,AP-3 complex subunit sigma-2,23775,-0.0128945258314234,0.00320945479592899,-0.0191850572314442,-0.00660399443140261,5.89576579144945e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNPY4,Protein canopy homolog 4,28091,0.0203561739919137,0.00507090373014685,0.0104172026808259,0.0302951453030016,5.97749817539782e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",27702,0.0195699886177153,0.00487755363603547,0.0100099834910858,0.0291299937443448,6.02995009183879e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL17,C-C motif chemokine 17,28155,0.0246598150227409,0.00614852315763703,0.0126087096337723,0.0367109204117095,6.06980367976359e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRG2,Bone marrow proteoglycan,23862,0.0140241213158148,0.00349789663278324,0.00716824391555969,0.02087999871607,6.10839470812164e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKT3,RAC-gamma serine/threonine-protein kinase,27431,0.0156581421004601,0.00390957457731073,0.00799537592893106,0.0233209082719891,6.21610006636229e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPK1,Thiamin pyrophosphokinase 1,23846,0.00746767520363104,0.00186485681223049,0.00381255585165928,0.0111227945556028,6.23574600165549e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRN,Progranulin,28061,0.0066947639212301,0.00167229267284232,0.00341707028245916,0.00997245756000104,6.26138288641033e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,23188,-0.00945110594602363,0.00236374474933003,-0.0140840456547105,-0.00481816623733677,6.39801170064756e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARID4B,AT-rich interactive domain-containing protein 4B,27544,-0.0111895977392904,0.00279956746967571,-0.0166767499798548,-0.00570244549872599,6.43438878512134e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDKN1A,Cyclin-dependent kinase inhibitor 1,28091,-0.0285567331800943,0.00715366941685382,-0.0425779252371278,-0.0145355411230609,6.57125733850016e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LY6D,Lymphocyte antigen 6D,28031,0.0103874526555936,0.00260623974457065,0.0052792227562351,0.0154956825549521,6.74776521713004e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPE,Carboxypeptidase E,28206,0.010396800822277,0.00261109460968947,0.00527905538728567,0.0155145462572684,6.85729202690255e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,23846,-0.01943813997279,0.00489238904813865,-0.0290272225071418,-0.0098490574384383,7.11403748800985e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNER,Delta and Notch-like epidermal growth factor-related receptor,28125,0.00684804259471361,0.00172961037527517,0.00345800625917428,0.0102380789302529,7.53554110353437e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC12A2,Solute carrier family 12 member 2,23071,0.00738889111734018,0.00186979271224981,0.00372409740133056,0.0110536848333498,7.78236921747707e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BPIFA2,BPI fold-containing family A member 2,22395,-0.0295514751159496,0.00749773342779414,-0.0442470326344261,-0.0148559175974731,8.12576883537349e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMPRSS11D,Transmembrane protease serine 11D,23733,0.0102308870365878,0.00259673554582604,0.00514128536676879,0.0153204887064069,8.17478198793714e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MST1,Hepatocyte growth factor-like protein,23549,0.0171598089074094,0.00436090474835217,0.00861243560063914,0.0257071822141796,8.34635895942816e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,27702,0.00967410780332767,0.00246000810988102,0.00485249190796087,0.0144957236986945,8.42537306725013e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL22,C-C motif chemokine 22,27920,0.0137073210979197,0.00348731934998552,0.00687217517194804,0.0205424670238913,8.49320213860377e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TP53I3,Quinone oxidoreductase PIG3,22885,-0.0141837431096817,0.00361002504283913,-0.0212593921936464,-0.00710809402571698,8.55549307978142e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPY30,Protein dpy-30 homolog,28336,-0.0159444462604903,0.0040596967607395,-0.0239014519115398,-0.00798744060944093,8.60378710483081e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TINAGL1,Tubulointerstitial nephritis antigen-like,28174,0.00592326151673819,0.00151090043680403,0.00296189666060229,0.00888462637287409,8.86289446466372e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDCP1,CUB domain-containing protein 1,27965,-0.0138016125424664,0.00352372446483975,-0.0207081124935523,-0.00689511259138052,8.99570958308064e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAA4,Serum amyloid A-4 protein,23893,-0.00859398949999255,0.00219417468641387,-0.0128945718853637,-0.00429340711462136,9.00078518655099e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSTP1,Glutathione S-transferase P,27385,0.0185345395999507,0.0047341613175101,0.00925558341763087,0.0278134957822705,9.05995236721733e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP5IF1,"ATPase inhibitor, mitochondrial",28320,0.0291097006949665,0.00743970709376945,0.0145278747911784,0.0436915265987547,9.14648906733519e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHMP6,Charged multivesicular body protein 6,23846,-0.0149417116795602,0.0038189743643685,-0.0224269014337224,-0.00745652192539792,9.1601568166577e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C7orf50,Uncharacterized protein C7orf50,23775,-0.00590752498898865,0.00151093803845752,-0.0088689635443654,-0.00294608643361191,9.26139369641301e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NECTIN2,Nectin-2,28182,-0.00789793387555205,0.00202078803813249,-0.0118586784302917,-0.00393718932081236,9.31483897192565e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BANK1,B-cell scaffold protein with ankyrin repeats,28176,-0.0280491845442774,0.00718265745979485,-0.0421271931654753,-0.0139711759230795,9.43957505591127e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMOC2,SPARC-related modular calcium-binding protein 2,28320,-0.0102414933385318,0.00262328855705799,-0.0153831389103655,-0.00509984776669817,9.48088977346469e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRG2,Adhesion G-protein coupled receptor G2,28224,0.00716819729753852,0.00183687498542866,0.00356792232609834,0.0107684722689787,9.54697572114102e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,23188,0.0156807236263435,0.00402630577752391,0.00778916430239661,0.0235722829502903,9.8649619180391e-05
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDIA4,Protein disulfide-isomerase A4,23862,0.0160003749155756,0.00411205663812054,0.00794074390485929,0.0240600059262918,0.000100066739665581
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PMVK,Phosphomevalonate kinase,27528,0.0287848983806246,0.0073996929798566,0.0142815001401056,0.0432882966211435,0.000100474775687999
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LONP1,"Lon protease homolog, mitochondrial",23198,0.022832937240918,0.00587950414999269,0.0113091091069323,0.0343567653749037,0.000103257577955482
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC39A14,Zinc transporter ZIP14,27544,0.0088222094845263,0.00227392975361455,0.00436530716744179,0.0132791118016108,0.000104820354714002
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],28091,0.0149202711535743,0.00384761940336369,0.00737893712298143,0.0224616051841671,0.000105648432529529
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRM,Receptor-type tyrosine-protein phosphatase mu,28140,-0.00640292968980788,0.00165258059213476,-0.00964198765039202,-0.00316387172922375,0.000107084305608523
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTRB1,Chymotrypsinogen B,28187,-0.0145007984861094,0.0037518826122905,-0.0218544884061988,-0.00714710856602002,0.000111365874043751
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMEM25,Transmembrane protein 25,23795,-0.0117997714650552,0.00305734975293584,-0.0177921769808095,-0.00580736594930097,0.000113930025369988
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCGB1A1,Uteroglobin,28264,0.0143974592511459,0.0037314297722363,0.00708385689756276,0.021711061604729,0.000114371353735081
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKT2,RAC-beta serine/threonine-protein kinase,23795,0.032941819277708,0.00854015853540507,0.0162031085483141,0.0496805300071019,0.000114955981627057
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAEA,E3 ubiquitin-protein transferase MAEA,27562,-0.0103755859328298,0.00269802286890275,-0.0156637107558792,-0.00508746110978041,0.000120515680030388
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLPS,Colipase,28144,0.0184439707618622,0.00479716244982371,0.00904153236020769,0.0278464091635167,0.000120932708940637
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNF,Tumor necrosis factor,27638,0.00998262004525739,0.00259861950301094,0.00488932581935596,0.0150759142711588,0.000122553448018402
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL10,C-X-C motif chemokine 10,28320,0.0173956504425003,0.00453111170639361,0.00851467149796884,0.0262766293870318,0.000123725858561647
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL8,Interleukin-8,27970,-0.0176104415123834,0.00459280208602386,-0.0266123336009902,-0.00860854942377669,0.000126169280337536
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXLNA,Alpha-taxilin,27965,-0.0229718814252274,0.00599196917349889,-0.0347161410052852,-0.0112276218451696,0.000126466369759893
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,QPCT,Glutaminyl-peptide cyclotransferase,28261,0.00697225416822114,0.00181880017699044,0.00340740582131987,0.0105371025151224,0.000126639541503442
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERP29,Endoplasmic reticulum resident protein 29,23337,0.0308196504951897,0.00803957451559033,0.0150620844446326,0.0465772165457467,0.000126668228893773
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA4C,Semaphorin-4C,28091,0.00729816658248309,0.00190933182245259,0.00355587621047602,0.0110404569544902,0.000132461959778589
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLXDC2,Plexin domain-containing protein 2,23775,-0.00699061190840442,0.00182988558569433,-0.0105771876563653,-0.00340403616044353,0.000133658098878156
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,22614,0.0278388714028925,0.00729561285869268,0.0135394701998548,0.0421382726059301,0.000136083335153273
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNPDA1,Glucosamine-6-phosphate isomerase 1,23198,-0.00853608504675918,0.00223786069038061,-0.0129222919999052,-0.00414987809361318,0.000136870707528733
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,23337,-0.00969665021227204,0.00254382232413365,-0.014682541967574,-0.0047107584569701,0.000138289217448814
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JAM2,Junctional adhesion molecule B,28428,-0.00688914453806671,0.0018118180386185,-0.010440307893759,-0.00333798118237445,0.000143636499215796
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SATB1,DNA-binding protein SATB1,23795,-0.00759088904866588,0.00199694264212723,-0.0115048966272352,-0.00367688147009652,0.00014432387404495
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REG1A,Lithostathine-1-alpha,28105,-0.0126946448709854,0.00334136981124938,-0.0192437297010342,-0.00614556004093661,0.000145449981833539
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLO1,Lactoylglutathione lyase,27682,-0.0148771644240261,0.00391949189427347,-0.0225593685368021,-0.00719496031125008,0.000147549028889036
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LACRT,Extracellular glycoprotein lacritin,23665,-0.0127863893892776,0.00337009778769329,-0.0193917810531564,-0.00618099772539871,0.000148566450043951
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGA,Fibrinogen alpha chain,23353,0.00790258957539872,0.00208368009175425,0.0038185765955604,0.011986602555237,0.000149446758868937
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SELENOP,Selenoprotein P,23893,0.00578491382284947,0.00152614561326182,0.00279366842085629,0.00877615922484265,0.000150690418512542
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRR,Receptor-type tyrosine-protein phosphatase R,23775,0.00936355897751421,0.00247657291345988,0.00450947606713285,0.0142176418878956,0.000156674044396985
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFNA4,Ephrin-A4,27918,-0.00787768117262404,0.00208579822102144,-0.0119658456858261,-0.00378951665942202,0.000159173940427085
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IDS,Iduronate 2-sulfatase,28521,0.00227418231531512,0.000603099755016988,0.00109210679548182,0.00345625783514841,0.000163038580619392
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL2RA,Interleukin-2 receptor subunit alpha,27977,0.0103153149110766,0.00273690680922655,0.00495097756499255,0.0156796522571606,0.000164260397761739
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NBL1,Neuroblastoma suppressor of tumorigenicity 1,28307,-0.00687684679480972,0.00182707693041935,-0.0104579175784316,-0.00329577601118779,0.000167653961660976
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB1,Integrin beta-1,28218,0.00552728537355177,0.00147209997851083,0.00264196941567055,0.008412601331433,0.000173901572830126
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,23071,0.00520445862937403,0.00138623481890278,0.00248743838432458,0.00792147887442348,0.000174194514434379
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFER,FAD-linked sulfhydryl oxidase ALR,27562,-0.0162733882019855,0.00433823024266142,-0.0247763194776019,-0.0077704569263691,0.00017638003018265
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AK2,"Adenylate kinase 2, mitochondrial",23775,0.026819112352262,0.0071594941959206,0.0127865037282576,0.0408517209762664,0.000180136403322329
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DIABLO,"Diablo homolog, mitochondrial",28142,0.0277153765331492,0.0074083080702046,0.0131950927155482,0.0422356603507502,0.000183565086472953
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIPC3,PDZ domain-containing protein GIPC3,23738,0.0248109117389346,0.00663382245002848,0.0118086197368788,0.0378132037409904,0.000184407079400399
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LPO,Lactoperoxidase,27237,-0.015206786345633,0.00406685499118787,-0.0231778221283613,-0.0072357505629048,0.000184984439507884
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNR,Tenascin-R,27965,0.0106634481999606,0.00285793892819344,0.00506188790070147,0.0162650084992197,0.00019097165954778
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",23071,0.0109524551317408,0.00293808027436119,0.00519381779399289,0.0167110924694888,0.00019365177227382
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL28,C-C motif chemokine 28,28072,0.0149578262724724,0.00401289181253043,0.00709255831991278,0.0228230942250321,0.000193811910297139
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IMPACT,Protein IMPACT,23775,-0.0139837850530005,0.00375386086528801,-0.021341352348965,-0.00662621775703603,0.000195632032364185
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1RL1,Interleukin-1 receptor-like 1,28470,-0.0117081736897741,0.00314485281238518,-0.0178720852020491,-0.00554426217749918,0.000197277078309271
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCDC80,Coiled-coil domain-containing protein 80,28224,-0.00887911830880849,0.00238786585986204,-0.0135593353941381,-0.00419890122347889,0.000200850650508363
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK13,Kallikrein-13,27607,-0.0110510441456695,0.00298154655607638,-0.0168948753955792,-0.00520721289575982,0.000210570184545058
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD5,T-cell surface glycoprotein CD5,28411,-0.00860578015108878,0.00233058976374355,-0.0131737360880261,-0.00403782421415142,0.000222447065528318
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP6AP2,Renin receptor,27562,-0.0101067537516025,0.00274241335479848,-0.0154818839270075,-0.00473162357619746,0.000228825964157086
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD99,CD99 antigen,28187,0.00490822335688443,0.0013331392961544,0.00229527033642182,0.00752117637734705,0.000232113402977946
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,28277,-0.0161381174416955,0.00438487773488692,-0.0247324778020739,-0.00754375708131718,0.000233298298906275
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIFBP,KIF-binding protein,28091,0.020485521525477,0.00556733646471213,0.00957354205464119,0.0313975009963127,0.000234044877177485
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F11R,Junctional adhesion molecule A,28187,-0.0139866936609951,0.00380181025599117,-0.0214382417627378,-0.00653514555925239,0.000234626353217205
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,XG,Glycoprotein Xg,28430,0.00802560955454621,0.00218334785226103,0.00374624776411459,0.0123049713449778,0.000237516047333072
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD80,T-lymphocyte activation antigen CD80,23846,-0.00845042277689485,0.0023065293081027,-0.0129712202207761,-0.00392962533301356,0.000249140220567737
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD34,Hematopoietic progenitor cell antigen CD34,28331,0.00600419926618211,0.0016423592829619,0.00278517507157678,0.00922322346078744,0.000256806977810416
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LIPF,Gastric triacylglycerol lipase,23198,-0.0151121762870849,0.00413506325823424,-0.023216900273224,-0.00700745230094575,0.00025810930557768
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DBI,Acyl-CoA-binding protein,28082,0.0193578026925691,0.00530242077706227,0.00896505796952707,0.0297505474156112,0.000261952211834213
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,23795,0.00933565320157864,0.00255753063584914,0.00432289315531433,0.014348413247843,0.000262535474046538
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHCHD6,MICOS complex subunit MIC25,23725,-0.00717190530503801,0.00196539620945238,-0.0110240818755647,-0.00331972873451135,0.000263736722047515
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSNA1,Sjoegren syndrome nuclear autoantigen 1,23738,-0.0126311172513909,0.00346295465677177,-0.0194185083786636,-0.00584372612411825,0.000265374111088157
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCARB2,Lysosome membrane protein 2,27531,-0.00783851942292219,0.00215308312451973,-0.0120585623469808,-0.00361847649886352,0.000272499390567223
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMEM106A,Transmembrane protein 106A,23725,0.0173615574483684,0.00478402469462863,0.00798486904689625,0.0267382458498405,0.000285042588695499
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRSS22,Brain-specific serine protease 4,23188,-0.00861509910486887,0.00237445962556192,-0.0132690399709702,-0.00396115823876752,0.000285977806877487
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAS2,Growth arrest-specific protein 2,23393,-0.0130314616104934,0.00359803754303317,-0.0200836151948384,-0.00597930802614841,0.000293151075956701
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL6ST,Interleukin-6 receptor subunit beta,28224,-0.0043151644962536,0.00119278069260386,-0.00665301465375717,-0.00197731433875004,0.000297711201190298
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLTP,Phospholipid transfer protein,28439,0.00879093979406108,0.00243207286425496,0.00402407698012136,0.0135578026080008,0.000301345845335799
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PEAR1,Platelet endothelial aggregation receptor 1,28553,0.00556384373842346,0.00153948124169965,0.00254646050469214,0.00858122697215478,0.000301907354098257
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,27562,0.0305922267801325,0.00848878995095967,0.0139541984762516,0.0472302550840135,0.000314104589404999
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCT5,T-complex protein 1 subunit epsilon,27562,-0.011058942608942,0.00306888036388837,-0.0170739481221632,-0.0050439370957208,0.000314422205602537
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,28553,-0.00662818120106825,0.00183965298138545,-0.0102339010445837,-0.00302246135755276,0.000315158384307345
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,23738,-0.00730973514173816,0.0020288356935624,-0.0112862531011205,-0.00333321718235585,0.000315304184486251
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS3BP,Galectin-3-binding protein,23893,-0.00736586194726716,0.00205225341569804,-0.0113882786420353,-0.00334344525249901,0.000332411812551713
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM172A,Cotranscriptional regulator FAM172A,23198,0.0148597776402912,0.00414386439004976,0.00673780343579372,0.0229817518447888,0.000336516468798769
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERP44,Endoplasmic reticulum resident protein 44,28044,-0.00627694226720268,0.00175050647158177,-0.00970793495150294,-0.00284594958290242,0.000336635096424836
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HEPACAM2,HEPACAM family member 2,23775,-0.0101891536427045,0.00284195167471002,-0.0157593789251361,-0.00461892836027283,0.000337409167066299
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNIP1,TNFAIP3-interacting protein 1,23775,-0.0213722008501378,0.00596712306455818,-0.0330677620566719,-0.00967663964360378,0.000342100657566659
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLAMF8,SLAM family member 8,27562,0.0130138506325861,0.00363397340102246,0.00589126276658204,0.0201364384985901,0.000342656969588491
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAT2,Linker for activation of T-cells family member 2,28091,-0.0300826958582472,0.00840259168752709,-0.0465517755658003,-0.0136136161506941,0.000343951590269526
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,28363,0.00836577562505337,0.00233752935504643,0.00378421808916237,0.0129473331609444,0.000345623704412262
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HDGFL2,Hepatoma-derived growth factor-related protein 2,23775,-0.0152000842793746,0.00426349320277897,-0.0235565309568214,-0.00684363760192779,0.000364331883255428
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTPN,Myotrophin,27682,0.00793071466902352,0.0022252483866693,0.00356922783115168,0.0122922015068954,0.000365904833580399
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,28277,-0.0122781990040965,0.00345281348485666,-0.0190457134344156,-0.00551068457377745,0.000377161603465476
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RILP,Rab-interacting lysosomal protein,28363,-0.0142860407406537,0.00402418984498371,-0.0221734528368218,-0.00639862864448561,0.000385793907257688
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJC6,Putative tyrosine-protein phosphatase auxilin,23198,-0.0202344812212303,0.00570278389169162,-0.0314119376489459,-0.00905702479351476,0.000388675135871936
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTC,Probetacellulin,27562,0.017883037796305,0.00504631479055408,0.00799226080681903,0.027773814785791,0.000395084394886072
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPTX1,Neuronal pentraxin-1,28187,-0.00975922738808365,0.00275785358662245,-0.0151646204178636,-0.00435383435830366,0.000402743611085273
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGMN,Legumain,28320,0.0085804012203317,0.00242513268298294,0.00382714116168515,0.0133336612789783,0.00040363775262682
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD6,T-cell differentiation antigen CD6,28496,-0.0125690324092928,0.00355783309043774,-0.0195423852665508,-0.00559567955203481,0.000411869019391715
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRDX5,"Peroxiredoxin-5, mitochondrial",28521,0.0161516300191757,0.00457534715304798,0.00718394959920166,0.0251193104391498,0.000415989616599909
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FNDC1,Fibronectin type III domain-containing protein 1,23775,-0.0110906995534205,0.00315102615253765,-0.0172667108123943,-0.00491468829444673,0.000432826211928947
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHRDL1,Chordin-like protein 1,28276,0.00749673331690997,0.00213017221603556,0.00332159577348028,0.0116718708603397,0.000433353161219617
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIA1,Nucleolysin TIA-1 isoform p40,27320,0.0291138824261115,0.00828769798370829,0.0128699943780432,0.0453577704741797,0.000443954704283466
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ART3,Ecto-ADP-ribosyltransferase 3,28336,0.00821181193403556,0.00233772797608902,0.00362986510090109,0.01279375876717,0.000444215283675634
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TLR3,Toll-like receptor 3,28521,-0.0145001373739135,0.00413270816132732,-0.0226002453701151,-0.00640002937771198,0.00045111757837554
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLXNB3,Plexin-B3,28132,0.0112450579533936,0.00320709608341283,0.00495914962990445,0.0175309662768827,0.000455081650142663
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LARP1,La-related protein 1,23725,-0.0148614173237043,0.00424161984291471,-0.0231749922158171,-0.0065478424315915,0.000459665506074735
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGEF12,Rho guanine nucleotide exchange factor 12,28176,-0.0245827438446408,0.00701834766802897,-0.0383387052739776,-0.0108267824153041,0.000461385779123916
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA12,Serpin A12,27412,-0.0264428980162377,0.00755172358493418,-0.0412442762427087,-0.0116415197897667,0.00046325915174692
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASET2,Ribonuclease T2,28438,-0.00629207658481507,0.00179939034132324,-0.00981888165380862,-0.00276527151582152,0.000471624103258069
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NT5C3A,Cytosolic 5'-nucleotidase 3A,28115,0.020703020810826,0.00592844526157149,0.00908326809814592,0.0323227735235062,0.000479884646472752
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CES2,Cocaine esterase,28091,-0.0129406246677843,0.00370690758760289,-0.020206163539486,-0.00567508579608265,0.000482047212190723
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS9,Galectin-9,28194,0.00752966747872248,0.00215723318110517,0.00330149044375634,0.0117578445136886,0.000482984311164715
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL1,Growth-regulated alpha protein,28165,0.0224767112168553,0.00643976197412175,0.00985477774757662,0.0350986446861339,0.000483213895134715
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,23071,0.00872528179406502,0.00250139227143994,0.00382255294204274,0.0136280106460873,0.000487244939198486
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GMFG,Glia maturation factor gamma,23846,0.0168876343969217,0.00484710812654727,0.00738730246888905,0.0263879663249544,0.000494748164131814
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,28182,-0.0270360045470701,0.00776173315510685,-0.0422490015310795,-0.0118230075630607,0.000496129735091407
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A16,Protein S100-A16,27500,-0.0144605042130047,0.00415306251902506,-0.0226005067502938,-0.00632050167571557,0.000498662484655523
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TAFA5,Chemokine-like protein TAFA-5,28091,0.00855545848549337,0.00246105645312158,0.00373178783737507,0.0133791291336117,0.000509083630017766
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RABGAP1L,Rab GTPase-activating protein 1-like,27702,-0.0140904910789645,0.00405386996587715,-0.0220360762120837,-0.00614490594584527,0.000510088609517064
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADA,Adenosine deaminase,28521,-0.00819474597250008,0.00235900836464571,-0.0128184023672057,-0.00357108957779449,0.000513886563357187
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IST1,IST1 homolog,23577,0.0233081994221878,0.00670956487330398,0.010157452270512,0.0364589465738636,0.000513918522606542
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DLL1,Delta-like protein 1,28307,0.00703978645345228,0.00202753981111742,0.00306580842366214,0.0110137644832424,0.000517207592020772
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,23056,0.0144540239781766,0.00416326678305661,0.0062940210833856,0.0226140268729675,0.000517931333309739
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL8,C-C motif chemokine 8,28411,0.0141889982105301,0.0040916030005197,0.00616945632951151,0.0222085400915488,0.000525448904173354
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,27562,-0.0230855463096824,0.00665762548957407,-0.0361344922692476,-0.0100366003501172,0.000526057594477812
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCR1,Natural cytotoxicity triggering receptor 1,28120,0.00869081341430693,0.00250873384453956,0.0037736950790094,0.0136079317496045,0.000532557883278159
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAD23B,UV excision repair protein RAD23 homolog B,27562,0.0109889348865792,0.0031721319091872,0.00477155634457233,0.0172063134285861,0.000532597238509232
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,27702,-0.00996824540481183,0.00288097795724057,-0.0156149622010033,-0.0043215286086203,0.000540945724917379
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",23738,0.024099176894496,0.00697914859253952,0.0104200456531185,0.0377783081358734,0.000555303828368245
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOC1,Apolipoprotein C-I,23845,0.00864719360789109,0.00251413228034365,0.00371949433841753,0.0135748928773646,0.000583927999365983
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDAP1,28 kDa heat- and acid-stable phosphoprotein,23846,0.0227670239396772,0.0066197379597576,0.00979233753855225,0.035741710340802,0.000584296767941894
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAL,Galanin peptides,28320,0.0149624840149236,0.00437707768325945,0.00638341175573507,0.0235415562741121,0.000630854100632139
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL18,C-C motif chemokine 18,27928,0.0162094218165224,0.00475671558334412,0.00688625927316789,0.0255325843598768,0.000656072411065671
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DTD1,D-aminoacyl-tRNA deacylase 1,23337,0.0200998891584406,0.00590765334727199,0.00852088859778748,0.0316788897190937,0.000669218368970202
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGF,Placenta growth factor,28521,-0.00604510631171798,0.00177725822792438,-0.00952853243844976,-0.0025616801849862,0.000671419188196084
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,23139,-0.00638539627864958,0.00187771089817826,-0.010065709639079,-0.0027050829182202,0.000673448992814458
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YES1,Tyrosine-protein kinase Yes,28091,-0.0260940593927535,0.00770042398116658,-0.04118689039584,-0.011001228389667,0.00070333521013259
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL15A1,Collagen alpha-1(XV) chain,23862,0.00606410026713149,0.00178998064063111,0.00255573821149451,0.00957246232276847,0.000705689435850033
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGBP1,Immunoglobulin-binding protein 1,23795,-0.0138422381133436,0.0040893868730734,-0.0218574363845675,-0.00582703984211979,0.000713146322123511
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,28204,-0.0132863780659542,0.00393045061761907,-0.0209900612764876,-0.0055826948554208,0.000724864308153112
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,27965,-0.0100460903933174,0.00297584240864635,-0.0158787415142643,-0.00421343927237058,0.000736798300112986
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINB8,Serpin B8,28521,-0.0128632406357883,0.00381280390078217,-0.0203363362813213,-0.00539014499025524,0.000742650036111638
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,23188,-0.0101966910549342,0.00302368419922884,-0.0161231120854227,-0.00427027002444568,0.000746721956981568
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TYMP,Thymidine phosphorylase,28053,0.0151839185005368,0.00451402938402708,0.00633642090784372,0.0240314160932299,0.000770032292195429
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX7,Syntaxin-7,23188,0.0112451566075724,0.00334726217853519,0.00468452273764342,0.0178057904775014,0.000782070688592096
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GP1BB,Platelet glycoprotein Ib beta chain,23071,0.0155400982112408,0.00462750538613498,0.00647018765441627,0.0246100087680654,0.000785781857115396
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLAT,Tissue-type plasminogen activator,28470,-0.0113804078007795,0.00338992302985408,-0.0180246569392935,-0.00473615866226547,0.00078859582026613
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TJAP1,Tight junction-associated protein 1,28307,-0.0188191952705713,0.00560609565158181,-0.0298071427476717,-0.00783124779347097,0.000789206773305242
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD200,OX-2 membrane glycoprotein,28176,0.00604007399972975,0.00179991727521526,0.00251223614030784,0.00956791185915166,0.000792543960601901
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGMB,RGM domain family member B,28428,0.00610402884814753,0.00182693697826971,0.0025232323707389,0.00968482532555616,0.000835464848985518
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD14,Monocyte differentiation antigen CD14,27713,0.00936690332371694,0.00280359989072283,0.00387184753790019,0.0148619591095337,0.000835793681031311
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTN2,Contactin-2,28452,-0.0100892372518547,0.00302137912495019,-0.0160111403367571,-0.00416733416695231,0.000841031214965402
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STK4,Serine/threonine-protein kinase 4,28224,0.0195888387093436,0.00586739819280035,0.00808873825145492,0.0310889391672323,0.000843136209838932
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NID2,Nidogen-2,28187,0.0165774922393739,0.00496674682832178,0.00684266845586322,0.0263123160228846,0.000845853950585959
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCTD,Deoxycytidylate deaminase,23337,0.0214159745252987,0.00641906745041399,0.0088346023224873,0.0339973467281101,0.000850321577561948
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD160,CD160 antigen,28521,0.0105863482845679,0.00317457305971454,0.00436418508752735,0.0168085114816084,0.00085490714521226
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JCHAIN,Immunoglobulin J chain,27702,0.0138198642767063,0.00415487949201292,0.00567630047236094,0.0219634280810516,0.000881605164396622
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,28182,0.00722365148551828,0.00217212596826411,0.00296628458772063,0.0114810183833159,0.000883368639122585
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACP1,Low molecular weight phosphotyrosine protein phosphatase,23188,-0.0098998588109537,0.00297700224685927,-0.0157347832147979,-0.00406493440710953,0.000884144002151439
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL2L15,Bcl-2-like protein 15,23188,-0.0126654362591943,0.00381059920129209,-0.0201342106937268,-0.00519666182466177,0.000889569880131741
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,USP25,Ubiquitin carboxyl-terminal hydrolase 25,23725,-0.0162181743769395,0.00488107229291798,-0.0257850760710588,-0.0066512726828203,0.000892963794130474
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",23862,0.0140578904935846,0.0042312053782741,0.00576472795216737,0.0223510530350018,0.000893707165291874
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EVPL,Envoplakin,23393,0.00761762833759671,0.00229459284866716,0.00312022635420908,0.0121150303209843,0.00090214226216052
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLIC5,Chloride intracellular channel protein 5,23163,0.00711930530324871,0.00215219569323436,0.00290100174450937,0.011337608861988,0.00094132699676969
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BLMH,Bleomycin hydrolase,28553,0.00712181391519803,0.00215469450893129,0.00289861267769271,0.0113450151527034,0.000950071087026442
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRC38,Leucine-rich repeat-containing protein 38,23163,-0.0108142889976351,0.0032765981142671,-0.0172364213015986,-0.00439215669367155,0.000966715208810373
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MANSC4,MANSC domain-containing protein 4,23071,0.0148810072162475,0.00451447899359664,0.00603262838879805,0.0237293860436969,0.000981207090517623
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EEF1D,Elongation factor 1-delta,23846,-0.0203001312674584,0.00617042151274709,-0.0323941574324427,-0.0082061051024741,0.00100364835162518
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMD1,26S proteasome non-ATPase regulatory subunit 1,23795,-0.0107948087645782,0.00328399700621172,-0.0172314428967532,-0.00435817463240327,0.001013735328142
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL4R,Interleukin-4 receptor subunit alpha,28176,-0.0081662078947902,0.00248483683459953,-0.0130364880906053,-0.00329592769897512,0.0010159505764694
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MED18,Mediator of RNA polymerase II transcription subunit 18,27562,0.0169836872417769,0.00516863242995078,0.00685316767907333,0.0271142068044804,0.00101778649164558
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,27176,-0.0142491568052035,0.00434093069730336,-0.0227573809719181,-0.00574093263848888,0.0010301650141118
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TOP1,DNA topoisomerase 1,23738,-0.0251191467237031,0.00766918273956691,-0.0401507448932542,-0.0100875485541519,0.00105687843486104
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,27965,-0.0135244932141105,0.00413255037889601,-0.0216242919567467,-0.00542469447147434,0.00106664234178201
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCSK7,Proprotein convertase subtilisin/kexin type 7,23725,-0.0100048250639038,0.00305825983288168,-0.0159990143363519,-0.00401063579145573,0.00107165058238657
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA2,Annexin A2,22875,-0.0156965166779651,0.0047985791918988,-0.0251017318940868,-0.00629130146184348,0.0010729778788518
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DKK1,Dickkopf-related protein 1,28428,0.0130961003771667,0.00400973181539435,0.00523702601899373,0.0209551747353396,0.00109177030631032
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RANBP1,Ran-specific GTPase-activating protein,23198,-0.0115412826893344,0.00353418746629532,-0.0184682901232732,-0.00461427525539558,0.00109386539649957
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRL1,Fc receptor-like protein 1,28224,0.0100388797537926,0.00308065113679424,0.00400080352567584,0.0160769559819093,0.00112061251492915
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSAPL1,Proactivator polypeptide-like 1,23738,0.0111160159421964,0.00341216804847617,0.00442816656718316,0.0178038653172097,0.00112454154284154
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ULBP2,UL16-binding protein 2,27965,-0.00841876434444816,0.00258854476427781,-0.0134923120824327,-0.00334521660646365,0.00114604563447773
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BID,BH3-interacting domain death agonist,28176,0.0146473596392357,0.00450702674235908,0.00581358722421187,0.0234811320542595,0.00115583443713144
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCN4,CCN family member 4,28452,-0.00877512526045266,0.00270460398429144,-0.0140761490696639,-0.00347410145124143,0.00117787134382781
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EHD3,EH domain-containing protein 3,23198,0.0256619341453041,0.00791051608434741,0.0101573226199832,0.041166545670625,0.00118019100857766
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",23071,0.0109431509561342,0.00337387380923845,0.00433035829002689,0.0175559436222416,0.00118239875957895
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRRT3,Proline-rich transmembrane protein 3,23198,0.00830381286681502,0.002568505616659,0.00326954185816338,0.0133380838754667,0.00122696539903728
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL6A3,Collagen alpha-3(VI) chain,28553,-0.0076734316547967,0.00237513456608313,-0.0123286954043196,-0.00301816790527377,0.00123611991639128
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD74,HLA class II histocompatibility antigen gamma chain,28428,-0.00756722981442444,0.00234407124248019,-0.0121616094496856,-0.00297285017916326,0.00124694758397714
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK4,Kallikrein-4,28452,0.0137561361554206,0.00426167722979292,0.00540324878502644,0.0221090235258147,0.00124857353620211
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LCP1,Plastin-2,23862,0.0103295678343796,0.00320135286410388,0.00405491622073602,0.0166042194480232,0.00125428160944163
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,23738,0.0257102694148171,0.00797613018889632,0.0100770542445803,0.0413434845850539,0.00126849083397531
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VPS4B,Vacuolar protein sorting-associated protein 4B,23725,0.0205368304875911,0.006378196783715,0.00803556479150967,0.0330380961836725,0.00128430857772189
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,23795,0.0172195350804421,0.0053530636414194,0.00672753034326005,0.0277115398176241,0.00129819272175045
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL6,Interleukin-6,28091,-0.0160514665160779,0.004991518241791,-0.0258348422699882,-0.0062680907621675,0.0013025212713868
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HGFAC,Hepatocyte growth factor activator,23653,0.00611742573945329,0.00190235055761563,0.00238881864652665,0.00984603283237994,0.00130292882707718
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTF1,Cardiotrophin-1,27682,0.0183277066942131,0.00571738192070276,0.00712163812963574,0.0295337752587905,0.00134928708217495
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NLGN2,Neuroligin-2,23056,0.0103300003596021,0.00322258603395901,0.0040137317330424,0.0166462689861617,0.00135011713258243
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NMI,N-myc-interactor,23642,0.0156177011902716,0.00488032761712814,0.00605225906070047,0.0251831433198428,0.00137545293184504
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SDCCAG8,Serologically defined colon cancer antigen 8,23725,-0.0246368588752031,0.00769930854863517,-0.0397275036305281,-0.00954621411987819,0.00137666043864477
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCN4B,Sodium channel subunit beta-4,23198,-0.00918781828250804,0.00287732312609362,-0.0148273716096515,-0.00354826495536455,0.00140901859667766
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,28521,-0.00839971724939115,0.00263207611610616,-0.0135585864369592,-0.00324084806182308,0.00141792720995402
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPARCL1,SPARC-like protein 1,28235,0.00594792270205362,0.0018647553952574,0.00229300212734911,0.00960284327675813,0.00142599353603421
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,28091,-0.00970584950702657,0.00304451804231186,-0.0156731048699578,-0.00373859414409533,0.00143429639647024
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NTF4,Neurotrophin-4,27562,0.00848274800012289,0.00266753809397633,0.00325437333592929,0.0137111226643165,0.00147442499943549
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB1BP2,Integrin beta-1-binding protein 2,27682,0.0238025353305881,0.00751624444372644,0.00907069622088423,0.0385343744402919,0.0015428705570909
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,28195,-0.00635375147207453,0.00200742197718274,-0.0102882985473527,-0.00241920439679636,0.00155178565815448
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK10,Kallikrein-10,28210,0.00857157669240914,0.00270829398241494,0.00326332048687587,0.0138798328979424,0.00155282013505754
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC16A1,Monocarboxylate transporter 1,27544,-0.0123665039378305,0.00390886679861459,-0.0200278828631151,-0.00470512501254588,0.0015594358430492
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",28363,-0.015228379502957,0.00481766786406676,-0.0246710085165279,-0.00578575048938617,0.00157424063105525
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AK1,Adenylate kinase isoenzyme 1,28224,-0.0134482941543977,0.00426056006354794,-0.0217989918789516,-0.00509759642984369,0.0015986390235887
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUT8,"Alpha-(1,6)-fucosyltransferase",27965,0.0124251316633933,0.00393644270888661,0.00470970395397553,0.020140559372811,0.00159879173225563
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OGFR,Opioid growth factor receptor,28091,-0.00696686441144499,0.00221248549460399,-0.0113033359808688,-0.00263039284202116,0.0016406585181101
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACSL1,Long-chain-fatty-acid--CoA ligase 1,23071,0.00804043282128836,0.00255591973510962,0.00303083014047351,0.0130500355021032,0.00165839217019592
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",27910,0.020462037515404,0.00650529423892263,0.0077116608071157,0.0332124142236924,0.00166009192198694
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRGN,Neurogranin,23872,0.0194118023405119,0.00617499207288569,0.00730881787765596,0.0315147868033679,0.0016707887324731
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH3BP1,SH3 domain-binding protein 1,23738,-0.010155764430371,0.00323196853603776,-0.016490422761005,-0.00382110609973696,0.00167841340263407
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BOLA2_BOLA2B,BolA-like protein 2,23198,-0.0115099690607809,0.00366951845510473,-0.0187022252327862,-0.00431771288877568,0.00171107858293631
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKT1S1,Proline-rich AKT1 substrate 1,27544,-0.014217995016124,0.00454344413166595,-0.0231231455141893,-0.00531284451805873,0.00175380619080565
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APP,Amyloid-beta precursor protein,28142,0.014051250443046,0.00450179186204356,0.00522773839344062,0.0228747624926514,0.00180262953794924
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA1,Alpha-1-antitrypsin,23488,0.00171546749412508,0.000549837146978917,0.000637786686046404,0.00279314830220376,0.00181097379872549
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TOP2B,DNA topoisomerase 2-beta,23188,-0.0168321699988877,0.00540055236095988,-0.0274172526263691,-0.00624708737140637,0.00183080252940099
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARF6,ADP-ribosylation factor 6,23738,-0.0225295642889495,0.00722946469582239,-0.0366993150927613,-0.00835981348513759,0.00183321433803769
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IPCEF1,Interactor protein for cytohesin exchange factors 1,27918,-0.0187982169933367,0.00603706052202075,-0.0306308556164974,-0.00696557837017604,0.00184879602201671
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MED21,Mediator of RNA polymerase II transcription subunit 21,23071,0.0101991392615726,0.00328442772592611,0.00376166091875741,0.0166366176043877,0.00190315366173283
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIMAP8,GTPase IMAP family member 8,22978,-0.0106835427889589,0.00344666516575803,-0.0174390065138446,-0.00392807906407317,0.00193967110399673
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTN1,Contactin-1,28553,0.00571076245485047,0.00184465470215085,0.00209523923863481,0.00932628567106613,0.00196443868492085
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFHR2,Complement factor H-related protein 2,23725,0.0119378463990136,0.00386084773044544,0.0043705848473405,0.0195051079506866,0.00199025239614537
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA1,Annexin A1,23240,-0.00892061933795647,0.00289043071167367,-0.0145858635328369,-0.00325537514307608,0.00202930257023234
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CST1,Cystatin-SN,20725,-0.0220077961534284,0.0071332219428324,-0.0359889111613799,-0.00802668114547693,0.00203646890740576
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPP7,Dipeptidyl peptidase 2,28033,-0.012596031755784,0.00408972317118989,-0.0206118891713161,-0.00458017434025177,0.00207254613765016
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F7,Coagulation factor VII,28286,-0.00638260964462891,0.00207324103824381,-0.0104461620795868,-0.00231905720967104,0.0020819852635361
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERI1,3'-5' exoribonuclease 1,23393,-0.00708546444878816,0.00230207752482749,-0.01159753639745,-0.00257339250012627,0.00208736469957909
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R9B,Neurabin-2,28521,-0.0196208867103312,0.00637538367156007,-0.032116638706589,-0.00712513471407349,0.00208872098993649
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TJP3,Tight junction protein ZO-3,23056,0.00894454837911791,0.00290893085340898,0.00324304390643632,0.0146460528517995,0.00210849380403681
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLSTN3,Calsyntenin-3,23775,-0.00633041161279928,0.00205897225248044,-0.0103659972276609,-0.0022948259979376,0.00211059963604212
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NSFL1C,NSFL1 cofactor p47,28428,-0.0134930090240111,0.0043929568626643,-0.0221032044748331,-0.0048828135731891,0.00213180557637574
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GH2,Growth hormone variant,27562,0.0344249207741674,0.0112118173984549,0.0124497586731958,0.056400082875139,0.00213970294459814
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGRN,Agrin,28320,-0.00713118592966556,0.00233373075881433,-0.0117052982169417,-0.00255707364238947,0.00224743196942485
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VWC2,Brorin,27863,0.00824182073962659,0.00269901438017023,0.00295175255449293,0.0135318889247602,0.0022629583986806
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD101,Immunoglobulin superfamily member 2,23738,-0.00883045974383788,0.00289718560913627,-0.014508943537745,-0.00315197594993079,0.00230666280724953
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC6,Sialic acid-binding Ig-like lectin 6,28452,-0.00692942129951635,0.00227655997666468,-0.0113914788537791,-0.00246736374525357,0.00233814145686595
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PMS1,PMS1 protein homolog 1,23163,-0.0104510903465133,0.00343668033238837,-0.0171869837979945,-0.00371519689503213,0.0023602430490505
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LSM1,U6 snRNA-associated Sm-like protein LSm1,27562,0.0113975595628662,0.0037489676219116,0.00404958302391946,0.0187455361018129,0.00236653854568208
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHA4,Ephrin type-A receptor 4,23337,-0.0058661619758042,0.00193347254382385,-0.00965576816169896,-0.00207655578990944,0.00241597404883378
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,23163,0.0110868117314403,0.00365434166135367,0.00392430207518706,0.0182493213876935,0.00241702978150778
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SETMAR,Histone-lysine N-methyltransferase SETMAR,27881,-0.00616824573571794,0.00203325771584272,-0.0101534308587697,-0.0021830606126662,0.00241815916726191
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIRREL1,Kin of IRRE-like protein 1,23056,0.0120951701630434,0.00398811719964851,0.00427846045173237,0.0199118798743545,0.00242563944665236
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,23738,-0.00813473295302653,0.00268502278452962,-0.0133973776107046,-0.00287208829534847,0.00245084563031085
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REXO2,"Oligoribonuclease, mitochondrial",23071,0.00979275015187876,0.00323490152457476,0.00345234316371223,0.0161331571400453,0.00247088887402094
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HPGDS,Hematopoietic prostaglandin D synthase,27562,0.00773161093456895,0.00255771313261018,0.002718493194653,0.0127447286744849,0.00250627499359522
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UROD,Uroporphyrinogen decarboxylase,23337,-0.0141338594214779,0.00467763778080578,-0.0233020294718572,-0.00496568937109857,0.00251731308352942
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD93,Complement component C1q receptor,27136,0.00646046062356177,0.00214018693125149,0.00226569423830885,0.0106552270088147,0.00254145261944519
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,28260,0.0100270015644795,0.00332683261981097,0.00350640962965004,0.016547593499309,0.00258074863235434
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL13RA2,Interleukin-13 receptor subunit alpha-2,23056,0.00589778336611928,0.00195773277879782,0.00206062711967556,0.00973493961256301,0.0025933717373586
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GM2A,Ganglioside GM2 activator,23373,0.00781542475303875,0.00259536232597198,0.00272851459413367,0.0129023349119438,0.00260406421395013
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACE,Angiotensin-converting enzyme,23872,-0.00530667851467072,0.0017685702240033,-0.00877307615371719,-0.00184028087562425,0.00269773342814395
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HBQ1,Hemoglobin subunit theta-1,28452,-0.012190369411717,0.00406451115408243,-0.0201568112737185,-0.00422392754971539,0.00270904607878097
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKG1,cGMP-dependent protein kinase 1,23337,0.0254480392724767,0.00848757630867055,0.00881238970748243,0.042083688837471,0.00271803788110554
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPEP1,Dipeptidase 1,27910,0.00983759072335278,0.00328193684188763,0.00340499451325303,0.0162701869334525,0.00272447526877735
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF149,E3 ubiquitin-protein ligase RNF149,23198,-0.0062239540284755,0.0020764431504404,-0.0102937826033387,-0.00215412545361232,0.00272571497470307
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLXDC1,Plexin domain-containing protein 1,27562,-0.00669830804758796,0.00223478354734635,-0.0110784838003868,-0.00231813229478912,0.00272628715016384
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPNMB,Transmembrane glycoprotein NMB,27508,-0.00580032059296059,0.00194257829115007,-0.00960777404361473,-0.00199286714230645,0.00283005447108928
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP7,Matrilysin,27638,-0.0101402276820389,0.00339857178545354,-0.0168014283815278,-0.00347902698254996,0.00285059680709547
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLA2G4A,Cytosolic phospholipase A2,28320,0.0176816612917504,0.0059296049539129,0.0060596355820811,0.0293036870014197,0.00286682163258225
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",28091,-0.00674427360700223,0.00226179476819123,-0.011177391352657,-0.00231115586134743,0.00286782639302177
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA11,Serpin A11,28553,0.00826582238006375,0.00277209568119553,0.00283251484492052,0.013699129915207,0.00286805232122959
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMEM132A,Transmembrane protein 132A,23198,-0.0126140996346561,0.00423572062977108,-0.0209161120690074,-0.00431208720030475,0.00290408412604527
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAB2,Disabled homolog 2,28452,0.0222595568627113,0.00747584347816033,0.00760690364551704,0.0369122100799055,0.00290824960940467
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP3,"Fatty acid-binding protein, heart",23846,-0.0101902017197698,0.00342605311707857,-0.0169052658292438,-0.0034751376102958,0.00293926233733585
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDNF,Cerebral dopamine neurotrophic factor,28091,0.00654465455586505,0.00220119348365814,0.00223031532789511,0.010858993783835,0.00294933697745648
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPC2,NPC intracellular cholesterol transporter 2,23545,-0.00640393093430711,0.00215626329124387,-0.0106302069851451,-0.00217765488346913,0.00298177191160833
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADRA2A,Alpha-2A adrenergic receptor,23071,0.0142658207718347,0.004809160158214,0.00483986686173529,0.0236917746819342,0.00301631903961405
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP1,"Fatty acid-binding protein, liver",28195,-0.0188501971027534,0.00636868457612211,-0.0313328188719527,-0.00636757533355402,0.00308069120808649
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMPRSS5,Transmembrane protease serine 5,27831,0.00764111436339917,0.0025819967326688,0.00258040076736831,0.01270182795943,0.00308516536154904
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGH,Gamma-glutamyl hydrolase,27750,0.00682423607068869,0.00230660858190002,0.00230328325016466,0.0113451888912127,0.00309342609333254
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,23393,0.0143623017922685,0.00485560632961557,0.00484531338622199,0.023879290198315,0.00310072431004844
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BPIFB2,BPI fold-containing family B member 2,23778,0.0130124351388562,0.00439985014242756,0.00438872885969822,0.0216361414180143,0.0031047773372532
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEPTIN3,Neuronal-specific septin-3,23795,0.0151444720940281,0.00512546359657444,0.00509856344474218,0.025190380743314,0.00313227442007348
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL3RA,Interleukin-3 receptor subunit alpha,27702,-0.00631937540497528,0.002140766042135,-0.0105152768475599,-0.00212347396239068,0.00316067046783384
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGF2R,Cation-independent mannose-6-phosphate receptor,28187,-0.00466759291450063,0.00158724538405576,-0.00777859386724992,-0.00155659196175133,0.0032775075863602
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPR1,Atrial natriuretic peptide receptor 1,23071,0.00824996450733755,0.00280613348800816,0.00274994287084156,0.0137499861438335,0.00328563630051301
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAP,Prolyl endopeptidase FAP,28553,-0.00546922416940688,0.00186206892057136,-0.00911887925372674,-0.00181956908508701,0.00331480675261673
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSPN,Persephin,28176,-0.0186662460340816,0.00635882689474364,-0.0311295467477791,-0.00620294532038402,0.00333294920869238
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCDC134,Coiled-coil domain-containing protein 134,23725,0.00964755293534431,0.00328877824926876,0.00320154756677753,0.0160935583039111,0.00335510142068351
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",23198,0.0051449068524625,0.00175451028205823,0.00170606669962837,0.00858374700529663,0.00336693878325046
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXK,Tyrosine-protein kinase TXK,23393,0.0148061693424149,0.00505532502367048,0.00489773229602075,0.024714606388809,0.00340572828339761
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,23738,-0.0161902517123331,0.00554040352660256,-0.0270494426244742,-0.00533106080019212,0.00347879142805534
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNLZ,DNL-type zinc finger protein,23056,0.0178065673622613,0.00610725974103459,0.0058363382698335,0.0297767964546891,0.00355302439018917
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL28A1,Collagen alpha-1(XXVIII) chain,23163,-0.0152614829018229,0.00523570596856671,-0.0255234666002137,-0.00499949920343219,0.00356160079272224
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA4,Kallistatin,23502,-0.0047005445650703,0.00161438695109099,-0.00786474298920865,-0.00153634614093196,0.00359852801343643
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RRP15,RRP15-like protein,23056,0.0179770445920798,0.0061774601745285,0.00586922265000394,0.0300848665341557,0.00361655519604644
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,23736,-0.0159265425819398,0.00547571160459436,-0.0266589373269447,-0.0051941478369348,0.00363411632025292
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD300E,CMRF35-like molecule 2,28377,0.00801514050525202,0.00275944752433299,0.00260662335755937,0.0134236576529447,0.00367985615207072
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC10A,C-type lectin domain family 10 member A,27965,0.00710441141191371,0.00244767773757007,0.00230696304627636,0.0119018597775511,0.00370473452046931
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPC5,Glypican-5,27965,0.0110290694055863,0.00380505883312418,0.00357115409266287,0.0184869847185096,0.00375210347102945
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARTN,Artemin,27702,0.00878952580583441,0.00303468860381797,0.0028415361423512,0.0147375154693176,0.00377824385871169
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EXOSC10,Exosome component 10,23071,0.0119325605906228,0.0041270123263549,0.0038436164309672,0.0200215047502784,0.00383971577833062
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL22RA1,Interleukin-22 receptor subunit alpha-1,27702,-0.00842694153846999,0.00291721076976076,-0.0141446746472011,-0.0027092084297389,0.00387140008212178
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPR158,Probable G-protein coupled receptor 158,23795,0.00699256573349619,0.00242203150869223,0.00224538397645941,0.011739747490533,0.00389202431001484
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,23071,0.00619001564359727,0.00214507048597302,0.00198567749109015,0.0103943537961044,0.00390914678573477
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIRT2,NAD-dependent protein deacetylase sirtuin-2,28091,0.0172260854304387,0.00597311009585989,0.00551878964255332,0.0289333812183241,0.00393033193346794
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEPTIN7,Septin-7,23393,0.0102584057720844,0.00357014922931089,0.00326091328263508,0.0172558982615338,0.00406467302185504
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSRA,Mitochondrial peptide methionine sulfoxide reductase,28307,0.0140402914694578,0.00489341890367497,0.00444919041825487,0.0236313925206607,0.00411791108467047
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPING1,Plasma protease C1 inhibitor,23845,0.00363923590307927,0.0012692668116675,0.00115147295221096,0.00612699885394758,0.00414490320764626
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGAP25,Rho GTPase-activating protein 25,27562,-0.011607773532342,0.00405492971347996,-0.0195554357707627,-0.00366011129392133,0.00420454325248245
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMPRSS11B,Transmembrane protease serine 11B,23056,0.0150207517876626,0.00524991995390416,0.00473090867801049,0.0253105948973148,0.00422501447442437
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SF3B4,Splicing factor 3B subunit 4,28091,0.0141172471524924,0.00493430094618011,0.00444601729797935,0.0237884770070054,0.00422561506261381
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,28224,0.0161046368517763,0.00563053050831311,0.00506879705548264,0.02714047664807,0.00423638758246686
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRND,Prion-like protein doppel,23775,-0.00996687523140691,0.00348494517175048,-0.0167973677680378,-0.00313638269477597,0.00424036153686825
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LCAT,Phosphatidylcholine-sterol acyltransferase,23872,0.0042886543126762,0.00150061459686702,0.00134744970281683,0.00722985892253556,0.00426780922302001
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCSK9,Proprotein convertase subtilisin/kexin type 9,28553,-0.00760210128248034,0.00266014608590251,-0.0128159876108493,-0.00238821495411142,0.00426930187920856
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",23198,0.00955658447753525,0.00334806229698902,0.00299438237543677,0.0161187865796337,0.00431614840500772
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD1C,T-cell surface glycoprotein CD1c,28307,0.00468380382583184,0.00164208218967937,0.00146532273406028,0.0079022849176034,0.00434278437347335
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK11,Kallikrein-11,28048,-0.00596716141531234,0.00209551652137181,-0.0100743737972011,-0.00185994903342359,0.00440843479774643
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRLF1,Cytokine receptor-like factor 1,28320,-0.00496985291109666,0.0017456661324543,-0.00839135853070709,-0.00154834729148623,0.00441697625306649
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHA2,Ephrin type-A receptor 2,27126,-0.00606572128736022,0.00213364117080667,-0.0102476579821413,-0.00188378459257915,0.00447389676974148
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACTN2,Alpha-actinin-2,23071,-0.011408146453452,0.00401549006324283,-0.0192785069774079,-0.00353778592949603,0.00450068363688057
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APPL2,DCC-interacting protein 13-beta,23337,0.0215037018106312,0.00757613031994129,0.00665448638354629,0.0363529172377161,0.00453867292188167
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,23056,0.0118443491591706,0.004173387485384,0.00366450968781792,0.0200241886305232,0.00454274512561734
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NIT1,Deaminated glutathione amidase,23198,-0.00901295992312372,0.00317706680445125,-0.0152400108598482,-0.00278590898639927,0.00455961115959878
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17D,Interleukin-17D,27702,0.00649023104558065,0.00228804111781752,0.00200567045465831,0.010974791636503,0.00456314351040432
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPHA2,Glycoprotein hormone alpha-2,23738,0.00891568661711852,0.0031472285907745,0.0027471185792005,0.0150842546550365,0.00461711619882389
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLEKHO1,Pleckstrin homology domain-containing family O member 1,23775,-0.0132718917216967,0.00468729854255629,-0.022458996865107,-0.00408478657828636,0.00463751627586397
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CMC1,COX assembly mitochondrial protein homolog,23846,0.0173423563183464,0.00612810448229525,0.0053312715330477,0.0293534411036451,0.00465911832604424
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRC1,Macrophage mannose receptor 1,23872,0.00541386613034901,0.00191318049567839,0.00166403235881937,0.00916369990187864,0.00466199620132677
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HPSE,Heparanase,23623,0.0179372852138976,0.00634385695081746,0.00550332559029542,0.0303712448374999,0.00469517973629581
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SFTPA1,Pulmonary surfactant-associated protein A1,27562,0.0110352876226189,0.00390598377396571,0.00337955942564613,0.0186910158195917,0.00472812168928014
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,23795,-0.0091731240801108,0.00325407269888897,-0.0155511065699332,-0.00279514159028842,0.00482182488737826
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK8,Serine protease inhibitor Kazal-type 8,23071,0.00719944701655872,0.00255432267516656,0.00219297457323227,0.0122059194598852,0.00482844855626966
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,28176,0.0190179905808642,0.00675958413583649,0.00576920567462463,0.0322667754871037,0.00490415754692172
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",28187,-0.00877183441356456,0.0031221319283906,-0.0148912129932101,-0.00265245583391899,0.0049642589038466
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AXIN1,Axin-1,28176,-0.0180678192426771,0.0064389833483504,-0.0306882266054439,-0.00544741187991034,0.00501943334923528
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GKN1,Gastrokine-1,26907,-0.00533059541243539,0.00190309897453488,-0.00906066940252374,-0.00160052142234703,0.00509796256896846
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ING1,Inhibitor of growth protein 1,27489,-0.00873638321764874,0.00312024535904136,-0.0148520641213698,-0.00262070231392769,0.00511536887640655
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UXS1,UDP-glucuronic acid decarboxylase 1,27562,-0.00997264230567426,0.00356187339721194,-0.0169539141642097,-0.00299137044713885,0.00511649999050403
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17F,Interleukin-17F,27702,0.0144783723737537,0.00517184716811499,0.00434155192424832,0.0246151928232591,0.005122379071601
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYBPC2,"Myosin-binding protein C, fast-type",23198,-0.0160783257476568,0.00574438166408395,-0.0273373138092613,-0.00481933768605226,0.00513089658151996
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,27562,-0.0160810773005297,0.00574865091691869,-0.0273484330976904,-0.0048137215033691,0.00515569617093721
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAP1L4,Nucleosome assembly protein 1-like 4,23700,-0.00772818172317259,0.00276442284861839,-0.0131464505064646,-0.00230991293988054,0.00518474191988803
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKR1C4,Aldo-keto reductase family 1 member C4,27682,-0.0101193639556058,0.00362103721751292,-0.0172165969019311,-0.00302213100928044,0.0051999132954923
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ST13,Hsc70-interacting protein,23337,-0.0105356247843225,0.00377206716344391,-0.0179288764246726,-0.00314237314397244,0.00522539095473972
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRC25,Leucine-rich repeat-containing protein 25,28091,0.00738215923852679,0.00264417979453541,0.00219956684123739,0.0125647516358162,0.0052442697291022
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,23188,-0.00590822608749315,0.00211830423308195,-0.0100601023843338,-0.00175634979065251,0.00528929475813131
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLRF1,Killer cell lectin-like receptor subfamily F member 1,23188,-0.0082421587650219,0.00295742022907138,-0.0140387024140018,-0.002445615116042,0.00532512811776504
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,23725,0.0102214973227924,0.00366978347049902,0.00302872172061431,0.0174142729249705,0.00535184275796228
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA7,Carbonic anhydrase 7,23393,0.00647921628081455,0.00232820245365663,0.00191593947164755,0.0110424930899815,0.00539142265462445
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,28520,-0.00518420190124898,0.00186304707653585,-0.00883577417125925,-0.00153262963123872,0.00539529346472854
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAPK9,Mitogen-activated protein kinase 9,28176,-0.00807001822893644,0.0029018142260628,-0.0137575741120195,-0.00238246234585335,0.00542235428688996
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNPEP,Aspartyl aminopeptidase,23775,-0.0109306838253734,0.00393507484943756,-0.018643430530271,-0.0032179371204758,0.00547783598894307
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ABL1,Tyrosine-protein kinase ABL1,28091,-0.0127579858449405,0.00459410870372945,-0.0217624389042502,-0.00375353278563074,0.00548941799211144
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUGT1,Protein SGT1 homolog,27562,0.0151500253753362,0.0054570111836828,0.00445428345531789,0.0258457672953545,0.00550270807510614
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHMT1,"Serine hydroxymethyltransferase, cytosolic",28276,-0.0161744739022263,0.00583172010902821,-0.0276046453159215,-0.00474430248853096,0.00554873996916826
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,23725,0.00834264248373924,0.0030113566494752,0.00244038345076785,0.0142449015167106,0.00560322011623273
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C3,Complement C3,22744,0.00871015775481217,0.00314400772396001,0.00254790261585055,0.0148724128937738,0.0056033008994412
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAMT,Guanidinoacetate N-methyltransferase,23071,0.00698569237399652,0.00252757339645132,0.00203164851695193,0.0119397362310411,0.00571789164523233
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,27544,0.0208850409875695,0.00757487704346476,0.00603828198237855,0.0357317999927604,0.00583467452484471
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD86,T-lymphocyte activation antigen CD86,23738,0.0055420929320575,0.00201241353402331,0.00159776240537181,0.00948642345874318,0.0058924991358561
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA11,Annexin A11,28115,0.0124013202252342,0.00450363996397219,0.00357418589584866,0.0212284545546196,0.0058977737250352
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGMA,Repulsive guidance molecule A,28428,-0.00586561848603761,0.00213123667844096,-0.0100428423757819,-0.00168839459629332,0.0059231444647394
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATXN2,Ataxin-2,23056,0.0206372701231224,0.00750049270185683,0.00593630442748296,0.0353382358187617,0.00593774777299361
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLGN,Calmegin,23163,-0.00834712336678267,0.00304027142289992,-0.0143060553556665,-0.00238819137789882,0.00604618640207544
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RABEP1,Rab GTPase-binding effector protein 1,23337,-0.01449454303246,0.00528095118250277,-0.0248452073501655,-0.0041438787147546,0.00606154998425689
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC26,Anaphase-promoting complex subunit CDC26,23700,0.0130129961316516,0.00474554496868112,0.00371172799303661,0.0223142642702666,0.00610842908033894
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEL1L,Protein sel-1 homolog 1,23198,-0.0059133654966066,0.00215884149050223,-0.010144694817991,-0.00168203617522224,0.00616475143627059
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SRPK2,SRSF protein kinase 2,28176,-0.015549703747571,0.00569017304815237,-0.0267024429219496,-0.00439696457319232,0.00628510717420026
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",23071,0.0159826656266855,0.0058525257919814,0.00451171507440191,0.027453616178969,0.00632095406118965
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALY,Neuron-specific vesicular protein calcyon,23071,0.00710621525585144,0.00260640633613499,0.00199765883702686,0.012214771674676,0.00640696085623819
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGA4,Pepsin A-4,23872,-0.0131796710173661,0.00483405110298822,-0.022654411179223,-0.00370493085550915,0.00640715216160043
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSTM2B,V-set and transmembrane domain-containing protein 2B,23393,0.0075667423289348,0.00277762801580287,0.00212259141796119,0.0130108932399084,0.00645104045961045
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GHRHR,Growth hormone-releasing hormone receptor,27544,0.0101350726599455,0.00372478036476664,0.00283450314500287,0.0174356421748881,0.00651285447865521
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HEXIM1,Protein HEXIM1,28176,-0.014957502437055,0.00549754298661654,-0.0257326866908234,-0.00418231818328654,0.00651717539173997
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYDGF,Myeloid-derived growth factor,23846,0.0183415472144901,0.00674464530999036,0.00512204240690899,0.0315610520220712,0.00654431755939616
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DKK3,Dickkopf-related protein 3,28553,0.00542474612496399,0.00199545271462843,0.00151365880429227,0.00933583344563571,0.00656075446707799
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TACC3,Transforming acidic coiled-coil-containing protein 3,28091,0.0213865268852448,0.00787413424364922,0.00595322376769233,0.0368198300027973,0.00661067634682754
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TEF,Thyrotroph embryonic factor,23071,0.00786630296425846,0.00290181221431702,0.0021787510241971,0.0135538549043198,0.00671658626018681
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF13,Tumor necrosis factor ligand superfamily member 13,28320,-0.00494666891228591,0.00182609311423888,-0.00852581141619412,-0.00136752640837769,0.00675511480120693
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTSS2,Protein MTSS 2,23725,-0.0181623560485646,0.00671056179189647,-0.0313150571606816,-0.00500965493644747,0.00680385083836103
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSH,Pro-cathepsin H,27623,-0.0134003914867281,0.00496001557501974,-0.0231220220137668,-0.00367876095968939,0.00690315595521668
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHGA,Chromogranin-A,23862,-0.0160614758780227,0.00594521192734122,-0.0277140912556115,-0.00440886050043387,0.00690593004961058
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDGFC,Platelet-derived growth factor C,27562,-0.00526117155842836,0.00195122350803105,-0.00908556963416922,-0.0014367734826875,0.00701476379137106
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HS1BP3,HCLS1-binding protein 3,23198,0.0163930304627718,0.00608973920406158,0.00445714162281109,0.0283289193027325,0.0071095091261799
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINB6,Serpin B6,28358,0.0107655562052412,0.00400784480385579,0.00291018038968386,0.0186209320207985,0.00723290156976737
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNG,Interferon gamma,27702,-0.0206794531750062,0.00769893350597105,-0.0357693628467094,-0.00558954350330289,0.00723528998687164
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUSD2,Sushi domain-containing protein 2,28187,0.00520421552495669,0.00193754308985591,0.00140663106883911,0.00900179998107427,0.00723582867687733
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ODAM,Odontogenic ameloblast-associated protein,27500,0.0097890048914318,0.0036447119822858,0.00264536940615163,0.016932640376712,0.00723976144015021
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOLR1,Folate receptor alpha,28129,-0.00525796961238534,0.0019604979781254,-0.00910054564951113,-0.00141539357525955,0.00732358061875126
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SDC1,Syndecan-1,28224,0.00731099148042014,0.00273105612045796,0.00195812148432253,0.0126638614765177,0.00743313101404793
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SFTPA2,Pulmonary surfactant-associated protein A2,27562,0.00918550092998134,0.00343233344692563,0.00245812737400711,0.0159128744859556,0.00745133585704189
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL26,C-C motif chemokine 26,28176,0.0161777639484646,0.00604778792129573,0.00432409962272498,0.0280314282742042,0.00747749592509987
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECI2,Enoyl-CoA delta isomerase 2,23071,0.0111350740257903,0.00416602214023081,0.0029696706309379,0.0193004774206427,0.007526700666644
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAD1,Glutamate decarboxylase 1,22978,0.00471136796405438,0.00176399373715781,0.00125394023922507,0.00816879568888369,0.00757120831049707
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX1,ATP-dependent RNA helicase DDX1,23738,-0.00904298311692733,0.00338790610807602,-0.0156832790887563,-0.00240268714509834,0.0076084964509575
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,23337,-0.00761495650714737,0.00285315507530859,-0.0132071404547522,-0.00202277255954253,0.00761391848510398
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CYB5R2,NADH-cytochrome b5 reductase 2,23469,0.0100706685290999,0.0037759777783744,0.00266975208348604,0.0174715849747137,0.00765760046435677
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DSG4,Desmoglein-4,27985,0.00894376462620472,0.00335850151847828,0.00236110164998729,0.0155264276024221,0.00774865991032949
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPBP,Platelet basic protein,23751,0.0152166120501962,0.00572104023022256,0.00400337319895999,0.0264298509014324,0.00782481322968031
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ART5,Ecto-ADP-ribosyltransferase 5,23056,0.0113509645365925,0.0042690181193973,0.00298368902257375,0.0197182400506112,0.00784464647579892
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TP53INP1,Tumor protein p53-inducible nuclear protein 1,27682,0.00566285080944149,0.00213200832036847,0.00148411450151929,0.00984158711736369,0.00790929060631988
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRSF1,G-rich sequence factor 1,22833,0.0145487348163833,0.00547953927917329,0.00380883782920361,0.0252886318035629,0.00793395126857826
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMY2B,Alpha-amylase 2B,26395,0.00878192605700566,0.00331173690686643,0.00229092171954746,0.0152729303944639,0.00801216920731509
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FYB1,FYN-binding protein 1,28144,-0.0164795820244865,0.00621665716241452,-0.028664230062819,-0.00429493398615409,0.00803284672267623
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSBP1,Heat shock factor-binding protein 1,23198,0.0171082808653269,0.00645437273966387,0.0044577102955857,0.0297588514350681,0.0080391695641123
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLITRK2,SLIT and NTRK-like protein 2,28452,-0.00702697445868281,0.00265232827239024,-0.0122255378725677,-0.00182841104479794,0.00806887724414364
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL6,C-X-C motif chemokine 6,28521,-0.0137192083670602,0.00518859608748522,-0.0238888566985312,-0.00354956003558912,0.00819513672105953
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,27562,-0.0106560881865444,0.00403721440666133,-0.0185690284236006,-0.00274314794948815,0.00830836264763755
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,23738,-0.0193092970015668,0.00733147886451936,-0.0336789955760247,-0.00493959842710882,0.00845019366642318
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,B4GALT1,"Beta-1,4-galactosyltransferase 1",28320,-0.00492135589195788,0.00186944623065244,-0.00858547050403667,-0.00125724127987909,0.00847998678884052
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HGF,Hepatocyte growth factor,28521,-0.00610948465634652,0.00232145659617812,-0.0106595395848556,-0.00155942972783741,0.00849930262255165
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UNG,Uracil-DNA glycosylase,23725,0.00609920966338424,0.00231865060788365,0.00155465447193228,0.0106437648548362,0.0085314554373271
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNNI3,"Troponin I, cardiac muscle",27682,-0.014957726654445,0.00569268869396774,-0.0261153964946218,-0.00380005681426822,0.0086053975751552
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MATN3,Matrilin-3,27918,0.00570727667603928,0.00217373833657827,0.00144674953634587,0.00996780381573269,0.00865541887021438
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARG2,"Arginase-2, mitochondrial",23725,0.00765793203494546,0.00292015976416949,0.00193441889717326,0.0133814451727177,0.0087359477437659
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",27881,0.00723183443466683,0.00276685091265723,0.00180880664585865,0.012654862223475,0.00896047730828989
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SARG,Specifically androgen-regulated gene protein,23747,-0.0192657280564797,0.00737398118191659,-0.0337187311730362,-0.00481272493992316,0.00898964497226551
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDHR1,Cadherin-related family member 1,27544,-0.00754926097275587,0.00289380356534537,-0.0132211159608328,-0.00187740598467894,0.00909180390834095
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFB103A_DEFB103B,Beta-defensin 103,23075,-0.00729266589545675,0.00279915365094662,-0.0127790070513121,-0.00180632473960138,0.00918498301730969
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFCAB14,EF-hand calcium-binding domain-containing protein 14,23738,-0.00484085318526693,0.00185949359014823,-0.00848546062195746,-0.0011962457485764,0.00923837352896677
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGFBP2,Fibroblast growth factor-binding protein 2,23862,-0.00885014268994493,0.00340485169512146,-0.015523652012383,-0.00217663336750686,0.00934786845316958
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,23795,0.0147664358736303,0.00568622583942178,0.00362143322836359,0.025911438518897,0.00941331839706801
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPXM1,Probable carboxypeptidase X1,28307,0.0120369483295013,0.00464186760524738,0.00293888782321645,0.0211350088357862,0.00951568260175363
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXNDC5,Thioredoxin domain-containing protein 5,28428,0.011905500313624,0.00459621848191669,0.00289691208906733,0.0209140885381808,0.0095946397245074
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IRAK1,Interleukin-1 receptor-associated kinase 1,27702,-0.0121560689539676,0.00470007816993515,-0.0213682221670405,-0.00294391574089467,0.00970476178366089
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF20,Fibroblast growth factor 20,23188,0.00766708245993272,0.00296642056738541,0.00185289814785731,0.0134812667720081,0.00975457283399128
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAPK13,Mitogen-activated protein kinase 13,22978,-0.00742224373027928,0.00287440087658014,-0.0130560694483764,-0.00178841801218221,0.00982373894437582
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRDT,Bromodomain testis-specific protein,23071,0.0064201184236018,0.00249209164229259,0.00153561880470833,0.0113046180424953,0.00999554225108063
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSTM4,Glutathione S-transferase Mu 4,23071,0.0126597597529313,0.00491878475273813,0.00301894163756452,0.022300577868298,0.0100662587808609
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,P4HB,Protein disulfide-isomerase,28064,0.00674071067533149,0.00262531218578608,0.00159509879119078,0.0118863225594722,0.0102461177223371
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOBR,Apolipoprotein B receptor,23198,0.00737748248443093,0.00287435532472368,0.00174374604797251,0.0130112189208893,0.0102746496645629
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCN1,Transcobalamin-1,23481,0.00591709467187452,0.00231055593318007,0.00138840504284159,0.0104457843009075,0.0104464416350985
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,28095,-0.0321360940865764,0.012548992381953,-0.0567321191552043,-0.00754006901794842,0.0104468053217979
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPPED1,Serine/threonine-protein phosphatase CPPED1,28428,-0.0112915269503771,0.00441791267256699,-0.0199506357886084,-0.00263241811214582,0.0105980004022894
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NXPE4,NXPE family member 4,23071,0.00597691997719197,0.00234071949726059,0.0013891097625612,0.0105647301918227,0.0106724087941203
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAA10,N-alpha-acetyltransferase 10,23071,0.00880963936938694,0.00345084474777057,0.00204598366375663,0.0155732950750173,0.0106895963873196
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMC3,26S proteasome regulatory subunit 6A,22978,0.00523542921211369,0.00205341001824966,0.00121074557634435,0.00926011284788303,0.0107902685822153
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PF4,Platelet factor 4,23757,0.0166894453627397,0.00655986835276222,0.00383210339132576,0.0295467873341537,0.0109599346761667
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SFTPD,Pulmonary surfactant-associated protein D,28224,-0.0115276662878094,0.0045315532070842,-0.0204095105736945,-0.00264582200192441,0.010968585198351
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ELAC1,Zinc phosphodiesterase ELAC protein 1,23795,0.0146334136095934,0.00575360477497471,0.00335634825064297,0.0259104789685438,0.0109858884286353
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGSF21,Immunoglobulin superfamily member 21,23198,-0.00679846072968177,0.00267380043069159,-0.0120391095738373,-0.00155781188552626,0.0110088993324869
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KHDC3L,KH domain-containing protein 3,22978,0.0116705505668646,0.00459512981848301,0.00266409612263793,0.0206770050110913,0.0110992265967818
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CWC15,Spliceosome-associated protein CWC15 homolog,23615,-0.0103608821628872,0.0040839030705095,-0.0183653321810858,-0.00235643214468856,0.0111869216184059
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFCAB2,Dynein regulatory complex protein 8,23393,0.00601526996195395,0.00237547837635469,0.00135933234429875,0.0106712075796091,0.0113402826344371
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP15,Matrix metalloproteinase-15,23846,0.00841881656045664,0.00332658478750154,0.00189871037695362,0.0149389227439597,0.0113876672756892
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LIF,Leukemia inhibitory factor,27544,-0.00876143558867369,0.0034623759793642,-0.0155476925082275,-0.00197517866911985,0.0113965347045064
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP43,Centrosomal protein 43,27481,-0.0119359550500311,0.00472180566821348,-0.0211906941597295,-0.00268121594033271,0.0114823205495851
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCN2,CCN family member 2,28220,0.0097490052903385,0.00386114690553903,0.002181157355482,0.017316853225195,0.0115785958918769
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GBP2,Guanylate-binding protein 2,27702,0.0102455596203838,0.00405985256404156,0.00228824859486238,0.0182028706459053,0.0116206078352036
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SORT1,Sortilin,28182,-0.00635231137639772,0.00252164772715269,-0.011294740921617,-0.00140988183117844,0.0117706333937244
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL2L1,Bcl-2-like protein 1,23775,0.0169509811719767,0.00673009908100921,0.00375998697319863,0.0301419753707548,0.011786000760342
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AFP,Alpha-fetoprotein,27881,0.0115616556872432,0.0045911496252375,0.00256300242177774,0.0205603089527087,0.0117995623204473
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PECAM1,Platelet endothelial cell adhesion molecule,28187,-0.0051302195003799,0.00203730202493206,-0.00912333146924673,-0.00113710753151308,0.0118030090280148
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD274,Programmed cell death 1 ligand 1,27965,0.00583973757981815,0.00232023569742254,0.00129207561286997,0.0103873995467663,0.0118457133677209
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD58,Lymphocyte function-associated antigen 3,28152,-0.00299962790804176,0.00119198272469814,-0.00533591404845012,-0.000663341767633397,0.0118581096025748
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC7A,C-type lectin domain family 7 member A,28521,0.00999106220438243,0.00398605282448281,0.00217839866839611,0.0178037257403687,0.0121986475466731
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HHEX,Hematopoietically-expressed homeobox protein HHEX,23775,-0.0128724934387028,0.00513999540113843,-0.0229468844249341,-0.00279810245247151,0.0122733212371947
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZFYVE19,Abscission/NoCut checkpoint regulator,23738,0.0153263766443408,0.00612327113572966,0.00332476521831063,0.0273279880703709,0.0123221945735394
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSPAN15,Tetraspanin-15,23071,0.00858430709072878,0.00343135189385465,0.00185885737877366,0.0153097568026839,0.0123657774933572
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TST,Thiosulfate sulfurtransferase,27477,0.0128301346511246,0.00513037017165765,0.00277460911467555,0.0228856601875735,0.0123963758539252
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJC9,DnaJ homolog subfamily C member 9,23738,-0.0128817852746295,0.00515115571633514,-0.0229780504786464,-0.0027855200706126,0.0123995305858888
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INSL3,Insulin-like 3,23775,0.0127869085418551,0.00511367426120185,0.00276410698989947,0.0228097100938107,0.0124073574107552
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAS6,Growth arrest-specific protein 6,28380,-0.00429685589628904,0.00172116123291172,-0.00767033191279602,-0.000923379879782073,0.0125486702349847
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CETN3,Centrin-3,23738,0.0130924994689789,0.00524601270780199,0.00281031456168699,0.0233746843762708,0.0125774511609233
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,23188,-0.0060471185495049,0.00242966616988586,-0.0108092642424812,-0.00128497285652861,0.012822014328612
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRI1,Methylthioribose-1-phosphate isomerase,23163,-0.0113926590061,0.00458725114531503,-0.0203836712509175,-0.00240164676128256,0.0130150980154246
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOS2,"Nitric oxide synthase, inducible",23071,0.00665996663238854,0.00268939981973053,0.00138874298571671,0.0119311902790604,0.0132794726200437
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC5,Sialic acid-binding Ig-like lectin 5,28187,0.0199236933135628,0.00805536437460646,0.00413517913933414,0.0357122074877915,0.0133913462354567
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HNMT,Histamine N-methyltransferase,27832,-0.00787476723212598,0.00319602311471628,-0.0141389725369699,-0.00161056192728207,0.0137484182030548
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA3,Annexin A3,28378,0.0116005947369155,0.00471024985806759,0.002368505015103,0.0208326844587279,0.0137900136054006
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLMAP,Sarcolemmal membrane-associated protein,23738,-0.0138937299755426,0.00564252756138255,-0.0249530839958524,-0.00283437595523277,0.0138110526069394
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,23893,0.00311349668198772,0.00126617552634625,0.000631792650349062,0.00559520071362637,0.0139403898259137
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,27965,0.00695057251788656,0.00283389379934339,0.00139614067117352,0.0125050043645996,0.0141865725623309
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,28319,0.0185757409025955,0.00758078099443194,0.00371741015350893,0.0334340716516821,0.0142768397509743
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,POMC,Pro-opiomelanocortin,23198,0.0116777924371265,0.00477232514338374,0.00232403515609441,0.0210315497181587,0.0144131843430541
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCRIB,Protein scribble homolog,23198,-0.014900125727205,0.00609331682373669,-0.0268430267017289,-0.00295722475268111,0.0144796466849957
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGACT,Gamma-glutamylaminecyclotransferase,23846,0.0117086778313474,0.00479097900396661,0.0023183589835729,0.021098996679122,0.0145366168928478
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTA,Lymphotoxin-alpha,28176,-0.00664636444670299,0.00271990734840923,-0.0119773828495851,-0.0013153460438209,0.0145476508712187
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRSS27,Serine protease 27,28142,0.00665735569124724,0.00272477110033548,0.00131680433458971,0.0119979070479048,0.0145608862823367
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMMR,Hyaluronan mediated motility receptor,22940,0.00806696682241951,0.00330366300245587,0.00159178733760601,0.014542146307233,0.0146207341356208
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNU13,NHP2-like protein 1,23071,-0.0103800017055289,0.00425394385894439,-0.0187177316690599,-0.00204227174199792,0.0146911222471832
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFKB1,Nuclear factor NF-kappa-B p105 subunit,23071,-0.0122698839942893,0.00504262854185779,-0.0221534359363305,-0.00238633205224799,0.0149722657442878
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRUNE2,Protein prune homolog 2,23393,-0.00481226810519184,0.00197849983283532,-0.00869012777754908,-0.000934408432834605,0.0150115031484278
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ABHD14B,Protein ABHD14B,27870,0.00940653258516772,0.00387480724572905,0.00181191038353879,0.0170011547867966,0.0152048432288854
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAPGEF2,Rap guanine nucleotide exchange factor 2,23393,-0.0087694829286019,0.0036126689803697,-0.0158503141301265,-0.00168865172707729,0.0152139319183445
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLI2,Zinc finger protein GLI2,23188,0.00543645067147592,0.00223999598990036,0.00104605853127122,0.00982684281168063,0.0152321941411887
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFA1_DEFA1B,Neutrophil defensin 1,27632,0.00862667898873412,0.00355829612964672,0.00165241857462655,0.0156009394028417,0.0153407228519129
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,23393,0.0142869148184624,0.00589405901811531,0.00273455914295641,0.0258392704939684,0.0153601787584094
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DMD,Dystrophin,23198,-0.00847637079155458,0.00349766208866912,-0.0153317884853461,-0.00162095309776311,0.0153819372640913
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",23170,-0.013033018645143,0.00538353302415444,-0.0235847433724857,-0.00248129391780029,0.0154895868842822
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PMCH,Pro-MCH,23071,0.0137067029485033,0.00566205716723582,0.0026090709007211,0.0248043349962855,0.0154941043125546
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FZD10,Frizzled-10,23163,-0.00988534939844315,0.00408543222498406,-0.0178927965594119,-0.00187790223747439,0.0155427558324428
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCPEP1,Retinoid-inducible serine carboxypeptidase,23100,-0.00821254919155152,0.00339423389886248,-0.014865247633322,-0.00155985074978106,0.0155470136090069
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGFR4,Fibroblast growth factor receptor 4,23337,0.00864689821733109,0.00357776107260533,0.00163448651502465,0.0156593099196375,0.0156632539160315
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PROCR,Endothelial protein C receptor,23071,0.00585949911224104,0.00242463040237879,0.0011072235235786,0.0106117747009035,0.0156714987130342
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL20,Interleukin-20,27702,0.00797789840798264,0.00330474626525272,0.00150059572808731,0.014455201087878,0.0157817497950238
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,27682,-0.00503979872565247,0.00208959354228206,-0.00913540206852531,-0.00094419538277964,0.0158780159499578
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,23337,0.0111752404769623,0.00464015726390588,0.00208053223970675,0.0202699487142178,0.0160314028767234
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIE1,Tyrosine-protein kinase receptor Tie-1,28553,0.00669621376157398,0.0027826333718454,0.00124225235275698,0.012150175170391,0.0161155835621911
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL7R,Interleukin-7 receptor subunit alpha,28187,0.00852437364340827,0.00354695296567932,0.0015723458306768,0.0154764014561397,0.0162545042983382
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCT,Secretin,23163,-0.00766410975423159,0.00318944193429742,-0.0139154159454545,-0.00141280356300865,0.0162706682667571
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMOT,Angiomotin,23337,-0.0065323068012037,0.00271917302245228,-0.0118618859252102,-0.00120272767719724,0.0162994942204743
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL9,C-X-C motif chemokine 9,28320,0.0107731545946146,0.00449490080702893,0.00196314901283788,0.0195831601763913,0.0165476391904298
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TALDO1,Transaldolase,23813,-0.00718304712060219,0.00300162236152057,-0.0130662269491825,-0.00129986729202186,0.016716441854394
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF4B,Eukaryotic translation initiation factor 4B,27965,-0.00932847174969346,0.00390130165905693,-0.016975023001445,-0.00168192049794189,0.0168037369487798
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA12,Carbonic anhydrase 12,28091,-0.00528016896929495,0.00221061229785566,-0.00961296907309205,-0.000947368865497859,0.0169213431931663
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD300LF,CMRF35-like molecule 1,28452,0.00973848090170586,0.00408693820289597,0.00172808202402977,0.017748879779382,0.0171866321844143
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,27544,-0.0103655622651182,0.00435079302848335,-0.0188931166009455,-0.00183800792929081,0.017204448669331
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP4,Insulin-like growth factor-binding protein 4,27734,-0.00709484359257413,0.00297842891379795,-0.0129325642636181,-0.00125712292153014,0.0172220548119541
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,23846,0.00992603417526179,0.00416722833233088,0.00175826664389325,0.0180938017066303,0.0172301045690582
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CACYBP,Calcyclin-binding protein,23287,0.0165485669522654,0.00695789581650194,0.00291109115192159,0.0301860427526092,0.0173966008012509
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP2,Caspase-2,28176,0.0109506911532136,0.00460436722424877,0.00192613139368599,0.0199752509127412,0.0173980222720545
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP7,Caspase-7,23775,0.0134944295316801,0.00567609523297383,0.00236928287505142,0.0246195761883088,0.0174423638186495
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYH4,Myosin-4,23071,0.0075419934524827,0.00317321270734398,0.0013224965460885,0.0137614903588769,0.0174731368454223
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUCB2,Nucleobindin-2,28381,0.00600761561346833,0.00252798332775925,0.0010527682910602,0.0109624629358765,0.0174869214833742
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCAR2,Cell cycle and apoptosis regulator protein 2,23775,-0.00890612228213357,0.00375291495609007,-0.0162618355960701,-0.00155040896819704,0.0176463803047151
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBC1D5,TBC1 domain family member 5,28176,-0.0125267782693491,0.00528566308851109,-0.0228866779228309,-0.00216687861586741,0.0177969979849799
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REST,RE1-silencing transcription factor,22978,0.00561963933507763,0.00237963090861699,0.000955562754188328,0.0102837159159669,0.0182065644346584
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PKD2,Polycystin-2,23071,0.00942452507374787,0.00399552192138129,0.00159330210784055,0.0172557480396552,0.018343813585168
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCLRE1C,Protein artemis,22978,0.00497362017245457,0.00210909610668685,0.000839791803348354,0.00910744854156079,0.0183733093482689
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MDH1,"Malate dehydrogenase, cytoplasmic",23777,-0.00638842661924187,0.00271230493642846,-0.0117045442946416,-0.0010723089438421,0.0185133629498649
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCN3B,Sodium channel subunit beta-3,23056,0.00737699944754106,0.00313387332987329,0.00123460772098942,0.0135193911740927,0.0185831657180787
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAMBP,STAM-binding protein,27910,-0.0101668528001551,0.00431934790760691,-0.0186327746990647,-0.00170093090124558,0.0185898308862824
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DUSP13,Dual specificity protein phosphatase 13 isoform A,23725,0.00670176515809423,0.0028473121391669,0.0011210333653271,0.0122824969508614,0.0185949029720283
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,23725,0.0154545949749215,0.00657073597572781,0.00257595246249504,0.028333237487348,0.0186791956924221
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRADD,Death domain-containing protein CRADD,27910,0.0120305293671163,0.00511659177267934,0.00200200949266481,0.0220590492415678,0.0187159710114583
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNW1,Interferon omega-1,23071,0.00576813446269935,0.0024535223671089,0.000959230623165909,0.0105770383022328,0.0187333887460096
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VIM,Vimentin,27682,-0.018428771962876,0.00785458540875627,-0.0338237593640383,-0.00303378456171377,0.0189707182435687
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXNL1,Thioredoxin-like protein 1,23026,-0.0156383965864963,0.00666616229019498,-0.0287040746752784,-0.00257271849771411,0.0189877569360699
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYO6,Unconventional myosin-VI,23795,0.00595039404058715,0.0025393123892814,0.000973341757595598,0.0109274463235787,0.0191217296345854
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCARF2,Scavenger receptor class F member 2,28428,-0.00461888180298327,0.00197150266340349,-0.00848302702325411,-0.000754736582712421,0.0191453207223668
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DTYMK,Thymidylate kinase,23846,-0.0107971421148372,0.00461766763264489,-0.0198477706748212,-0.00174651355485325,0.0193838470560348
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,XPNPEP2,Xaa-Pro aminopeptidase 2,28307,0.0156050377375641,0.00668229432463797,0.00250774086127366,0.0287023346138545,0.019535676982001
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSS,Cathepsin S,22397,0.00386812080650197,0.00165833106631849,0.00061779191651773,0.0071184496964862,0.0196812048661393
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLT4,Vascular endothelial growth factor receptor 3,28307,0.00528130395582981,0.00226677223706213,0.000838430371188037,0.00972417754047158,0.0198195693080995
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCGB2A2,Mammaglobin-A,23071,0.00495505982618116,0.00212819566646424,0.000783796319911263,0.00912632333245107,0.0199052337224301
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFB1,Transforming growth factor beta-1 proprotein,28496,-0.00601641266657412,0.00258716778136202,-0.0110872615180437,-0.000945563815104572,0.0200531761923174
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLIT2,Slit homolog 2 protein,27544,-0.00818130237517568,0.00352025610002483,-0.0150810043312244,-0.00128160041912701,0.0201292752271977
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LACTB2,Endoribonuclease LACTB2,28224,0.0103930977102061,0.0044721793308964,0.00162762622164919,0.0191585691987631,0.0201355215144595
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,23738,0.0110623478614058,0.00476425662280661,0.0017244048807048,0.0204002908421067,0.0202442517121827
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CANT1,Soluble calcium-activated nucleotidase 1,28120,0.0031764998766484,0.00137025670340798,0.000490796737968761,0.00586220301532803,0.0204467525799412
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSPAN1,Tetraspanin-1,27682,-0.00898097604282037,0.00387467956728463,-0.0165753479946982,-0.00138660409094249,0.0204640290456057
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1RAP,Interleukin-1 receptor accessory protein,28187,0.00688071020773122,0.00297030888858793,0.00105890478609889,0.0127025156293636,0.0205383114429935
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD59,CD59 glycoprotein,27082,0.00361873293514749,0.00156646290756164,0.000548465636326663,0.00668900023396831,0.0208884421338701
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RPS10,40S ribosomal protein S10,23071,0.00658902294081386,0.00285402707685193,0.000995129870184073,0.0121829160114436,0.0209703840593709
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA7A,Semaphorin-7A,28470,-0.00431686134751847,0.00187023723636305,-0.00798252633079004,-0.000651196364246904,0.0209957510732838
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP3,Caspase-3,28553,0.0137326661566689,0.00594965567592381,0.00207134103185823,0.0253939912814796,0.0209982040676813
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMAD2,Mothers against decapentaplegic homolog 2,23725,-0.010833992982388,0.00470296613070409,-0.020051806598568,-0.001616179366208,0.0212508447607009
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",23188,0.00552367537690773,0.00239901058675501,0.000821614626867901,0.0102257361269476,0.0213169008961325
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,27508,-0.00909090172295703,0.0039554457245975,-0.0168435753431681,-0.00133822810274592,0.0215507380898262
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALDH2,"Aldehyde dehydrogenase, mitochondrial",23725,-0.00799976472363323,0.00348170380342118,-0.0148239041783387,-0.00117562526892772,0.0215899248869913
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL34,Interleukin-34,27500,-0.00562180999376157,0.00244828958166584,-0.0104204575738266,-0.000823162413696516,0.0216708279709886
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL1A1,Collagen alpha-1(I) chain,28553,-0.00387131005697684,0.00168980469507078,-0.00718332725931557,-0.000559292854638118,0.0219717795623992
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL18RAP,Interleukin-18 receptor accessory protein,27791,0.0266228697277287,0.0116257023076592,0.00383649320471671,0.0494092462507408,0.0220287202924641
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RARRES2,Retinoic acid receptor responder protein 2,28367,-0.00731193935001037,0.00319337900552559,-0.0135709622008405,-0.00105291649918022,0.0220449451093096
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPRY2,Protein sprouty homolog 2,27702,0.0142945444720183,0.00625894243880905,0.0020270172919526,0.0265620716520841,0.0223873319802963
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH4,Cadherin-4,23056,0.00743476990669323,0.00325616759684207,0.00105268141688277,0.0138168583965037,0.0224224436577712
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXNDC9,Thioredoxin domain-containing protein 9,23775,0.00823596759834205,0.00360922164188213,0.00116189318025307,0.015310042016431,0.0225026590997207
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPCDC,Phosphopantothenoylcysteine decarboxylase,28428,-0.00721949323468377,0.00316779336328343,-0.0134283682267193,-0.00101061824264824,0.0226727189177961
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERMAP,Erythroid membrane-associated protein,23188,-0.00687234922521691,0.00302296426647175,-0.0127973591875015,-0.000947339262932274,0.0230123450138471
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNLR1,Interferon lambda receptor 1,28176,0.00568364421778945,0.00250254724967554,0.000778651608425384,0.0105886368271535,0.0231457990351587
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,28307,-0.00696119552954396,0.00306529595558162,-0.0129691756024839,-0.000953215456603983,0.0231562671984234
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNN,Tenascin-N,23862,-0.00663500637710503,0.00292707403080516,-0.0123720714774831,-0.000897941276726927,0.02341313723949
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AOC3,Membrane primary amine oxidase,28336,-0.00463342846845317,0.00204486804261179,-0.00864136983197227,-0.000625487104934075,0.0234661599181226
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH5,Cadherin-5,28553,0.00465185790445143,0.00205331878071224,0.000627353094255449,0.00867636271464742,0.0234875574155735
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD79B,B-cell antigen receptor complex-associated protein beta chain,28521,0.00684668221810963,0.00302660504079406,0.000914536338153266,0.012778828098066,0.0236946611239724
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,23795,0.0101557329162519,0.0044914009241721,0.00135258710487454,0.0189588787276292,0.0237589416564614
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTAG1A_CTAG1B,Cancer/testis antigen 1,23348,0.00775338532444691,0.00343077477540927,0.00102906676464474,0.0144777038842491,0.0238334274086988
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRSK2,Serine/threonine-protein kinase BRSK2,23795,0.00586733653710949,0.00259641535271472,0.000778362445788638,0.0109563106284303,0.0238437003154059
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MASP1,Mannan-binding lectin serine protease 1,27910,-0.00359410488600571,0.00159459997366929,-0.00671952083439751,-0.000468688937613903,0.0242087669411321
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPR101,Probable G-protein coupled receptor 101,23056,0.0094339390562144,0.00418643913339836,0.00122851835475361,0.0176393597576752,0.0242400335217303
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,23071,0.0100770974145477,0.00447615429155074,0.00130383500310824,0.0188503598259871,0.0243768911987551
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,27489,0.00734176290394592,0.00326119516532424,0.000949820379910417,0.0137337054279814,0.0243776291709234
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDHR5,Cadherin-related family member 5,28224,0.00591877865017365,0.0026331474156777,0.000757809715445354,0.0110797475849019,0.0245968828276786
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,28187,0.00558842362946326,0.00248647182308289,0.000714938856220803,0.0104619084027057,0.0246137870298592
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHMP1A,Charged multivesicular body protein 1a,27965,0.0120277246337702,0.00536143723859989,0.00151930764611439,0.0225361416214259,0.0248803176390636
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAGR1,PAXIP1-associated glutamate-rich protein 1,23198,-0.00658424819164526,0.00293948465746891,-0.0123456381202843,-0.0008228582630062,0.0251047213502406
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MGLL,Monoglyceride lipase,28276,0.0131393510878296,0.00586647030205222,0.00164106929580719,0.0246376328798519,0.0251157398929541
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CABP2,Calcium-binding protein 2,23163,0.00989485171284281,0.00442169429494013,0.00122833089476015,0.0185613725309255,0.025243806232211
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF3,Granulocyte colony-stimulating factor,27702,0.00731190015683415,0.00327453616012607,0.000893809282987061,0.0137299910306812,0.0255597055797709
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAPKAPK2,MAP kinase-activated protein kinase 2,23393,0.0111205911849367,0.00498443027290566,0.00135110785004156,0.0208900745198318,0.0256862261637691
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AP2B1,AP-2 complex subunit beta,23163,-0.0073929005222662,0.00331994895803725,-0.0139000004800192,-0.000885800564513204,0.0259694560251537
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC9,Sialic acid-binding Ig-like lectin 9,28411,-0.00450001052397963,0.0020234395857165,-0.00846595211198396,-0.000534068935975293,0.026160239007907
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,28091,-0.00672896786038267,0.00302914417782845,-0.0126660904489264,-0.000791845271838896,0.0263312219495371
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MINK1,Misshapen-like kinase 1,23775,0.0139016043056166,0.00626082782045914,0.00163038177751667,0.0261728268337165,0.026400349422016
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,28029,-0.00394575599610631,0.0017788722606886,-0.00743234562705596,-0.000459166365156655,0.0265544917241662
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFE2,Transcription factor NF-E2 45 kDa subunit,23198,-0.0111312436664059,0.00502192513839564,-0.0209742169376614,-0.00128827039515046,0.026664949229327
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TK1,"Thymidine kinase, cytosolic",23393,-0.00686451715538789,0.00309871183875559,-0.0129379923593488,-0.000791041951426937,0.0267503896989736
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OSM,Oncostatin-M,28037,0.0106277245010868,0.00479803175901407,0.00122358225341917,0.0200318667487543,0.0267668716434744
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APLP1,Amyloid-like protein 1,28224,0.00772285972183502,0.00348832741987578,0.000885737978878488,0.0145599814647915,0.026842606812867
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRE2,Adhesion G protein-coupled receptor E2,28320,-0.00423294211670355,0.00191235267900824,-0.0079811533675597,-0.000484730865847398,0.0268729565365157
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17C,Interleukin-17C,27702,-0.0105207869505583,0.00475637428913947,-0.0198432805572716,-0.0011982933438449,0.0269793450950689
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP13,Collagenase 3,27544,0.00489280510737919,0.0022158268661157,0.000549784449792425,0.00923582576496596,0.0272443253752348
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,23795,0.00390721118400377,0.00177201765844673,0.000434056573448182,0.00738036579455937,0.0274671058772868
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NT5E,5'-nucleotidase,28307,-0.00836666292625643,0.00379631300695497,-0.0158074364198882,-0.000925889432624683,0.0275399814931727
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DSG3,Desmoglein-3,28320,-0.00509482820469956,0.00231945169285282,-0.00964095352269109,-0.000548702886708043,0.0280595514045256
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHB6,Ephrin type-B receptor 6,27910,0.00473943145428755,0.00215895355884923,0.00050788247894305,0.00897098042963204,0.0281542542009271
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,23846,-0.00942316951494731,0.00430095856858936,-0.0178530483093824,-0.000993290720512166,0.0284653228550466
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SULT1A1,Sulfotransferase 1A1,28428,0.0189952795423034,0.00867311877982573,0.00199596673384498,0.0359945923507619,0.0285227258511855
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HAVCR2,Hepatitis A virus cellular receptor 2,28187,0.00522495004195371,0.00238585585408513,0.00054867256794685,0.00990122751596057,0.028534664281364
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TDRKH,Tudor and KH domain-containing protein,27544,-0.0126035500096326,0.00576562459912099,-0.0239041742239098,-0.00130292579535547,0.0288253352238915
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFRC,Transferrin receptor protein 1,28305,0.00570131366957901,0.00260916152192645,0.00058735708660317,0.0108152702525548,0.028888710773066
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,28252,0.00334142876543866,0.00153222155257862,0.000338274522384565,0.00634458300849275,0.0292083680114501
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGAP45,Rho GTPase-activating protein 45,23337,0.0121878005740252,0.00559253076455156,0.00122644027550414,0.0231491608725463,0.0293193831553702
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX58,Antiviral innate immune response receptor RIG-I,27562,-0.0083660058154762,0.00385914579590371,-0.0159299315754475,-0.000802080055504924,0.0301794916317755
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLMP,CXADR-like membrane protein,28452,-0.00311232816604552,0.00143736341377241,-0.00592956045703945,-0.000295095875051596,0.0303727305775924
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPP10,Inactive dipeptidyl peptidase 10,28176,-0.00516611864478227,0.00238921752183249,-0.00984898498757395,-0.000483252301990589,0.0306062379561
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSMB,Beta-microseminoprotein,28072,0.0101679148416491,0.00470267585864498,0.000950670158704944,0.0193851595245933,0.0306146434145673
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JPT2,Jupiter microtubule associated homolog 2,23738,0.0128047410731401,0.00592352031917193,0.00119464124756311,0.0244148408987171,0.0306530048123407
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STIP1,Stress-induced-phosphoprotein 1,28134,-0.00945764648865914,0.00438493852993491,-0.0180521260073316,-0.000863166969986713,0.031025946805885
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGLON5,IgLON family member 5,22978,0.0136286743710252,0.00632828322807751,0.00122523924399324,0.0260321094980571,0.031280892706366
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSPG5,Chondroitin sulfate proteoglycan 5,23056,0.00730396463183025,0.00340543928831861,0.000629303626725776,0.0139786256369347,0.0319797719355895
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,23775,0.00693006404238829,0.00323179621653433,0.000595743457981,0.0132643846267956,0.0320159122884469
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAG1,Dystroglycan,28320,0.00687342559159758,0.00320975809892823,0.000582299717698241,0.0131645514654969,0.0322490618212478
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMTOR5,Ragulator complex protein LAMTOR5,23725,0.00588312442945775,0.00275055273958052,0.000492041059879922,0.0112742077990356,0.0324549195875695
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFB104A_DEFB104B,Beta-defensin 104,23056,0.00814613360178141,0.00381282466754323,0.000672997253396674,0.0156192699501661,0.0326484643616476
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,28276,0.011004640625239,0.00515155058086105,0.000907601486751357,0.0211016797637267,0.0326732899269657
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOLR3,Folate receptor gamma,28204,0.0271387457175889,0.0127090079409092,0.002229090153407,0.0520484012817709,0.0327373927214826
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCR,Breakpoint cluster region protein,28176,-0.0132315356722381,0.00619678948814688,-0.025377243069006,-0.00108582827547023,0.0327512940020537
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAPN3,Calpain-3,23725,-0.00547971212812622,0.00256775387658403,-0.0105125097262309,-0.000446914530021525,0.0328490140576469
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEPE,Matrix extracellular phosphoglycoprotein,28195,0.00362705377527384,0.00170143712082623,0.000292237018454429,0.00696187053209326,0.0330352939017391
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP2B4,Plasma membrane calcium-transporting ATPase 4,23071,0.00899465266428903,0.00421999848334576,0.000723455636931346,0.0172658496916467,0.0330638622497544
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRELP,Prolargin,28195,0.003362497762479,0.00157825600957337,0.000269115983715186,0.00645587954124282,0.0331377704401078
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRELD2,Protein disulfide isomerase CRELD2,28276,0.00750583182755259,0.00352450465033129,0.000597802712903271,0.0144138609422019,0.0332121717592085
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TUBB3,Tubulin beta-3 chain,23056,0.00406499558378256,0.00191005321418529,0.000321291283979382,0.00780869988358573,0.0333302038697185
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HCLS1,Hematopoietic lineage cell-specific protein,28521,0.00797321714845664,0.00375143665643489,0.000620401301844265,0.015326032995069,0.0335637429340203
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPL,Periplakin,23188,-0.00468411031463106,0.00220584065116104,-0.00900755799090669,-0.000360662638355427,0.0337222485205385
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HTR1A,5-hydroxytryptamine receptor 1A,23056,0.0110705136227814,0.00521763747061787,0.000843944180370331,0.0212970830651924,0.0338695190771384
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL31RA,Interleukin-31 receptor subunit alpha,23100,-0.00564832767434118,0.00267620897093393,-0.0108936972573717,-0.000402958091310676,0.0348199720251192
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM26,Tripartite motif-containing protein 26,22978,-0.00801308716103958,0.00379711788568518,-0.0154554382169825,-0.000570736105096636,0.034842644595756
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD40,Tumor necrosis factor receptor superfamily member 5,28194,0.00714216820767924,0.00338569806487223,0.000506200000529674,0.0137781364148288,0.0349092693534546
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PALLD,Palladin,23188,0.00573295671406445,0.00271768168173935,0.000406300617855323,0.0110596128102736,0.034911911976484
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,23795,-0.0095370987792285,0.00452315937318926,-0.0184024911506795,-0.000671706407777547,0.0349978639797664
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",23775,0.013895690272336,0.00659249633260239,0.000974397460435353,0.0268169830842367,0.0350583906220973
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAPRT,Nicotinate phosphoribosyltransferase,23775,-0.00472895861487127,0.00224731584007163,-0.00913369766141165,-0.000324219568330882,0.0353654053989578
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHCY,Adenosylhomocysteinase,28224,0.00963994995708243,0.00458203104217814,0.000659169114413286,0.0186207307997516,0.0353995247008544
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RICTOR,Rapamycin-insensitive companion of mTOR,23188,0.00689876545233717,0.00328318810267661,0.000463716771091018,0.0133338141335833,0.0356306933217425
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TYRO3,Tyrosine-protein kinase receptor TYRO3,28224,0.00403256794587313,0.00192069131201812,0.000268012974317627,0.00779712291742864,0.0357781993721302
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEGF11,Multiple epidermal growth factor-like domains protein 11,23071,0.00463066851013541,0.00220563966031879,0.000307614775910573,0.00895372224436024,0.0357865621451326
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB2B,Ras-related protein Rab-2B,23725,0.00874188001598677,0.00416961723859542,0.000569430228339735,0.0169143298036338,0.0360425314288981
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TWF2,Twinfilin-2,23862,0.0118714135539855,0.00566760390335155,0.000762909903416429,0.0229799172045545,0.0362162985685309
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TADA3,Transcriptional adapter 3,23725,-0.00561215833006739,0.00267976756974889,-0.0108645027667752,-0.000359813893359561,0.0362464738991868
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBL1X,F-box-like/WD repeat-containing protein TBL1X,27562,0.0120152763451539,0.00573964263947923,0.000765576771774605,0.0232649759185332,0.0363240057441457
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VPS53,Vacuolar protein sorting-associated protein 53 homolog,28091,-0.0108931525485716,0.00520510871705035,-0.0210951656339903,-0.000691139463152943,0.0363776631826127
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A4,Protein S100-A4,28307,-0.00805234616294542,0.00384808398356565,-0.0155945907707341,-0.00051010155515674,0.0363973475368899
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNPY2,Protein canopy homolog 2,27682,0.0086309266302497,0.0041261490458032,0.000543674500475417,0.016718178760024,0.0364687992963488
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VGF,Neurosecretory protein VGF,23795,0.00428186413300757,0.00205110468214424,0.000261698956004852,0.00830202931001028,0.0368455168728423
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DUSP3,Dual specificity protein phosphatase 3,27544,0.0120641237603788,0.00578433586168376,0.0007268254714786,0.0234014220492789,0.037019153092046
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLSCR3,Phospholipid scramblase 3,23735,-0.00826064686693983,0.00396331943552612,-0.016028752960571,-0.000492540773308629,0.0371458497237138
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC8,Sialic acid-binding Ig-like lectin 8,23198,-0.00645998441905255,0.00310138042414604,-0.0125386900503788,-0.000381278787726314,0.0372677693726166
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,23071,0.00689634767553296,0.00331109863648542,0.000406594348021526,0.0133861010030444,0.0372806866875166
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,28521,-0.00493596870037811,0.00237215715672503,-0.00958539672755916,-0.000286540673197056,0.0374617364958082
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSPYL1,Testis-specific Y-encoded-like protein 1,23188,0.00570371757744858,0.00274532628203658,0.000322878064656874,0.0110845570902403,0.0377562705638616
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL5,Interleukin-5,27702,0.0199062499766279,0.00960411670551812,0.00108218123381236,0.0387303187194434,0.0382114036951634
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNMBP,Dynamin-binding protein,27965,-0.00856413521698916,0.00413790180729144,-0.0166744227592804,-0.00045384767469793,0.0384914274091342
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEPTIN9,Septin-9,28091,0.00397831756743584,0.00192400437711506,0.000207268988290328,0.00774936614658135,0.0386747536992299
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MORC3,MORC family CW-type zinc finger protein 3,23775,-0.00393557959626448,0.00190338355679921,-0.00766621136759092,-0.000204947824938036,0.0386813439730699
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VAV3,Guanine nucleotide exchange factor VAV3,23056,0.0138862966564343,0.00672027250947502,0.000714562537863294,0.0270580307750054,0.0388085353958557
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ABO,Histo-blood group ABO system transferase,23872,0.0201023802986618,0.00975571159301925,0.000981185576344048,0.0392235750209795,0.0393543721681387
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CST7,Cystatin-F,28238,0.012989802425206,0.00631276905629075,0.000616775074876159,0.0253628297755359,0.0396278371520596
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,23795,-0.00446496382905442,0.00217073922667815,-0.0087196127133436,-0.000210314944765246,0.039708044436428
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRE5,Adhesion G protein-coupled receptor E5,28411,-0.00423078613247485,0.00206306907457848,-0.00827440151864868,-0.00018717074630102,0.0403029489208128
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RTKN2,Rhotekin-2,23071,0.00718214193974202,0.00350329179897263,0.000315690013755667,0.0140485938657284,0.0403647479370589
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INPP1,Inositol polyphosphate 1-phosphatase,28091,0.0074370431783315,0.00362871617354063,0.000324759478191874,0.0145493268784711,0.0404228044084917
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRTN3,Myeloblastin,27448,0.00656205828307373,0.00320704639169496,0.000276247355351597,0.0128478692107959,0.0407523448203357
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KDR,Vascular endothelial growth factor receptor 2,28307,0.00349185933623343,0.00170965286327988,0.000140939724204865,0.006842778948262,0.0411173905437224
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SYAP1,Synapse-associated protein 1,23337,0.00798180575967541,0.00390818766486558,0.00032175793653887,0.0156418535828119,0.0411301102126726
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINB9,Serpin B9,27965,0.00456168371480982,0.00223613848843765,0.000178852277472024,0.00894451515214761,0.0413614346588879
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCTPP1,dCTP pyrophosphatase 1,28224,-0.00438468744751619,0.00215578719158943,-0.00861003034303148,-0.000159344552000912,0.0419695249165885
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DUOX2,Dual oxidase 2,27682,0.00984038157014112,0.00484201331306348,0.000350035476536696,0.0193307276637456,0.0421337055372796
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLT3,Receptor-type tyrosine-protein kinase FLT3,27562,0.00420864182330805,0.00207294283557258,0.000145673865585795,0.0082716097810303,0.0423382889849799
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF16,Fibroblast growth factor 16,23188,-0.00652560937447415,0.00322449725505031,-0.0128456239943728,-0.000205594754575537,0.0430062782274974
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BEX3,Protein BEX3,22978,0.00648871167970276,0.0032080661784442,0.000200901969952125,0.0127765213894534,0.0431234935102474
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL13,C-C motif chemokine 13,28471,-0.00941249617167826,0.00466319509427898,-0.0185523585564651,-0.000272633786891463,0.0435522162248228
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENDOU,Poly(U)-specific endoribonuclease,22043,-0.00728464672257439,0.00361353527528359,-0.0143671758621302,-0.000202117583018552,0.0438190492813513
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,27965,0.0142890716415497,0.00709718096002378,0.000378596959903088,0.0281995463231963,0.044087946593495
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1R,Complement C1r subcomponent,23893,0.00262738427305018,0.00130713503533671,6.53996037902238e-05,0.00518936894231013,0.044438944644621
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATG16L1,Autophagy-related protein 16-1,23738,-0.011596776845428,0.00577369506395028,-0.0229132191707706,-0.000280334520085485,0.0445957915264223
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CUZD1,CUB and zona pellucida-like domain-containing protein 1,23163,-0.00518485717863819,0.00258162557991595,-0.0102448433152735,-0.000124871042002929,0.0446156714923989
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKAP12,A-kinase anchor protein 12,23337,0.00291710814558995,0.00145253660422862,7.0136401301853e-05,0.00576407988987805,0.0446244731822908
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TEK,Angiopoietin-1 receptor,28307,-0.00296533206782531,0.00147817092337928,-0.00586254707764871,-6.81170580019174e-05,0.0448570017884229
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DRG2,Developmentally-regulated GTP-binding protein 2,28091,0.0076769777943761,0.00382839347991255,0.000173326573747501,0.0151806290150047,0.0449433452791897
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC14A,C-type lectin domain family 14 member A,28187,-0.00431612437064464,0.00215384939145975,-0.00853766917790576,-9.45795633835308e-05,0.0450890572504397
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRNN,Cornulin,27346,0.0090879065609332,0.00453621218396092,0.000196930680369805,0.0179788824414966,0.0451428282628131
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINE2,Glia-derived nexin,23846,0.00872456828673245,0.00435548523009255,0.000187817235751054,0.0172613193377138,0.0451754979346028
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPP6,Dipeptidyl aminopeptidase-like protein 6,28091,-0.00455146082993874,0.00227278004029632,-0.00900610970891952,-9.681195095795e-05,0.0452302380861513
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NECTIN4,Nectin-4,28307,0.00433520005002467,0.00217171772067744,7.86333174968784e-05,0.00859176678255246,0.0459208657595329
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KAZN,Kazrin,23738,-0.0140604534497336,0.00704810182223304,-0.0278747330213103,-0.000246173878156813,0.0460621870144458
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SRC,Proto-oncogene tyrosine-protein kinase Src,28268,0.0161227676421108,0.00808525474326756,0.000275668345306391,0.0319698669389152,0.0461512461979886
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OTOA,Otoancorin,23056,0.00724650753140996,0.0036354216746633,0.000121081049069901,0.01437193401375,0.0462397296293607
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATF4,Cyclic AMP-dependent transcription factor ATF-4,22978,0.00460832909873121,0.00231330689736557,7.4247579894683e-05,0.00914241061756773,0.0463723613355819
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSLP,Thymic stromal lymphopoietin,27682,0.0081529592518783,0.00409686227876512,0.000123109185498661,0.0161828093182579,0.0465952934764236
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEC31A,Protein transport protein Sec31A,23198,0.0103070526266297,0.00518078943274369,0.000152705338452064,0.0204613999148073,0.0466604945256125
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPL46,"39S ribosomal protein L46, mitochondrial",27544,0.00373658366652417,0.00187975873947604,5.22565371511401e-05,0.00742091079589721,0.046843747241806
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HCG22,Protein PBMUCL2,23071,0.00742661568718943,0.00374987227680742,7.68660246468732e-05,0.014776365349732,0.0476594295781042
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,28176,-0.00503280132266123,0.00254458494148675,-0.0100201878079753,-4.54148373471982e-05,0.0479556293786895
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLAU,Urokinase-type plasminogen activator,28187,0.00390079028982125,0.00197255455650412,3.45833590731678e-05,0.00776699722056933,0.0479912270009163
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SORCS2,VPS10 domain-containing receptor SorCS2,27562,-0.00478969668388385,0.00242475163295643,-0.00954220988447844,-3.71834832892572e-05,0.0482401134442483
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSAP,Prosaposin,23692,0.00379077781856886,0.00191980101238273,2.79678342987068e-05,0.007553587802839,0.0483287837290014
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRME1,Break repair meiotic recombinase recruitment factor 1,23056,0.00552590984449985,0.00280070449079065,3.65290425501782e-05,0.0110152906464495,0.0485026183837631
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOST,Sclerostin,28182,0.00516045084473332,0.00261690912487907,3.13089599703349e-05,0.0102895927294963,0.0486234730879359
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUCA1,Tissue alpha-L-fucosidase,28362,-0.0109611289826049,0.00556498694906295,-0.0218685034027683,-5.37545624415461e-05,0.0488871371298076
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJB14,DnaJ homolog subfamily B member 14,23738,0.00855341435907611,0.00434365369197978,3.98531227957417e-05,0.0170669755953565,0.0489446151565338
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAX,Apoptosis regulator BAX,27500,0.0120364701821219,0.00613073063872282,2.02381302251819e-05,0.0240527022340186,0.0496212653164699
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OGA,Protein O-GlcNAcase,23738,-0.00938556077847748,0.0047850280482556,-0.0187642157530584,-6.90580389650988e-06,0.0498390210005517
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB39B,Ras-related protein Rab-39B,23071,0.0119392428732201,0.0060928715304977,-2.78532655534694e-06,0.0238812710729956,0.0500612761705364
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,28176,-0.019858066547887,0.0101394185588354,-0.0397313269232044,1.51938274303778e-05,0.0501810499142878
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NINJ1,Ninjurin-1,27562,0.00733910971606062,0.00374904692801937,-9.02226285734789e-06,0.0146872416949786,0.0502878176398668
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAGED1,Melanoma-associated antigen D1,27562,0.00642004188771043,0.00328299667842531,-1.46316020031732e-05,0.012854715377424,0.0505290819346484
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YTHDF3,YTH domain-containing family protein 3,27702,0.0112636827141352,0.00576310162212273,-3.19964652253507e-05,0.0225593618934957,0.0506583034982325
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNMA1,Paraneoplastic antigen Ma1,23198,0.00745250421627405,0.00381449671227352,-2.39093397820618e-05,0.0149289177723302,0.050744930392686
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HYAL1,Hyaluronidase-1,28023,0.00304953905578421,0.00156158171189975,-1.11610995392926e-05,0.00611023921110772,0.050846997451101
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPRKB,EKC/KEOPS complex subunit TPRKB,22978,0.00875056061341267,0.0044887632055937,-4.74152695509791e-05,0.0175485364963763,0.0512554278849271
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMY2A,Pancreatic alpha-amylase,27109,0.00631508176434987,0.00323976586917264,-3.48593392284916e-05,0.0126650228679282,0.0512770541093811
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFB118,Beta-defensin 118,23056,0.00760788530299383,0.0039063288069902,-4.85191587069637e-05,0.0152642897646946,0.0514774460056321
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UNC79,Protein unc-79 homolog,22978,-0.00741337537086937,0.00381266395264227,-0.0148861967180482,5.94459763094881e-05,0.0518584297859085
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOXJ3,Forkhead box protein J3,23188,-0.00583050210264736,0.0030003746803123,-0.0117112364760595,5.02322707647577e-05,0.0519970853800283
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NTRK2,BDNF/NT-3 growth factors receptor,28224,-0.00337571838678426,0.00173941790948845,-0.00678497748938162,3.35407158130905e-05,0.0523025286084147
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDF1,Endothelial differentiation-related factor 1,23795,0.00887111315164565,0.00458273785070463,-0.000111053035735418,0.0178532793390267,0.0529080696044243
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCP2,Non-specific lipid-transfer protein,27562,-0.00999445827360033,0.00516376467115989,-0.0201154370290737,0.000126520481873055,0.0529393847517578
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPT1,Angiopoietin-1,28072,0.0110178190498077,0.00569550919749346,-0.000145378977279464,0.0221810170768949,0.0530648174717298
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRD3,Bromodomain-containing protein 3,23071,0.00628443609901641,0.00325085121902362,-8.72322902698815e-05,0.0126561044883027,0.0532279400224682
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRAP2,GRB2-related adapter protein 2,28224,0.0167198818573307,0.0086550387421309,-0.000243994077245839,0.0336837577919073,0.0533930856940764
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMD5,26S proteasome non-ATPase regulatory subunit 5,23163,-0.00729014651391348,0.00377558535117089,-0.0146902938022084,0.000110000774381462,0.0535119161467531
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,23846,0.0116943326339687,0.00605976453980125,-0.000182805864041775,0.0235714711319791,0.0536394066220588
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",28176,0.0125335840415203,0.00649543812307843,-0.000197474679713398,0.0252646427627541,0.0536667067223626
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD69,Early activation antigen CD69,28091,0.0114383087546148,0.00593540144498719,-0.000195078077560142,0.0230716955867897,0.0539731190155123
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL14,C-X-C motif chemokine 14,27702,0.00774644717997764,0.00402006935504842,-0.000132888755917261,0.0156257831158725,0.0539968715333367
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NECAP2,Adaptin ear-binding coat-associated protein 2,23071,0.00865215847401612,0.0044919307163223,-0.000152025729975582,0.0174563426780078,0.0540972001374866
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RARRES1,Retinoic acid receptor responder protein 1,27562,-0.00436812975741411,0.00227444487179764,-0.00882604170613749,8.97821913092714e-05,0.0548018453520571
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMED8,Protein TMED8,23738,0.0133490569653544,0.00695103349413963,-0.000274968683159269,0.0269730826138681,0.054814061139716
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STEAP4,Metalloreductase STEAP4,23056,0.0096388849039423,0.00502047169739846,-0.000201239622958685,0.0194790094308433,0.0548808183540916
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RYR1,Ryanodine receptor 1,23071,0.00439669095084988,0.00229661637226121,-0.000104677138782095,0.00889805904048185,0.0555787286412495
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,23071,0.00660203653984958,0.00344932626134879,-0.000158642932394058,0.0133627160120932,0.0556315558163418
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRV1,Adhesion G-protein coupled receptor V1,23056,0.00908129428337327,0.00476078673424616,-0.00024984771574919,0.0184124362824957,0.0564657474311996
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP6,Insulin-like growth factor-binding protein 6,28146,0.00388902240415548,0.00203964007114385,-0.000108672135286463,0.00788671694359742,0.0565670397718455
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",28307,-0.00449242278259405,0.00235937315025592,-0.00911679415709565,0.000131948591907539,0.0569105868855151
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCNA,Proliferating cell nuclear antigen,22978,0.00818408856301893,0.0043013017554415,-0.000246462877646413,0.0166146400036843,0.0570921451776762
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",23775,0.0070630089316596,0.00371466507021116,-0.00021773460595426,0.0143437524692735,0.0572636705258203
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FASLG,Tumor necrosis factor ligand superfamily member 6,28521,0.00471114855831433,0.00248193400496636,-0.000153442091419742,0.0095757392080484,0.0576829390299067
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",27544,0.00388955727371691,0.00204977950293112,-0.000128010552028098,0.00790712509946191,0.0577659558367846
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HARS1,"Histidine--tRNA ligase, cytoplasmic",28187,0.00990208473065906,0.00522025332571693,-0.000329611787746127,0.0201337812490643,0.0578567618038864
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBCB,Tubulin-folding cofactor B,27965,0.0128608315168053,0.00678142713476778,-0.000430765667339504,0.0261524287009502,0.0579070865157875
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,28237,0.00392077960630869,0.00207119236821221,-0.000138757435387236,0.00798031664800461,0.0583672907132093
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,27562,-0.00741217074857446,0.00391573179119558,-0.0150870050593178,0.000262663562168886,0.0583788542831608
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GC,Vitamin D-binding protein,23893,0.00331340069516136,0.00175070117677861,-0.00011797361132472,0.00674477500164745,0.0584213688549629
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZNRD2,Protein ZNRD2,23738,-0.00880780242953328,0.00465529849069508,-0.0179321874712956,0.000316582612229076,0.0585037852073916
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGR,Progesterone receptor,23188,0.0130252514652883,0.00688840282734373,-0.000476018076305446,0.026526521006882,0.0586507269107968
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIAA2013,Uncharacterized protein KIAA2013,23725,0.00712827581282453,0.00377106318890877,-0.000263008037436662,0.0145195596630857,0.0587358788942166
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC25A,M-phase inducer phosphatase 1,22978,0.00518380213913152,0.00274796911745537,-0.000202217331081005,0.010569821609344,0.0592520517597186
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GOLGA3,Golgin subfamily A member 3,23795,-0.00992902252486419,0.00527697139382829,-0.0202718864567676,0.000413841407039253,0.0599058162604773
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,23056,0.00627690115755386,0.00333809849950247,-0.000265771901470986,0.0128195742165787,0.0600686041735627
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THTPA,Thiamine-triphosphatase,23687,0.0111958242885475,0.00595851616897316,-0.000482867402639876,0.0228745159797349,0.0602619848599561
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSC1,Hamartin,23188,0.00951187045697498,0.00506695498773361,-0.000419361318982903,0.0194431022329329,0.0604983031180952
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ROBO1,Roundabout homolog 1,28237,-0.00307069696134731,0.00163612433825828,-0.00627750066433354,0.000136106741638913,0.0605542430785496
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KCNC4,Potassium voltage-gated channel subfamily C member 4,23056,0.00713679818877963,0.00380462320362163,-0.000320263290318761,0.014593859667878,0.0606922762066317
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",23795,-0.00601339034944371,0.00321045177692311,-0.012305875832213,0.000279095133325588,0.0610714307934516
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAB2,Stabilin-2,23862,-0.0035537826169293,0.0018979520087107,-0.00727376855400227,0.00016620332014368,0.0611593400190705
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAG4,BAG family molecular chaperone regulator 4,23188,-0.00628612365203336,0.00335958542030054,-0.0128709110758224,0.000298663771755692,0.0613436733375834
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,QDPR,Dihydropteridine reductase,28096,-0.00545908193771355,0.00291964192737104,-0.0111815801153608,0.000263416239933693,0.0615250644078567
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R2,Protein phosphatase inhibitor 2,28224,0.0101222266907723,0.00541380302633981,-0.00048882724085374,0.0207332806223983,0.0615348345764871
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,22978,0.0105806631763136,0.0056636216213599,-0.000520035201551848,0.021681361554179,0.0617497462234693
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMP2,Metalloproteinase inhibitor 2,23846,-0.00335656329525778,0.00179963776418857,-0.00688385331306738,0.000170726722551825,0.0621750817301095
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CADPS,Calcium-dependent secretion activator 1,23163,0.00545520679136256,0.00292697556582799,-0.000281665317660294,0.0111920789003854,0.0623667790871251
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMA1,Laminin subunit alpha-1,23071,0.00681299538118426,0.00365968165310044,-0.000359980658892608,0.0139859714212611,0.0626671195077853
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL19,C-C motif chemokine 19,28428,0.0154298273796194,0.00830228803285202,-0.000842657164770517,0.0317023119240094,0.0631079481290122
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSLNL,Mesothelin-like protein,23163,0.00472786139525519,0.00254839242327383,-0.000266987754361511,0.00972271054487189,0.0635756827978173
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THBD,Thrombomodulin,28224,0.00360465759017482,0.00194347100741635,-0.000204545584361214,0.00741386076471086,0.0636420134631872
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD3E,T-cell surface glycoprotein CD3 epsilon chain,23393,0.00446114449086689,0.00240567743302291,-0.000253983277858004,0.00917627225959179,0.0636911949695033
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDDM3B,Epididymal secretory protein E3-beta,23725,0.00652668313335046,0.00352268022754295,-0.000377770112633712,0.0134311363793346,0.0639290967606369
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP6V1D,V-type proton ATPase subunit D,28091,0.00328367099879989,0.00177265907567016,-0.000190740789513632,0.00675808278711341,0.0639791096356952
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,23725,0.0104077275780365,0.00562197521714752,-0.000611343847572617,0.0214267990036457,0.0641448460284532
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MKI67,Proliferation marker protein Ki-67,23188,-0.00487392230965432,0.0026355245070583,-0.0100395503434886,0.000291705724179938,0.0644246665140318
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMOC1,SPARC-related modular calcium-binding protein 1,28452,-0.0040760736504393,0.00220638944360354,-0.00840059695990223,0.000248449659023632,0.0647002385530234
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRAP,BRCA1-associated protein,23509,-0.0136846310100445,0.00740967891930186,-0.0282076016918762,0.000838339671787099,0.0647801676800497
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPL28,"39S ribosomal protein L28, mitochondrial",23795,0.00455624576329994,0.00247311666607777,-0.000291062902212486,0.00940355442881237,0.065442365662146
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FIS1,Mitochondrial fission 1 protein,28195,0.00962400772263927,0.005230012161458,-0.000626816113818415,0.019874831559097,0.0657567038279871
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGOLN2,Trans-Golgi network integral membrane protein 2,23872,0.00322917105116267,0.00175556402794842,-0.000211734443616238,0.00667007654594158,0.065869915554976
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF1R,Macrophage colony-stimulating factor 1 receptor,23872,-0.00499009409352727,0.00271549963665259,-0.0103124733813664,0.00033228519431181,0.0661288027786699
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX4,Syntaxin-4,28091,-0.00738283157668706,0.00401794844987035,-0.0152580105384329,0.00049234738505883,0.0661521361452492
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICOSLG,ICOS ligand,28091,0.00237450513207957,0.00129273930446589,-0.00015926390467358,0.00490827416883272,0.0662498099133745
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL9A1,Collagen alpha-1(IX) chain,28176,0.00582087537579696,0.00316937956997703,-0.000391108581358011,0.0120328593329519,0.0662798335499715
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL11,Interleukin-11,27702,0.0077612535546031,0.00424137581778033,-0.00055184304824634,0.0160743501574525,0.0672770516491104
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOD1,Superoxide dismutase [Cu-Zn],27601,-0.00597236193565222,0.00326527151526131,-0.0123722941055644,0.000427570234259943,0.0674021242581234
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINA6,Corticosteroid-binding globulin,23893,0.00206737743744301,0.00113114488724212,-0.000149666541551551,0.00428442141643758,0.0676091938755652
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AOC1,Amiloride-sensitive amine oxidase [copper-containing],27702,0.00689148491088417,0.0037713505642421,-0.000500362195030349,0.0142833320167987,0.0676616070446012
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MCFD2,Multiple coagulation factor deficiency protein 2,28078,0.00547082735421023,0.00299579959857465,-0.000400939858996092,0.0113425945674166,0.06783588099266
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEND1,Cell cycle exit and neuronal differentiation protein 1,23056,0.00730021621817843,0.00400028613850311,-0.000540344613287672,0.0151407770496445,0.0680255135748029
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LCN15,Lipocalin-15,23795,-0.0076303895053322,0.00418341978003895,-0.0158298922742085,0.000569113263544145,0.0681706936220844
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BHLHE40,Class E basic helix-loop-helix protein 40,23056,0.00875762245251505,0.0048060105221704,-0.000662158170938931,0.018177403075969,0.068434126270785
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WFDC1,WAP four-disulfide core domain protein 1,23276,-0.00665177521415379,0.00365041263433731,-0.0138065839774549,0.000503033549147323,0.0684377557964157
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ROBO4,Roundabout homolog 4,23198,-0.00221514818387098,0.00121667463159366,-0.00459983046179455,0.000169534094052596,0.0686717725085399
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,23198,0.00494986035058578,0.00272010912188226,-0.000381553528303447,0.010281274229475,0.068813236528081
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OTUD6B,Deubiquitinase OTUD6B,23738,0.00718748791026461,0.00395191087237998,-0.000558257399600155,0.0149332332201294,0.0689641124514629
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DYNLT3,Dynein light chain Tctex-type 3,23725,-0.00537506417626388,0.00295771965143389,-0.0111721946930743,0.000422066340546541,0.0691837934381194
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CELA2A,Chymotrypsin-like elastase family member 2A,23862,-0.0075140991810335,0.00413570073893579,-0.0156200726293476,0.000591874267280643,0.0692470279042834
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD302,CD302 antigen,28091,-0.00375267234665705,0.0020673442532565,-0.00780466708303978,0.00029932238972568,0.0695016845165889
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP112,Centrosomal protein of 112 kDa,23071,-0.00560750577066168,0.00309453546943086,-0.0116727952907462,0.000457783749422797,0.0699888391967148
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,23795,-0.00363472911583071,0.00200662696427223,-0.00756771796580428,0.000298259734142871,0.0700973457948999
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPT1,Translationally-controlled tumor protein,27702,0.00798118585655429,0.00441231340183076,-0.000666948411034001,0.0166293201241426,0.0704861118299974
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCGB3A1,Secretoglobin family 3A member 1,23337,-0.00312712456010067,0.0017290887961877,-0.00651613860062856,0.000261889480427218,0.0705355224887174
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD8A,T-cell surface glycoprotein CD8 alpha chain,28428,-0.00604884134558634,0.00334718104222371,-0.0126093161883448,0.000511633497172138,0.0707502530282914
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCG3,Secretogranin-3,28237,0.00408074283063775,0.00225916611342309,-0.000347222751671511,0.00850870841294701,0.070881374082673
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MFAP3,Microfibril-associated glycoprotein 3,27682,-0.00596736500904193,0.0033057214351892,-0.0124465790220128,0.000511849003928899,0.0710600934408744
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NELL2,Protein kinase C-binding protein NELL2,28320,0.00349281234897755,0.00193728969104405,-0.000304275445468786,0.00728990014342389,0.0714086524229058
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF5,Fibroblast growth factor 5,27702,-0.00403421834336081,0.00223933592330115,-0.00842331675303108,0.000354880066309451,0.0716311368413051
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHNAK,Neuroblast differentiation-associated protein AHNAK,23198,-0.00384761562998258,0.00213665023405065,-0.00803545008872186,0.000340218828756688,0.0717521310894093
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRISP2,Cysteine-rich secretory protein 2,28452,0.00701712893897729,0.00389861294586362,-0.000624152434915416,0.01465841031287,0.0718863963782952
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENO2,Gamma-enolase,28428,0.00798420123979824,0.00443768180743341,-0.00071365510277124,0.0166820575823677,0.0720003593689939
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNX15,Sorting nexin-15,23337,-0.00657960295034738,0.00365796083071129,-0.0137492061785415,0.000590000277846754,0.0720778267535735
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD82,CD82 antigen,23393,0.00505874339693122,0.00282339045608301,-0.000475101896991471,0.0105925886908539,0.0731897213992548
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS3,Galectin-3,28288,0.00360488713929903,0.00201437392286672,-0.000343285749519748,0.00755306002811781,0.0735318468488461
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC37,Hsp90 co-chaperone Cdc37,28307,0.0101273217652359,0.00566539520377542,-0.00097685283416395,0.0212314963646357,0.0738552177930798
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL7A,B-cell CLL/lymphoma 7 protein family member A,22978,0.00773173510940251,0.00433072695288821,-0.000756489718258382,0.0162199599370634,0.0742225578278619
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRDX1,Peroxiredoxin-1,27442,0.0108976770518545,0.00610799484733016,-0.00107399284891259,0.0228693469526216,0.0744077378744929
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPM1A,Protein phosphatase 1A,27562,0.00374759591446588,0.00210929136601085,-0.00038661516291539,0.00788180699184714,0.075627244705293
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTBR,Tumor necrosis factor receptor superfamily member 3,28070,0.00342579426282355,0.00193020246521887,-0.000357402569005434,0.00720899109465253,0.0759356873341265
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP2,Microtubule-associated protein 2,23775,0.00556185525909125,0.00313553161289658,-0.000583786702186046,0.0117074972203685,0.0761064418131527
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBCC,Tubulin-specific chaperone C,27965,0.00966922516592707,0.00546510755561184,-0.00104238564307214,0.0203808359749263,0.0768605135209537
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBQLN3,Ubiquilin-3,23071,-0.00603561823808775,0.00341612361923136,-0.0127312205317812,0.000659984055605719,0.0772744156711647
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYN,Tyrosine-protein kinase Lyn,28091,0.0100434797531757,0.00570537582372755,-0.00113905686133029,0.0212260163676817,0.078358731610018
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TF,Serotransferrin,23893,-0.00256731643733825,0.00145992388534048,-0.0054287672526056,0.000294134377929097,0.0786705887723173
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSTT2B,Glutathione S-transferase theta-2B,23775,0.0284427077388612,0.016175638241482,-0.0032615432144435,0.0601469586921658,0.0786979645436788
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJB8,DnaJ homolog subfamily B member 8,27682,0.00685281570984134,0.00390065859499179,-0.000792475136342567,0.0144981065560252,0.0789569029476246
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSL,Cathepsin L1,28224,-0.00289728015716689,0.00164951510549885,-0.00613032976394465,0.000335769449610863,0.0790235524310559
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",23163,-0.00586043407627803,0.00334017334894707,-0.0124071738402143,0.00068630568765823,0.0793529771426138
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOXO3,Forkhead box protein O3,27562,-0.0114376719979639,0.00652352289736869,-0.0242237768768066,0.00134843288087868,0.0795621910308109
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHM,Rab proteins geranylgeranyltransferase component A 1,23163,0.00726171449888743,0.00414409766891054,-0.000860716932177225,0.0153841459299521,0.079734970788509
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD63,CD63 antigen,27918,0.0060707620755223,0.00346637345034121,-0.000723329887146472,0.0128648540381911,0.0799001555972674
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACP5,Tartrate-resistant acid phosphatase type 5,28344,-0.00386436940072031,0.00221185693790119,-0.00819960899900665,0.00047087019756603,0.0806281516011712
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GBP1,Guanylate-binding protein 1,23747,-0.0076067481940565,0.00435613325227996,-0.0161447693685252,0.000931272980412217,0.0807864188350485
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPSG1,Tryptase gamma,23188,0.00315243416482896,0.0018057905252987,-0.0003869152647565,0.00669178359441442,0.080870027109283
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,23846,-0.00909459136476013,0.00521230603061367,-0.0193107111847629,0.00112152845524267,0.0810272400092674
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHIT1,Chitotriosidase-1,28322,0.017981634080697,0.0103098060237693,-0.00222558572589095,0.0381888538872849,0.081147411406894
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYOM2,Myomesin-2,23071,-0.00603318791363503,0.00346030995520229,-0.0128153954258315,0.000749019598561456,0.0812527073883997
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THAP12,52 kDa repressor of the inhibitor of the protein kinase,22936,-0.0103393249952345,0.00593540720853406,-0.0219727231239613,0.0012940731334922,0.0815264082012268
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A13,Protein S100-A13,23188,0.00414311841973329,0.0023791539436021,-0.000520023309726836,0.00880626014919341,0.0816223592386782
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MFAP5,Microfibrillar-associated protein 5,28553,-0.00480270772259924,0.00275866661042105,-0.0102096942790245,0.000604278833826025,0.0817026693676129
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,23393,0.00812107812780932,0.00466874311174216,-0.00102965837120531,0.017271814626824,0.081967561381558
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNLIPRP2,Pancreatic lipase-related protein 2,28195,-0.034828471794017,0.0200345953625566,-0.074096278704628,0.00443933511659392,0.0821483674465227
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTD,Biotinidase,23893,-0.00241982421435143,0.0013928342061072,-0.00514977925832154,0.000310130829618689,0.0823403681343216
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HLA_A,,23795,0.00384593223438891,0.00221370888914521,-0.0004929371883357,0.00818480165711353,0.0823427329254184
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASE6,Ribonuclease K6,23755,-0.00359324928897839,0.00206996915115128,-0.0076503888252349,0.000463890247278117,0.0825953598486948
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,22936,0.00615740832968187,0.00354710365386141,-0.000794914831886499,0.0131097314912502,0.0825953992115002
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLIN3,Perilipin-3,28224,-0.00501489718656137,0.00289164415645499,-0.0106825197332131,0.000652725360090406,0.0828807758546888
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAT2,Thialysine N-epsilon-acetyltransferase,23393,-0.00817053333169706,0.00471200592407933,-0.0174060649428926,0.00106499827949843,0.0829344639337464
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FBLN2,Fibulin-2,23862,0.003664379809083,0.00211732424735651,-0.000485575715735757,0.00781433533390177,0.0835243957238234
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTGES2,Prostaglandin E synthase 2,23007,0.00645832577194505,0.00373515916314849,-0.000862586187825992,0.0137792377317161,0.0838112301996341
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LMOD1,Leiomodin-1,23795,-0.00412477039099713,0.00238641341655586,-0.00880214068744661,0.000552599905452353,0.0839225006554465
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CELA3A,Chymotrypsin-like elastase family member 3A,28524,-0.00672502020639112,0.0038914391907877,-0.014352241020335,0.000902200607552772,0.0839708012334195
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACP6,Lysophosphatidic acid phosphatase type 6,28404,0.0078337306378023,0.00453486549595557,-0.00105460573427061,0.0167220670098752,0.0840986541762341
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,27965,-0.0081791459718798,0.00473553605012763,-0.01746079663013,0.00110250468637036,0.0841455239966987
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",23795,0.00798757915830851,0.00462691750438006,-0.00108117915027641,0.0170563374668934,0.0843013340699661
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PODXL,Podocalyxin,28091,0.00176790085044914,0.00102534027161985,-0.000241766081925779,0.00377756778282405,0.0846811400258594
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADA2,Adenosine deaminase 2,28082,0.00500074631345036,0.0029015664217366,-0.000686323873153384,0.0106878165000541,0.0848155978523357
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOX2,Transcription factor SOX-2,23757,0.00278324673382483,0.00161553701413468,-0.00038320581387914,0.0059496992815288,0.0849377686773379
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,23393,0.00751383216508172,0.00436373952637249,-0.00103909730660836,0.0160667616367718,0.0851046375778714
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARNT,Aryl hydrocarbon receptor nuclear translocator,27702,-0.0043428815838646,0.00252348871083721,-0.00928891945710554,0.000603156289376338,0.0852650506944441
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DBH,Dopamine beta-hydroxylase,23841,-0.0127317650393899,0.00740284524344272,-0.0272413417165377,0.00177781163775783,0.0854731477296461
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGT,Angiotensinogen,23872,-0.00267841772805422,0.00155884016927466,-0.00573374445983255,0.000376909003724103,0.0857709464637689
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZP4,Zona pellucida sperm-binding protein 4,22978,0.00371655567396125,0.0021669518232927,-0.00053066989969245,0.00796378124761495,0.0863389806940107
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEDD9,Enhancer of filamentation 1,23188,0.00387536330461261,0.00225970003496071,-0.000553648763910386,0.0083043753731356,0.0863604015585817
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ELOB,Elongin-B,23071,0.00461360760706271,0.00269107771434292,-0.000660904713049423,0.00988811992717484,0.0864670923571553
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCHE,Cholinesterase,23467,-0.00323758393484856,0.00188946624826968,-0.00694093778145713,0.000465769911760012,0.086635411789793
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TEX33,Testis-expressed protein 33,23393,0.00456362323807173,0.00266368438872938,-0.000657198163837858,0.00978444463998132,0.0866752607259766
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RTBDN,Retbindin,28091,0.00343771753552531,0.00201050163909335,-0.000502865677097662,0.00737830074814828,0.0872990230523355
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSPB1,Heat shock protein beta-1,27806,0.00792510732561745,0.00463931986985636,-0.00116795961930102,0.0170181742705359,0.087601564752445
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TEX101,Testis-expressed protein 101,23163,0.00589575324003294,0.0034553666866801,-0.000876765465860051,0.0126682719459259,0.0879731340457378
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HDGF,Hepatoma-derived growth factor,28415,-0.0107964413448262,0.00632904899615747,-0.0232013773772949,0.00160849468764239,0.0880459704914358
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDHD2,Phospholipase DDHD2,23795,-0.00763154611683179,0.00447789459113122,-0.016408219515449,0.00114512728178541,0.0883435239045081
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EHBP1,EH domain-binding protein 1,23846,-0.00861582172266763,0.00505673455728171,-0.0185270214549398,0.00129537800960452,0.0884256780987231
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP5F1D,"ATP synthase subunit delta, mitochondrial",23071,0.00592923108582666,0.00348054221191593,-0.000892631649528563,0.0127510938211819,0.088481168226149
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",23738,0.0168336151173996,0.00989818928639121,-0.00256683588392718,0.0362340661187264,0.0890169091412554
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",23198,0.00519378881026133,0.00305539697860139,-0.000794789267797383,0.01118236688832,0.0891681081667989
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAT,Linker for activation of T-cells family member 1,28521,0.00866971716763387,0.00510258523385796,-0.00133134989072773,0.0186707842259955,0.0893144075331136
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP1B4,Protein ATP1B4,22978,0.00483401078572655,0.00285031479774982,-0.000752606217863102,0.0104206277893162,0.0899076146903585
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ID4,DNA-binding protein inhibitor ID-4,23393,0.00502871181146108,0.00296631489382609,-0.00078526538043806,0.0108426890033602,0.090037071428681
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFHD1,EF-hand domain-containing protein D1,23795,-0.004047966457054,0.00238823720767492,-0.00872891138409686,0.000632978469988848,0.0900961074198292
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,23071,-0.00322515158829477,0.00190477444487933,-0.00695850950025825,0.000508206323668719,0.0904321619679495
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,28224,0.00560502898493209,0.00332506849316073,-0.000912105261662949,0.0121221632315271,0.0918669149314672
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PADI2,Protein-arginine deiminase type-2,27702,-0.0064249817338911,0.00381560557057958,-0.0139035686522271,0.00105360518444487,0.0922181696438874
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL36G,Interleukin-36 gamma,23110,-0.00771691522993465,0.0045838813661999,-0.0167013227076865,0.00126749224781716,0.0922939234793168
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DGCR6,Protein DGCR6,23056,-0.00499194685637495,0.00296862039471872,-0.0108104428300236,0.000826549117273736,0.0926655512296292
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IDO1,"Indoleamine 2,3-dioxygenase 1",23198,0.0072533160646578,0.00431363079649628,-0.00120140029647491,0.0157080324257905,0.092681740080441
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",23393,0.0080097920376365,0.00476404588084859,-0.00132773788882674,0.0173473219640997,0.0927179455886243
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC5A,C-type lectin domain family 5 member A,28142,0.00332611017436796,0.00197994236683188,-0.000554576864622521,0.00720679721335845,0.0929873881363026
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LETM1,Mitochondrial proton/calcium exchanger protein,23795,-0.00599069617073127,0.00356700966445436,-0.0129820351130618,0.00100064277159927,0.0930730464198774
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",27489,0.0053331427501776,0.00317733065170665,-0.000894425327167426,0.0115607108275226,0.093261316947696
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAAA,N-acylethanolamine-hydrolyzing acid amidase,27842,-0.0067291019167726,0.00401080059931551,-0.014590271091431,0.00113206725788581,0.0934080585354704
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD300C,CMRF35-like molecule 6,28428,0.00393123185458186,0.00234343365370262,-0.000661898106675267,0.00852436181583899,0.0934455849748076
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL12RB1,Interleukin-12 receptor subunit beta-1,27702,0.00426882673216491,0.00255868210531808,-0.000746190194258521,0.00928384365858834,0.0952537411413208
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VEGFA,Vascular endothelial growth factor A,28422,-0.00649995948654153,0.00389720578921471,-0.0141384828334024,0.0011385638603193,0.0953562837764471
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLP1R,Glucagon-like peptide 1 receptor,23056,0.00429550389944192,0.00257994446262857,-0.000761187247310073,0.00935219504619391,0.0959343652917968
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX8,Syntaxin-8,28176,0.00544384808998971,0.00326976087323907,-0.000964883221558866,0.0118525794015383,0.0959424154997007
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CBX2,Chromobox protein homolog 2,23071,0.00453991465698432,0.00272968732997132,-0.00081027250975947,0.00989010182372811,0.0962934256262628
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EGFL7,Epidermal growth factor-like protein 7,27562,0.00445703077732892,0.00268085754566212,-0.000797450012168843,0.00971151156682668,0.0964160855509146
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APOH,Beta-2-glycoprotein 1,28187,0.00403336367825058,0.00243410213078409,-0.000737476498086249,0.0088042038545874,0.0975259214862966
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGCT,Gamma-glutamylcyclotransferase,23828,0.00535574428429465,0.00323507937936842,-0.000985011299267455,0.0116964998678568,0.0978318839752885
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCAR,Immunoglobulin alpha Fc receptor,28176,0.00534860481129232,0.00323152934483087,-0.00098519270457618,0.0116824023271608,0.0979090444875469
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERBB4,Receptor tyrosine-protein kinase erbB-4,28307,-0.00268454892919779,0.00162354417482144,-0.00586669551184781,0.000497597653452224,0.0982379059943978
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH22,Cadherin-22,23393,0.00321386846664692,0.00194626328670164,-0.000600807575288293,0.00702854450858214,0.0986903538816042
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTNL10,Butyrophilin-like protein 10,22978,0.00460747037359791,0.00279367894238794,-0.000868140353482447,0.0100830811006783,0.0991104450407111
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACTA2,"Actin, aortic smooth muscle",27682,-0.00486641746261782,0.00295339987904827,-0.0106550812255524,0.000922246300316781,0.0994186182591674
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FETUB,Fetuin-B,28291,-0.0036673735877645,0.00223320565364712,-0.00804445666891286,0.000709709493383867,0.100559379652161
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSPA2,Heat shock-related 70 kDa protein 2,23725,-0.00378734100962742,0.00230774370261704,-0.00831051866675681,0.000735836647501975,0.100780675028062
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCTN6,Dynactin subunit 6,27544,0.00794756502972534,0.00484496128606784,-0.00154855909096762,0.0174436891504183,0.100938144403904
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,23163,0.00351790353939264,0.00214484159315998,-0.000685985983200921,0.0077217930619862,0.100983537620121
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TTN,Titin,23071,-0.00745950239465883,0.00454963318446303,-0.0163767834362064,0.00145777864688871,0.10110548889749
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOD2,"Superoxide dismutase [Mn], mitochondrial",28187,0.00419328598853107,0.00255854421565013,-0.000821460674143189,0.00920803265120533,0.101238099851023
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WFDC2,WAP four-disulfide core domain protein 2,26744,-0.00444645431657951,0.00271386509446533,-0.00976562990173154,0.000872721268572529,0.101345612976349
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,28336,-0.00471260861416444,0.00287636241753273,-0.0103502789525286,0.000925061724199716,0.101351095504992
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,23337,0.00667326165701555,0.00408080876791979,-0.00132512352810725,0.0146716468421383,0.102004028506903
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OSCAR,Osteoclast-associated immunoglobulin-like receptor,28237,0.00376120952215821,0.00230194440269546,-0.000750601507124896,0.00827302055144131,0.102285295930268
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LHB,Lutropin subunit beta,27562,0.00960111929098822,0.00587746482495248,-0.00191871176591863,0.0211209503478951,0.102365279544201
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DOC2B,Double C2-like domain-containing protein beta,23163,0.00401627766634549,0.00246107657399077,-0.000807432418676414,0.00883998775136739,0.102710149045462
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F13B,Coagulation factor XIII B chain,23766,-0.00284303737599254,0.00174261817990928,-0.00625856900861472,0.000572494256629638,0.102803463124213
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP3,Stromelysin-1,28187,0.00541973096126069,0.00332327479321631,-0.00109388763344328,0.0119333495559647,0.1029351676002
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMP1,Metalloproteinase inhibitor 1,27935,-0.00313280204448643,0.00192497459980514,-0.00690575226010452,0.00064014817113165,0.103652608131615
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MIF,Macrophage migration inhibitory factor,28134,0.00744319327432267,0.0045907928226844,-0.00155476065813877,0.0164411472067841,0.104957949100675
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17A,Interleukin-17A,27652,-0.00468629482571227,0.00289307028621215,-0.0103567125866881,0.000984122935263539,0.105279259572328
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GMPR2,GMP reductase 2,23337,-0.00734582710225552,0.00453730184956676,-0.0162389387274064,0.00154728452289534,0.105463847199044
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD83,CD83 antigen,28176,0.00372667350726129,0.00230799277167966,-0.000796992325230843,0.00825033933975342,0.106390862660247
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RASA1,Ras GTPase-activating protein 1,27544,-0.00355539134584339,0.00220587783214312,-0.00787891189684391,0.000768129205157123,0.107021129739873
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPTXR,Neuronal pentraxin receptor,28224,0.00373214335364951,0.00231702317397151,-0.000809222067334652,0.00827350877463368,0.107245573179722
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFT20,Intraflagellar transport protein 20 homolog,23163,-0.00472768965714529,0.00293904529939161,-0.0104882184439529,0.00103283912966226,0.107721834424381
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",27562,0.00547199835085837,0.003404073558632,-0.00119998582406035,0.0121439825257771,0.107959402408227
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CGN,Cingulin,23163,-0.00435750698794956,0.00271514455552979,-0.00967919031678796,0.000964176340888836,0.108531765785861
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GABARAP,Gamma-aminobutyric acid receptor-associated protein,23725,0.00536673678150384,0.00334456368724068,-0.0011886080454879,0.0119220816084956,0.108591894745179
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,23775,-0.00442834944943714,0.00276102984032296,-0.00983996793647015,0.000983269037595865,0.108754682553172
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIGYF2,GRB10-interacting GYF protein 2,23795,-0.00822639162761305,0.00513567050333715,-0.0182923058141539,0.00183952255892777,0.109209911156387
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGCC,Regulator of cell cycle RGCC,23795,0.00815796273857815,0.00511023158206155,-0.00185809116226249,0.0181740166394188,0.110413281891043
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,23071,0.00631526697105516,0.00395950066815314,-0.001445354338525,0.0140758882806353,0.110733656278001
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PARP1,Poly [ADP-ribose] polymerase 1,28176,-0.00609116864259386,0.00382363632782929,-0.0135854958451393,0.00140315855995154,0.111164609835313
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM171A2,Protein FAM171A2,23795,0.0170460994964944,0.0107177003545158,-0.00396059319835669,0.0380527921913454,0.11174390546549
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJB6,DnaJ homolog subfamily B member 6,23135,0.00910339691639805,0.00573373858178664,-0.00213473070390377,0.0203415245366999,0.112370227797348
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENOPH1,Enolase-phosphatase E1,23725,0.00597071663350404,0.0037612080989386,-0.00140125124041561,0.0133426845074237,0.112424888733013
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSG1,Pregnancy-specific beta-1-glycoprotein 1,27965,0.0123018700644447,0.00775452719067275,-0.00289700322927389,0.0275007433581633,0.112657335968977
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP1,Interstitial collagenase,27196,-0.00984371407477257,0.00620786960289602,-0.0220111384964488,0.00232371034690363,0.112822841350803
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",22978,0.00616456205291788,0.00389077375293995,-0.00146135450284442,0.0137904786086802,0.11311531589994
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF7,Fibroblast growth factor 7,22978,0.00851652177896041,0.0053855399842379,-0.00203913659014587,0.0190721801480667,0.113807641422957
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPARC,SPARC,28307,0.00750020439891979,0.00474546815205012,-0.00180091317909845,0.016801321976938,0.114003971843369
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNXB,Tenascin-X,28187,-0.00276062549343126,0.00174802559024551,-0.00618675565031247,0.000665504663449936,0.114282596513692
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WASF1,Wiskott-Aldrich syndrome protein family member 1,27682,-0.0100112537679889,0.0063433970861019,-0.0224443120567486,0.0024218045207708,0.114527319442705
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BOC,Brother of CDO,27682,-0.00250553660695793,0.00158769626569234,-0.00561742128771492,0.000606348073799058,0.114555064229017
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP9,Fatty acid-binding protein 9,28176,0.00599249963983612,0.00379823469577593,-0.00145204036388469,0.0134370396435569,0.114644279739248
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRTN,Neurturin,27702,-0.00523196377890256,0.00333208011683902,-0.011762840807907,0.00129891325010191,0.116384792145624
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAMBI,BMP and activin membrane-bound inhibitor homolog,27562,-0.0031929203261338,0.00203406252480606,-0.00717968287475368,0.000793842222486085,0.116490412583207
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F11,Coagulation factor XI,23543,0.00330649034686555,0.0021080929128834,-0.00082537176238591,0.00743835245611702,0.116783842938875
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAGE2A,G antigen 2A,22978,0.0067278533551603,0.00431748543020476,-0.00173441808804104,0.0151901247983616,0.119180549761371
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MELTF,Melanotransferrin,23846,-0.00312322280625756,0.0020051823802765,-0.0070533802715995,0.000806934659084376,0.119347205585394
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZNF75D,Zinc finger protein 75D,23393,0.00637211154892299,0.00409431628951904,-0.00165274837853432,0.0143969714763803,0.119642928758698
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,23337,0.00896599458842394,0.00577470607907295,-0.00235242932655904,0.0202844185034069,0.120524597498377
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TARBP2,RISC-loading complex subunit TARBP2,27544,-0.00830146969082891,0.00534907143161994,-0.018785649696804,0.00218271031514617,0.120686654340828
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OFD1,Oral-facial-digital syndrome 1 protein,23393,0.00707103423300937,0.00455734797193908,-0.00186136779199124,0.01600343625801,0.120779215734672
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDCD5,Programmed cell death protein 5,28428,-0.00606542024818712,0.00391471504228988,-0.0137382617310753,0.00160742123470104,0.12129913903208
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DBNL,Drebrin-like protein,28320,0.00967376688244412,0.00625064329072736,-0.00257749396738152,0.0219250277322698,0.121719353903529
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,APRT,Adenine phosphoribosyltransferase,27940,-0.00497582537394289,0.00321767803508895,-0.0112824743227172,0.00133082357483145,0.122018721057622
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENPEP,Glutamyl aminopeptidase,23071,-0.00467389773530862,0.00302381823037036,-0.0106005814668345,0.00125278599621729,0.122192208107679
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DSCAM,Down syndrome cell adhesion molecule,23795,-0.00372599582631948,0.00241079592009586,-0.00845115582970736,0.000999164177068393,0.122227574240998
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANKRA2,Ankyrin repeat family A protein 2,22978,0.00585251196163569,0.00378683321105811,-0.0015696811320382,0.0132747050553096,0.122241622985393
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PROS1,Vitamin K-dependent protein S,23893,0.00265282506010079,0.00172116070269133,-0.000720649917174219,0.0060263000373758,0.123257029985334
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD72,B-cell differentiation antigen CD72,23337,0.00445871116020656,0.00289387453491908,-0.00121328292823483,0.010130705248648,0.123393399218878
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF2RB,Cytokine receptor common subunit beta,23188,0.00453057418243863,0.00294639017332406,-0.00124435055727653,0.0103054989221538,0.124143107645963
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL2,Apoptosis regulator Bcl-2,23738,-0.00556060228077237,0.00363330171623196,-0.012681873644587,0.00156066908304228,0.12591764711453
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LDLR,Low-density lipoprotein receptor,28244,0.00541374952195722,0.00354354550802555,-0.00153159967377286,0.0123590987176873,0.126578964404187
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFI,Complement factor I,23893,-0.00204650474691991,0.00134094225224008,-0.00467475156131047,0.000581742067470639,0.126980979241174
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STC2,Stanniocalcin-2,28143,-0.00267423789876553,0.00175246287835211,-0.00610906514033567,0.000760589342804619,0.127024014214005
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,23738,-0.00666929713974638,0.00437321523176232,-0.0152407989940005,0.00190220471450776,0.127264219963227
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIT1,ARF GTPase-activating protein GIT1,23188,-0.0100570984804119,0.00659715258995012,-0.0229875175567142,0.00287332059589031,0.12740736495453
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GUCY2C,Heat-stable enterotoxin receptor,23393,0.0086271735426524,0.00566419905615769,-0.00247465660741668,0.0197290036927215,0.127745802815744
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPHS2,Podocin,23188,0.0106534235169422,0.00699877496554998,-0.00306417541553575,0.0243710224494202,0.127976618656103
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VAMP8,Vesicle-associated membrane protein 8,23188,0.00909070106269353,0.00597243515435011,-0.00261527183983269,0.0207966739652198,0.127995257797706
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHNAK2,Protein AHNAK2,23198,-0.00304539909363425,0.00200341782355934,-0.00697209802781055,0.000881299840542059,0.128499022503374
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,23393,0.00743785069574939,0.00489824303595864,-0.00216270565472954,0.0170384070462283,0.128908676782182
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTLA4,Cytotoxic T-lymphocyte protein 4,23862,0.00306109833755943,0.00201720622434962,-0.000892625862165828,0.00701482253728468,0.129155263054956
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,23163,0.0048821536037428,0.00322043257612549,-0.00142989424546316,0.0111942014529488,0.129534748306983
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPON1,Spondin-1,28237,-0.00337064382211224,0.00222366278081716,-0.00772902287251388,0.000987735228289405,0.129579336597016
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERBB3,Receptor tyrosine-protein kinase erbB-3,28112,0.00199473849224724,0.00131773553134477,-0.000588023149188509,0.00457750013368299,0.130097361432619
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAND5,DAN domain family member 5,23188,0.00559599319712815,0.00370251178907908,-0.00166092990946685,0.0128529163037232,0.13069904390165
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPIND1,Heparin cofactor 2,23845,-0.0028797614269616,0.00190549668104115,-0.00661453492180225,0.000855012067879042,0.130727392515251
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,28224,0.00325853974148281,0.00215915141556268,-0.000973397033020048,0.00749047651598567,0.131264982142579
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUGP1,SURP and G-patch domain-containing protein 1,23738,-0.00408490006801085,0.00271413536100132,-0.00940460537557344,0.00123480523955173,0.132325421477126
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HEBP1,Heme-binding protein 1,27682,0.00542816271832882,0.00361061909086642,-0.00164865069976937,0.012504976136427,0.132750339643716
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP170,Centrosomal protein of 170 kDa,23198,0.00781995536832729,0.00520553406122655,-0.00238289139167675,0.0180228021283313,0.133049061087773
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB1BP1,Integrin beta-1-binding protein 1,27562,0.00414989249180306,0.00276357163621467,-0.00126670791517769,0.0095664928987838,0.133201308722876
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",27544,0.00511072164558491,0.00340594588974741,-0.00156493229832002,0.0117863755894898,0.133488814220327
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD36,Platelet glycoprotein 4,23188,-0.00459858773934759,0.00306927027119622,-0.0106143574708922,0.00141718199219699,0.13407739839703
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SWAP70,Switch-associated protein 70,23738,-0.00361701980253005,0.0024160947002055,-0.00835256541493282,0.00111852580987272,0.134392988485734
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL19,Interleukin-19,27434,-0.00715287008489337,0.00478119211405159,-0.0165240066284345,0.00221826645864775,0.134653899759589
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDCL2,Phosducin-like protein 2,22978,0.00539167301163551,0.00361214563560651,-0.00168813243415326,0.0124714784574243,0.13554228804386
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CORO1A,Coronin-1A,27615,0.00896638882385401,0.00603490462389719,-0.00286202423898449,0.0207948018866925,0.137355397474834
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCAMP3,Secretory carrier-associated membrane protein 3,28091,-0.00850717639043678,0.00572810856173151,-0.0197342691714305,0.00271991639055698,0.137511808497295
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC15,Sialic acid-binding Ig-like lectin 15,27544,0.00788796950604089,0.00531418544070652,-0.0025278339577439,0.0183037729698257,0.13773460895941
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNL2,Interferon lambda-2,23056,0.0062267419930658,0.00420051120641992,-0.00200625997151724,0.0144597439576488,0.138253635842474
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FABP5,Fatty acid-binding protein 5,28362,0.00681123393543192,0.00460099070587929,-0.00220670784809149,0.0158291757189553,0.138781857987418
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEB,Nebulin,23071,-0.00377232984659566,0.00255260217235953,-0.00877543010442034,0.00123077041122903,0.139465080843646
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,23725,0.00869627598618192,0.00588892408890059,-0.00284601522806323,0.0202385672004271,0.139764717574166
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDH1,Protocadherin-1,28452,-0.00211955892184607,0.00143717591386002,-0.0049364237130117,0.00069730586931957,0.14027516770476
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BST2,Bone marrow stromal antigen 2,28428,-0.00524760545938561,0.00356022764797478,-0.0122256516494162,0.00173044073064496,0.140505533474073
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SDHB,Succinate dehydrogenase,23738,0.00686150230325119,0.0046568016708563,-0.00226582897162716,0.0159888335781296,0.140646598553167
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDIA3,Protein disulfide-isomerase A3,23337,0.0024837292134506,0.00168824952321828,-0.000825239852057226,0.00579269827895843,0.141254289607542
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GJA8,Gap junction alpha-8 protein,22978,0.00623012369022621,0.00423770390205667,-0.00207577595780487,0.0145360233382573,0.141530788895751
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNCA,Alpha-synuclein,23337,0.0115167491801023,0.00783679848347938,-0.00384337584751732,0.0268768742077218,0.141690866139405
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UHRF2,E3 ubiquitin-protein ligase UHRF2,23071,0.00351439169918035,0.0023918191495083,-0.00117357383385592,0.00820235723221661,0.141754672472436
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAP18,Histone deacetylase complex subunit SAP18,23393,0.00729563226728215,0.00496989740518582,-0.00244536664688206,0.0170366311814464,0.142127356962767
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARMCX2,Armadillo repeat-containing X-linked protein 2,23056,0.0062044822903691,0.00423179549169167,-0.00208983687334657,0.0144988014540848,0.142618798902731
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,B2M,Beta-2-microglobulin,23893,0.00306680731994838,0.00209224925980475,-0.00103400122926893,0.00716761586916569,0.14271746497729
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,23862,0.0025178363223348,0.00171879023051726,-0.000850992529479037,0.00588666517414864,0.142964478942534
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPPB,Natriuretic peptides B,27682,-0.0132917842032692,0.00907738768635515,-0.0310834640685253,0.00449989566198693,0.143130416692861
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",23846,-0.00299259709774775,0.00204589165218979,-0.00700254473603974,0.00101735054054424,0.143553122722187
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRC37A2,Leucine-rich repeat-containing protein 37A2,23738,0.00423348965930808,0.00289665489382264,-0.00144395393258429,0.00991093325120046,0.143888818989442
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALCB,Calcitonin gene-related peptide 2,23775,0.00395161859237005,0.00271181968946474,-0.00136354799898084,0.00926678518372094,0.145078980839028
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP10,Caspase-10,27544,-0.00703826232936079,0.00483587085349304,-0.0165165692022071,0.00244004454348557,0.145562184197852
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL12B,Interleukin-12 subunit beta,28521,-0.00535957280458117,0.00368284994835863,-0.0125779587033641,0.00185881309420174,0.145603153407423
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RANBP2,E3 SUMO-protein ligase RanBP2,23056,0.00326874430114254,0.00224887395063154,-0.00113904864209528,0.00767653724438035,0.146097856713223
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RELT,Tumor necrosis factor receptor superfamily member 19L,28187,0.00282417993816653,0.00194500918069789,-0.000988038056001327,0.0066363979323344,0.146508937324981
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL18A1,Collagen alpha-1(XVIII) chain,28299,0.00229630143124932,0.00158176343798231,-0.000803954907196001,0.00539655776969464,0.146586379444174
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HIP1,Huntingtin-interacting protein 1,23071,0.00329383784711861,0.00226946643171149,-0.00115431635903591,0.00774199205327313,0.146690175521742
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PI16,Peptidase inhibitor 16,23872,0.00240833135860201,0.00166084936043194,-0.00084693338784458,0.00566359610504861,0.147054911025378
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,28091,-0.00311965084295914,0.00215292668227229,-0.00733938714021283,0.00110008545429456,0.147340957557581
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,METAP1,Methionine aminopeptidase 1,27544,-0.0029312852204106,0.0020279259672459,-0.00690602011621257,0.00104344967539136,0.148340193142956
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MB,Myoglobin,28553,-0.00514344697582536,0.00356270675405804,-0.0121263522137791,0.00183945826212839,0.148836946267662
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,27281,-0.00835987117343378,0.00580029354678139,-0.0197284465251253,0.00300870417825774,0.149515905930086
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,23738,0.0135890945559593,0.0094409163931196,-0.00491510157455511,0.0320932906864737,0.15005523216584
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD244,Natural killer cell receptor 2B4,28521,0.00262766360075928,0.00182873401923881,-0.000956655076948788,0.00621198227846735,0.150764270800866
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATXN10,Ataxin-10,27544,0.0070799379050003,0.00492954883408037,-0.00258197780979723,0.0167418536197978,0.150949884607049
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,28452,-0.00314118501392231,0.00218718517485495,-0.00742806795663801,0.00114569792879338,0.150962985599632
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRL,Prolactin,28428,-0.0073801577832542,0.00514480553710104,-0.0174639766359722,0.00270366106946384,0.151444279491172
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PYDC1,Pyrin domain-containing protein 1,23198,-0.00405881924367723,0.00282979446474002,-0.00960521639456766,0.00148757790721321,0.151495617631953
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATRN,"Attractin, Isoform 2",23893,-0.0016120705451398,0.00112408045329415,-0.00381526823359634,0.000591127143316739,0.151550028243888
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NECTIN1,Nectin-1,23188,-0.00314361522528014,0.00219321117591047,-0.00744230913006467,0.00115507867950439,0.15177445797488
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NENF,Neudesin,23725,0.010625079518199,0.00743463346957498,-0.003946802082168,0.0251969611185659,0.1529792040225
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OTUD7B,OTU domain-containing protein 7B,23795,0.00610217684986064,0.00427035011607296,-0.00226770937764237,0.0144720630773637,0.153027697445741
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCDC28A,Coiled-coil domain-containing protein 28A,23163,-0.00288219469284422,0.00201791602767318,-0.00683731010708365,0.0010729207213952,0.153218273390703
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UPK3A,Uroplakin-3a,23056,0.00478126072262303,0.0033500739159239,-0.00178488415258782,0.0113474055978339,0.153532775001619
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OGN,Mimecan,28187,0.00407108284153783,0.00286010677531536,-0.00153472643808027,0.00967689212115593,0.154630611571315
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RCC1,Regulator of chromosome condensation,23725,-0.00493339238736901,0.00347181704950104,-0.011738153804391,0.00187136902965303,0.155334904037236
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EP300,Histone acetyltransferase p300,23188,0.00291279249828918,0.00205151324012907,-0.00110817345236379,0.00693375844894216,0.155671701622468
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRE1,Adhesion G protein-coupled receptor E1,23738,0.00525441992224585,0.0037037825808488,-0.0020049939362178,0.0125138337807095,0.156010377174717
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DYNLT1,Dynein light chain Tctex-type 1,23163,-0.00771848072970973,0.00544742942984678,-0.0183954424122094,0.00295848095278996,0.156524659185684
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUMB,Protein numb homolog,23188,-0.00800871119329461,0.00565409181309356,-0.019090731146958,0.00307330876036876,0.156658640171079
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGA2,Integrin alpha-2,23337,0.00329298371462886,0.00232509613021529,-0.00126420470059311,0.00785017212985082,0.156707328178614
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,23636,-0.00289687515882625,0.00205006864412681,-0.0069150097013148,0.00112125938366229,0.157650518973432
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PXDNL,Peroxidasin-like protein,23725,-0.00550743178851167,0.00389876015832962,-0.0131490016988377,0.00213413812181438,0.15778323521098
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL31,Interleukin-31,23188,0.00545891591254452,0.00386635827540061,-0.00211914630724068,0.0130369781323297,0.157992479510295
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACYP1,Acylphosphatase-1,23256,-0.00625799366158276,0.0044406774436483,-0.0149617214511334,0.0024457341279679,0.158776702064246
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A11,Protein S100-A11,27966,0.00435060032308161,0.00308933697995172,-0.00170450015762376,0.010405700803787,0.159064199134221
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAEP,Glycodelin,27965,0.0124770271153567,0.00886269523310596,-0.00489385554153099,0.0298479097722444,0.159197251875459
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SKIV2L,Helicase SKI2W,23071,0.00380274976652371,0.00270863240605002,-0.00150616974933434,0.00911166928238175,0.160351022850612
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,23198,-0.00726047748222874,0.00517213397554735,-0.0173978600743015,0.00287690510984406,0.160401264340001
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RHOC,Rho-related GTP-binding protein RhoC,27840,0.0110670718018031,0.00788417752897931,-0.00438591615499636,0.0265200597586025,0.16041740468209
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,23393,0.00600465851482399,0.00428154413198458,-0.00238716798386579,0.0143964850135138,0.160793705298743
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NTproBNP,N-terminal prohormone of brain natriuretic peptide,28224,-0.00990629526465088,0.00708656563962147,-0.023795963918309,0.0039833733890072,0.162154718947507
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",23393,0.00468867881127783,0.0033563831194988,-0.00188983210293982,0.0112671897254955,0.162443711042795
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",27682,-0.00833091024586396,0.0059827472532377,-0.0200570948622098,0.00339527437048192,0.163785535004082
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENG,Endoglin,28553,-0.00162178271072689,0.00116512056710502,-0.00390541902225274,0.000661853600798954,0.163950170242654
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IRAK4,Interleukin-1 receptor-associated kinase 4,28176,0.0097788670806298,0.00704899798723786,-0.0040371689743564,0.023594903135616,0.165370267883364
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTR,Methionine synthase,23071,0.00613956491412195,0.00442685799502279,-0.00253707675612272,0.0148162065843666,0.165488726533313
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAPRE3,Microtubule-associated protein RP/EB family member 3,22978,0.013530693655037,0.00975916291030482,-0.00559726564916046,0.0326586529592344,0.165619800794337
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMIGO2,Amphoterin-induced protein 2,28091,0.00215272879061684,0.00155277519374911,-0.000890710589131424,0.0051961681703651,0.16564341864042
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTRC,Chymotrypsin-C,28198,0.00598090730738321,0.00431513365736614,-0.00247675466105442,0.0144385692758208,0.165748524442458
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OSMR,Oncostatin-M-specific receptor subunit beta,28367,0.0018987901978338,0.00137048265092648,-0.000787355797982099,0.00458493619364971,0.16591354441602
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMARCA2,Probable global transcription activator SNF2L2,27544,0.00687256380411159,0.00496198522687735,-0.00285292724056801,0.0165980548487912,0.166050486918055
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOSB,Protein fosB,27544,-0.00362188390167523,0.00261663112698955,-0.00875048091057474,0.00150671310722428,0.166315100747287
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCN2,Transcobalamin-2,28494,0.00280233158256385,0.00202942878707184,-0.00117534884009695,0.00678001200522465,0.167336703251153
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH6,Cadherin-6,28224,-0.00358765790254052,0.00260264970328464,-0.0086888513209784,0.00151353551589737,0.168071127456704
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTN3A2,Butyrophilin subfamily 3 member A2,28176,-0.00352664793571395,0.00256024581044436,-0.0085447297241849,0.001491433852757,0.168379603280198
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD3D,T-cell surface glycoprotein CD3 delta chain,23056,0.0032099527022116,0.00233050146784006,-0.00135783017475492,0.00777773557917812,0.168412601722761
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HTR1B,5-hydroxytryptamine receptor 1B,23056,0.00401581458832243,0.00291708432639391,-0.00170167069140964,0.00973329986805449,0.168632752053616
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYOM1,Myomesin-1,23056,0.00446214503242136,0.00324438852601544,-0.00189685647856891,0.0108211465434116,0.169038694522396
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAG,Myelin-associated glycoprotein,23163,0.00442608310120118,0.00322198417886289,-0.00188900588937008,0.0107411720917724,0.169543952308311
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,28411,0.00321672799965175,0.00234172978019141,-0.00137306236952341,0.00780651836882691,0.169559766022943
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,23738,-0.00436356697512813,0.00318770829328048,-0.0106114752299579,0.0018843412797016,0.171052019585971
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL7,C-C motif chemokine 7,28176,0.00543698032708463,0.00397378890020895,-0.00235164591732491,0.0132256065714942,0.171257062019921
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSIG10,V-set and immunoglobulin domain-containing protein 10,23725,-0.00324182630874548,0.00237235859892754,-0.00789164916264346,0.0014079965451525,0.171795265538923
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCUN1D2,DCN1-like protein 2,22978,0.0074197936779515,0.0054314534888429,-0.00322585516018058,0.0180654425160836,0.171927596646775
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DLL4,Delta-like protein 4,23198,-0.00798674174963507,0.00584978403501302,-0.0194523184582606,0.00347883495899045,0.172170328697682
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HRG,Histidine-rich glycoprotein,23766,-0.00288451540275606,0.00211981058360303,-0.007039344146618,0.00127031334110588,0.173608131675617
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,28091,-0.00350296895040345,0.00257466787937545,-0.00854931799397932,0.00154338009317244,0.17366630252777
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SELP,P-selectin,28336,0.00523756226457831,0.0038506211516424,-0.0023096551926408,0.0127847797217974,0.173781792275552
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LUZP2,Leucine zipper protein 2,23725,-0.0041217078760029,0.00303164132442409,-0.0100637248718741,0.00182030911986832,0.173981129584644
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRSS53,Serine protease 53,23775,0.00343648660805884,0.00252779447666678,-0.00151799056620805,0.00839096378232572,0.174007365098178
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBC1D23,TBC1 domain family member 23,28091,0.00826751328827803,0.00608283106166164,-0.00365483559257878,0.0201898621691349,0.174108236009102
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,27965,-0.00273985958071586,0.00201613142748923,-0.00669147717859475,0.00121175801716303,0.174167460604501
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,23056,0.00679261525856195,0.00499913248593898,-0.00300568441387845,0.0165909149310023,0.174236333031009
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MUCL3,Mucin-like protein 3,22978,0.00402235217917923,0.00296206272043085,-0.00178329075286523,0.00982799511122369,0.174490845161632
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLHL41,Kelch-like protein 41,23795,-0.00458763260240006,0.00337905232770678,-0.0112105751647053,0.00203530995990522,0.17458180722504
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,23846,-0.00676447518664865,0.00499230079877026,-0.0165493847522384,0.00302043437894106,0.175436296941812
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL3,C-C motif chemokine 3,28176,-0.0054351368276911,0.00401810129717691,-0.0133106153701578,0.00244034171477565,0.176174185980646
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LATS1,Serine/threonine-protein kinase LATS1,23188,-0.00780514272209251,0.00578153529150438,-0.0191369518934411,0.00352666644925608,0.177025280253126
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPPP3,Tubulin polymerization-promoting protein family member 3,27544,0.00358161363902169,0.00266248118859614,-0.00163684949062675,0.00880007676867013,0.178566408121057
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THY1,Thy-1 membrane glycoprotein,28428,-0.00260773615029663,0.00193965294825933,-0.00640945592888491,0.00119398362829165,0.178818688428419
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,28187,-0.00272071921744062,0.0020245421217478,-0.00668882177606631,0.00124738334118506,0.179001603000716
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DKKL1,Dickkopf-like protein 1,28091,-0.00781309413696875,0.00581391941870221,-0.0192083761976251,0.00358218792368758,0.179004500676465
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCK2,Cytoplasmic protein NCK2,28320,0.00960395318032453,0.00714910270886476,-0.00440828812905041,0.0236161944896995,0.179160110203976
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK6,Kallikrein-6,28260,0.00278783526749418,0.00207593885309455,-0.00128100488457113,0.0068566754195595,0.179306258151056
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,USO1,General vesicular transport factor p115,28091,0.00814048056485724,0.00607586686232347,-0.00376821848529676,0.0200491796150113,0.180319391642136
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SYTL4,Synaptotagmin-like protein 4,23846,-0.00661446931057887,0.00494158274297006,-0.0162999714868002,0.00307103286564245,0.180735668407348
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAM,Signal transducing adapter molecule 1,23725,0.00333981191975269,0.00249513464212994,-0.00155065197882198,0.00823027581832736,0.180736646842862
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARAF,Serine/threonine-protein kinase A-Raf,23393,0.00611776185722949,0.00457183849832403,-0.0028430415994856,0.0150785653139446,0.18086368330737
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,23738,-0.00309948068639615,0.00231669291633089,-0.0076401988024047,0.0014412374296124,0.180945065012332
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINB1,Leukocyte elastase inhibitor,28103,0.00805288463447754,0.00602827645961954,-0.00376253722637677,0.0198683064953318,0.181608504331217
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTTG1,Securin,23393,0.00375440710308773,0.00281096933107428,-0.00175509278581785,0.00926390699199332,0.181684156666606
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COPB2,Coatomer subunit beta',23071,0.00389631484726761,0.00292001992169876,-0.00182692419926196,0.00961955389379719,0.182103896685197
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RUVBL1,RuvB-like 1,27562,-0.00933880520280089,0.00700158187686504,-0.0230619056814564,0.00438429527585458,0.182275976377018
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CREBZF,CREB/ATF bZIP transcription factor,22978,0.0023584807496182,0.00177108080340772,-0.00111283762506094,0.00582979912429733,0.182984546399718
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINB5,Serpin B5,27682,-0.00439455922350576,0.00330114648933107,-0.0108648063425947,0.00207568789558314,0.183126904029951
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD226,CD226 antigen,23188,0.00379568246360677,0.00285412098503225,-0.00179839466705644,0.00938975959426999,0.183565815253807
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPIE,Peptidyl-prolyl cis-trans isomerase E,23393,0.00563599359511007,0.00424637087582064,-0.00268689332149839,0.0139588805117185,0.184439125945518
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLSPN,Claspin,27489,0.00312315279861478,0.00235358731500957,-0.00148987833880397,0.00773618393603353,0.184527801559415
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PITHD1,PITH domain-containing protein 1,22936,0.00716348367843825,0.00539981075608119,-0.00342014540348089,0.0177471127603574,0.184648445780264
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F12,Coagulation factor XII,23893,-0.00371522345848734,0.00280327945365472,-0.00920965118765059,0.00177920427067591,0.185079949595325
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF9,Fibroblast growth factor 9,22936,0.00367485984924681,0.00277430603441583,-0.00176277997820822,0.00911249967670185,0.185315377944756
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCN3,CCN family member 3,28529,-0.00303695720781139,0.00229797520678184,-0.0075409886131038,0.00146707419748102,0.186318775302746
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MPHOSPH8,M-phase phosphoprotein 8,27682,0.00679067481735798,0.00514061623126789,-0.00328493299592709,0.016866282630643,0.186517427824254
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BGLAP,Osteocalcin,23862,0.0078650148353881,0.00596374176950121,-0.00382391903283427,0.0195539487036105,0.187246843068098
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MILR1,Allergin-1,27702,-0.0044979404918764,0.00341241146928351,-0.0111862669716721,0.00219038598791928,0.187477063861995
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MORN4,MORN repeat-containing protein 4,22978,0.00702207824869701,0.00533539413341494,-0.00343529425279627,0.0174794507501903,0.188143174995506
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FARSA,Phenylalanine--tRNA ligase alpha subunit,23163,-0.00616685559848884,0.00468699265811906,-0.0153533612084022,0.00301965001142451,0.18827493544837
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CENPJ,Centromere protein J,23393,0.0063822830302126,0.00485097750683361,-0.00312563288318127,0.0158901989436065,0.18829790520843
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTDH,Protein LYRIC,23188,0.00830469465886111,0.00631584359828255,-0.00407435879377268,0.0206837481114949,0.188556954650229
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GORASP2,Golgi reassembly-stacking protein 2,23738,0.00419875450263567,0.0031944709107697,-0.00206240848247293,0.0104599174877443,0.18873045104105
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZPR1,Zinc finger protein ZPR1,23056,0.00862992484161386,0.00656774575338735,-0.00424285683502534,0.0215027065182531,0.18886405455102
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GZMA,Granzyme A,28521,0.00307422493385055,0.00234662703637631,-0.00152516405744701,0.00767361392514812,0.190185703063016
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CR2,Complement receptor type 2,28336,-0.00412687399709945,0.00315172903648888,-0.0103042629086177,0.00205051491441876,0.190409514016664
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL9,Interleukin-9,23393,0.00503463484958766,0.00384895080184309,-0.0025093087220248,0.0125785784212001,0.190867911533116
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CYB5A,Cytochrome b5,22978,0.00642001829807754,0.00491236965116548,-0.0032082262182068,0.0160482628143619,0.191256831090557
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINT1,Kunitz-type protease inhibitor 1,28082,-0.00230917852773815,0.00176774070508779,-0.00577395030971021,0.00115559325423391,0.191465329548745
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP1,Caspase-1,27544,0.00601093509270629,0.00460855706257341,-0.0030218367499376,0.0150437069353502,0.192142654651279
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BLNK,B-cell linker protein,23188,0.00353057853233472,0.00271261792769393,-0.00178615260594539,0.00884730967061483,0.193086898606513
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,23795,-0.00578361576914117,0.00445213628516789,-0.0145098028880702,0.0029425713497879,0.19393411410652
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,23725,-0.00308145820294909,0.00237250896565244,-0.00773157577562788,0.0015686593697297,0.194018902820196
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERVV_1,,23071,0.00403712884898333,0.00311318702003385,-0.00206471771028301,0.0101389754082497,0.194718745142281
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD48,CD48 antigen,28276,0.00263549814071802,0.00203251194223453,-0.00134822526606166,0.00661922154749769,0.194755193264842
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LXN,Latexin,27871,-0.00589649030129285,0.004556049892774,-0.0148263480911299,0.0030333674885442,0.19560324566698
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHGB,Secretogranin-1,28325,0.00360616993677013,0.00279111399928167,-0.00186441350182194,0.0090767533753622,0.196361406626412
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRX,Cone-rod homeobox protein,27682,0.00936601968190138,0.00725716624573052,-0.00485802615973043,0.0235900655235332,0.196856980780309
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL15RA,Interleukin-15 receptor subunit alpha,27702,0.00307269085404314,0.00238284483022974,-0.00159768501320714,0.00774306672129342,0.197233273148336
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FHIT,Bis(5'-adenosyl)-triphosphatase,27544,0.00642958646698802,0.00500204947586655,-0.00337443050571042,0.0162336034396865,0.198666700709002
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX3,Syntaxin-3,23775,-0.00331992856537682,0.00259293878613536,-0.00840208858620212,0.00176223145544848,0.200426517189834
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCRN1,Secernin-1,28176,0.00484219506558698,0.0037824770825037,-0.00257146001612026,0.0122558501472942,0.200497629732417
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MCEMP1,Mast cell-expressed membrane protein 1,23188,0.00782083393840547,0.00611952205438579,-0.00417342928819069,0.0198150971650016,0.201257343959902
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DBN1,Drebrin,23188,0.00443072552020794,0.00346880803651993,-0.00236813823137112,0.011229589271787,0.201507419183574
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTK7,Inactive tyrosine-protein kinase 7,27544,-0.00332879044474317,0.00260627499144454,-0.00843708942797447,0.00177950853848812,0.201534831251404
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF168,E3 ubiquitin-protein ligase RNF168,23188,-0.00351458181178363,0.00275292074420308,-0.00891030647042166,0.00188114284685441,0.201730224661937
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LELP1,Late cornified envelope-like proline-rich protein 1,23056,0.00634109084271784,0.00497317344093974,-0.00340632910152405,0.0160885107869597,0.202301124259656
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REG3G,Regenerating islet-derived protein 3-gamma,23725,-0.00342657323015882,0.0026972548193923,-0.00871319267616773,0.0018600462158501,0.203957194975427
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ESPL1,Separin,22978,0.00476566859747015,0.00375306216310105,-0.00259033324220791,0.0121216704371482,0.204165874716194
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGLYRP4,Peptidoglycan recognition protein 4,23071,-0.0051811288591406,0.00408494495766318,-0.0131876209761604,0.00282536325787922,0.204686762695197
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RELB,Transcription factor RelB,23188,0.00422857171551252,0.00333990495224738,-0.00231764199089235,0.0107747854219174,0.205498792564847
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MLN,Promotilin,28176,-0.00760832422992047,0.00601177804844859,-0.0193914092048797,0.00417476074503877,0.205677644635214
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CST3,Cystatin-C,28274,-0.00242793575300207,0.00192041795531832,-0.00619195494542597,0.00133608343942183,0.206141889423816
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",23846,0.00456047569269165,0.00361142364142759,-0.00251791464450643,0.0116388660298897,0.206676414244861
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK5,Serine protease inhibitor Kazal-type 5,28187,0.00289638540775038,0.0022976448323816,-0.00160699846371755,0.00739976927921831,0.20746746556238
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,23198,-0.00533792819033928,0.00423781302760028,-0.0136440417244358,0.00296818534375726,0.207828172596451
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,23337,-0.00495244638135961,0.00393178945550961,-0.0126587537141584,0.00275386095143923,0.207829569538662
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",23188,-0.00240082961272791,0.00190674747845336,-0.00613805467049649,0.00133639544504067,0.20799858918961
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,XCL1,Lymphotactin,28452,-0.00473473622178327,0.00376337686537993,-0.0121109548779279,0.0026414824343614,0.208362868637285
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FN1,Fibronectin,23893,0.00226870176467412,0.00180675366418357,-0.00127253541712568,0.00580993894647392,0.209244836956653
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP10,Stromelysin-2,28181,0.00500696181897358,0.00398902322583193,-0.00281152370365701,0.0128254473416042,0.209422050009986
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THSD1,Thrombospondin type-1 domain-containing protein 1,23029,-0.00292033128719405,0.00232913265281549,-0.0074854312867124,0.00164476871232431,0.209917335036522
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRAME,Melanoma antigen preferentially expressed in tumors,22978,0.00215229493385196,0.00171778182093388,-0.00121455743517843,0.00551914730288236,0.210236618963769
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTF,Ciliary neurotrophic factor,23056,0.00290760019575848,0.00232210268590175,-0.00164372106860895,0.00745892146012591,0.210531165537042
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL16,C-X-C motif chemokine 16,28520,-0.00199550497608243,0.00159493732329954,-0.00512158212974952,0.00113057217758467,0.210890220021967
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,XIAP,E3 ubiquitin-protein ligase XIAP,23188,-0.00490251592249262,0.00391889437835383,-0.0125835489040661,0.00277851705908089,0.210949056750565
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TACSTD2,Tumor-associated calcium signal transducer 2,24857,-0.00264264779171987,0.00212070602204034,-0.00679923159491894,0.0015139360114792,0.2127332010911
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECSCR,Endothelial cell-specific chemotaxis regulator,23056,0.00425059771203272,0.00341672295900623,-0.0024461792876195,0.0109473747116849,0.213491283722987
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,27544,0.00399404918338767,0.00322237931182097,-0.00232181426778143,0.0103099126345568,0.215181288636042
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAMR1,Inactive serine protease PAMR1,28187,0.00230297310124506,0.0018629375727683,-0.0013483845413808,0.00595433074387092,0.216392607228998
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINI1,Neuroserpin,23287,0.0025590215573321,0.00207131218648951,-0.00150075032818734,0.00661879344285154,0.216672148078609
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PEPD,Xaa-Pro dipeptidase,23872,0.00218878870460179,0.00177346740095815,-0.00128720740127618,0.00566478481047975,0.217145745625214
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AFAP1,Actin filament-associated protein 1,23337,0.00703917156527206,0.00570822686667828,-0.00414895309341738,0.0182272962239615,0.21752755512667
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MICALL2,MICAL-like protein 2,23163,-0.00570959584548403,0.00464329703530527,-0.0148104580346824,0.00339126634371429,0.218843466859541
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,27562,0.00563054537733264,0.00458108025926239,-0.00334837193082164,0.0146094626854869,0.219049753782944
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC42BPB,Serine/threonine-protein kinase MRCK beta,23738,-0.00851981495910946,0.00694106695054093,-0.0221243061821697,0.00508467626395076,0.219665556655605
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGAP1,Rho GTPase-activating protein 1,27562,0.00380986988392951,0.0031217649071727,-0.00230878933412898,0.009928529101988,0.222315471586081
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPTL3,Angiopoietin-related protein 3,28266,-0.00292898804162815,0.00240052966335027,-0.00763402618179468,0.00177605009853839,0.222421079545077
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DEFB116,Beta-defensin 116,23056,0.00636317275408104,0.00522308563079726,-0.0038740750822816,0.0166004205904437,0.223130643848074
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TG,Thyroglobulin,23725,0.00919088410140246,0.00755438220963331,-0.00561570502947882,0.0239974732322837,0.223757331143961
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFBR1,TGF-beta receptor type-1,23188,0.00176855630190409,0.00145366491465909,-0.00108062693082773,0.0046177395346359,0.223761614837004
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CBLN1,Cerebellin-1,23056,0.00789405862603406,0.00649212034887282,-0.00483049725775668,0.0206186145098248,0.224018486624366
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NTF3,Neurotrophin-3,28176,-0.00284359006583401,0.0023528833517808,-0.00745524143532438,0.00176806130365637,0.226843816898384
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HDAC9,Histone deacetylase 9,23056,0.00530967435091396,0.00439444999821723,-0.00330344764559181,0.0139227963474197,0.226956501991739
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHB4,Ephrin type-B receptor 4,28553,-0.00204020288760823,0.00169049432373011,-0.00535357176211924,0.00127316598690278,0.227493126565534
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,28452,0.0021111862267726,0.00175465389903371,-0.00132793541533348,0.00555030786887868,0.228911893548138
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK15,Kallikrein-15,23687,-0.00420957053487184,0.00349870765281928,-0.0110670375343976,0.00264789646465395,0.228919206846768
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EVI2B,Protein EVI2B,22978,0.0033486518237279,0.00278440970339497,-0.00210879119492624,0.00880609484238203,0.229126762996837
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL4,C-C motif chemokine 4,28238,-0.00530740273051829,0.00441354852905121,-0.0139579578474587,0.00334315238642209,0.229170249141756
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IMPG1,Interphotoreceptor matrix proteoglycan 1,23056,0.00246672933845258,0.00205158876053357,-0.00155438463219322,0.00648784330909838,0.229240007455874
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAK4,Serine/threonine-protein kinase PAK 4,27544,-0.00499224991269278,0.00415576876927295,-0.0131375567004677,0.0031530568750822,0.229652193417934
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITM2A,Integral membrane protein 2A,28176,0.00491979550406105,0.00409669414832934,-0.00310972502666446,0.0129493160347866,0.229792944821193
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WASHC3,WASH complex subunit 3,23775,-0.00611547478239954,0.00509294807645219,-0.0160976530122458,0.00386670344744675,0.229851219667237
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPTP,Ceramide-1-phosphate transfer protein,23071,0.00324152873111406,0.00270207723295001,-0.00205454264546795,0.00853760010769607,0.230290246266723
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH2B3,SH2B adapter protein 3,27562,-0.00794782928397178,0.00663556641576203,-0.0209535394588654,0.0050578808909218,0.231019991049902
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AIF1,Allograft inflammatory factor 1,27562,0.00426363801452092,0.00356132788083041,-0.00271656463190669,0.0112438406609485,0.231237130809313
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INSL4,Early placenta insulin-like peptide,23725,-0.00414631043168427,0.00346556424599823,-0.0109388163538408,0.00264619549047226,0.231540155262761
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA8,Carbonic anhydrase-related protein,23188,-0.00218092325013091,0.00182568282074145,-0.00575926157878415,0.00139741507852232,0.232263593254458
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASE3,Eosinophil cationic protein,28092,-0.00879532083918757,0.00736389506527966,-0.0232285551671357,0.00563791348876057,0.232337755005263
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSRP3,Cysteine and glycine-rich protein 3,23071,-0.00796342249079929,0.006671286313251,-0.0210391436647713,0.00511229868317267,0.232613017092132
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTNNA1,Catenin alpha-1,23056,0.00280765185191349,0.00235269093343993,-0.00180362237762877,0.00741892608145574,0.232733279377652
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCGB3A2,Secretoglobin family 3A member 2,28276,0.00662482485322185,0.00555257189746401,-0.0042582160658076,0.0175078657722513,0.23283660789511
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",23725,0.00298190786081567,0.00250856629723833,-0.00193488208177146,0.0078986978034028,0.234573552307838
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC1,Sialoadhesin,28320,0.00341305917173036,0.00287539824336596,-0.00222272138526692,0.00904883972872764,0.23524286930308
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,28176,0.00810291637010749,0.00683374355584875,-0.00529122099935606,0.021497053739571,0.235742321984745
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFBR3,Transforming growth factor beta receptor type 3,28553,0.00253478408464241,0.00213957787142091,-0.00165878854334257,0.00672835671262738,0.236141108480346
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL3,Interleukin-3,22978,0.00485430705159288,0.00410421150752125,-0.00318994750314876,0.0128985616063345,0.236915571437754
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAD2,Glutamate decarboxylase 2,23188,0.00371546843455717,0.00314513946996916,-0.00244900492658238,0.00987994179569671,0.237481147846206
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINH1,Serpin H1,23393,0.010290767884574,0.00871261334917656,-0.00678595427981206,0.02736749004896,0.237561326596143
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,23071,0.00319736518682096,0.00271556152678161,-0.002125135405671,0.00851986577931292,0.239038781345292
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCUN1D1,DCN1-like protein 1,23056,0.00598020784340758,0.00507961917817825,-0.00397584574582179,0.015936261432637,0.239090132029244
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIAA1549L,UPF0606 protein KIAA1549L,23393,0.00224831740014913,0.00190999202026224,-0.00149526695956487,0.00599190175986313,0.239153831823481
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",23846,0.00585028008339167,0.00497396128971853,-0.00389868404445665,0.01559924421124,0.239534197846697
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PECR,Peroxisomal trans-2-enoyl-CoA reductase,23198,0.00221980364306082,0.00188763665249153,-0.00147996419582259,0.00591957148194422,0.239619030925718
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKCQ,Protein kinase C theta type,27702,-0.00344862294038565,0.00293733691271703,-0.00920580328931103,0.00230855740853974,0.240379296944791
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,28378,0.00230895083687001,0.00196694594748739,-0.00154626322020527,0.0061641648939453,0.240454513236625
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD3G,T-cell surface glycoprotein CD3 gamma chain,23188,0.00721810570099253,0.0061580873297716,-0.0048517454653598,0.0192879568673449,0.241155169720529
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RRAS,Ras-related protein R-Ras,23163,0.0104090522361971,0.00888414044777451,-0.00700386304144097,0.0278219675138351,0.241351965769208
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLT1,Vascular endothelial growth factor receptor 1,28033,0.00177322017938556,0.00151554022485066,-0.00119723866132173,0.00474367902009285,0.242000799823668
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,23056,0.00253354024334839,0.00216543402386868,-0.00171071044343423,0.00677779093013101,0.242016334386408
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",23071,-0.00321699484906897,0.00275381046320593,-0.0086144633569526,0.00218047365881466,0.242739136175776
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB6A,Ras-related protein Rab-6A,28176,0.0036616583029663,0.00313544139628821,-0.0024838068337586,0.0098071234396912,0.242885774617885
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VCAM1,Vascular cell adhesion protein 1,28291,0.00216287371760505,0.00185475595309452,-0.00147244795046022,0.00579819538567031,0.243574523130173
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MUC16,Mucin-16,28091,-0.014899933383996,0.0128046377523933,-0.0399970233786869,0.010197156610695,0.244581573162963
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASC3,Protein CASC3,23163,0.00332020580673438,0.00285825723751022,-0.00228197837878566,0.00892238999225442,0.245402253015797
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMP4,Metalloproteinase inhibitor 4,28187,0.00315943531275357,0.00272715059899541,-0.00218577986127745,0.00850465048678458,0.246665184213733
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NXPH1,Neurexophilin-1,27544,0.0029938015814983,0.00258732737955569,-0.00207736008243086,0.00806496324542745,0.247240745653493
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAFB2,Scaffold attachment factor B2,23795,-0.00214819962307662,0.00186020938086712,-0.00579421000957618,0.00149781076342295,0.248177372587442
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AKR1B1,Aldo-keto reductase family 1 member B1,27562,0.00589844137589952,0.00510795210579507,-0.00411314475145883,0.0159100275032579,0.248200133268398
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDK1,Cyclin-dependent kinase 1,22978,-0.00285247873154963,0.00248027425026259,-0.0077138162620643,0.00200885879896504,0.250128723897354
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZNF830,Zinc finger protein 830,23725,-0.00617152017886554,0.00537072989681993,-0.0166981507766326,0.00435511041890154,0.250525229871835
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACVRL1,Serine/threonine-protein kinase receptor R3,27918,0.0019417831753153,0.00168995236542632,-0.00137052346092028,0.00525408981155088,0.250559020118898
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PALM,Paralemmin-1,23600,0.00232274521623896,0.00202438569563661,-0.00164505074720879,0.0062905411796867,0.251235107674052
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASRGL1,Isoaspartyl peptidase/L-asparaginase,23198,0.00790942017536533,0.00689388822496908,-0.00560260074557407,0.0214214410963047,0.251265764919382
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GID8,Glucose-induced degradation protein 8 homolog,23795,0.00261797760037535,0.00228687056545724,-0.00186428870792084,0.00710024390867154,0.252309302448504
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEP1B,Meprin A subunit beta,28224,-0.00904243999311232,0.0079144755658384,-0.0245548121021556,0.00646993211593094,0.253247982196442
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC3B,Tetranectin,23327,0.00165022947250295,0.00144504997090456,-0.00118206847046998,0.00448252741547588,0.253470809567969
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LZTFL1,Leucine zipper transcription factor-like protein 1,23337,0.00553215321500757,0.00484981508341352,-0.00397348434848294,0.0150377907784981,0.25400914749328
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSTB,Cystatin-B,27786,-0.00328735378682979,0.00288222634538091,-0.00893651742377637,0.0023618098501168,0.254062659928865
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANK2,Ankyrin-2,23071,0.00555326304927102,0.00487178346205877,-0.00399543253636417,0.0151019586349062,0.254346897834468
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPLX2,Complexin-2,22978,0.0023618242602933,0.00207699806242181,-0.00170909194205345,0.00643274046264004,0.255494309436975
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GUK1,Guanylate kinase,23071,0.00309632824231086,0.00272443005887026,-0.00224355467307485,0.00843621115769657,0.255757107673937
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ROBO2,Roundabout homolog 2,28428,-0.00178136988712413,0.00156841274321032,-0.00485545886381636,0.0012927190895681,0.256058746491415
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,23862,0.0020173850110391,0.00178503728385964,-0.0014812880653258,0.005516058087404,0.258418460775356
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,27562,0.00362686973053718,0.00321884979291536,-0.00268207586357693,0.00993581532465128,0.259853973519575
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX16,Syntaxin-16,27562,-0.00443720404906083,0.00394329711722456,-0.012166066398821,0.0032916583006993,0.260491950939976
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMAD5,Mothers against decapentaplegic homolog 5,28091,0.00153721289640861,0.00136751082623275,-0.00114310832300758,0.0042175341158248,0.260982084080635
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADGRB3,Adhesion G protein-coupled receptor B3,27918,-0.00256264972499561,0.00228008057439605,-0.00703160765081187,0.00190630820082066,0.261052621773383
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP4,Caspase-4,23393,0.0127983058531163,0.0114175756708201,-0.00958014246169097,0.0351767541679237,0.262329070866517
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,23738,-0.00384122268109239,0.00343146979903104,-0.0105669034871932,0.00288445812500845,0.262976466511298
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPS16,"28S ribosomal protein S16, mitochondrial",23188,0.0022021294435079,0.00196725006307368,-0.00165368068011651,0.00605793956713232,0.26298336063996
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KCNH2,Potassium voltage-gated channel subfamily H member 2,23163,0.00594560096975517,0.00531835913439336,-0.00447838293365581,0.0163695848731662,0.263604658287308
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHC1,SHC-transforming protein 1,22978,0.00884400496902853,0.00791592906855577,-0.00667121600534078,0.0243592259433978,0.263902742360941
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GCLM,Glutamate--cysteine ligase regulatory subunit,23071,-0.00339994297911712,0.00304375933417667,-0.0093657112741034,0.00256582531586916,0.26399700217769
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EBI3_IL27,Interleukin-27,28404,0.00233287005745417,0.00209496437041408,-0.00177326010855743,0.00643900022346577,0.26547710829141
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,23056,0.00491524708249459,0.00441549049188011,-0.00373911428159043,0.0135696084465796,0.265641636649372
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LMNB1,Lamin-B1,23693,-0.00442505459320133,0.00397807887484866,-0.0122220891879047,0.00337198000150205,0.265994820863875
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX5,Syntaxin-5,23188,-0.00306697322208135,0.00275792102597934,-0.00847249843300086,0.00233855198883816,0.266123957519485
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP6V1G2,V-type proton ATPase subunit G 2,23071,0.00746320778375734,0.0067113642195192,-0.00569106608650029,0.020617481654015,0.266138804574322
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F10,Coagulation factor X,23872,-0.0020779672451772,0.00186914295719861,-0.00574148744128649,0.00158555295093208,0.266268923566393
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,METAP2,Methionine aminopeptidase 2,28404,-0.00430819960971941,0.00388082848724395,-0.0119146234447176,0.00329822422527874,0.266955136001471
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,27562,0.00268390611371224,0.0024227038252964,-0.00206459338386871,0.00743240561129319,0.267951664694127
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP6V1F,V-type proton ATPase subunit F,27489,-0.00497401862725374,0.00449535249007179,-0.0137849095077945,0.00383687225328697,0.268528407041268
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHP1,Calcineurin B homologous protein 1,23056,0.00546531059174206,0.00495246003501309,-0.0042415110768836,0.0151721322603677,0.269797871822809
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD163,Scavenger receptor cysteine-rich type 1 protein M130,28336,-0.00320566319801827,0.00290489660510284,-0.00889926054401983,0.00248793414798329,0.269803063320096
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATF2,Cyclic AMP-dependent transcription factor ATF-2,27544,0.00509192326118937,0.00461815505234345,-0.00395966064140379,0.0141435071637825,0.270215675863195
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTNAP4,Contactin-associated protein-like 4,23163,0.0077218349788472,0.00701893153300941,-0.00603527082585125,0.0214789407835457,0.271280852450798
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEK7,Serine/threonine-protein kinase Nek7,23393,0.00557622950460227,0.00506865556821706,-0.00435833540910316,0.0155107944183077,0.271282561406392
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,A1BG,Alpha-1B-glycoprotein,23893,0.00126885786828505,0.00115369107018287,-0.000992376629273365,0.00353009236584347,0.271419621015828
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C2CD2L,Phospholipid transfer protein C2CD2L,27489,-0.00315198827914862,0.00286983273953384,-0.00877686044863495,0.00247288389033771,0.272075382098004
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBM19,Probable RNA-binding protein 19,23071,0.00357163277353724,0.00325409827671909,-0.00280639984883218,0.00994966539590667,0.272399447522331
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,F3,Tissue factor,28275,-0.00202370356315752,0.00184513409168497,-0.00564016638286006,0.00159275925654501,0.272747537954944
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPAG1,Sperm-associated antigen 1,23795,-0.00428277927896065,0.00390947455626379,-0.0119453494092377,0.00337979085131637,0.273314350696505
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB33A,Ras-related protein Rab-33A,23071,-0.00492633590655036,0.00451124881483508,-0.0137683835836271,0.00391571177052639,0.274839425320015
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLA2,Src-like-adapter 2,23795,0.00770283055516676,0.00706807434514145,-0.00615059516131047,0.021556256271644,0.275809607918515
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEO1,Neogenin,23795,-0.00161642562562823,0.00148886004369682,-0.004534591311274,0.00130174006001755,0.277631581338053
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CERT,Ceramide transfer protein,27544,0.00452094948041575,0.00416893346655249,-0.00365016011402712,0.0126920590748586,0.27818018088152
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CIAPIN1,Anamorsin,28307,0.00459719394124039,0.00423931438263754,-0.00371186224872918,0.01290625013121,0.278188211780496
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BIRC2,Baculoviral IAP repeat-containing protein 2,27562,-0.00464886979401742,0.00429145538345016,-0.0130601223455797,0.00376238275754489,0.278691365664407
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUSD4,Sushi domain-containing protein 4,23725,0.00306014349816376,0.00283231632289601,-0.00249119649471242,0.00861148349103994,0.279957964451448
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,23795,-0.00429869931834895,0.00397889356334065,-0.0120973307024966,0.00349993206579873,0.2799859357584
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TAP1,Antigen peptide transporter 1,23393,-0.00438920710358772,0.00406759946445503,-0.0123617020539196,0.00358328784674413,0.28056956841965
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD22,B-cell receptor CD22,28521,0.00304550179413828,0.00282695435237427,-0.00249532873651529,0.00858633232479186,0.281351607548596
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL17,C-X-C motif chemokine 17,28521,-0.0030579827134974,0.00284104383236229,-0.00862642862492748,0.00251046319793268,0.281775900872455
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENAH,Protein enabled homolog,27702,-0.00346733504400141,0.00322696644448137,-0.0097921892751849,0.00285751918718208,0.282613616483476
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SV2A,Synaptic vesicle glycoprotein 2A,23163,0.0045160623728237,0.00420487898656559,-0.00372550044084486,0.0127576251864923,0.282831494993393
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSNK2A1,Casein kinase II subunit alpha,23795,0.00325392273434906,0.00303887461790565,-0.00270227151674602,0.00921011698544415,0.284285656154886
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TOP1MT,"DNA topoisomerase I, mitochondrial",22978,0.00353870417789474,0.00330542507619399,-0.00293992897144547,0.010017337327235,0.284371994445715
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GCC1,GRIP and coiled-coil domain-containing protein 1,23775,0.00780175353143687,0.00729115067559191,-0.00648890179272327,0.022092408855597,0.284616453981128
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ORM1,Alpha-1-acid glycoprotein 1,23779,0.00144037873097206,0.00134615694289216,-0.00119808887709658,0.0040788463390407,0.2846332513748
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,23795,0.00834504806225081,0.00782085101390365,-0.00698381992500034,0.023673916049502,0.285971118568791
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DUSP29,Dual specificity phosphatase 29,23163,-0.00484188947550926,0.00454066005605544,-0.0137415831853779,0.0040578042343594,0.286280892707788
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DIPK1C,Divergent protein kinase domain 1C,23163,0.00307235873096557,0.00288240326198542,-0.00257715166252585,0.008721869124457,0.286479166835169
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",23337,0.00749177868291503,0.00703414566167036,-0.00629514681395887,0.0212787041797889,0.286860351174015
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL20,C-C motif chemokine 20,28521,-0.00630314570576319,0.00592513948336693,-0.0179164190931624,0.005310127681636,0.287429673932184
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCDC50,Coiled-coil domain-containing protein 50,23795,0.00550062569261885,0.00517465725335166,-0.00464170252395039,0.0156429539091881,0.287795809750124
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUP50,Nuclear pore complex protein Nup50,23071,0.00240887688534683,0.0022733958913566,-0.0020469790617121,0.00686473283240576,0.28934039615745
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SH3GL3,Endophilin-A3,23261,0.006023118646355,0.00568474068171295,-0.00511897308980238,0.0171652103825124,0.289372256502332
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFBI,Transforming growth factor-beta-induced protein ig-h3,28111,0.00193860492962601,0.00183170624581108,-0.00165153931216371,0.00552874917141573,0.289900370507789
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARSB,Arylsulfatase B,28091,0.00395271256519572,0.00373848115582754,-0.00337471050022626,0.0112801356306177,0.290381783720261
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PI3,Elafin,27773,0.00393965444624766,0.00373069510342646,-0.0033725079564682,0.0112518168489635,0.290972455642352
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CR1,Complement receptor type 1,23826,-0.00256132703025583,0.00242598043029331,-0.00731624867363072,0.00219359461311906,0.291074662509088
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRLB,Fc receptor-like B,27562,-0.00438453608906552,0.00415581475849746,-0.0125299330157205,0.0037608608375895,0.291417902946047
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KYAT1,Kynurenine--oxoglutarate transaminase 1,28191,-0.00405617608952085,0.0038476717444984,-0.0115976127087377,0.00348526052969601,0.291805094132612
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HRAS,GTPase Hras,23370,0.00704398875190008,0.00669385083427212,-0.00607595888327328,0.0201639363870734,0.292669425469601
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL2RB,Interleukin-2 receptor subunit beta,27702,0.0026551340289126,0.00252426114035943,-0.00229241780619188,0.00760268586401709,0.292879381761077
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRHBP,Corticotropin-releasing factor-binding protein,28195,-0.00197026553525906,0.00187843798139741,-0.00565200397879798,0.00171147290827986,0.294240017340328
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TTF2,Transcription termination factor 2,23163,-0.00349273605362523,0.00333163756695114,-0.0100227456848495,0.00303727357759901,0.29448641694448
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NIT2,Omega-amidase NIT2,23744,-0.00526150594528752,0.00502595985096727,-0.0151123872531834,0.00458937536260833,0.295172097302764
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYPLA2,Acyl-protein thioesterase 2,23056,0.00768468608484489,0.00734182565444463,-0.00670529219786659,0.0220746643675564,0.295249120849257
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFF3,Trefoil factor 3,28174,-0.0032546096042774,0.00311025132374342,-0.0093507021988145,0.0028414829902597,0.295379050559438
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIGLEC10,Sialic acid-binding Ig-like lectin 10,28176,-0.00240065629594788,0.00230273840821326,-0.00691402357604587,0.0021127109841501,0.297178510192801
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA3G,Semaphorin-3G,23337,0.00312064389798232,0.00299421690954999,-0.00274802124473565,0.0089893090407003,0.297318769324792
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NARS1,"Asparagine--tRNA ligase, cytoplasmic",23795,0.00331906952956164,0.00318601068096103,-0.00292551140512199,0.00956365046424526,0.297531946627951
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP350,Centrosome-associated protein 350,22978,0.00261264732063239,0.00251038710344077,-0.00230771140211151,0.00753300604337629,0.298009585660759
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,23188,0.00563758560898689,0.0054272439353074,-0.00499981250421562,0.0162749837221894,0.298928775183049
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD300A,CMRF35-like molecule 8,23337,0.00209829021276043,0.0020256321996606,-0.00187194889857434,0.00606852932409521,0.300273860589472
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OPLAH,5-oxoprolinase,23198,-0.00479234196721847,0.00462995657255753,-0.0138670568494312,0.00428237291499429,0.300645725058716
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DGKA,Diacylglycerol kinase alpha,23188,-0.00383604316196723,0.00371474708870524,-0.0111169474558295,0.00344486113189505,0.301777289343648
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ABRAXAS2,BRISC complex subunit Abraxas 2,23071,0.00466131086335937,0.00452090176800028,-0.00419965660192118,0.0135222783286399,0.302524548025628
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHX2,Bifunctional epoxide hydrolase 2,27682,-0.00430843578268516,0.0041815221831727,-0.0125042192617036,0.00388734769633332,0.302854248310419
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ELAVL4,ELAV-like protein 4,23056,-0.00591987555883321,0.00574744759350108,-0.0171848728420953,0.00534512172442891,0.303020446273949
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DGKZ,Diacylglycerol kinase zeta,27702,0.00247135847037764,0.0024067144245883,-0.00224580180181544,0.00718851874257071,0.304495421763639
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",28050,-0.0072900304544792,0.00710402535652555,-0.0212139201532693,0.00663385924431088,0.304814159837066
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYPD3,Ly6/PLAUR domain-containing protein 3,28091,-0.00238725395356357,0.00232641685787792,-0.00694703099500429,0.00217252308787715,0.304829463276011
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,27965,0.00652509182438117,0.0063656028815815,-0.00595148982351857,0.0190016734722809,0.305346199587312
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RPA2,Replication protein A 32 kDa subunit,23188,0.00222213445714692,0.00216814501993483,-0.00202742978192535,0.00647169869621919,0.305420501052307
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAPG,Macrophage-capping protein,27917,0.00403242523937052,0.00395194539172102,-0.00371338772840268,0.0117782382071437,0.307564415543403
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,23393,0.00263998381211929,0.00258831774008885,-0.00243311895845486,0.00771308658269345,0.307757390454406
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",27562,0.00546961554985241,0.00539318119031427,-0.00510101958316355,0.0160402506828684,0.310509399651511
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBCA,Tubulin-specific chaperone A,23337,0.00585790263763061,0.00579199070148729,-0.00549439913728448,0.0172102044125457,0.311845157640569
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTX3,Pentraxin-related protein PTX3,28176,0.00337257273978197,0.00334454066058487,-0.00318272695496437,0.00992787243452831,0.313280041498613
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NLGN1,Neuroligin-1,23163,0.00468883858798971,0.00465024026065213,-0.00442563232288846,0.0138033094988679,0.313320864451712
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",23846,0.00599684680708196,0.00598005710267423,-0.00572406511415954,0.0177177587283235,0.315963875001683
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UGDH,UDP-glucose 6-dehydrogenase,23071,0.00666335708448097,0.00665533496627615,-0.00638109944942027,0.0197078136183822,0.316738039571449
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,28553,0.00184499757490521,0.00185687767692427,-0.00179448267186636,0.00548447782167679,0.320425041407622
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OMG,Oligodendrocyte-myelin glycoprotein,28091,0.00441962346703595,0.00445907451097856,-0.00432016257448202,0.0131594095085539,0.321619594445398
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PER3,Period circadian protein homolog 3,23188,0.00806551528393982,0.00815863594134936,-0.00792541116110493,0.0240564417289846,0.322875939413292
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",23188,-0.00414421584747256,0.00419530571586348,-0.012367015050565,0.00407858335561985,0.323250078614031
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGAP30,Rho GTPase-activating protein 30,23393,0.00258604400908152,0.0026235735709751,-0.00255616019002967,0.00772824820819271,0.324292881399731
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DXO,Decapping and exoribonuclease protein,23775,0.00303530520946993,0.00307997287820748,-0.00300144163181673,0.00907205205075659,0.324389851225237
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSAP,Gamma-secretase-activating protein,27562,0.00578935024251486,0.00588208194078561,-0.00573953036142493,0.0173182308464547,0.325008681073454
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",28176,-0.00287849160023672,0.00292911287681076,-0.00861955283878581,0.00286256963831236,0.325754749917494
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZP3,Zona pellucida sperm-binding protein 3,23198,-0.0175124624537808,0.017829863306836,-0.0524589945351795,0.0174340696276178,0.326012386088619
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL12A_IL12B,Interleukin-12,28091,-0.00517203121887583,0.00526614348037158,-0.0154936724404041,0.00514961000265246,0.326044857479324
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL10,Interleukin-10,27702,-0.00541563027232833,0.00551480387624186,-0.0162246458697624,0.00539338532510572,0.326100132914262
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRHR1,Corticotropin-releasing factor receptor 1,27682,-0.0040529026712567,0.00413033610925894,-0.0121483614454042,0.00404255610289082,0.326476815744718
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAGA,Alpha-N-acetylgalactosaminidase,23140,-0.00386299999205066,0.0039399535088733,-0.0115853088694423,0.00385930888534101,0.326865207413758
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFAT5,Nuclear factor of activated T-cells 5,23188,-0.0057344005552622,0.00584871954101487,-0.0171978908556514,0.00572908974512695,0.326872293537782
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDCD1LG2,Programmed cell death 1 ligand 2,28091,-0.0020809519294139,0.00212328592354153,-0.00624259233955531,0.0020806884807275,0.327063941010689
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,QSOX1,Sulfhydryl oxidase 1,23444,-0.00279174977723602,0.0028560780270335,-0.00838966271022169,0.00280616315574964,0.328343290446061
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAP1A,Ras-related protein Rap-1A,23188,0.00458014000790966,0.00468917181999453,-0.00461063675927962,0.0137709167750989,0.32870403559324
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCBP2,Poly(rC)-binding protein 2,23795,0.00476996293960811,0.00488719586858607,-0.00480894096282058,0.0143488668420368,0.329068331547852
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPHS1,Nephrin,23188,0.00224625199703854,0.00230482643093754,-0.00227120780759904,0.00676371180167611,0.329775742154749
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GART,Trifunctional purine biosynthetic protein adenosine-3,23795,-0.00178299012440967,0.00182989440009484,-0.00536958314859555,0.00180360289977622,0.329883877616635
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOXO1,Forkhead box protein O1,28176,-0.00563401533703749,0.0057854901438616,-0.0169735760190062,0.00570554534493124,0.33015520137684
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,THRAP3,Thyroid hormone receptor-associated protein 3,23071,-0.00745255491927872,0.00768815849287033,-0.0225213455653046,0.00761623572674712,0.332378261576854
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,23071,0.00311625627413747,0.00322003101174772,-0.00319500450888805,0.009427517057163,0.333168336019486
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PKN3,Serine/threonine-protein kinase N3,23393,-0.00493490045549845,0.00510504773461706,-0.0149407940153479,0.00507099310435098,0.33371864013761
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,23393,0.00690460415513951,0.00714746731360795,-0.00710443177953206,0.0209136400898111,0.334043621061088
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERCC1,DNA excision repair protein ERCC-1,22978,0.00220210496066551,0.00228196370092656,-0.00227054389315055,0.00667475381448157,0.33455278117732
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WFDC12,WAP four-disulfide core domain protein 12,28390,-0.00416397513747922,0.0043159957702203,-0.012623326847111,0.00429537657215256,0.334664544454219
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",22978,0.00335317932304088,0.00347587148462644,-0.00345952878682695,0.0101658874329087,0.334704374395813
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF4E,Eukaryotic translation initiation factor 4E,23188,0.00592825735315071,0.00614857640707434,-0.00612295240471501,0.0179794671110164,0.334972031881621
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DOK1,Docking protein 1,23775,0.00885657513567703,0.00921269640049694,-0.00920030980929697,0.026913460080651,0.336388755978116
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,28521,-0.00641338490159624,0.00667538660346756,-0.0194971426443927,0.00667037284120017,0.336685488883837
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEBPA,CCAAT/enhancer-binding protein alpha,23188,-0.00242226268356308,0.00252250344429525,-0.00736636943438177,0.00252184406725562,0.336933691482566
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,28307,0.00618387500721143,0.00644705463142982,-0.00645235207039101,0.0188201020848139,0.337477118474799
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCN3A,Sodium channel protein type 3 subunit alpha,23163,0.00245990848049376,0.00256950285552497,-0.00257631711633519,0.0074961340773227,0.338401621360269
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VCPKMT,Protein-lysine methyltransferase METTL21D,22978,0.0056284407831521,0.00588197715377485,-0.00590023443824661,0.0171571160045508,0.338629791834959
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DTX2,Probable E3 ubiquitin-protein ligase DTX2,23163,0.00409404130833246,0.00427871930296522,-0.00429224852547936,0.0124803311421443,0.338659010833869
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPMT,Thiopurine S-methyltransferase,27562,0.00470258014831483,0.00492979425503717,-0.00495981659155803,0.0143649768881877,0.340137559750239
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATRAID,All-trans retinoic acid-induced differentiation factor,23738,-0.00182488622459639,0.00191500830423054,-0.00557830250088825,0.00192853005169547,0.340630653803994
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALB1,Calbindin,28091,-0.00282724779235975,0.00296928554062732,-0.00864704745198929,0.0029925518672698,0.34102184201483
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFH,Complement factor H,22663,0.00149384199147047,0.00157946803758142,-0.00160191536218912,0.00458959934513006,0.344266792760391
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRR4,Proline-rich protein 4,23165,0.00445321348964974,0.00471458288678036,-0.00478736896843977,0.0136937959477392,0.344892647033942
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC27A4,Long-chain fatty acid transport protein 4,27544,-0.00430616374911893,0.00456027169064402,-0.0132442962627812,0.00463196876454336,0.34503594610399
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TTR,Transthyretin,23644,-0.00161154034031788,0.00170744354192741,-0.00495812968249559,0.00173504900185984,0.345265009283026
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSR1,Macrophage scavenger receptor types I and II,28428,0.00293340064539232,0.00311301679040486,-0.0031681122638012,0.00903491355458584,0.346046270014427
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",23198,-0.00209512104939675,0.00222472974231976,-0.00645559134434349,0.00226534924554999,0.346334648043114
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TFAP2A,Transcription factor AP-2-alpha,23056,0.0038208681249159,0.00405891258531519,-0.00413460054230186,0.0117763367921337,0.346534037850414
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTBP3,Latent-transforming growth factor beta-binding protein 3,27562,-0.00342669519582616,0.00364195727572529,-0.0105649314562477,0.00371154106459541,0.346767510775823
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL14,C-C motif chemokine 14,28184,-0.00251744593287095,0.00268839142972089,-0.0077866931351239,0.00275180126938199,0.3490683756004
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK12,Kallikrein-12,27562,0.00871024152159307,0.00938335906412231,-0.00968114224408666,0.0271016252872728,0.353278383695149
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,27965,-0.00223599308027064,0.00240958234345018,-0.00695877447343299,0.00248678831289171,0.353436967242683
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB6B,Ras-related protein Rab-6B,27544,0.00302257941551277,0.00326826660826667,-0.00338322313668989,0.00942838196771544,0.355064294357837
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FMR1,Synaptic functional regulator FMR1,27562,-0.00222874651999791,0.00241353155385068,-0.00695926836554524,0.00250177532554943,0.35578713426289
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,28496,0.00237768206612329,0.00257937615019582,-0.00267789518826051,0.0074332593205071,0.356638059553619
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYH7B,Myosin-7B,22978,0.0027747064026687,0.00301637069821893,-0.0031373801658404,0.00868679297117779,0.357643864762521
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TXN,Thioredoxin,23587,-0.00272495355329355,0.00296488998083432,-0.00853613791572883,0.00308623080914172,0.358066225878353
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PREB,Prolactin regulatory element-binding protein,27702,-0.00180403770678573,0.00196299391789937,-0.0056515057858685,0.00204343037229704,0.358091242300749
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL18,Interleukin-18,28082,-0.00284947724107531,0.00310785464139065,-0.00894087233820097,0.00324191785605036,0.359222259808741
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PARK7,Parkinson disease protein 7,28187,0.00323218209782354,0.00353085080783895,-0.0036882854855408,0.0101526496811879,0.359983379732856
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAGEA3,Melanoma-associated antigen 3,23393,0.00522275012512186,0.00570984097281083,-0.00596853818158738,0.0164140384318311,0.36036238655575
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,23071,0.00325797071378571,0.00356411832649721,-0.00372770120614881,0.0102436426337202,0.360672364703145
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDH7,Protocadherin-7,23738,-0.00214757576765629,0.00235600188962552,-0.00676533947132232,0.00247018793600973,0.362023354569891
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNX18,Sorting nexin-18,23738,-0.00275372307149029,0.00302331459285292,-0.008679419673482,0.00317197353050143,0.362394653148711
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCN,Decorin,27682,-0.00141218108840364,0.00155056994897276,-0.00445129818839026,0.00162693601158298,0.362435214384955
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPL24,"39S ribosomal protein L24, mitochondrial",23071,0.00242749071421449,0.00266604376734397,-0.00279795506977969,0.00765293649820866,0.362556959212322
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOP56,Nucleolar protein 56,23071,0.00681463439881192,0.0075017551918078,-0.00788880577713136,0.0215180745747552,0.363673605391749
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICAM5,Intercellular adhesion molecule 5,28224,-0.00276572899141052,0.00304488899251229,-0.00873371141673462,0.00320225343391357,0.363717732368312
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAAM1,Disheveled-associated activator of morphogenesis 1,23337,-0.00509157891092726,0.00561924521968893,-0.0161052995415176,0.00592214171966304,0.364894092532002
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGB5,Integrin beta-5,28307,0.00232184394306453,0.00256422898256919,-0.00270404486277109,0.00734773274890015,0.365221776305869
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GASK1A,Golgi-associated kinase 1A,23071,-0.00263843131869849,0.00292001811407175,-0.00836166682227911,0.00308480418488213,0.366234611225258
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DSC2,Desmocollin-2,27900,0.00209734664430703,0.00232598426015521,-0.00246158250559718,0.00665627579421124,0.367222524608583
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CINP,Cyclin-dependent kinase 2-interacting protein,23393,0.0026739812705821,0.0029684525283574,-0.00314418568499839,0.0084921482261626,0.367704083942738
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF6,Fibroblast growth factor 6,23188,0.0024995901579708,0.00277689226392378,-0.0029431186793198,0.0079422989952614,0.368055420245383
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGEF10,Rho guanine nucleotide exchange factor 10,23795,-0.00566985051772444,0.00631761420715973,-0.0180523743637575,0.00671267332830864,0.369478839344966
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",27702,0.00717244756755634,0.00799448680399874,-0.00849674656828119,0.0228416417033939,0.369633752994176
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,23188,-0.00339251563124396,0.00378787383814875,-0.0108167483540155,0.00403171709152758,0.370462222929195
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ISM2,Isthmin-2,23862,0.00264867851818015,0.00296799851019526,-0.00316859856180257,0.00846595559816286,0.372180959654029
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLINT1,Clathrin interactor 1,22978,0.00290782583230419,0.00325969515063491,-0.00348117666294024,0.00929682832754862,0.372373050948854
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD55,Complement decay-accelerating factor,27281,0.00159134002610437,0.00178485290870309,-0.00190697167495368,0.00508965172716242,0.372625700144759
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,22978,-0.00160080917491045,0.0017971276635517,-0.00512317939547179,0.00192156104565088,0.373067349047839
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDT5,ADP-sugar pyrophosphatase,28187,-0.00307812059483643,0.00345996414653606,-0.00985965032204711,0.00370340913237424,0.37366711332885
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCRG1,Scrapie-responsive protein 1,23846,-0.00165060247632474,0.00185804992719193,-0.00529238033362093,0.00199117538097145,0.374360371112039
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,28428,-0.0031308269204615,0.00353046600465077,-0.010050540289577,0.00378888644865401,0.375192618697581
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACRV1,Acrosomal protein SP-10,23188,-0.00463605908127083,0.00523267079056516,-0.0148920938307785,0.00561997566823689,0.37563570466454
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,23725,0.0039967173380209,0.0045169165313794,-0.00485643906348271,0.0128498737395245,0.376255617081333
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAPPA,Pappalysin-1,27702,0.0028235693231573,0.00319167338399495,-0.0034321105094728,0.0090792491557874,0.376343737315826
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNAP23,Synaptosomal-associated protein 23,28224,-0.0051874723480103,0.0058722771427741,-0.0166971355478476,0.00632219085182694,0.377036666198932
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJC21,DnaJ homolog subfamily C member 21,23775,-0.00229035383186041,0.00259301730200397,-0.00737266774378819,0.00279196008006737,0.377095295399473
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLAMF6,SLAM family member 6,27562,-0.00228877283610254,0.00259249823456094,-0.00737006937584199,0.0027925237036369,0.377327991279667
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSDE1,Cold shock domain-containing protein E1,23071,0.00706981314301813,0.00800897438944395,-0.00862777666029201,0.0227674029463283,0.377387918623843
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMIGO1,Amphoterin-induced protein 1,23163,0.00301386893201707,0.00341581478588159,-0.00368112804831086,0.00970886591234499,0.377608635973827
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CXCL13,C-X-C motif chemokine 13,28428,0.00360934717237075,0.00409364580212208,-0.00441419859978852,0.01163289294453,0.377949205771149
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDLIM5,PDZ and LIM domain protein 5,23795,0.00703780779501333,0.00798406285597911,-0.00861095540270571,0.0226865709927324,0.378065894396027
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINK6,Serine protease inhibitor Kazal-type 6,28452,-0.00320721184458471,0.00364404654573679,-0.0103495430742288,0.00393511938505939,0.37879972162467
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL24,Interleukin-24,27702,0.0028911368997362,0.00328889735496713,-0.00355510191599939,0.00933737571547178,0.379376572435208
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YAP1,Transcriptional coactivator YAP1,23775,-0.00160307483846572,0.00182819986075711,-0.00518634656554966,0.00198019688861822,0.380571695840604
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSPAN7,Tetraspanin-7,23056,0.0055931844829119,0.00638622347242686,-0.00692381352304474,0.0181101824888686,0.381136834471763
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL12RB2,Interleukin-12 receptor subunit beta-2,23188,0.00246546775446876,0.00282111101962986,-0.00306390984400576,0.00799484535294327,0.382162690566627
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",23071,0.00360915811588014,0.00413316273076398,-0.00449184083641726,0.0117101570681775,0.382552565385876
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,27562,-0.00262797417864362,0.00301672839260252,-0.00854076182814456,0.00328481347085731,0.383688672120471
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYL6B,Myosin light chain 6B,23163,-0.00542747939193716,0.00623209444848177,-0.0176423845109614,0.0067874257270871,0.383822314732081
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,USP47,Ubiquitin carboxyl-terminal hydrolase 47,23071,-0.00503687907639911,0.00578623809646172,-0.0163779057454641,0.00630414759266586,0.384040170038305
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,23725,-0.00448382162246782,0.00519138298966961,-0.0146589322822203,0.0056912890372846,0.387758895772371
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,23071,0.00300105873347274,0.00349106914327419,-0.00384143678734466,0.00984355425429014,0.389997078944197
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,23725,0.0036207753502617,0.00421333568310359,-0.00463736258862134,0.0118789132891447,0.390150200227643
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAD51,DNA repair protein RAD51 homolog 1,23393,-0.00310967452612931,0.00362029200855101,-0.0102054468628893,0.00398609781063066,0.39037314365873
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEZ6,Seizure protein 6 homolog,23163,0.00181241304510182,0.00211802736064611,-0.00233892058176456,0.0059637466719682,0.392168147696142
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,27965,-0.00452570577369579,0.005303345945201,-0.0149202638262898,0.00586885227889818,0.393462568799193
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STK24,Serine/threonine-protein kinase 24,27544,0.00357547747040885,0.00419646884438693,-0.00464960146458952,0.0118005564054072,0.394210127394154
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASQ2,Calsequestrin-2,23071,0.00282250708299749,0.00332110154082816,-0.0036868519370257,0.00933186610302068,0.395405769458812
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANPEP,Aminopeptidase N,28278,0.00161392399711173,0.00190537008064128,-0.00212060136094518,0.00534844935516864,0.396980196087564
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GTPBP2,GTP-binding protein 2,23163,0.00461970855735197,0.00548671375881744,-0.00613425040993021,0.0153736675246342,0.399807305238445
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRYZL1,Quinone oxidoreductase-like protein 1,23198,0.00522148100768095,0.00620352710075716,-0.00693743210980308,0.017380394125165,0.399967084803117
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MMP12,Macrophage metalloelastase,28202,0.00302409421226347,0.00359578150662798,-0.00402363754072737,0.0100718259652543,0.40034853039218
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRC59,Leucine-rich repeat-containing protein 59,23846,-0.00271369414756434,0.0032284068839756,-0.00904137164015652,0.00361398334502784,0.400598662762758
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CFB,Complement factor B,23480,0.00185850083515446,0.00221275370399911,-0.00247849642468378,0.00619549809499271,0.400970734103994
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP6V1G1,V-type proton ATPase subunit G 1,23198,-0.00409748248766657,0.00489250513594962,-0.0136867925541278,0.00549182757879468,0.402319126492458
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,23393,0.00296471958250156,0.00354040541481358,-0.00397447503053306,0.00990391419553618,0.402378851192165
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNX2,Sorting nexin-2,23725,0.00459100607678652,0.00548590931211768,-0.00616137617496413,0.0153433883285372,0.402672731604716
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",28091,0.00195593423542254,0.00234694566375545,-0.00264407926553813,0.00655594773638322,0.4046287338478
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL13,Interleukin-13,27702,0.0027298180684977,0.00328119751433683,-0.00370132905960249,0.00916096519659788,0.405439904861466
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LMOD2,Leiomodin-2,23056,0.0035677135817206,0.0042976738350889,-0.00485572713505364,0.0119911542984948,0.4064626276501
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF5,Eukaryotic translation initiation factor 5,23071,0.00247878591321123,0.00299197531386064,-0.00338548570195562,0.00834305752837809,0.407408388890876
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NELL1,Protein kinase C-binding protein NELL1,28307,0.00236718080891617,0.00286905849681132,-0.00325617384483401,0.00799053546266635,0.409337478000992
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL25,Interleukin-25,22882,0.00193633674991658,0.00235072653683923,-0.00267108726228831,0.00654376076212146,0.410108160807699
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAT1,Diamine acetyltransferase 1,23071,0.00281530325133136,0.00342275684272795,-0.00389330016041543,0.00952390666307815,0.410786640485722
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IZUMO1,Izumo sperm-egg fusion protein 1,22978,0.00275346262177861,0.0033491067048854,-0.00381078651979678,0.00931771176335399,0.411000994629884
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,22978,-0.0037081202402605,0.00452152873139876,-0.0125703165538021,0.00515407607328106,0.412165782807484
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDIA2,Protein disulfide-isomerase A2,22978,0.00224293749264595,0.00275555958421259,-0.00315795929241072,0.00764383427770263,0.415671687978528
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSPA1A,Heat shock 70 kDa protein 1A,28277,-0.0039060022142133,0.00480003800362315,-0.0133140767013147,0.00550207227288807,0.415798466800104
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF2,Fibroblast growth factor 2,28176,0.00372570165919765,0.00458219789787992,-0.00525540622064699,0.0127068095390423,0.416178041090671
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,23071,0.00380639508129242,0.00468782190140935,-0.00538173584546991,0.0129945260080547,0.416814250046693
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCDH9,Protocadherin-9,23738,-0.0018565187339206,0.00229055669199789,-0.00634600985023647,0.00263297238239526,0.417655343121629
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMAD3,Mothers against decapentaplegic homolog 3,23725,0.00280847741067389,0.00347477004578114,-0.00400207187905714,0.00961902670040492,0.418955695904878
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ESAM,Endothelial cell-selective adhesion molecule,28553,0.00174368949631753,0.00215838682354933,-0.00248674867783915,0.00597412767047422,0.419173881389303
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TET2,Methylcytosine dioxygenase TET2,23370,0.00547075998074255,0.00680494299477514,-0.00786692828901673,0.0188084482505018,0.421440309601254
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSCA,Prostate stem cell antigen,23738,-0.0140756127667047,0.0175420249879749,-0.0484579817431356,0.0203067562097262,0.422333213674527
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL20RB,Interleukin-20 receptor subunit beta,23188,-0.00228619619331886,0.00285757779342488,-0.00788704866843162,0.00331465628179391,0.423691838084707
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPVL,Probable serine carboxypeptidase CPVL,28390,-0.00221044122062191,0.00276300796689232,-0.00762593683573086,0.00320505439448703,0.423710187210267
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MSLN,Mesothelin,28036,0.00304479980478168,0.00380680248903522,-0.00441653307372736,0.0105061326832907,0.423815322524141
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NGFR,Tumor necrosis factor receptor superfamily member 16,23846,-0.00161297679550313,0.00201974233436968,-0.00557167177086771,0.00234571817986145,0.424527311066346
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFBP3,Insulin-like growth factor-binding protein 3,28336,0.00160369769673334,0.00201763022403934,-0.00235085754238377,0.00555825293585045,0.42671194572985
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTN1A1,Butyrophilin subfamily 1 member A1,23684,-0.00214572896418519,0.00270860791687928,-0.00745460048126857,0.0031631425528982,0.428258513798144
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MRPL52,"39S ribosomal protein L52, mitochondrial",22940,0.0013909549414775,0.00175697397633579,-0.00205271405214064,0.00483462393509565,0.428557541007159
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZNF174,Zinc finger protein 174,23188,0.00202134431206806,0.00255471294570082,-0.00298589306150556,0.00702858168564167,0.428822730148798
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHD,SH2 domain-containing adapter protein D,23023,0.00457002690154561,0.0057828872268154,-0.00676443206301257,0.0159044858661038,0.429379801217073
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VIPR1,Vasoactive intestinal polypeptide receptor 1,23198,0.00132780168705034,0.00168438642035288,-0.00197359569684129,0.00462919907094198,0.430529352149915
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCND2,G1/S-specific cyclin-D2,23393,-0.00196564866955518,0.00250026528307716,-0.00686616862438641,0.00293487128527605,0.431772326702531
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,23056,0.00174603605855248,0.00222720481051845,-0.00261928537006367,0.00611135748716864,0.433072542345955
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",23331,-0.00339922233877137,0.00433605652614388,-0.0118978931300134,0.00509944845247064,0.433081360987842
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",23056,0.00300592245344568,0.00384402869380378,-0.00452837378640973,0.0105402186933011,0.434239118084774
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",23675,-0.00576770826320124,0.00737924019819104,-0.0202310190516557,0.0086956025252532,0.434450009187719
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,23337,-0.00151861460293682,0.00194502820575657,-0.0053308698862197,0.00229364068034606,0.434947238959364
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL10RA,Interleukin-10 receptor subunit alpha,27702,0.00307146992568617,0.00393507467380338,-0.00464127643496845,0.0107842162863408,0.435081748061791
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT5,"Keratin, type II cytoskeletal 5",27544,-0.00269648965240196,0.00345821923503451,-0.00947459935306959,0.00408162004826568,0.435554414139287
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RLN1,Prorelaxin H1,23795,-0.00360710214234535,0.00462932647556815,-0.0126805820344589,0.00546637774976822,0.435878448453364
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRRN1,Leucine-rich repeat neuronal protein 1,27702,0.00207743890955177,0.0026736858541485,-0.0031629853645793,0.00731786318368284,0.437168718079154
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",23775,0.00134728966555645,0.00173469226265016,-0.00205270716923787,0.00474728650035076,0.437359104109241
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEXN,Nexilin,23872,-0.00362298737661182,0.00467282758966026,-0.0127817294523459,0.00553575469912228,0.438151870419808
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,23163,0.00544031801209095,0.00703280649913292,-0.00834398272620957,0.0192246187503915,0.439197232916276
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FES,Tyrosine-protein kinase Fes/Fps,27562,-0.0024779701363221,0.00321568409418919,-0.00878071096093291,0.00382477068828872,0.440957312394328
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFKB2,Nuclear factor NF-kappa-B p100 subunit,23393,0.00291467007477322,0.00378787659961766,-0.00450956806047739,0.0103389082100238,0.441620136613763
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALCAM,CD166 antigen,28553,0.0010134300407685,0.00132369113642207,-0.00158100458661876,0.00360786466815576,0.443915232256434
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSH1,Chorionic somatomammotropin hormone 1,23872,0.00164620106978856,0.00215453286107469,-0.00257668333791783,0.00586908547749495,0.444836640037648
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL4A4,Collagen alpha-4(IV) chain,23355,0.00273549870275806,0.00358795504443751,-0.00429689318433945,0.00976789058985557,0.445822063323319
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,22978,0.00298882865145849,0.00393082869035909,-0.00471559558164532,0.0106932528845623,0.447049703195238
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,22978,0.00228342932018448,0.0030043734895531,-0.00360514271933961,0.00817200135970856,0.447241403982528
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF3R,Granulocyte colony-stimulating factor receptor,23188,0.00158474093409475,0.00208511153652971,-0.00250207767750349,0.00567155954569299,0.447246215455628
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,23149,0.00184901931899223,0.00243454650069089,-0.00292269182236192,0.00662073046034637,0.447565857537208
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CST6,Cystatin-M,27600,0.00250857749781548,0.00330900900344779,-0.00397708014894219,0.00899423514457315,0.44839438090231
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MITD1,MIT domain-containing protein 1,27965,0.0049430631021057,0.00652351751865791,-0.0078430312344638,0.0177291574386752,0.448619191276861
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHRM1,Muscarinic acetylcholine receptor M1,23163,0.00189466272850022,0.00250156358893142,-0.00300840190580537,0.0067977273628058,0.448823120899067
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FHIP2A,FHF complex subunit HOOK interacting protein 2A,23071,0.00237880897489223,0.00316113432761293,-0.00381701430722911,0.00857463225701357,0.451747578255356
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC44A4,Choline transporter-like protein 4,23163,0.0035048095287192,0.00466482383208343,-0.00563824518216433,0.0126478642396027,0.452463336745112
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMOX2,Heme oxygenase 2,27544,-0.00237605801621803,0.00316339580275112,-0.00857631378961022,0.00382419775717417,0.452592917241417
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC1B,C-type lectin domain family 1 member B,28428,0.00487007315208509,0.00648592882232462,-0.00784234733967117,0.0175824936438413,0.452738620195582
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLITRK6,SLIT and NTRK-like protein 6,27682,0.00174202604851847,0.00232060595781946,-0.00280636162880767,0.00629041372584461,0.452853314677202
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STOML2,"Stomatin-like protein 2, mitochondrial",22978,-0.00472066951538703,0.00628870871341854,-0.0170465385936874,0.00760519956291331,0.452866196137723
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,27910,-0.00560485767677311,0.00755084606976611,-0.0204045159735147,0.00919480061996846,0.457922700642095
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCN2A,Sodium channel protein type 2 subunit alpha,23056,0.00246680599656759,0.00333241688176031,-0.00406473109168263,0.00899834308481781,0.459158696031947
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MPO,Myeloperoxidase,28187,0.00229770255876368,0.00310653099979442,-0.00379109820083338,0.00838650331836073,0.459526976845383
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REG3A,Regenerating islet-derived protein 3-alpha,28553,0.00309399234226477,0.00419155628635793,-0.00512145797899678,0.0113094426635263,0.460430087049946
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CKAP4,Cytoskeleton-associated protein 4,28415,-0.00135627378650132,0.00184180974794943,-0.00496622089248221,0.00225367331947956,0.461504919050956
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PILRA,Paired immunoglobulin-like type 2 receptor alpha,28187,0.00211326120802663,0.00286987850909223,-0.00351170066979414,0.00773822308584739,0.461518308400968
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRD2,Bromodomain-containing protein 2,23056,0.00173308091607184,0.00236271579818733,-0.00289784204837534,0.00636400388051901,0.463253538691413
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGA5,Integrin alpha-5,28187,-0.00124025345876861,0.00169260807874784,-0.00455776529311437,0.00207725837557715,0.46371886029199
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF5,E3 ubiquitin-protein ligase RNF5,23198,0.00361304682537388,0.00493629570722044,-0.00606209276077818,0.0132881864115259,0.464215736318512
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK1,Kallikrein-1,27956,0.00629070275905606,0.00865181274382361,-0.0106668502188382,0.0232482557369503,0.467172934598362
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CREB3,Cyclic AMP-responsive element-binding protein 3,22978,0.00277840900460169,0.00382461820981424,-0.00471784268663422,0.0102746606958376,0.467567932659801
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJA1,DnaJ homolog subfamily A member 1,22978,0.00229669727781592,0.00316181260880533,-0.00390045543544252,0.00849384999107437,0.467609407356964
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYOC,Myocilin,28187,-0.0022447646778289,0.00309464210826578,-0.00831026321002981,0.00382073385437202,0.46823027846762
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NME1,Nucleoside diphosphate kinase A,23188,0.00107343768012973,0.0014800178274374,-0.00182739726164758,0.00397427262190705,0.468283306991595
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRPV3,Transient receptor potential cation channel subfamily V member 3,23071,0.00248083784231611,0.00342088981611951,-0.00422410619727813,0.00918578188191036,0.468335169935345
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DARS1,"Aspartate--tRNA ligase, cytoplasmic",27910,-0.00357524609752762,0.00494310541894771,-0.0132637327186651,0.0061132405236099,0.469514338365646
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",23795,-0.00391001532368427,0.00540878435288773,-0.0145112326553442,0.00669120200797568,0.469747851843988
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLRD1,Natural killer cells antigen CD94,28521,0.00227005308928219,0.00314100201912936,-0.00388631086821136,0.00842641704677574,0.469860180657407
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPTLC1,Serine palmitoyltransferase 1,23775,-0.00180506740157646,0.002501926040671,-0.00670884244129161,0.0030987076381387,0.470626797426756
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",23188,0.00216318851818105,0.00300383961314975,-0.00372433712359246,0.00805071415995456,0.471445355725198
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,23893,-0.00094570531378078,0.0013142000364635,-0.00352153738524924,0.00163012675768768,0.471775089396472
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMPD3,Sphingomyelin phosphodiesterase 3,23188,0.00279385349910334,0.00389554570403383,-0.00484141608080297,0.0104291230790096,0.473262976655416
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TSC22D1,TSC22 domain family protein 1,23795,-0.00323593004196402,0.00451776985432146,-0.0120907589564341,0.00561889887250605,0.473833453214522
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANXA5,Annexin A5,27431,0.00147159021543848,0.00206309063319297,-0.00257206742561973,0.00551524785649669,0.475669907067982
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARID3A,AT-rich interactive domain-containing protein 3A,23056,0.00194531251009051,0.00272852485449488,-0.00340259620471946,0.00729322122490048,0.475881487340064
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASEH2A,Ribonuclease H2 subunit A,23795,-0.0023373077112704,0.00328340912341979,-0.0087727895931732,0.00409817417063239,0.476562211627741
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOD3,Extracellular superoxide dismutase,23872,0.00287184300981714,0.00406002425706611,-0.00508580453403243,0.0108294905536667,0.479358227805151
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CETN2,Centrin-2,27544,-0.00323126205948681,0.00458234692965893,-0.0122126620416183,0.00575013792264469,0.480720126795269
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AHSG,Alpha-2-HS-glycoprotein,23872,-0.00127465476289585,0.00181542642543547,-0.00483289055674937,0.00228358103095767,0.482608583038861
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GBP4,Guanylate-binding protein 4,27544,-0.00234326306003569,0.00334263328029074,-0.00889482428940555,0.00420829816933417,0.483294540103447
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRKL,Crk-like protein,28233,0.00501573712996294,0.00716627883799556,-0.00903016939250836,0.0190616436524342,0.483990422536394
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TREM2,Triggering receptor expressed on myeloid cells 2,28195,0.00246372905792694,0.00352759704370393,-0.00445036114773276,0.00937781926358663,0.484923041588765
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGBL2,Cytosolic carboxypeptidase 2,23056,0.00432008269716566,0.00619081946518732,-0.00781392345460149,0.0164540888489328,0.485296300174136
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTO1,Protein LTO1 homolog,27702,-0.00194570782663062,0.0027950851385164,-0.00742407469812276,0.00353265904486151,0.486361057968272
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDA1,DET1- and DDB1-associated protein 1,23071,0.00188144678492244,0.0027077138708802,-0.00342567240200275,0.00718856597184764,0.487158209327636
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LDLRAP1,Low density lipoprotein receptor adapter protein 1,23795,0.00458214181168441,0.00659990410097274,-0.00835367022622216,0.017517953849591,0.487517175836618
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HK2,Hexokinase-2,27682,0.00129415250826094,0.00186441089407097,-0.00236009284411817,0.00494839786064004,0.487603495861767
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPB41L5,Band 4.1-like protein 5,23163,-0.00297533344088112,0.00428650660446969,-0.0113768863856417,0.00542621950387948,0.487616339634835
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BOLA1,BolA-like protein 1,23056,-0.00256760219588515,0.00371091410516132,-0.00984099384200134,0.00470578945023104,0.48900359455768
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPSD1,Tryptase delta,23795,-0.00174261935491783,0.00252303270517146,-0.0066877634570539,0.00320252474721823,0.489770629869882
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,23198,-0.00195251106403326,0.00285724795953796,-0.00755271706472766,0.00364769493666114,0.494390176174339
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,POLR2A,DNA-directed RNA polymerase II subunit RPB1,23188,0.00136095977080577,0.0019927300631261,-0.00254479115292138,0.00526671069453293,0.494637408922473
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PON2,Serum paraoxonase/arylesterase 2,27682,0.00159994277169452,0.00234996306996546,-0.00300598484543778,0.00620587038882683,0.495980072946123
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FDX1,"Adrenodoxin, mitochondrial",23071,-0.00289504702275395,0.00425449300507429,-0.0112338533126996,0.00544375926719167,0.496214909100179
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DOK2,Docking protein 2,28224,0.00560736197283906,0.00824271962928468,-0.0105483685005589,0.021763092446237,0.496332410365748
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPC1,Glypican-1,28452,-0.00135674325785832,0.00199856346694291,-0.00527392765306642,0.00256044113734978,0.49723258434128
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLAMF1,Signaling lymphocytic activation molecule,27702,-0.00270942357285025,0.00403215243841931,-0.0106124423521521,0.00519359520645159,0.501618175294362
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAT2,Signal transducer and activator of transcription 2,23188,0.00352466959819047,0.00525770509304609,-0.00678043238417987,0.0138297715805608,0.502621138988194
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC1A4,Neutral amino acid transporter A,23163,-0.00234186912592735,0.00350023706278131,-0.00920233376897871,0.00451859551712402,0.503463782655854
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBP1,Retinol-binding protein 1,23163,0.0031515169379928,0.00471517183615537,-0.00609021986087171,0.0123932537368573,0.503899024086128
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,28174,-0.00276903255040971,0.00415227366794341,-0.0109074889395788,0.00536942383875936,0.504859745153526
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DAPK2,Death-associated protein kinase 2,23188,0.00241432599666273,0.00363392741556379,-0.0047081717378423,0.00953682373116775,0.506450694351437
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH23,Cadherin-23,23775,-0.00118912765162078,0.00179145599544799,-0.00470038140269884,0.00232212609945727,0.506839358176788
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,23795,-0.00479314728832342,0.00722771867099454,-0.0189594758834727,0.00937318130682587,0.507233329504286
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGAX,Integrin alpha-X,23393,0.0023976869792495,0.00362266912952829,-0.00470274451462594,0.00949811847312495,0.508069738874921
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TP73,Tumor protein p73,23163,-0.00154925075103297,0.0023477503873831,-0.00615084151030384,0.0030523400082379,0.509332696163271
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECHS1,"Enoyl-CoA hydratase, mitochondrial",23198,-0.00430985205013835,0.00654417591673041,-0.0171364368469299,0.00851673274665325,0.510173161000695
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC34A3,Sodium-dependent phosphate transport protein 2C,22978,0.00219026139748209,0.0033431490254508,-0.00436231069240148,0.00874283348736566,0.512378262454683
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TGFB2,Transforming growth factor beta-2 proprotein,23725,-0.00230422561609067,0.0035325402385963,-0.00922800448373942,0.00461955325155807,0.514223182010788
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPRING1,SREBP regulating gene protein,22978,0.00262995947241471,0.00404069621794512,-0.00528980511475773,0.0105497240595871,0.515138274902012
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCL7B,B-cell CLL/lymphoma 7 protein family member B,23725,0.00196964964304874,0.00302819550736231,-0.00396561355138138,0.00790491283747886,0.515416447707434
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VNN2,Vascular non-inflammatory molecule 2,28091,-0.00201520772377189,0.00311108720980379,-0.00811293865498733,0.00408252320744354,0.51715175121064
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATOX1,Copper transport protein ATOX1,28307,0.00311624765658341,0.00482113731171548,-0.00633318147437893,0.0125656767875458,0.51804378065341
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CALB2,Calretinin,27544,0.00134081719470046,0.00207467148530899,-0.00272553891650515,0.00540717330590607,0.518103891091851
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HIF1A,Hypoxia-inducible factor 1-alpha,23188,0.00287006270929196,0.00444267078365732,-0.00583757202667638,0.0115776974452603,0.518271556651309
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNX5,Sorting nexin-5,23198,0.00130433978264854,0.00202213186991052,-0.00265903868237609,0.00526771824767316,0.518912825504559
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MORF4L2,Mortality factor 4-like protein 2,22978,0.00161293899030537,0.00250303587330179,-0.00329301132136614,0.00651888930197687,0.519327008519145
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FBN2,Fibrillin-2,23163,0.00264457376587086,0.00410675673787474,-0.00540466944036363,0.0106938169721054,0.519609853106829
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SUMF1,Formylglycine-generating enzyme,23188,0.00286891234669296,0.00445998951353482,-0.00587266709983528,0.0116104917932212,0.520064754610422
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CGA,Glycoprotein hormones alpha chain,28187,-0.00342410904337657,0.0053810980320776,-0.0139710611862487,0.00712284309949552,0.524571982403197
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCN2,Ficolin-2,28129,0.00176114176494549,0.00276877404172727,-0.00366565535683995,0.00718793888673094,0.524734172598043
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX25,ATP-dependent RNA helicase DDX25,23163,0.00163052635814394,0.00257072364508008,-0.00340809198621302,0.00666914470250089,0.525912555966359
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTNAP2,Contactin-associated protein-like 2,28176,-0.00177179618220003,0.002797005933067,-0.00725392781101134,0.00371033544661129,0.526437317022866
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANGPTL2,Angiopoietin-related protein 2,28232,-0.00170329868424827,0.00269075771088954,-0.00697718379759177,0.00357058642909523,0.52672686800701
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DPP4,Dipeptidyl peptidase 4,27761,0.00128232736913151,0.00202959285036534,-0.00269567461758456,0.00526032935584757,0.527512923842578
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRK5,G protein-coupled receptor kinase 5,27682,-0.00222790572416997,0.00353412404232699,-0.00915478884713087,0.00469897739879092,0.528439241109108
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WASF3,Wiskott-Aldrich syndrome protein family member 3,27544,0.00359987421194551,0.00572004464189919,-0.00761141328617689,0.0148111617100679,0.529129272529282
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUB1,NEDD8 ultimate buster 1,28176,0.00356198689366425,0.00567405446327465,-0.00755915985435406,0.0146831336416826,0.530161360123316
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JAM3,Junctional adhesion molecule C,23337,-0.00215410308537713,0.00343137948465009,-0.00887960687529131,0.00457140070453705,0.530163443409216
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICAM2,Intercellular adhesion molecule 2,28553,0.00134152697180709,0.00215463469217918,-0.00288155702486411,0.0055646109684783,0.533536701854883
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,USP28,Ubiquitin carboxyl-terminal hydrolase 28,23775,-0.00154878444605696,0.00249066298236655,-0.00643048389149539,0.00333291499938148,0.534055535520527
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPM3,Tropomyosin alpha-3 chain,23071,0.00185961067103811,0.00299735272986354,-0.00401520067949443,0.00773442202157065,0.534988957667843
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP290,Centrosomal protein of 290 kDa,23393,-0.00223244231348271,0.00360160397185616,-0.00929158609832078,0.00482670147135536,0.535364764748861
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNST,Consortin,28224,-0.00454198010650835,0.00733123934717808,-0.0189112092269774,0.00982724901396068,0.535567112848728
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPRR1B,Cornifin-B,23393,0.00358862342130177,0.00582159758058595,-0.00782170783664668,0.0149989546792502,0.537614944287732
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC2L,C-type lectin domain family 2 member L,23163,0.00209427325005087,0.00341162921753758,-0.00459252001632278,0.00878106651642452,0.539311835218258
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AIDA,"Axin interactor, dorsalization-associated protein",23163,0.0035122441687829,0.00572625349364471,-0.00771121267876073,0.0147357010163265,0.539645587067765
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF5A,Eukaryotic translation initiation factor 5A-1,27702,0.00124454802666438,0.00203451610222466,-0.00274310353369595,0.00523219958702472,0.540730054413465
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLKB1,Plasma kallikrein,23396,0.00103383096980047,0.00169793654748551,-0.00229412466327113,0.00436178660287207,0.542613268265305
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TLR1,Toll-like receptor 1,23188,0.00108759857369476,0.00179064168588511,-0.00242205913064007,0.00459725627802958,0.543605218223105
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,23056,-0.00245275607643617,0.00403836356128362,-0.0103679486565521,0.00546243650367973,0.543615452644131
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BMP10,Bone morphogenetic protein 10,23337,-0.00117170835933772,0.00192938255881325,-0.00495329817461168,0.00260988145593624,0.543659700028171
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",23198,-0.00282198571633407,0.00467897304861114,-0.0119927728916119,0.00634880145894376,0.546434265879873
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,28428,-0.00190077107100026,0.00316645380500337,-0.00810702052880687,0.00430547838680635,0.548321869520046
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRL6,Fc receptor-like protein 6,28176,0.00276684462466696,0.0046163070372114,-0.00628111716826739,0.0118148064176013,0.548935523392074
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL20RA,Interleukin-20 receptor subunit alpha,27702,0.00183660502454367,0.00306582139080733,-0.0041724049014387,0.00784561495052604,0.54913906708312
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDIA5,Protein disulfide-isomerase A5,22978,-0.00248629300091064,0.00415048456862686,-0.0106212427554193,0.00564865675359801,0.549154252987459
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCNE1,G1/S-specific cyclin-E1,23188,0.00374499975622292,0.00625253097370006,-0.0085099609522292,0.015999960464675,0.549207140978749
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VAMP5,Vesicle-associated membrane protein 5,27682,-0.00219669866815049,0.00366936209455263,-0.00938864837347365,0.00499525103717267,0.549404835943601
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINT3,Kunitz-type protease inhibitor 3,23738,-0.005953857662089,0.00998621609752076,-0.0255268412132297,0.0136191258890517,0.551042255547651
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MZT1,Mitotic-spindle organizing protein 1,27562,0.00212173383367424,0.00356317951830484,-0.00486209802220324,0.00910556568955173,0.551540366065232
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,28195,-0.00155920268165592,0.00262246580518942,-0.00669923565982719,0.00358083029651535,0.552145097055429
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNGB3,Cyclic nucleotide-gated cation channel beta-3,23056,0.00219022758054214,0.00368756313864156,-0.00503739617119531,0.00941785133227958,0.552551485277691
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSD17B3,Testosterone 17-beta-dehydrogenase 3,23071,0.00194378940699121,0.00327462047021491,-0.00447446671463001,0.00836204552861244,0.552790673545745
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PFDN2,Prefoldin subunit 2,27544,0.00223802239663382,0.00377255344797077,-0.00515618236138889,0.00963222715465653,0.553026699035655
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,28187,-0.00111373887541114,0.00187881020657979,-0.00479620688030753,0.00256872912948525,0.553326824772653
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PAM,Peptidyl-glycine alpha-amidating monooxygenase,28391,0.00112906410506193,0.00190489201723249,-0.00260452424871376,0.00486265245883762,0.553374504327447
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPT1,Palmitoyl-protein thioesterase 1,23163,0.00313832645697815,0.00529502943889931,-0.0072399312432645,0.0135165841572208,0.553392470333937
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NEFL,Neurofilament light polypeptide,27448,0.00179942264080465,0.00304188921604447,-0.00416268022264252,0.00776152550425182,0.554158363058683
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,23198,-0.00104226754194366,0.00176817135281057,-0.00450788339345238,0.00242334830956506,0.555558004858974
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TDO2,"Tryptophan 2,3-dioxygenase",23163,-0.00156342400354639,0.00265564657913273,-0.00676849129864654,0.00364164329155376,0.55605694776739
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCYT2,Ethanolamine-phosphate cytidylyltransferase,23738,0.00302764333088859,0.005160085450943,-0.00708612415295969,0.0131414108147369,0.557381996169782
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK8,Kallikrein-8,27232,-0.00142826810123875,0.00243546404573872,-0.00620177763088664,0.00334524142840914,0.557580715990076
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFSF8,Tumor necrosis factor ligand superfamily member 8,23862,0.00143041040822427,0.00244331156486457,-0.0033584802589103,0.00621930107535883,0.558257965652506
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MPRIP,Myosin phosphatase Rho-interacting protein,23663,0.00175238751104225,0.00299415592918265,-0.00411615811015574,0.00762093313224025,0.558372245897411
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPI,Glucose-6-phosphate isomerase,23872,0.00186617816345014,0.00320079398903221,-0.00440737805505298,0.00813973438195326,0.559874568265978
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GBA,Lysosomal acid glucosylceramidase,23163,0.00212179005900113,0.00365137281210334,-0.00503490065272142,0.00927848077072368,0.561182902455759
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAMDC2,MAM domain-containing protein 2,23846,0.00136081786204179,0.00234613787700562,-0.00323761237688923,0.00595924810097282,0.56190346084282
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VWF,von Willebrand factor,28553,0.00284320486764431,0.00490584015682771,-0.006772241839738,0.0124586515750266,0.562219228516955
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPBGL,Trophoblast glycoprotein-like,23163,0.00162658449463143,0.00280895024165075,-0.00387895797900403,0.0071321269682669,0.562546212067318
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAPT,Microtubule-associated protein tau,27544,-0.00207977636188009,0.00359558565139722,-0.00912712423861864,0.00496757151485846,0.56298200147258
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MARS1,"Methionine--tRNA ligase, cytoplasmic",23287,-0.00334901457643358,0.00580107307481286,-0.0147191178030668,0.00802108865019963,0.563735984083193
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COMT,Catechol O-methyltransferase,27373,-0.00328710761459384,0.0056986529203353,-0.014456467338451,0.00788225210926334,0.564064542182581
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,28553,0.00272431407869268,0.00474517784758894,-0.00657623450258165,0.012024862659967,0.565889332135194
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HLA_E,,28176,0.00112638395608661,0.00196808849357297,-0.00273106949131641,0.00498383740348963,0.567107172963085
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRYM,Ketimine reductase mu-crystallin,23056,-0.00294136131829633,0.005159256690857,-0.0130535044323761,0.00717078179578339,0.56860635302608
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL2RG,Cytokine receptor common subunit gamma,23725,0.00143053973343664,0.00252457027946001,-0.00351761801430498,0.00637869748117825,0.570959518453601
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM40,E3 ubiquitin ligase TRIM40,23163,-0.00277894461802413,0.00491428036286583,-0.0124109341292412,0.0068530448931929,0.571750402713505
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMED10,Transmembrane emp24 domain-containing protein 10,23071,0.00191364221575555,0.00338647694410709,-0.00472385259469435,0.00855113702620544,0.572022474462047
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,23163,0.00196161070915474,0.00348614930829371,-0.00487124193510093,0.0087944633534104,0.5736535235437
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAG,S-arrestin,23056,-0.00201546671297525,0.00358245943196799,-0.00903708719963251,0.005006153773682,0.573717511348665
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNL1,Interferon lambda-1,27544,-0.00172340886391902,0.00306536169605648,-0.00773151778818973,0.00428470006035169,0.573970444806432
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNPO1,Transportin-1,23393,0.00134398244406674,0.00239073076111839,-0.0033418498477253,0.00602981473585878,0.574009768448404
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GSR,"Glutathione reductase, mitochondrial",23790,-0.000861164247739299,0.0015368782626937,-0.00387344564261895,0.00215111714714035,0.575257317821138
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF3,Fibroblast growth factor 3,23188,0.00114032788181359,0.00203685309188855,-0.00285190417828796,0.00513255994191515,0.575588614263534
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNAR1,Interferon alpha/beta receptor 1,23738,-0.000970382162759801,0.00173789752481629,-0.00437666131139972,0.00243589698588012,0.576600039803514
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPDC1,Neural proliferation differentiation and control protein 1,28224,0.00121495575305914,0.00217595450469904,-0.00304991507615097,0.00547982658226926,0.576606214245152
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",23056,-0.00121762386319127,0.00218156546620254,-0.00549349217694826,0.00305824445056571,0.576752673178381
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPON2,Spondin-2,28063,0.00131686402315508,0.00236003576368864,-0.00330880607367465,0.00594253411998482,0.576859234494589
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCL1A,T-cell leukemia/lymphoma protein 1A,27942,-0.00367278886339178,0.00664697645145466,-0.0167008627082429,0.00935528498145935,0.580575801131554
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCDC2C,Doublecortin domain-containing protein 2C,22978,0.00237257150089378,0.00430278356476884,-0.00606088428605315,0.0108060272878407,0.581362214707137
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,23071,0.00246875081457812,0.00448203241389844,-0.00631603271666281,0.0112535343458191,0.581768876374766
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,22479,0.00186958556788896,0.00339662590816875,-0.00478780121212178,0.0085269723478997,0.582033831979275
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS7_LGALS7B,Galectin-7,28061,0.00156323269180412,0.00284300905744414,-0.0040090650607864,0.00713553044439463,0.582425635226088
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BSND,Barttin,22978,0.00125907292309602,0.0022936080462224,-0.00323639884749989,0.00575454469369192,0.583046062422632
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GGA1,ADP-ribosylation factor-binding protein GGA1,27544,-0.0025305467399244,0.00461747763205256,-0.0115808028987474,0.00651970941889861,0.583671215782977
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGF12,Fibroblast growth factor 12,23188,0.00173010899427923,0.00315926619383189,-0.00446205274563128,0.00792227073418974,0.583951249414392
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERC2,ERC protein 2,23163,0.00280423031768079,0.00512260320704644,-0.00723607196813023,0.0128445326034918,0.58409350168665
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGEF1,Rho guanine nucleotide exchange factor 1,23775,0.00332809390993874,0.00609736795473369,-0.0086227472813393,0.0152789351012168,0.585191581148255
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,H2AP,Huntingtin-interacting protein M,22978,0.00189595548300586,0.00347474754571333,-0.00491454970659226,0.00870646067260399,0.585319864075918
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRYBB2,Beta-crystallin B2,23775,-0.0025420317563022,0.00466148095602483,-0.0116785344301109,0.00659447091750647,0.585533707446763
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTGDS,Prostaglandin-H2 D-isomerase,28046,-0.00112768054078217,0.00207276445614775,-0.00519029887483176,0.00293493779326742,0.586413704330934
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REEP4,Receptor expression-enhancing protein 4,23795,-0.00226758886888503,0.00420101701926302,-0.0105015822266406,0.00596640448887049,0.589359741867818
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PFDN4,Prefoldin subunit 4,22978,0.00194472772569707,0.00361705572457323,-0.00514470149446646,0.00903415694586059,0.590820532367246
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPESP1,Sperm equatorial segment protein 1,23846,-0.00110343117657052,0.00206060911920177,-0.00514222505020598,0.00293536269706494,0.592317543868343
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TLR4,Toll-like receptor 4,23188,0.00102687219647074,0.00191879610448273,-0.00273396816831542,0.0047877125612569,0.592541016851868
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,23738,-0.00624355788608804,0.0116727380813838,-0.0291221245256004,0.0166350087534243,0.592735260590885
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF31,E3 ubiquitin-protein ligase RNF31,23188,0.0013184740525312,0.00246966445046603,-0.00352206827038223,0.00615901637544462,0.593438198950534
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,23163,0.00197176006323222,0.00370231930690417,-0.00528478577829995,0.00922830590476438,0.594333417564124
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BRD1,Bromodomain-containing protein 1,23393,0.00110307580956741,0.0020718640695664,-0.00295777776678274,0.00516392938591755,0.594448904993031
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAMP3,Lysosome-associated membrane glycoprotein 3,28496,0.00183661150296899,0.00347400668535274,-0.00497244160032238,0.00864566460626036,0.597036835841389
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSTM1,V-set and transmembrane domain-containing protein 1,27544,0.00176793884966151,0.00335063431159879,-0.00479930440107212,0.00833518210039513,0.597751371673206
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NCLN,Nicalin,27702,0.0018604562321468,0.00353664237020801,-0.0050713628134609,0.0087922752777545,0.598856597561541
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRXN3,Neurexin-3,23163,0.0012591621061666,0.00239433190859657,-0.00343372843468267,0.00595205264701587,0.598967672962066
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,23071,0.00118553327946488,0.00228141112617711,-0.00328603252784226,0.00565709908677202,0.603313145334026
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BABAM1,BRISC and BRCA1-A complex member 1,23188,0.00103288837720391,0.00198839907158023,-0.00286437380309333,0.00493015055750116,0.603446855909618
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,23163,0.00146432045034602,0.00282234046056741,-0.00406746685236611,0.00699610775305815,0.603882883853347
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZBP1,Z-DNA-binding protein 1,23188,-0.00142344095383676,0.0027506675658599,-0.00681474938292216,0.00396786747524864,0.60481959591992
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,28553,-0.00080924128956054,0.0015667183775636,-0.00388000930958519,0.00226152673046411,0.605495314892508
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FH,"Fumarate hydratase, mitochondrial",23056,-0.00294840930882931,0.00571071864798285,-0.0141414178588757,0.00824459924121707,0.605654097482777
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP20,Centrosomal protein 20,27562,0.00259195104015215,0.0050371392570966,-0.00728084190375718,0.0124647439840615,0.606859008386385
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COPE,Coatomer subunit epsilon,27544,0.00164925168848902,0.00321024825191493,-0.00464283488526425,0.00794133826224229,0.607433820713582
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TERF1,Telomeric repeat-binding factor 1,23188,0.00101728174720549,0.00198270130171469,-0.0028688128041553,0.00490337629856628,0.607901182138306
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMOD4,Tropomodulin-4,22978,-0.00142592588645885,0.00278140910280403,-0.00687748772795476,0.00402563595503705,0.608191918318287
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PACS2,Phosphofurin acidic cluster sorting protein 2,23071,-0.00215982412427966,0.00421665343571687,-0.0104244648582847,0.00610481660972541,0.608506948484355
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,23846,0.00139062217433292,0.00271558142915684,-0.00393191742681449,0.00671316177548033,0.608592747456341
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AP3B1,AP-3 complex subunit beta-1,23738,0.00265041305691908,0.00518615749940363,-0.00751445564191204,0.0128152817557502,0.60931712023971
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,27562,0.00266481379974355,0.00524703594203003,-0.00761937664663531,0.0129490042461224,0.611548359739769
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCN2B,Sodium channel subunit beta-2,23163,0.00099993065511619,0.00197325856829804,-0.00286765613874797,0.00486751744898035,0.612341515021885
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIF20B,Kinesin-like protein KIF20B,23056,0.00262892957862362,0.00519157885902429,-0.00754656498506399,0.0128044241423112,0.612592340208651
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CMIP,C-Maf-inducing protein,23725,-0.00284051526614853,0.00561202209368982,-0.0138400785697806,0.00815904803748351,0.612757273451109
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLIP2,CAP-Gly domain-containing linker protein 2,28176,0.00383631552246521,0.00759555310391964,-0.0110509685612173,0.0187235996061477,0.61351089443212
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TP53BP1,TP53-binding protein 1,23188,0.00298543832016949,0.00591311015355392,-0.00860425758079619,0.0145751342211352,0.613644684286053
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FZD8,Frizzled-8,23056,0.00150466802916907,0.00298962030526369,-0.00435498776914776,0.00736432382748591,0.614760028066472
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHH,Sonic hedgehog protein,23188,-0.00146954904990028,0.00292282582662084,-0.00719828767007712,0.00425918957027656,0.615121165044891
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGFL4,Insulin growth factor-like family member 4,23188,0.00255996164919496,0.00509545580799786,-0.00742713173448085,0.0125470550328708,0.615390310853736
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RANGAP1,Ran GTPase-activating protein 1,27562,0.00166114459906299,0.00330926219048433,-0.00482500929428631,0.00814729849241228,0.615693856441461
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1A,Interleukin-1 alpha,27702,0.00188290612214547,0.00377253396263582,-0.00551126044462073,0.00927707268891168,0.617706475467073
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,28320,0.00144138732955324,0.00289456429332997,-0.0042319586853735,0.00711473334447998,0.618513646448345
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD2,T-cell surface antigen CD2,23071,0.00129451282684897,0.0026105186325483,-0.0038221036929457,0.00641112934664365,0.61998141286054
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRYGD,Gamma-crystallin D,23775,0.00323019144626798,0.00653403943196612,-0.00957652584038562,0.0160369087329216,0.621053965832507
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DRAXIN,Draxin,27965,0.00142986956320947,0.0028988252732555,-0.00425182797237132,0.00711156709879025,0.621833979419686
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOX9,Transcription factor SOX-9,23163,-0.000915369769949352,0.00185733212440615,-0.00455574073378542,0.00272500119388671,0.62212948031358
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLB1,"Phospholipase B1, membrane-associated",23775,0.00199545054484866,0.00405952015930781,-0.00596120896739464,0.00995211005709196,0.623043185553468
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLAUR,Urokinase plasminogen activator surface receptor,28022,-0.000914472082679445,0.00186171423994748,-0.0045634319929765,0.00273448782761761,0.623289589281655
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAS,Tumor necrosis factor receptor superfamily member 6,28470,-0.00108536354731071,0.00221137807166128,-0.00541966456776683,0.0032489374731454,0.623565556674439
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SERPINE1,Plasminogen activator inhibitor 1,28553,0.00222201453937826,0.00452825415706999,-0.00665336360847891,0.0110973926872354,0.623642384245726
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IKZF2,Zinc finger protein Helios,27562,0.00303041373149013,0.00618437563076363,-0.00909096250480658,0.0151517899677868,0.624129829090516
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNAJA2,DnaJ homolog subfamily A member 2,28440,-0.00270458917859183,0.00552076736858331,-0.0135252932210151,0.00811611486383146,0.624212898705137
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DOCK9,Dedicator of cytokinesis protein 9,23056,0.00392099297230457,0.00801264251694964,-0.0117837863609167,0.0196257723055259,0.624598024721817
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WARS,"Tryptophan--tRNA ligase, cytoplasmic",28187,0.00126720516088887,0.00259228241504239,-0.00381366837259422,0.00634807869437196,0.624960468414613
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MOCS2,Molybdopterin synthase catalytic subunit,23337,-0.00222047758925118,0.0045500886787644,-0.0111386513996294,0.00669769622112704,0.625549086914892
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIF1C,Kinesin-like protein KIF1C,23071,-0.00119373609180037,0.00244629193761683,-0.00598846828952935,0.00360099610592862,0.625570225061674
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VWA5A,von Willebrand factor A domain-containing protein 5A,22978,-0.00265344258639194,0.00543993963388037,-0.0133157242687975,0.00800883909601359,0.625716999042665
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMED4,Transmembrane emp24 domain-containing protein 4,23071,0.00187703750053938,0.00384971541943553,-0.00566840472155427,0.00942247972263303,0.625853241562831
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VSIG4,V-set and immunoglobulin domain-containing protein 4,28143,0.00134346128126664,0.00278273271181796,-0.00411069483389656,0.00679761739642985,0.629252244054844
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,22978,-0.00187246971721132,0.00389103746520566,-0.00949890314901441,0.00575396371459176,0.630360227667401
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CORO6,Coronin-6,23056,-0.00122532169245462,0.00255304145880505,-0.00622928295171252,0.00377863956680328,0.631270442453796
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPINT2,Kunitz-type protease inhibitor 2,28320,-0.00131861754267606,0.00275843890470098,-0.00672515779588998,0.00408792271053786,0.632632288153448
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAA80,N-alpha-acetyltransferase 80,23163,0.00391317875849248,0.00820059166481948,-0.0121599809045537,0.0199863384215387,0.633236682718711
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TRIM58,E3 ubiquitin-protein ligase TRIM58,23725,-0.00278040179094436,0.0058384713748143,-0.0142238056855804,0.00866300210369166,0.633921436035613
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,23725,0.00345650473970418,0.00728116307601652,-0.0108145748892882,0.0177275843686965,0.634991813516623
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YY1,Transcriptional repressor protein YY1,23188,0.000896789255852695,0.00189030652884042,-0.00280821154067453,0.00460179005237992,0.635208663353619
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STK11,Serine/threonine-protein kinase STK11,27682,0.00233194152825606,0.00494431793919193,-0.00735892163256012,0.0120228046890722,0.63718699643027
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD164L2,CD164 sialomucin-like 2 protein,23163,0.00116762369853168,0.00247844235993024,-0.00369012332693158,0.00602537072399495,0.637565264326525
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPHA10,Ephrin type-A receptor 10,27544,0.00208985700539304,0.00443694971983101,-0.00660656444547573,0.0107862784562618,0.637635826151205
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIMAP7,GTPase IMAP family member 7,23337,-0.00103174255713304,0.00219673164233838,-0.00533733657611627,0.00327385146185019,0.638594022298919
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD7,T-cell antigen CD7,23140,-0.00138204098306225,0.00294990078503279,-0.00716384652172653,0.00439976455560202,0.639428465628482
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX1B,Syntaxin-1B,23163,0.00132208026560866,0.00282213007352428,-0.00420929467849894,0.00685345520971625,0.6394536933146
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPSAB1,Tryptase alpha/beta-1,28488,-0.00165758258788365,0.00354607158714985,-0.00860788289869736,0.00529271772293006,0.640187298266926
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK3,Prostate-specific antigen,23862,0.0028036195461114,0.0060251258352085,-0.00900562709089727,0.0146128661831201,0.641705613540488
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HDDC2,5'-deoxynucleotidase HDDC2,23738,-0.00136004731810494,0.00295089288324989,-0.00714379736927471,0.00442370273306484,0.644879247854763
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP164,Centrosomal protein of 164 kDa,27702,-0.00197254068512489,0.00428178666787013,-0.0103648425541503,0.00641976118390055,0.645030617125258
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD109,CD109 antigen,28187,-0.00105247965052105,0.00228508060124762,-0.00553123762896639,0.00342627832792429,0.645098108468453
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRP1,Prolow-density lipoprotein receptor-related protein 1,28091,0.000828074556754344,0.00180083622780405,-0.0027015644497416,0.00435771356325029,0.645643389319529
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL18BP,Interleukin-18-binding protein,28336,-0.000962617939574839,0.00209519506904356,-0.00506920027490022,0.00314396439575054,0.645921235848691
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QA,Complement C1q subcomponent subunit A,28388,-0.000703462199551126,0.00153585148391315,-0.00371373110802091,0.00230680670891865,0.646936199326044
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RLN2,Prorelaxin H2,23284,-0.00344104093924623,0.00756829583628988,-0.0182749007783744,0.0113928188998819,0.649354342743164
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,23862,-0.00425858874518915,0.0093680642265128,-0.0226199946291542,0.0141028171387759,0.649411407425441
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASAH1,Acid ceramidase,23664,0.00142823090390829,0.00314391505939444,-0.0047338426125048,0.00759030442032139,0.649628463451916
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD28,T-cell-specific surface glycoprotein CD28,27562,-0.00112035450074538,0.00247489696215609,-0.00597115254657132,0.00373044354508056,0.650777468273364
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMOTL2,Angiomotin-like protein 2,23647,-0.00146489153699954,0.00326461175182316,-0.00786353057057293,0.00493374749657384,0.653638885002406
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NXPH3,Neurexophilin-3,23188,0.000917863791367551,0.00204692692544957,-0.00309411298251361,0.00492984056524871,0.653861064153703
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRL2,Fc receptor-like protein 2,28384,0.0014921132739113,0.00333426436323695,-0.00504304487803311,0.00802727142585572,0.654511015855544
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL2,Interleukin-2,27702,-0.00095291921794022,0.00213460942946981,-0.00513675369970105,0.00323091526382061,0.655301819857693
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDC123,Cell division cycle protein 123 homolog,22978,-0.00192902505719157,0.00432399794944107,-0.0104040610380961,0.00654601092371292,0.655514256299666
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL2A1,Collagen alpha-1(II) chain,23198,-0.00243446703709022,0.00546052448411811,-0.0131370950259617,0.00826816095178128,0.655724026793097
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL24,C-C motif chemokine 24,28276,0.00249094101269085,0.00560518887534437,-0.00849522918298412,0.0134771112083658,0.656757451188846
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLXNA4,Plexin-A4,28176,-0.00244960967648479,0.00551668277587323,-0.0132623079171963,0.00836308856422674,0.657019454013562
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPTN,Neuroplastin,27562,0.00245338347457725,0.00552528071813895,-0.0083761667329751,0.0132829336821296,0.657025287871568
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB11FIP3,Rab11 family-interacting protein 3,23846,-0.00320713004111661,0.00725157873981758,-0.0174202243711591,0.0110059642889258,0.658300413657489
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VPS28,Vacuolar protein sorting-associated protein 28 homolog,23393,-0.00198843707019315,0.0045030350405281,-0.0108143857496282,0.00683751160924191,0.658799355658941
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HBZ,Hemoglobin subunit zeta,23846,0.00315756149725034,0.0071524406263551,-0.0108612221304057,0.0171763451249063,0.658879458851225
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EXTL1,Exostosin-like 1,23071,0.00141675202606146,0.00322321802083797,-0.00490075529478097,0.00773425934690389,0.66027020441389
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMFR,E3 ubiquitin-protein ligase AMFR,27544,-0.00190086470682417,0.00433094712498995,-0.0103895210718045,0.00658779165815613,0.660735431132675
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RPE,Ribulose-phosphate 3-epimerase,23393,0.00209342073193092,0.00477762748712569,-0.00727072914283542,0.0114575706066973,0.661265934756897
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITGAL,Integrin alpha-L,23188,-0.0012915091306444,0.00294943041043898,-0.00707239273510479,0.00448937447381599,0.661474272732877
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FKBPL,FK506-binding protein-like,23738,-0.00174875139103032,0.00400282060887575,-0.00959427978442678,0.00609677700236615,0.662202512122836
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LEFTY2,Left-right determination factor 2,28404,-0.0015291825144996,0.00350085364728313,-0.00839085566317453,0.00533249063417533,0.662257723605651
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,27702,-0.0016193723828047,0.00371461357396049,-0.00890001498776727,0.00566127022215787,0.662879023959979
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OPHN1,Oligophrenin-1,23775,-0.00315314292227746,0.00726322848659402,-0.0173890707560018,0.0110827849114468,0.664202228130584
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,23846,-0.00095487461099477,0.00220916470399447,-0.00528483743082393,0.00337508820883438,0.665575749880753
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TDGF1,Teratocarcinoma-derived growth factor 1,27544,0.0042528981064762,0.00985820709303644,-0.0150691877958752,0.0235749840088276,0.666175945349266
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LGALS8,Galectin-8,28428,0.00177291255580171,0.00411042654143662,-0.00628352346541407,0.00982934857701748,0.66623838445772
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRP2BP,LRP2-binding protein,23163,0.00242131842306318,0.00561905974549871,-0.00859203867811428,0.0134346755242406,0.66653660933287
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBM25,RNA-binding protein 25,22978,0.00135341306807946,0.00316001852494754,-0.00484022324081771,0.00754704937697663,0.668442003327395
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL9A2,Collagen alpha-2(IX) chain,23393,0.00131268862570116,0.00307148983182636,-0.00470743144467851,0.00733280869608083,0.669107622317137
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NMRK2,Nicotinamide riboside kinase 2,22978,0.00119644121800552,0.00281470876193645,-0.00432038795538992,0.00671327039140097,0.670791451474349
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TMED1,Transmembrane emp24 domain-containing protein 1,23393,0.00154828743334585,0.00364567103473606,-0.00559722779473682,0.00869380266142852,0.671065102565495
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HDAC8,Histone deacetylase 8,23188,0.00175696483007771,0.004143558850533,-0.00636441051696697,0.00987834017712239,0.671552874095677
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,23725,0.00136473045946012,0.00322371298671403,-0.00495374699449938,0.00768320791341961,0.672050193108042
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM13A,Protein FAM13A,23738,0.00193141627400881,0.00456691717860471,-0.00701974139605642,0.010882573944074,0.672361351967499
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TPPP2,Tubulin polymerization-promoting protein family member 2,23393,-0.00228107666327543,0.0054051394422674,-0.0128751499701195,0.00831299664356867,0.673014338217415
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KCNIP4,Kv channel-interacting protein 4,27544,0.00145980761160375,0.00346914441660489,-0.00533971544494184,0.00825933066814933,0.673906175973397
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STX6,Syntaxin-6,27562,0.00190889095381246,0.0045516177297624,-0.00701227979652184,0.0108300617041468,0.674936328836543
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",23056,-0.00154474604231139,0.00369563499894465,-0.00878819064024291,0.00569869855562013,0.675956826260513
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDSN,Corneodesmosin,28414,0.00122484734687206,0.00293455491410263,-0.00452688028476909,0.00697657497851321,0.67639795026427
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PENK,Proenkephalin-A,23337,0.000873661254722766,0.00209386773018517,-0.00323031949644018,0.00497764200588571,0.676501162861958
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRR5,Proline-rich protein 5,23188,0.00134468388897533,0.00322454219227183,-0.00497541880787745,0.00766478658582811,0.676670975247606
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,28428,-0.00159861415117565,0.00384446632845663,-0.00913376815495064,0.00593653985259933,0.677543309302472
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,JUN,Transcription factor AP-1,27702,0.00139220706917976,0.00338634185968805,-0.00524502297580881,0.00802943711416833,0.680984651775239
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DENND2B,DENN domain-containing protein 2B,23071,-0.00141245119160386,0.00344080349940656,-0.00815642605044071,0.005331523667233,0.681442729074748
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,27562,-0.00216172073837485,0.00527428212099282,-0.0124993136955208,0.00817587221877107,0.681911353966045
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,23056,0.00158803568079844,0.00387539101648552,-0.00600773071151317,0.00918380207311005,0.681975322263554
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CPA4,Carboxypeptidase A4,22878,-0.0012168694846715,0.00297074125377649,-0.00703952234207343,0.00460578337273043,0.682089930789707
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VEGFD,Vascular endothelial growth factor D,28471,0.000993786003282239,0.00242964562528492,-0.00376831942227621,0.00575589142884069,0.682524331986828
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIAE,Sialate O-acetylesterase,28239,-0.00128997594646365,0.00315693904012233,-0.00747757646510343,0.00489762457217612,0.682824553565228
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,27562,-0.00178712244328636,0.00442764222990466,-0.0104653012138995,0.00689105632732678,0.686489082279954
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GIPR,Gastric inhibitory polypeptide receptor,23188,0.00128098305281592,0.00318013500400628,-0.00495208155503639,0.00751404766066824,0.687093368815483
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMS,Spermine synthase,23056,0.00175103774658922,0.0043560309000187,-0.00678678281744742,0.0102888583106259,0.687702398505126
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EFNB2,Ephrin-B2,23163,0.00157211960659593,0.00392669036020617,-0.00612419349940815,0.00926843271260002,0.688889476971727
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ALMS1,Alstrom syndrome protein 1,23393,0.00120190587061815,0.00303917703508082,-0.00475488111814026,0.00715869285937657,0.692499052023302
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCP11,T-complex protein 11 homolog,23393,0.00156115493339168,0.0040101712066542,-0.00629878063165055,0.00942109049843392,0.697058652159379
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOLH1,Glutamate carboxypeptidase 2,23188,0.00278788469684048,0.00716508868665255,-0.0112556891289985,0.0168314585226795,0.697211045806051
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL33,Interleukin-33,27702,0.00102021298644258,0.00264116025305522,-0.00415646110954566,0.00619688708243082,0.699296315398897
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DNM3,Dynamin-3,23795,0.00143392245733367,0.00371794064481332,-0.00585324120650043,0.00872108612116777,0.699739694575777
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WNT9A,Protein Wnt-9a,27702,0.000752169177924718,0.00195500739030067,-0.0030796453070646,0.00458398366291403,0.700433149951544
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YWHAQ,14-3-3 protein theta,23337,0.00191706129190144,0.00500541412548316,-0.00789355039404556,0.0117276729778484,0.70172507923185
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLURP1,Secreted Ly-6/uPAR-related protein 1,23731,0.000955696065167622,0.00252467797817443,-0.00399267277205425,0.0059040649023895,0.705031559990591
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RWDD1,RWD domain-containing protein 1,28428,0.00161848711749301,0.00429100146908595,-0.00679187576191545,0.0100288499969015,0.706041415152163
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRKD2,Serine/threonine-protein kinase D2,23071,0.00116850924092406,0.00310087164871931,-0.0049091991905658,0.00724621767241391,0.706301548384067
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,VTCN1,V-set domain-containing T-cell activation inhibitor 1,27562,-0.000818843484046103,0.00218054431008385,-0.00509271033181045,0.00345502336371824,0.707274796098208
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PARD3,Partitioning defective 3 homolog,23393,0.00187369244614606,0.00503742938717935,-0.00799966915272547,0.0117470540450176,0.709930405363874
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DHODH,Dihydroorotate dehydrogenase,23071,0.00118531178515168,0.003199487288289,-0.00508568329989476,0.00745630687019812,0.711036257244009
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MORF4L1,Mortality factor 4-like protein 1,23393,-0.00100308383952021,0.00271023271698597,-0.00631513996481271,0.00430897228577228,0.711303991692787
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MNAT1,CDK-activating kinase assembly factor MAT1,23393,-0.00110248031142022,0.00298696535615521,-0.00695693240948443,0.00475197178664399,0.712058677853584
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EVI5,Ecotropic viral integration site 5 protein homolog,23188,-0.00225054757011431,0.00610559196632045,-0.0142175078241024,0.00971641268387377,0.712426042823968
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHISA5,Protein shisa-5,23862,0.00062796346669461,0.00170983951842799,-0.00272332198942426,0.00397924892281348,0.713424942028753
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NRN1,Neuritin,23795,-0.000874801028302241,0.00242455525701851,-0.00562692933205852,0.00387732727545404,0.718245540764465
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSH3,Protein phosphatase Slingshot homolog 3,22978,-0.000717418476098953,0.00198847820937693,-0.00461483576647773,0.00317999881427982,0.718261478339978
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PSMA1,Proteasome subunit alpha type-1,27562,-0.00112556264649524,0.0031344286081862,-0.00726904271854019,0.00501791742554971,0.719525579479891
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SDK2,Protein sidekick-2,23337,-0.000942480248207631,0.00262655192179518,-0.00609052201492618,0.00420556151851091,0.719727048321751
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NAGK,N-acetyl-D-glucosamine kinase,23170,-0.00137371136508105,0.00383812769219392,-0.00889644164178114,0.00614901891161904,0.720412548121069
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,23056,0.0013979405682751,0.00393553132835609,-0.00631570083530284,0.00911158197185305,0.722435432583805
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1RL2,Interleukin-1 receptor-like 2,27702,0.000937360253039533,0.00264389859617921,-0.00424468099547172,0.00611940150155078,0.722939073791164
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ERBIN,Erbin,28091,-0.00245421585645089,0.00693023259673651,-0.0160374717460545,0.0111290400331527,0.723242758505241
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYPD1,Ly6/PLAUR domain-containing protein 1,27544,-0.00150414465397003,0.00429592273537069,-0.00992415321529659,0.00691586390735652,0.72624150543534
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SPART,Spartin,23337,0.00182953886643723,0.00523094426688414,-0.00842311189665568,0.0120821896295301,0.726527172657714
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIF22,Kinesin-like protein KIF22,23071,-0.00289829335967287,0.00832428933398399,-0.0192139004542815,0.0134173137349357,0.727713390845962
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,28428,0.000650560186134766,0.00187058157221831,-0.00301577969541311,0.00431690006768265,0.728004242169009
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,23393,-0.00265410247724743,0.00763818929111923,-0.0176249534878411,0.0123167485333462,0.728235397228098
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DFFA,DNA fragmentation factor subunit alpha,28521,-0.0015622719109951,0.00455946437510437,-0.0104988220861997,0.00737427826420946,0.731869020822504
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GDF2,Growth/differentiation factor 2,28224,0.000825800593636645,0.00241490461069927,-0.00390741244333393,0.00555901363060722,0.73238360052393
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIRREL2,Kin of IRRE-like protein 2,27544,-0.000926786226005963,0.00271410175011547,-0.00624642565623229,0.00439285320422036,0.732751864534663
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,27682,-0.000629961110380903,0.00185078829699746,-0.00425750617249593,0.00299758395173412,0.733577116179686
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PCARE,Photoreceptor cilium actin regulator,23056,-0.0019534420945077,0.00575535281631673,-0.0132339336144885,0.00932704942547308,0.734301650716174
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB37,Ras-related protein Rab-37,27702,0.00188754897537395,0.00557027603573319,-0.0090301920546631,0.012805290005411,0.734717060148323
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,YJU2,Splicing factor YJU2,23725,-0.000744205128263162,0.00220068670684694,-0.00505755107368317,0.00356914081715684,0.73523845108818
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFYA,Nuclear transcription factor Y subunit alpha,23071,-0.000876635568186924,0.00261054181487942,-0.00599329752535059,0.00424002638897674,0.737020231343587
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BAG3,BAG family molecular chaperone regulator 3,27918,0.000907250470753347,0.00271071539819479,-0.00440575170970845,0.00622025265121514,0.737861145642454
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ZCCHC8,Zinc finger CCHC domain-containing protein 8,23071,-0.00134888119214822,0.00403033770185155,-0.00924834308777726,0.00655058070348083,0.737868079820499
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASE10,Inactive ribonuclease-like protein 10,23198,0.00108600192845639,0.00325392357316092,-0.00529168827493902,0.0074636921318518,0.73857008993114
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMTN,Smoothelin,23707,-0.00212530275725401,0.0063787573627261,-0.0146276671881972,0.0103770616736891,0.738998004233204
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSNK1D,Casein kinase I isoform delta,23188,-0.00143830897537547,0.00431697942621214,-0.00989958865075127,0.00702297070000032,0.739005315091786
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COCH,Cochlin,23846,-0.00103557793127186,0.00312298200934278,-0.0071566226695837,0.00508546680703998,0.740194937405338
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OSBPL2,Oxysterol-binding protein-related protein 2,23775,0.000878020458102199,0.00264869975558062,-0.00431343106283581,0.00606947197904021,0.740276468165687
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COX6B1,Cytochrome c oxidase subunit 6B1,23846,0.000724081692931707,0.00219090632838566,-0.00357009471070419,0.00501825809656761,0.741029528377228
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX53,Probable ATP-dependent RNA helicase DDX53,23163,-0.000798976643168835,0.00243075992253049,-0.00556326609132859,0.00396531280499092,0.742389825935703
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBXN1,UBX domain-containing protein 1,23337,-0.00152428579580424,0.00467386452722488,-0.010685060269165,0.00763648867755652,0.744329192009832
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNPDA2,Glucosamine-6-phosphate isomerase 2,23337,0.000813826494926569,0.00250520751768018,-0.00409638023972659,0.00572403322957973,0.745294543353311
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIRT1,NAD-dependent protein deacetylase sirtuin-1,23188,0.00188333258769513,0.00587321026455255,-0.00962815953082787,0.0133948247062181,0.748467214281105
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPN1,Epsin-1,23393,0.000951227164798259,0.00296723250651771,-0.00486454854797645,0.00676700287757297,0.748533663890872
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDKL5,Cyclin-dependent kinase-like 5,23056,-0.00115321061856992,0.00362077045485748,-0.00824992071009058,0.00594349947295073,0.75010958075138
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AXL,Tyrosine-protein kinase receptor UFO,28336,0.000597512673089599,0.0018761703813343,-0.00307978127432563,0.00427480662050482,0.750127282231157
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB27B,Ras-related protein Rab-27B,23846,-0.00175266723097928,0.00553713592403466,-0.0126054536420872,0.00910011918012866,0.751603359773411
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCIN,Adseverin,23056,-0.00158038035431033,0.00499415976497834,-0.0113689334936679,0.00820817278504722,0.751667104981116
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AP1G2,AP-1 complex subunit gamma-like 2,23725,-0.00169999162564186,0.00537619998153306,-0.0122373435894467,0.00883736033816294,0.751848240689114
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD164,Sialomucin core protein 24,28187,-0.000568013725660099,0.00180057012282241,-0.00409713116639203,0.00296110371507183,0.752412276797656
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNAP29,Synaptosomal-associated protein 29,28307,-0.00194779608550777,0.0061800475761111,-0.0140606893346855,0.01016509716367,0.752631160757439
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WAS,Wiskott-Aldrich syndrome protein,27702,0.00142459196065861,0.00452365510999991,-0.00744177205494122,0.0102909559762584,0.752824350464858
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSP90B1,Endoplasmin,27411,0.00142882850590699,0.00454702414209151,-0.00748333881259237,0.0103409958244063,0.753345894074667
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIRPB1,Signal-regulatory protein beta-1,28152,0.00097274762675707,0.00313178220066396,-0.0051655454865443,0.00711104074005844,0.756103125174283
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SAMD9L,Sterile alpha motif domain-containing protein 9-like,28176,-0.00150848333758821,0.00490041485879375,-0.011113296460824,0.00809632978564754,0.758215734428896
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PGM2,Phosphoglucomutase-2,23163,-0.00126016554366884,0.00409731812288833,-0.00929090906452996,0.00677057797719229,0.758420971413092
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,27702,-0.000910328543135165,0.00296995726304962,-0.00673144477871242,0.00491078769244209,0.759216892382839
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FGL1,Fibrinogen-like protein 1,23872,0.00129523134430872,0.00429653718380042,-0.0071259815359401,0.00971644422455755,0.763066863689615
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GRIK2,"Glutamate receptor ionotropic, kainate 2",23795,0.000851635017872805,0.00283385406540486,-0.00470271895032072,0.00640598898606633,0.763781772405958
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COMMD1,COMM domain-containing protein 1,23198,-0.00123772196558524,0.00413137862730382,-0.00933522407510074,0.00685978014393025,0.764492184439601
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",27544,-0.00109133991382205,0.0036589184428073,-0.00826282006172437,0.00608014023408027,0.765500537128643
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PHLDB1,Pleckstrin homology-like domain family B member 1,23738,-0.00106886026688107,0.00358531271542691,-0.00809607318911781,0.00595835265535568,0.765612732106066
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,23795,-0.000476545468387066,0.00161018145646739,-0.00363250112306316,0.00267941018628903,0.767265032300215
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NFIC,Nuclear factor 1 C-type,23795,0.00088692555634746,0.00301312711668461,-0.00501880359235437,0.00679265470504929,0.768490099819019
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LAP3,Cytosol aminopeptidase,27702,0.000962176428578228,0.00328192690655048,-0.00547040030826071,0.00739475316541717,0.769391169607946
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,23198,-0.000939492689633166,0.0032400849049074,-0.00729005910325166,0.00541107372398533,0.771849982113118
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",23163,-0.00151337285565239,0.00527586284386116,-0.0118540640296203,0.00882731831831548,0.774230963020763
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TCL1B,T-cell leukemia/lymphoma protein 1B,27682,-0.0015044392637194,0.00530761652297724,-0.0119073676487548,0.00889848912131598,0.776834695526059
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NOMO1,Nodal modulator 1,28187,-0.000446483324500225,0.00159271576288508,-0.00356820621975498,0.00267523957075453,0.779227688099634
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DLG4,Disks large homolog 4,23775,0.00133556432543485,0.00479815634186159,-0.00806882210461387,0.0107399507554836,0.780746518321119
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGF1R,Insulin-like growth factor 1 receptor,28091,0.000406647401364838,0.00146789144318435,-0.00247041982727649,0.00328371463000617,0.781760451824137
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ASPSCR1,Tether containing UBX domain for GLUT4,23795,-0.00126277517301351,0.00456186222433121,-0.0102040251327027,0.00767847478667566,0.781927382760643
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT17,"Keratin, type I cytoskeletal 17",23071,0.000733590456265607,0.00265215120609585,-0.00446462590768225,0.00593180682021346,0.782088170981567
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MLLT1,Protein ENL,22978,-0.00129180927689145,0.00471010721502473,-0.0105236194183399,0.00794000086455701,0.783884797079378
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECM1,Extracellular matrix protein 1,23299,-0.000682431511093094,0.0024884709870166,-0.00555983464564563,0.00419497162345944,0.783904714433541
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGS8,Regulator of G-protein signaling 8,27702,0.00120730142741268,0.00442124502894874,-0.00745833882932686,0.00987294168415221,0.784802826387209
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SNX9,Sorting nexin-9,28224,0.0012568235285788,0.00463290043627261,-0.0078236613265155,0.0103373083836731,0.786175963081069
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NGRN,Neugrin,23775,-0.000404130237636795,0.0014972496274967,-0.00333873950753033,0.00253047903225674,0.787227937362668
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP8,Caspase-8,28363,0.00112219007858696,0.00417322966736769,-0.00705734006945372,0.00930172022662763,0.788007004059291
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LMNB2,Lamin-B2,23775,-0.000509322794199853,0.00189774353741105,-0.00422890012752551,0.0032102545391258,0.788406573588219
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ANG,Angiogenin,28184,-0.000609924930147154,0.00227895010923163,-0.00507666714424116,0.00385681728394685,0.78898288256576
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLK,STE20-like serine/threonine-protein kinase,23393,0.00141582497119449,0.00529938537260344,-0.00897097035910825,0.0118026203014972,0.789342347000814
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CRTAP,Cartilage-associated protein,23163,-0.00087216317636758,0.00330401533299105,-0.00734803322903003,0.00560370687629487,0.791804860875371
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATP5PO,"ATP synthase subunit O, mitochondrial",27544,0.000757182956627514,0.0028865229049248,-0.0049004019370251,0.00641476785028013,0.793079305761399
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LSM8,U6 snRNA-associated Sm-like protein LSm8,23393,0.00153486421770723,0.00585695832896299,-0.00994477410706022,0.0130145025424747,0.793278846899471
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD33,Myeloid cell surface antigen CD33,28307,0.00140599857662268,0.00537797937870241,-0.00913484100563405,0.0119468381588794,0.793758034801021
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC4D,C-type lectin domain family 4 member D,28176,0.00108681307143163,0.0041627336411869,-0.00707214486529469,0.00924577100815795,0.794031506186227
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MCTS1,Malignant T-cell-amplified sequence 1,23738,-0.000456982094228844,0.00176963899581554,-0.00392547452602731,0.00301151033756962,0.796228063224833
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FOS,Proto-oncogene c-Fos,22936,0.000622222980916033,0.00241306153482376,-0.00410737762733853,0.0053518235891706,0.796520171133496
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CTSV,Cathepsin L2,28348,-0.000720013122776273,0.00280441479643355,-0.00621666612378602,0.00477663987823348,0.797379243979172
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAC3,Ras-related C3 botulinum toxin substrate 3,23163,0.00120997345122483,0.00472132995481958,-0.00804383326022154,0.0104637801626712,0.7977383867989
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IDI2,Isopentenyl-diphosphate delta-isomerase 2,27544,-0.000829707945651381,0.0032402332766601,-0.00718056516790517,0.00552114927660241,0.797903129484023
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LY75,Lymphocyte antigen 75,28176,-0.000672923531624973,0.00263012012644344,-0.00582795897945411,0.00448211191620416,0.798066390216158
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,23393,-0.000850518336586493,0.00334944627703622,-0.00741543303957748,0.0057143963664045,0.799553382933577
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GLOD4,Glyoxalase domain-containing protein 4,28151,0.000606582732435564,0.00239403219118399,-0.00408572036228506,0.00529888582715618,0.799981965661844
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PEBP1,Phosphatidylethanolamine-binding protein 1,28187,-0.000978876462744853,0.00387575952874651,-0.00857536513908801,0.0066176122135983,0.800607167474671
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BMP6,Bone morphogenetic protein 6,27651,0.000704254949079373,0.00278916086640487,-0.00476250034907418,0.00617101024723292,0.80065875561494
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BATF,Basic leucine zipper transcriptional factor ATF-like,23163,0.00142154445886425,0.00567329338638245,-0.00969811057844535,0.0125411994961739,0.802150528278104
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ESR1,Estrogen receptor,23188,0.000964788507910146,0.00388825114204442,-0.00665618373049691,0.0085857607463172,0.80403666945872
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SRPX,Sushi repeat-containing protein SRPX,23846,0.000590805107903914,0.00239841491515537,-0.0041100881258006,0.00529169834160843,0.805427760624234
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL21R,Interleukin-21 receptor,23188,0.000913473343231839,0.00373993571197031,-0.00641680065222997,0.00824374733869365,0.80704060034385
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLK7,Kallikrein-7,22783,-0.000639300758943615,0.00265349487980434,-0.00584015072336013,0.0045615492054729,0.809613222718283
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLSTN1,Calsyntenin-1,27544,0.000834048322923263,0.00349964434420433,-0.00602525459171722,0.00769335123756375,0.81163178494895
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FCRL3,Fc receptor-like protein 3,27702,0.000864177761735357,0.00366910117483122,-0.00632726054093384,0.00805561606440455,0.813800331471619
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICAM1,Intercellular adhesion molecule 1,28140,0.000460519076408079,0.00195604096285391,-0.00337332121078559,0.00429435936360175,0.81387340386838
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PALM3,Paralemmin-3,23071,0.00117349183558851,0.00499672482361587,-0.0086200888186986,0.0109670724898756,0.814325533531462
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLASP1,CLIP-associating protein 1,22978,0.00115549417499484,0.00493110015739435,-0.00850946213349808,0.0108204504834878,0.814732543460131
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CCL21,C-C motif chemokine 21,28320,-0.00064647829529602,0.00276095081245307,-0.00605794188770404,0.004764985297112,0.814869756220802
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DENR,Density-regulated protein,23188,-0.000908297160469623,0.00389518226458296,-0.00854285439905222,0.00672626007811297,0.815619995184552
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLTA,Clathrin light chain A,27682,-0.000740362922382677,0.00319086804843809,-0.00699446429732132,0.00551373845255597,0.816519883165331
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PILRB,Paired immunoglobulin-like type 2 receptor beta,28224,-0.000902133193918211,0.00390167415308135,-0.00854941453395766,0.00674514814612124,0.817147940170492
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LYZL2,Lysozyme-like protein 2,22978,0.000566704930757597,0.00245116524243176,-0.00423757894440866,0.00537098880592385,0.817162907501829
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MN1,Transcriptional activator MN1,23163,0.000911125340257283,0.00400795670005473,-0.00694446979184998,0.00876672047236455,0.820169825128598
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,23198,0.000319932169160423,0.00141365730212008,-0.00245083614299494,0.00309070048131578,0.82095825355044
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",23071,0.00102076790364436,0.00453083785335621,-0.00785967428893381,0.00990121009622253,0.82175302373633
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SCARB1,Scavenger receptor class B member 1,27544,0.000866782062959421,0.0038989451270462,-0.00677515038605112,0.00850871451196997,0.824072705445812
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,28176,-0.00127698926035434,0.00575719380171111,-0.0125610891117081,0.0100071105909994,0.824465281928653
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,27562,0.00185487572921734,0.00837396551749585,-0.0145580966850745,0.0182678481435092,0.824700839417964
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COLEC12,Collectin-12,28195,-0.000392385637951696,0.00178921376900607,-0.0038992446252036,0.0031144733493002,0.826413135958286
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GNAS,Neuroendocrine secretory protein 55,23795,-0.00131197563664907,0.00599385049958,-0.0130599226158259,0.0104359713425277,0.826739993108941
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,27682,-0.00072045553259462,0.00329512677864629,-0.00717890401874135,0.00573799295355211,0.826929972663491
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX39A,ATP-dependent RNA helicase DDX39A,23188,-0.000346942009442176,0.00159034736906378,-0.00346402285280719,0.00277013883392284,0.827310374490576
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SHPK,Sedoheptulokinase,23393,0.000607314204396827,0.00281328263829946,-0.00490671976667012,0.00612134817546378,0.829087950566434
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD177,CD177 antigen,28159,0.00184440297421929,0.00867916157019261,-0.0151667537033582,0.0188555596517968,0.831711223956561
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC13A1,Solute carrier family 13 member 1,23725,0.000866551665070805,0.00411701277160897,-0.00720279336728277,0.00893589669742438,0.833294334381887
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MAVS,Mitochondrial antiviral-signaling protein,27562,-0.00130522544078331,0.00621004417969805,-0.0134769120329915,0.0108664611514249,0.833528949729488
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COMP,Cartilage oligomeric matrix protein,27969,-0.000477205323099582,0.00228040599097165,-0.00494680106540402,0.00399239041920486,0.834244210933325
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,23163,0.00069896502098463,0.00334715589952072,-0.00586146054207598,0.00725939058404524,0.834587813543819
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COL24A1,Collagen alpha-1(XXIV) chain,23738,0.000781799579743489,0.00374683840966948,-0.00656200370320869,0.00812560286269567,0.834718735498847
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,27682,0.0004522400497723,0.00216808822673965,-0.00379721287463741,0.00470169297418201,0.83477038375281
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC1A,C-type lectin domain family 1 member A,27682,-0.000471298001441337,0.0022672830511765,-0.00491517278174728,0.0039725767788646,0.835332736304539
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSF1,Macrophage colony-stimulating factor 1,28320,-0.000379562142716234,0.00182903345747611,-0.00396446771936942,0.00320534343393695,0.83560478973516
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SSB,Lupus La protein,27544,0.000829784216123199,0.00407143743783839,-0.00715023316204004,0.00880980159428644,0.838506449559833
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ACTN4,Alpha-actinin-4,27702,0.000440067636945684,0.00216281669795759,-0.00379905309105119,0.00467918836494256,0.838769431488755
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NPTX2,Neuronal pentraxin-2,23862,0.000458631953794157,0.00225504512820351,-0.00396125649748472,0.00487852040507304,0.838839462576368
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AAMDC,Mth938 domain-containing protein,23198,0.000730834875299588,0.00360126736756434,-0.00632764916512652,0.0077893189157257,0.839185082781658
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DCC,Netrin receptor DCC,23163,0.000315816764137227,0.001558557130051,-0.00273895521076273,0.00337058873903719,0.839422844438904
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BIN2,Bridging integrator 2,28187,0.00122905624634933,0.00609667232595374,-0.01072042151252,0.0131785340052187,0.840235119069496
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HTRA2,"Serine protease HTRA2, mitochondrial",28307,0.000815850115040941,0.00414888848672022,-0.00731597131893069,0.00894767154901257,0.844108286218336
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FRMD7,FERM domain-containing protein 7,23163,0.000443251882406315,0.00227655167585434,-0.0040187894022682,0.00490529316708083,0.845627020003945
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KIAA1549,UPF0606 protein KIAA1549,23393,-0.000915570188392731,0.00470949636130529,-0.0101461830565511,0.00831504267976564,0.84585704821704
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PPM1B,Protein phosphatase 1B,23188,0.000810605856312998,0.00421731579407989,-0.00745533310008358,0.00907654481270958,0.847580216770417
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,REPS1,RalBP1-associated Eps domain-containing protein 1,23188,0.000501345451558935,0.00262156768517055,-0.00463692721137534,0.00563961811449321,0.848340183901447
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CNTN4,Contactin-4,28187,0.000309869902969033,0.00162968188181025,-0.00288430658537907,0.00350404639131713,0.849199743250249
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,23278,-0.000620924013712771,0.00329293625033027,-0.0070750790643601,0.00583323103693456,0.850437437078409
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,INSR,Insulin receptor,23188,0.000214602580714225,0.00114847344053167,-0.00203640536272785,0.0024656105241563,0.8517728341516
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL4,Interleukin-4,27702,0.00116431831659256,0.00623570947308962,-0.0110576722506631,0.0133863088838482,0.851883221592815
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AMBN,Ameloblastin,27702,0.000362071119096498,0.00194614692713906,-0.00345237685809605,0.00417651909628905,0.852410749073697
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTN2A1,Butyrophilin subfamily 2 member A1,28320,-0.000327814952588618,0.0017938139543793,-0.00384369030317205,0.00318806039799481,0.85499748003919
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STAT5B,Signal transducer and activator of transcription 5B,28091,-0.00169816796600183,0.00929391998239024,-0.0199142511314867,0.016517915199483,0.85502048460946
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KLRK1,NKG2-D type II integral membrane protein,23775,-0.000572745923402956,0.00314573721593606,-0.00673839086663763,0.00559289901983171,0.855528958593189
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HNF1A,Hepatocyte nuclear factor 1-alpha,23163,0.000879471219452207,0.00484193716582107,-0.00861072562555708,0.0103696680644615,0.855869803549192
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL17RA,Interleukin-17 receptor A,28187,-0.000539432871393536,0.00297979452524377,-0.00637983014087133,0.00530096439808426,0.856345154570679
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FRMD4B,FERM domain-containing protein 4B,23071,-0.000848123587603253,0.0047585114810688,-0.0101748060904981,0.00847855891529159,0.858541591429335
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,23198,-0.000417105175140469,0.00236101353990855,-0.00504469171336122,0.00421048136308028,0.859774169397295
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MUC2,Mucin-2,23862,-0.00108426056552906,0.00617945083841289,-0.0131959842088183,0.0110274630777602,0.860717892725829
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASE4,Ribonuclease 4,23147,0.000325319384378668,0.00186207976740315,-0.00332435695973151,0.00397499572848885,0.861310967996018
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,23738,-0.000252780629405108,0.0014509381862339,-0.00309661947442356,0.00259105821561335,0.861695041238504
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT14,"Keratin, type I cytoskeletal 14",26796,0.00034285908139127,0.00197401661491883,-0.00352621348384964,0.00421193164663218,0.86211354075917
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IFNGR1,Interferon gamma receptor 1,28320,0.000242531690096377,0.00142542538580532,-0.00255130206608204,0.0030363654462748,0.864895837639272
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITPA,Inosine triphosphate pyrophosphatase,23071,0.000766179301593902,0.00457506962190855,-0.00820095715734686,0.00973331576053466,0.867003027718015
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLPBP,Pyridoxal phosphate homeostasis protein,28224,0.000764987927246296,0.00457828598033629,-0.00820845259421283,0.00973842844870542,0.867300067054707
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NGF,Beta-nerve growth factor,27965,-0.000137889139145637,0.00082571212680125,-0.00175628490767609,0.00148050662938481,0.867375817633603
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,XRCC4,DNA repair protein XRCC4,27544,0.000408637648693902,0.00251536199620989,-0.00452147186387749,0.00533874716126529,0.870947340996857
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ICA1,Islet cell autoantigen 1,27702,0.000864395156445502,0.00539261230955045,-0.00970512497027338,0.0114339152831644,0.872651858182289
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TLR2,Toll-like receptor 2,23393,0.00024947987727043,0.00156123720592946,-0.00281054504635132,0.00330950480089218,0.873042945328106
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PRC1,Protein regulator of cytokinesis 1,23725,0.000490136967466586,0.00307193788591536,-0.00553086128892752,0.00651113522386069,0.873234548233844
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HLA_DRA,,28068,-0.000384763097921471,0.0024496012123377,-0.00518598147410336,0.00441645527826042,0.875189448272846
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OSTN,Osteocrin,23163,-0.000435913175980906,0.0028055403912282,-0.00593477234278819,0.00506294599082637,0.876526389769751
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,AGER,Advanced glycosylation end product-specific receptor,28120,-0.000427800884916632,0.00276091703486626,-0.00583919827325449,0.00498359650342123,0.876862764464009
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",23056,-0.000478929742162245,0.00309866217276329,-0.0065523076007783,0.00559444811645381,0.877169428556313
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NACC1,Nucleus accumbens-associated protein 1,23725,-0.000572369058873584,0.0037385181751918,-0.00789986468224951,0.00675512656450234,0.87832031235937
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MFAP3L,Microfibrillar-associated protein 3-like,23163,0.000684346977922388,0.00447562335771716,-0.00808787480320325,0.00945656875904802,0.878474210416897
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,22829,-0.000330257245608479,0.00221513957242837,-0.00467193080756808,0.00401141631635112,0.881483190950893
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TAGLN3,Transgelin-3,22978,-0.000605079590189702,0.00410896000728764,-0.00865864120447347,0.00744848202409407,0.882929222075958
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,27965,-0.000939336722425881,0.00640589500743126,-0.0134948909369912,0.0116162174921394,0.883420160066583
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NUDC,Nuclear migration protein nudC,28521,0.000617305623809828,0.00427431451829375,-0.00776035083204592,0.00899496207966558,0.885168160613619
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CASP9,Caspase-9,23188,0.000614205477776537,0.00427717512885631,-0.00776905777478182,0.0089974687303349,0.885817011486276
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TP53,Cellular tumor antigen p53,27562,-0.000425166570667697,0.00296100997262803,-0.00622874611701863,0.00537841297568324,0.885826581759115
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNASE1,Ribonuclease pancreatic,23872,-0.000236470819520094,0.00164845048846561,-0.0034674337769127,0.00299449213787251,0.885935722491012
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BCAM,Basal cell adhesion molecule,28187,0.000233777486007888,0.00163282232388856,-0.00296655426881368,0.00343410924082946,0.886153892320376
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBPMS,RNA-binding protein with multiple splicing,23188,0.000615903774779162,0.00435205959754838,-0.00791413303641566,0.00914594058597398,0.887460336930984
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,C2orf69,UPF0565 protein C2orf69,23163,0.000560923088335,0.00403119925902802,-0.00734022745935991,0.00846207363602991,0.889336413585748
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDAN1,Codanin-1,23775,-0.000207109296447565,0.00152379709823718,-0.00319375160899243,0.0027795330160973,0.891888376319121
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PBK,Lymphokine-activated killer T-cell-originated protein kinase,22978,0.000280469845697517,0.00207383999204006,-0.00378425653870101,0.00434519623009604,0.892421887326208
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDGFRB,Platelet-derived growth factor receptor beta,28553,0.000314635745560327,0.00235544065130385,-0.00430202793099522,0.00493129942211587,0.893736990487089
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA11,Carbonic anhydrase-related protein 11,27562,0.000284897531205231,0.00217009852841825,-0.00396849558449453,0.004538290646905,0.895552220920563
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ATXN2L,Ataxin-2-like protein,23795,0.000426969039481087,0.00325979776563585,-0.00596223458116518,0.00681617266012735,0.89579206001531
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SKAP2,Src kinase-associated phosphoprotein 2,28320,0.000915434408453766,0.00705166095551388,-0.0129058210643534,0.014736689881261,0.89671113225098
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGAP5,Rho GTPase-activating protein 5,22978,-0.0006714745187656,0.0052028849636508,-0.0108691290475212,0.00952618000998997,0.897312795494261
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,S100A3,Protein S100-A3,23725,-0.000382225207985087,0.00298401755014454,-0.00623089960626839,0.00546644919029822,0.898078199525081
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MYO9B,Unconventional myosin-IXb,27702,-0.000569355186074221,0.00447485903933378,-0.00934007890316843,0.00820136853101999,0.898755948146951
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DTX3,Probable E3 ubiquitin-protein ligase DTX3,28091,-0.000190516994846415,0.00164179358100364,-0.00340843241361356,0.00302739842392073,0.907620093001312
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDA2R,Tumor necrosis factor receptor superfamily member 27,28452,0.000300696597394265,0.00261406626927705,-0.00482287329038874,0.00542426648517728,0.908421987324607
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SMC3,Structural maintenance of chromosomes protein 3,22978,0.000413733688069716,0.00365854802613755,-0.00675702044315989,0.00758448781929932,0.909962685293036
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,L1CAM,Neural cell adhesion molecule L1,28307,-0.000220307480676495,0.00196152465016393,-0.00406489579499779,0.0036242808336448,0.910574914606172
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,OMP,Olfactory marker protein,23056,-0.000370221319343814,0.00335554465911918,-0.0069470888512174,0.00620664621252977,0.912147663233723
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CAPS,Calcyphosin,23775,0.00069826077817459,0.00639218178803617,-0.0118304155263763,0.0132269370827255,0.913015682732894
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TOR1AIP1,Torsin-1A-interacting protein 1,23198,-0.000377843381511798,0.00346000269897525,-0.0071594486715033,0.0064037619084797,0.913042263983925
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RP2,Protein XRP2,28091,0.000309774894834775,0.00284659700376355,-0.00526955523254179,0.00588910502221134,0.913343750655104
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GPR15L,Protein GPR15L,23738,-0.000442185171239647,0.00412747402145497,-0.00853203425329139,0.00764766391081209,0.914685046798557
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GBP6,Guanylate-binding protein 6,23071,-0.000330763154303388,0.00310194124256169,-0.0064105679897243,0.00574904168111752,0.915082637275901
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,COMMD9,COMM domain-containing protein 9,23725,-0.000273238278684258,0.0026794820517989,-0.0055250231002101,0.00497854654284158,0.918777944909377
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",22978,-0.000375439729027941,0.00371258205268514,-0.00765210055229082,0.00690122109423494,0.919451074434076
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KDM3A,Lysine-specific demethylase 3A,23188,-0.000606850800420233,0.00612586296915203,-0.0126135422199582,0.0113998406191177,0.921088531009191
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CDH3,Cadherin-3,28428,0.000241431767248637,0.00245453828202713,-0.00456946326552454,0.00505232680002181,0.921646035805769
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FSHB,Follitropin subunit beta,23198,-0.000425930591500235,0.00433767755094003,-0.00892777859134269,0.00807591740834222,0.921779702999149
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDZD2,PDZ domain-containing protein 2,23071,-0.000397706264096611,0.00408443222537577,-0.00840319342583313,0.0076077808976399,0.922432423137174
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL1R1,Interleukin-1 receptor type 1,28135,0.00015149726025945,0.00156155600292377,-0.00290915250547115,0.00321214702599005,0.92271369657753
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,23393,0.000415010651597483,0.00438120913429693,-0.00817215925162449,0.00900218055481946,0.924533960185967
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,KRT6C,"Keratin, type II cytoskeletal 6C",23071,-0.00025415193600424,0.00270633680835936,-0.00555857208038859,0.0050502682083801,0.925181511190338
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,USP8,Ubiquitin carboxyl-terminal hydrolase 8,27682,-0.000593940319013805,0.0065048049027795,-0.0133433579284616,0.012155477290434,0.927248572189669
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,BTLA,B- and T-lymphocyte attenuator,22978,0.000526027588107404,0.00594043005302204,-0.0111172153158158,0.0121692704920306,0.929439982894003
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFRA2,GDNF family receptor alpha-2,28091,0.000125692174962696,0.00143032480789291,-0.0026777444485074,0.00292912879843279,0.929975329636109
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,NDRG1,Protein NDRG1,27544,-0.000394644297107298,0.00456197086481782,-0.00933610719215023,0.00854681859793564,0.931063692672438
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LRP2,Low-density lipoprotein receptor-related protein 2,23163,0.00020878527579334,0.0024701713667017,-0.004632750602942,0.00505032115452868,0.932641675669929
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LEG1,Protein LEG1 homolog,22594,0.000387776372439365,0.00472506591737929,-0.00887335282562404,0.00964890557050277,0.934593423732131
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",23188,-0.000267314478664501,0.00329115035613679,-0.00671796917669261,0.00618334021936361,0.935265944709255
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PHLDB2,Pleckstrin homology-like domain family B member 2,22978,0.00050455639684953,0.0063618906273781,-0.0119647492328116,0.0129738620265106,0.936787387277675
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBP7,Retinoid-binding protein 7,23738,0.000321463133284998,0.00406384538800039,-0.00764367382719577,0.00828660009376576,0.936951213491944
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DDX4,Probable ATP-dependent RNA helicase DDX4,23188,-0.000289411161357558,0.00369559111816845,-0.00753276975296772,0.00695394743025261,0.937580111415387
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RALB,Ras-related protein Ral-B,23188,0.000156024844310324,0.00199801436084422,-0.00376008330294436,0.004072132991565,0.937757174615506
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ESYT2,Extended synaptotagmin-2,23775,-0.000429480626584385,0.00556275580872966,-0.0113324820116945,0.0104735207585257,0.938459960899265
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ECE1,Endothelin-converting enzyme 1,27544,-0.000176836088930984,0.00239012577978819,-0.00486148261731583,0.00450781043945386,0.941021981747271
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FLI1,Friend leukemia integration 1 transcription factor,27562,-0.000552164276226771,0.00747072217955571,-0.015194779748156,0.0140904511957024,0.941082194567612
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,FAM171B,Protein FAM171B,23725,0.000135254754490068,0.00183041381958902,-0.00345235633190441,0.00372286584088454,0.941096155166988
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RPGR,X-linked retinitis pigmentosa GTPase regulator,23163,-0.000200407704402327,0.00284036216715749,-0.00576751755203101,0.00536670214322636,0.943750867657999
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CHEK2,Serine/threonine-protein kinase Chk2,27682,0.000158764849931526,0.00226085418153189,-0.00427250934587098,0.00459003904573404,0.944016363501019
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GOLM2,Protein GOLM2,28428,0.000103807515439878,0.00152898444566439,-0.00289300199806233,0.00310061702894209,0.945871197965702
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CA6,Carbonic anhydrase 6,28123,-0.000288104810606972,0.00427501269298968,-0.00866712968886675,0.00809092006765281,0.946269529560894
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,WASL,Neural Wiskott-Aldrich syndrome protein,23188,-0.000276223596017893,0.0041173816384929,-0.00834629160746398,0.0077938444154282,0.946512864431131
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LPP,Lipoma-preferred partner,23071,0.000289361214330827,0.00450848392523943,-0.00854726727913846,0.00912598970780012,0.948826272517339
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,TBR1,T-box brain protein 1,23163,0.000210490157224048,0.00329461587346254,-0.00624695695476252,0.00666793726921062,0.949059055521182
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CLEC12A,C-type lectin domain family 12 member A,23188,8.29521656377389e-05,0.00137798661349473,-0.00261790159681194,0.00278380592808741,0.9519983840085
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PFDN6,Prefoldin subunit 6,23163,0.000256107719314465,0.00444316213802965,-0.00845249007122364,0.00896470550985257,0.954035193852184
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEP152,Centrosomal protein of 152 kDa,22978,0.000157797823731998,0.00283541976040374,-0.00539962490665933,0.00571522055412333,0.955619229696213
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARHGEF5,Rho guanine nucleotide exchange factor 5,23056,-0.000280168537391842,0.00504775710794597,-0.010173772468966,0.00961343539418227,0.955737767518707
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CD200R1,Cell surface glycoprotein CD200 receptor 1,28087,-0.000126445751678274,0.00235949398200028,-0.00475105395639882,0.00449816245304227,0.957262046803456
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGHMBP2,DNA-binding protein SMUBP-2,23071,0.000199716953865088,0.00377334140532206,-0.00719603220056615,0.00759546610829632,0.957789408242622
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF4,E3 ubiquitin-protein ligase RNF4,23393,-0.000234995810653764,0.00447356535849626,-0.00900318391330643,0.0085331922919989,0.958106943467149
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,27863,0.000118499805718295,0.00225688244574247,-0.00430498978793695,0.00454198939937355,0.958125913804597
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EDNRB,Endothelin receptor type B,23188,0.000156845709746112,0.0030625163045949,-0.0058456862472599,0.00615937766675212,0.95915491719531
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CYTH3,Cytohesin-3,22978,0.000255149034097808,0.00499279752814672,-0.00953073412106976,0.0100410321892654,0.959243554458522
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SEMA6C,Semaphorin-6C,23188,8.83182501342169e-05,0.00175951077539347,-0.00336032286963698,0.00353695936990541,0.959967606646114
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",23188,0.00013408393787043,0.00300926168604379,-0.00576406896677541,0.00603223684251627,0.964460731355779
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,23071,0.000136269757177328,0.00310472965968303,-0.00594900037580142,0.00622153989015607,0.964991652045092
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MDM1,Nuclear protein MDM1,23163,8.90720110485224e-05,0.0021270499124076,-0.00407994581727037,0.00425808983936741,0.966598034072838
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SLC28A1,Sodium/nucleoside cotransporter 1,22978,0.000167695283462977,0.00401722554571039,-0.00770606678612938,0.00804145735305534,0.966703096783862
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,28268,-0.000161287663452302,0.00387720854516176,-0.00776061641196935,0.00743804108506475,0.966818733217505
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UPK3BL1,Uroplakin-3b-like protein 1,23355,0.000151773557568421,0.00369409903807247,-0.00708866055705362,0.00739220767219046,0.967228160775409
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PNMA2,Paraneoplastic antigen Ma2,23056,-0.000122042349552233,0.00297944338089356,-0.00596175137610361,0.00571766667699915,0.967326975768498
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPRC,Receptor-type tyrosine-protein phosphatase C,23862,6.10822440249848e-05,0.00153545609561601,-0.0029484117033824,0.00307057619143237,0.968267919404777
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDLIM7,PDZ and LIM domain protein 7,28320,0.000321842889749679,0.00847295569193359,-0.0162851502664402,0.0169288360459395,0.969700128993692
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CSPG4,Chondroitin sulfate proteoglycan 4,23862,8.42038458931988e-05,0.00222758345999849,-0.00428185973570384,0.00445026742749024,0.969847034441486
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HMOX1,Heme oxygenase 1,27928,0.000115668579875421,0.00326226576911503,-0.00627837232759003,0.00650970948734087,0.971715972936358
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PDRG1,p53 and DNA damage-regulated protein 1,23163,-0.000120612335133904,0.0035458957131382,-0.00707056793288478,0.00682934326261697,0.972865776668596
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,23862,8.92519331970449e-05,0.00268452787622188,-0.00517242270419784,0.00535092657059193,0.973478064342576
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,M6PR,Cation-dependent mannose-6-phosphate receptor,23198,-9.09510548578837e-05,0.00274041353687407,-0.00546216158713107,0.0052802594774153,0.973524309958333
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,IL13RA1,Interleukin-13 receptor subunit alpha-1,27781,4.99599173792124e-05,0.00152000127892374,-0.00292924258931132,0.00302916242406974,0.973779817176322
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,EPGN,Epigen,23725,-0.000105231881797013,0.00323247370698058,-0.00644088034747895,0.00623041658388492,0.974030050250128
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RCOR1,REST corepressor 1,27682,8.38626827515988e-05,0.00303616046382779,-0.00586701182635087,0.00603473719185407,0.977964396685074
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,UBE2B,Ubiquitin-conjugating enzyme E2 B,23725,-4.56270888754765e-05,0.00191483477382068,-0.00379870324556401,0.00370744906781305,0.98098983705112
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RAB10,Ras-related protein Rab-10,23846,-8.24860858604692e-05,0.00362497008219523,-0.00718742744696313,0.00702245527524219,0.981845917867558
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RNF43,E3 ubiquitin-protein ligase RNF43,23393,-8.92463460437796e-05,0.00392960291035736,-0.00779126805034421,0.00761277535825665,0.981880764928016
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,STXBP3,Syntaxin-binding protein 3,27562,-6.59769656475825e-05,0.00297152659280155,-0.00589016908753862,0.00575821515624345,0.982286142194742
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LEO1,RNA polymerase-associated protein LEO1,23795,-4.3999750513556e-05,0.00203341752928742,-0.0040294981079169,0.00394149860688979,0.982736642839535
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",23795,-0.000108330444838599,0.00523105558428899,-0.010361199390045,0.0101445385003678,0.983477884843357
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RABEPK,Rab9 effector protein with kelch motifs,27562,-7.25744158240004e-05,0.00400471518916163,-0.0079218161865808,0.0077766673549328,0.985541465949045
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,27556,8.57514199526492e-05,0.005334109969496,-0.0103691041202595,0.0105406069601648,0.987173836616217
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,LTB,Lymphotoxin-beta,23725,3.07652735923058e-05,0.0023551026059446,-0.00458523583405911,0.00464676638124372,0.989577447805017
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,23136,3.35184504157421e-05,0.00261480643545457,-0.00509150216307522,0.0051585390639067,0.989772538364784
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,ARL13B,ADP-ribosylation factor-like protein 13B,23071,-4.46804295129743e-05,0.00469902299568709,-0.00925476550105966,0.00916540464203371,0.992413550396395
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,RBPMS2,RNA-binding protein with multiple splicing 2,23198,5.95969594472522e-05,0.00692646067029981,-0.0135162659543404,0.0136354598732349,0.993134965088898
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,MEGF9,Multiple epidermal growth factor-like domains protein 9,28470,-9.68809068683799e-06,0.00138217680116673,-0.00271875462097362,0.00269937843959995,0.994407483349744
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,GFRAL,GDNF family receptor alpha-like,22981,-2.732100790686e-05,0.00424087739990173,-0.00833944071171425,0.00828479869590053,0.99485987915666
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,23872,6.15181028376913e-06,0.00290692622125583,-0.00569142358337766,0.0057037272039452,0.998311488157818
NMR metabolomics,X23581.Cholesteryl Esters to Total Lipids in Chylomicrons and Extremely Large VLDL percentage,DLGAP5,Disks large-associated protein 5,23795,-3.83484550753788e-06,0.00348326587318854,-0.00683103595695707,0.00682336626594199,0.999121591244851
